Final Program
TARGETING CANCER: Technology Biology
ASTRO’SO’S 556TH6 ANNUAL MEETING Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
Download ASTROmobile – the offi cial meeting app.
See page 22 for details.
www.astro.org/annualmeeting
#ASTRO14
Final Program
TARGETING CANCER: Technology Biology
ASTRO’SR O ’ S 556TH6 ANNUAL MEETING Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
Download ASTROmobile cial – the offi meeting app.
See page 22 for details.
www.astro.org/annualmeeting
HELD IN CONJUNCTION WITH: #ASTRO14 AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT) ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO) SOCIETY FOR RADIATION ONCOLOGY ADMINISTRATORSHeld in (SROA) conjunction with: American Society of Radiologic Technologists (ASRT) Association of Residents in Radiation Oncology (ARRO) Society for Radiation Oncology#ASTRO13 Administrators (SROA) Welcome TO THE 56TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY “Targeting Cancer: Technology and Biology”
Dear Colleagues,
It is my honor to welcome you to the vibrant city of San Francisco and ASTRO’s 56th Annual Meeting. We are confi dent that the meeting will provide ample opportunity for professional networking, exchange of new ideas and knowledge in clinical, basic and translational research as we continue our mission to move the fi eld of radiation oncology forward and improve the quality of life for the patients we serve.
The theme of this year’s meeting is “Targeting Cancer: Technology and Biology.” The Annual Meeting Scientifi c Program Committee, led by Lynn D. Wilson, MD, MPH, FASTRO, along with a dedicated group of volunteers, has assembled an inspiring and exciting program from a record-breaking number of abstract submissions. Novel developments in biology and cutting-edge technology will be highlighted in a broad spectrum of educational sessions, panel discussions, oral presentations, poster presentations and digital posters. The popular Plenary Session and Clinical Trials Session will both be unopposed to allow the entire membership to attend these highly rated and important sessions.
The meeting offi cially begins with the Presidential Symposium, “Local-regional Management of Breast Cancer: A Changing Paradigm. ”Moderated by Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO, the symposium will highlight recent practice-changing landmark studies and current developments in the local-regional management of breast cancer.
Our keynote speakers, Hedvig Hricak, MD, PhD, Frank McCormick, PhD, FRS, and Sidney Dekker, PhD, MA, MSc, will address a range of topics, including oncologic imaging, biology and targeting in oncology, and human error and safety concerns (see page 45 for more details).
I invite you to join me in congratulating our 2014 ASTRO Gold Medalists, Fellows and Honorary Member during the Awards Ceremony on Tuesday at 10:15 a.m. in the Esplanade Ballroom.
I also extend a very warm welcome and note of appreciation to our industry colleagues for their support and contributions to our specialty. I encourage you to visit the Exhibit Hall to learn about their latest developments.
I hope the Annual Meeting will provide you with new insights, ideas and inspiration to bring back to your practice and your patients. Enjoy the meeting and all that San Francisco has to off er.
Bruce G. Haff ty, MD, FASTRO President, ASTRO Chair, Annual Meeting Steering Committee
2 ASTRO 2014 / 56TH ANNUAL MEETING Table of Contents
WELCOME TO THE 56TH ANNUAL MEETING 2 Board of Directors 4 Continuing Medical Education 5 Annual Meeting Committee Members 8 Abstract Reviewers 10 Session Reviewers 12 Gold Medal Recipients 13 Fellow Recipients 14 Honorary Member Recipient 15 Annual Meeting Abstract Awards 16
GENERAL INFORMATION 19 ASTROmobile 22 Concessions 24 Industry-Expert Theater 26 Industry Satellite Symposia 27 Posters 29 Shuttle Service 31 Moscone Center Floor Plans 34
SCHEDULE OF EVENTS eContouring Learning Lab 41 Live Self-Assessment CME Sessions (SA-CME) 42 Presidential Symposium 44 Keynote Speakers 45 Meeting Highlights 47 ARRO Program 48 Young Physicians’ Workshop 51 Nurses’ Program 52 International Program 54 APEx 57 RO-ILS: Radiation Oncology Incident Learning System 58 Schedule by Day Saturday 61 Sunday 63 Monday 75 Tuesday 88 Wednesday 103
POSTER PRESENTATIONS 123 INDEXES By Author 185 By Topic 194
EXHIBITOR LISTINGS Exhibitor List 207 Exhibitor List by Product/Service Category 215 Exhibit Hall Floor Plan 218 Board of Directors 2014 Offi cers and Board of Directors
Colleen A.F. Lawton, MD, FASTRO, Chair
Bruce G. Haff ty, MD, FASTRO, President
Bruce D. Minsky, MD, President-elect
Phillip M. Devlin, MD, FASTRO, Secretary/Treasurer
Jeff Michalski, MD, MBA, FASTRO, Secretary/ Treasurer-elect
Michael L. Steinberg, MD, FASTRO, Immediate Past Chair
Council Chairs and Vice-chairs
Carol H. Hahn, MD, Clinical Aff airs and Quality Council Chair
Lawrence Marks, MD, FASTRO, Clinical Aff airs and Quality Council Vice-chair
Laura A. Dawson, MD, Education Council Chair
Paul M. Harari, MD, FASTRO, Education Council Vice-chair
Bharat B. Mittal, MD, FASTRO, Government Relations Council Chair
Geraldine M. Jacobson, MD, MBA, MPH, FASTRO Government Relations Council Vice-chair
Brian Kavanagh, MD, Health Policy Council Chair
Thomas J. Eichler, MD, FASTRO, Health Policy Vice-chair
Mary K. Martel, PhD, FASTRO, Science Council Chair
Theodore L. DeWeese, MD, Science Council Vice-chair
Laura I. Thevenot, Chief Executive Offi cer
4 ASTRO 2014 / 56TH ANNUAL MEETING Continuing Medical Education
NEEDS STATEMENT responsibilities. Program content has been designed Cancer is a leading cause of death worldwide. to address specifi c documented and clinically According to the World Health Organization (WHO), important practice gaps in physician knowledge and cancer deaths worldwide are projected to continue competence. We will continue to emphasize quality to rise to more than 11 million in 2030. The American and safety issues in the delivery of radiation therapy Cancer Society estimates that in 2014 1.6 million new in the areas of treatment techniques, equipment, cases of cancer will be diagnosed. Nearly two-thirds terminology and professional responsibilities. of these patients will receive radiation therapy during their illness – most with the intent to cure the Upon completion of this live activity, attendees should cancer. Advances in the applications, technologies be able to do the following: and methodologies of radiation oncology continue 1. Examine the advances in technology and biology to evolve rapidly and the delivery of radiation therapy that help improve patient outcomes and quality has become more complex, making it imperative that of life. the radiation oncology professional remain current in 2. Determine the value of combining novel the state-of-the-art techniques. The American Society strategies in technology and biology to radiation for Radiation Oncology is committed to providing therapy in the treatment of cancer. educational programming that creates a forum for 3. Employ quality and safety measures in the global collaboration on issues in radiation oncology delivery of radiation therapy. to improve professional practice by increasing level of knowledge, as required to improve competency in ELEMENTS OF COMPETENCE the fi eld of oncology. The Annual Meeting program has been designed to narrow the competency gaps of patient/ PROGRAM DESCRIPTION AND OBJECTIVES patient-centered care, medical knowledge, The scientifi c program will continue to be the ideal practice-based learning and improvement, platform to bring together clinicians, scientists and interpersonal skills and communication, researchers from all of the oncologic disciplines to professionalism, work in interdisciplinary teams, exchange ideas, promote multidisciplinary care and evidence-based practice, quality improvement, address the educational and professional utilization of informatics, professional standing and development interests of our attendees. Scientifi c and commitment to lifelong learning, 12 of the 15 core educational sessions will cover specifi c clinical areas competencies embraced by the American Board of including breast, central nervous system, Medical Specialties, the Accreditation Council for gastrointestinal, genitourinary, gynecological, head Graduate Medical Education and the Institute of and neck, lymphoma, musculoskeletal, pediatric, Medicine. sarcoma and thoracic cancers. Radiation biology and radiation physics concepts will also be explored. TARGET AUDIENCE During the 2014 Annual Meeting, we will highlight The Annual Meeting program is intended for all science that showcases how technology and biology health professionals in the fi eld of oncology, with advance the fi eld and improve patient outcomes and particular emphasis on radiation oncologists, quality of life. Signifi cant advances in both radiation oncology residents, radiation biologists, technology and biology continue to move our fi eld radiation physicists, medical dosimetrists, radiation forward, improving our ability to target cancer therapists, radiation oncology nurses, medical through both technologic and biologic approaches. oncologists, oncological surgeons and pathologists. At this year’s meeting, we will bring together the latest developments in basic, translational, applied CONTINUING MEDICAL EDUCATION technology and clinical sciences as they relate to our multidisciplinary eff orts to improve the quality of PHYSICIANS life and outcomes of our patients. Scientifi c sessions The American Society for Radiation Oncology (ASTRO) will highlight science that improves quality of care, is accredited by the Accreditation Council for outcomes and quality of life of our patients, and paves Continuing Medical Education to provide continuing the way for future directions, with an emphasis on the medical education for physicians. clinical, translational, biological and technical research helping us to “target cancer.” ASTRO designates this live activity for a maximum of The Annual Meeting, a live, four-day, interactive 37 AMA PRA Category 1 Credits™. Physicians should meeting, will feature a continued emphasis on patient claim only the credit commensurate with the extent quality and safety issues in the delivery of radiation of their participation in the activity. therapy in the areas of treatment techniques, equipment, terminology and professional
ASTRO 2014 / 56TH ANNUAL MEETING 5 PHYSICISTS DISCLOSURE OF VESTED INTEREST CAMPEP has approved this activity for 37 medical ASTRO is an accredited provider of continuing physics continuing education credit (MPCEC) hours. medical education. Since our accreditation is important to us, we plan activities that are compliant DOSIMETRISTS with the Accreditation Council for Continuing Medical An application has been submitted to the Medical Education (ACCME) and the content or format of CME Dosimetrist Certifi cation Board for designation of activities and related materials will promote MDCB credit. improvements or quality in health care and not a specifi c proprietary business interest or commercial NURSES bias. Planning Committee members and speakers are This activity has been submitted to the Oncology required to disclose the existence of any fi nancial or Nursing Society (ONS) for approval to award contact other relationship with the manufacturer(s) of any hours. ONS is accredited as an approver of continuing commercial product(s) or provider(s) of any nursing education by the American Nurses commercial services discussed in an educational Credentialing Center’s Commission on Accreditation. presentation. Any confl icts of interest are resolved prior to PROGRAM EVALUATION PROCESS AND participation. In addition to written disclosure, CONTINUING EDUCATION CREDITS presenters will disclose any vested interest or their All attendees are encouraged to complete the online intention to discuss off -label use of pharmaceuticals evaluation. However, you must be a full-conference or or devices, if applicable, to the audience at the one-day only registrant to receive continuing beginning of their presentation and in accordance education credit. To receive continuing education with ACCME standards and the Food and Drug credits, you must evaluate each of the sessions you Administration requirements. attended using the online evaluation form no later than October 17, 2014. In an eff ort to increase transparency and easy access to all disclosures, ASTRO’s Faculty, Committee and On-site Computer Stations Planner disclosure information will be available online • The evaluation can be completed on-site at for the 2014 Annual Meeting. Go to the ASTRO either the CE Central Booth or a Cyber Café. The Annual Meeting Program Web page at CE Central Booth is located outside Hall E, and www.astro.org/soe14. In addition, disclosure slides the Cyber Cafés are located in the North and will be shown at the beginning of each session, South Lobbies. and every presenter is also required to display their • Attendees can log in and out of the evaluation disclosure. Disclosure information will not be printed system throughout the meeting, allowing you to in paper versions of the meeting materials. save your progress as you go. • Attendees will be able to print or email their DISCLAIMER certifi cate after the evaluation has been ASTRO is committed to the free exchange of submitted. medical education. Inclusion of any presentation in this program, including presentations of off -label Post-meeting or Mobile Device During Meeting uses, does not imply an endorsement by ASTRO of the • Attendees wishing to complete the evaluation uses, products or techniques presented. using a mobile device or post-meeting should access the evaluation at www.astro.org/2014eval. The information contained in this program is current • You will need your badge number to complete as of August 12, 2014, and is subject to change. the evaluation form. Please write your badge Program changes will be provided in an addendum number here for future reference: ______and posted online. • Attendees will be able to print or email their certifi cate after the evaluation has been submitted.
For questions regarding continuing education credits, please visit the CE Central Booth located outside Hall E at Moscone Center.
6 ASTRO 2014 / 56TH ANNUAL MEETING UPCOMING ASTRO MEETINGS Mark Your Calendars! 2015 ASTRO ANNUAL REFRESHER COURSE March 6-8, 2015 The Roosevelt New Orleans New Orleans
12TH ANNUAL ADVOCACY DAY March 23-24, 2015 Renaissance Washington Washington, D.C.
STATE OF THE ART RADIATION THERAPY April 2015 Las Vegas
EXPLORING OPPORTUNITIES FOR RADIATION ONCOLOGY IN THE ERA OF BIG DATA August 13-14, 2015 NIH Campus Bethesda, Maryland
ASTRO 57TH ANNUAL MEETING October 18-21, 2015 Henry B. Gonzalez Convention Center San Antonio
BEST OF ASTRO November 2015 San Diego 2016
MULTIDISCIPLINARY HEAD AND NECK CANCER SYMPOSIUM February 18-20, 2016 JW Marriott Camelback Inn Resort and Spa Scottsdale, Arizona
ASTROASTRTRO 20142014 / 56TH ANNANNUALUAL MEETMEETINGING 7 2014 Committee Members
2014 Annual Meeting Steering Committee
Bruce G. Haff ty, MD, FASTRO ASTRO President
Bruce D. Minsky, MD ASTRO President-elect
Lynn D. Wilson, MD, MPH, FASTRO Annual Meeting Scientifi c Committee Chair
Benjamin Movsas, MD, FASTRO Annual Meeting Scientifi c Committee Vice-chair
Catherine C. Park, MD Annual Meeting Education Committee Chair
Brian G. Czito, MD Annual Meeting Education Committee Vice-chair
Laura A. Dawson, MD Education Council Chair
Theodore L. DeWeese, MD Best of ASTRO Chair
8 ASTRO 2014 / 56TH ANNUAL MEETING 2014 Annual Meeting Scientifi c Committee
Lynn D. Wilson, MD, MPH, Louis S. Constine, MD, FASTRO Alexander Lin, MD* FASTRO, Chair Bouthaina Dabaja, MD* Bo Lu, MD, PhD Benjamin Movsas, MD, FASTRO, Shari Damast, MD* Stephen Thomas Lutz, MD Vice-chair* Indra J. Das, PhD, FASTRO Anand Mahadevan, MD* Kevin V. Albuquerque, MD Roy H. Decker, MD, PhD Anita Mahajan, MD Kaled M. Alektiar, MD* Jun Deng, PhD Robert C. Miller, MD, MS Jonathan Ashman, MD, PhD Theodore L. DeWeese, MD Drew Moghanaki, MD Elizabeth H. Baldini, MD, MPH Lorraine Drapek, MSN, NP Aswatha Narayana, MD Beth M. Beadle, MD, MPH Jason A. Efstathiou, MD, PhD* Harald Paganetti, PhD Justin E. Bekelman, MD* Suzanne B. Evans, MD Arnold C. Paulino, MD* Jennifer R. Bellon, MD* Felix Y. Feng, MD* Kenneth Rosenzweig, MD* Lawrence B. Berk, MD, PhD Gary M. Freedman, MD Lakshmi Santanam, PhD Ramesh S. Bilimagga, MD James Alan Hayman, MD, MBA* Farzan Siddiqui, MD, PhD Kevin A. Camphausen, MD Alice Y. Ho, MD Ben J. Slotman, MD, PhD A. Bapsi Chakravarthy, MD* Rojyman Jacob, MD Benjamin D. Smith, MD Allen M. Chen, MD Salma Jabbour, MD Alexander Spektor, MD, PhD Ronald C. Chen, MD* David A. Jaff ray, PhD Akila N. Viswanathan, MD* Indrin J. Chetty, PhD* Lisa A. Kachnic, MD Stephanie E. Weiss, MD* Deborah E. Citrin, MD Jonathan P.S. Knisely, MD Maria Werner-Wasik, MD
* Track Chair
2014 Annual Meeting Education Committee
Catherine C. Park, MD, Chair* Kun (Kim) Huang, MD* Christopher F. Njeh, PhD Brian Czito, MD, Vice-chair* Jordan R. Kharofa, MD George Rodrigues, MD, PhD James Balter, PhD* Krystyna D. Kiel, MD Narayan Sahoo, PhD Changhu Chen, MD Patrick A. Kupelian, MD* Roy B. Tishler, MD, PhD* Robert B. Den, MD Joshua D. Lawson, MD* Christina Irene Tsien, MD Thomas J. Dilling, MD Harvey J. Mamon, MD, PhD Akila Viswanathan, MD, MPH* B. Ashleigh Guadagnolo, MD, Martha M. Matuszak, PhD Michelle Wallace, OCN, BSN, MPH* Karen J. Marcus, MD RN, CCRP Daniel A. Hamstra, MD, PhD Brian Marples, PhD George D. Wilson, PhD David Hodgson, MD Loren K. Mell, MD Suzanne L. Wolden, MD* Alice Y. Ho, MD Arno J. Mundt III, MD, FASTRO Min Yao, MD, PhD Janet K. Horton, MD Andrea K. Ng, MD, MPH* James B. Yu, MD*
*Track Chair
2014 Annual Meeting Press Planning Team David C. Beyer, MD, FASTRO Bruce G. Haff ty, MD, FASTRO Benjamin Movsas, MD, FASTRO Brian Czito, MD Paul M. Harari, MD, FASTRO Catherine C. Park, MD Laura A. Dawson, MD Bruce D. Minsky, MD Lynn D. Wilson, MD, MPH, FASTRO
ASTRO 2014 / 56TH ANNUAL MEETING 9 2014 Abstract Reviewers to the 2014 Thank You Abstract Reviewers May Abdel-Wahab, MD, PhD Louis S. Constine, MD, FASTRO Stephen M. Hahn, MD, FASTRO Nzhde Agazaryan, PhD Brett W. Cox, MD Lia M. Halasz, MD Salahuddin Ahmad, PhD Gilles Crehange, MD, PhD Christopher L. Hallemeier, MD Peter Ahn, MD Bruce H. Curran, MS Michele Yvette Halyard, MD Parham Alaei, PhD Bouthaina Dabaja, MD* Daniel A. Hamstra, MD, PhD Kevin V. Albuquerque, MD** Megan E. Daly, MD James E. Hansen, MD Kaled M. Alektiar, MD* Shari Damast, MD* Paul M. Harari, MD, FASTRO Berthe Aleman, MD, PhD Parima Daroui, MD, PhD James Alan Hayman, MD, MBA* Brian M. Alexander, MD Indra J. Das, PhD, FASTRO Mark A. Henderson, MD Ozer Algan, MD Prajnan Das, MD, MS Joseph M. Herman, MD, MS Penny R. Anderson, MD Laura A. Dawson, MD Michael G. Herman, PhD Christopher J. Anker, MD Ellen E. Day, PhD Susan M. Higgins, MD, MS Jonathan Ashman, MD, PhD** Joseph O. Deasy, PhD Alice Y. Ho, MD** Richard L. Bakst, MD Alicia DeCaria, BSN, RN, NE-BC David Hodgson, MD Elizabeth H. Baldini, MD, MPH Roy H. Decker, MD, PhD Karen E. Hoff man, MD Peter Balter, PhD Andre Dekker, PhD Theodore S. Hong, MD Voichita Bar Ad, MD John DeMarco, PhD Bradford S. Hoppe, MD Christopher Barker, MD Theodore L. DeWeese, MD Dimitre H. Hristov, PhD Beth Beadle, MD, PhD Sonja Dieterich, PhD I-Chow Joe Hsu, MD Clair Beard, MD Thomas A. DiPetrillo, MD Arthur Y. Hung, MD Jonathan Beitler, MD, MBA, FASTRO Nesrin Dogan, PhD Margie A. Hunt, MS Justin Bekelman, MD* Jadranka Dragovic, MD Mark David Hurwitz, MD Jennifer R. Bellon, MD* Lorraine C. Drapek, MSN, NP* Zain A. Husain, MD Ross Berbeco, PhD Warren D’Souza, PhD, MBA Geoff rey S. Ibbott, PhD, FASTRO Sushil Beriwal, MD Cheryl R. Duzenli, PhD Timothy Illidge, MD, PhD Lawrence Berk, MD, PhD** Jason A. Efstathiou, MD, PhD* Daniel J. Indelicato, MD Matthew Biagioli, MD, MS John P. Einck, MD Salma K. Jabbour, MD** Ramesh Bilimagga, MD Rodney J. Ellis, MD Rojymon Jacob, MD Ranjit Bindra, MD, PhD Mohamed A. Elshaikh, MD Jian-Yue Jin, PhD Jean-Pierre Bissonnette, PhD Natia Esiashvili, MD Ellen L. Jones, MD, PhD Seth Blacksburg, MD, MBA Andrew J. Evans, MD Mitchell Kamrava, MD James Bonner, MD, FASTRO Suzanne B. Evans, MD** Christopher R. Kelsey, MD Alberto Bossi, MD Bruce A. Faddegon, PhD Atif J. Khan, MD J. Daniel Bourland, PhD Alysa M. Fairchild, MD Krystyna D. Kiel, MD Kristin Bradley, MD Steven J. Feigenberg, MD Catherine S. Kim, MD Kristy Brock, PhD Felix Y. Feng, MD* Jinkoo Kim, PhD Michael Buckstein, MD, PhD Steven E. Finkelstein, MD Randall J. Kimple, MD, PhD Kevin Camphausen, MD Robert L. Foote, MD, FASTRO Christopher R. King, MD, PhD David Carlson, PhD Eric C. Ford, PhD David G. Kirsch, MD, PhD Jimmy Caudell, MD, PhD Kenneth M. Forster, PhD Eric E. Klein, PhD, FASTRO Keith Cengel, MD, PhD Barbara L. Fowble, MD, FASTRO Jonathan P.S. Knisely, MD** Laura Cervino, PhD Benedick A. Fraass, PhD, FASTRO Albert C. Koong, MD, PhD A. Bapsi Chakravarthy, MD* Steven J. Frank, MD David E. Kozono, MD, PhD Daniel Chamberlain, MD David Kassler Gaff ney, MD, PhD Matthew Krasin, MD Brian W. Chang, MD Thomas J. Galloway, MD Daniel J. Krauss, MD Eric Lin Chang, MD Yolanda Garces, MD Jon J. Kruse, PhD Joe Y. Chang, MD, PhD, MS Hiram A. Gay, MD Gregory J. Kubicek, MD Aileen Chen, MD John P. Gibbons, PhD Patrick A. Kupelian, MD Lili Chen, PhD Carri Glide-Hurst, PhD Marikki Laiho, MD, PhD Peter Y. Chen, MD Daniel R. Gomez, MD Brian E. Lally, MD Ronald C. Chen, MD* Alexander R. Gottschalk, MD, PhD Jerome C. Landry, MD, MBA Bhisham Chera, MD Phillip J. Gray, MD Joshua D. Lawson, MD Indrin J. Chetty, PhD* Katherine L. Griem, MD Andrew K. Lee, MD, MPH Junzo Chino, MD Inga S. Grills, MD Larissa J. Lee, MD Seungtaek Choi, MD B. Ashleigh Guadagnolo, MD, MPH Nancy Lee, MD Ananya Choudhury, MD, MB, PhD Thomas M. Guerrero, MD, PhD Percy Lee, MD Peter Chung, MBChB Vishal Gupta, MD W. Robert Lee, MD, MS, MEd Jay P. Ciezki, MD Marilyn L. Haas, PhD Zuofeng Li, DSc Deborah E. Citrin, MD** Daphne A. Haas-Kogan, MD Jay J. Liao, MD John J. Coen, MD Michael G. Haddock, MD Zhongxing Liao, MD C. Norman Coleman, MD, FASTRO Karl E. Haglund, MD, PhD Alexander Lin, MD*
10 ASTRO 2014 / 56TH ANNUAL MEETING Lilie Lin, MD Jean-Philippe Pignol, MD, PhD Samuel D. Swisher-McClure, MD Steven Lin, MD, PhD Matthew B. Podgorsak, PhD Alphonse G. Taghian, MD, PhD Holly Lincoln, MS Alan Pollack, MD, PhD James A. Tanyi, PhD Dale W. Litzenberg, PhD Richard Popple, PhD Randall K. Ten Haken, PhD, FASTRO Arthur K. Liu, MD, PhD Louis Potters, MD, FASTRO Joel E. Tepper, MD, FASTRO Chihray Liu, PhD Jean Pouliot, PhD Welela Tereff e, MD Fei-Fei Liu, MD Deepak G. Pradhan, MD Stephanie A. Terezakis, MD Simon S. Lo, MBChB Robert A. Price, PhD Juliette O. Thariat, MD, PhD, MS Daniel Low, PhD Rinaa S. Punglia, MD, MPH Charles R. Thomas, MD John N. Lukens, MD David Raben, MD Wade L. Thorstad, MD Stephen Thomas Lutz, MD Dirk Rades, MD Wolfgang A. Tome, PhD Gary Luxton, PhD Abram Recht, MD, FASTRO Mylin Torres, MD C.M. Charlie Ma, PhD Lei Ren, PhD Minh Tam Truong, MD Anand Mahadevan, MD* Ramesh Rengan, MD, PhD Christina Irene Tsien, MD Anita Mahajan, MD Nadeem Riaz, MD, MS Katherine S. Tzou, MD Raymond H. Mak, MD Andreas Rimner, MD James J. Urbanic, MD Harvey J. Mamon, MD, PhD Mark J. Rivard, PhD Riccardo Valdagni, MD, PhD Sheida Mani, MD Mack Roach, MD Neha Vapiwala, MD Karen J. Marcus, MD Kenneth B. Roberts, MD Andrew D. Vassil, MD Danielle N. Margalit, MD, MPH George Rodrigues, MD, PhD Akila N. Viswanathan, MD, MPH* Rufus J. Mark, MD Kenneth Rosenzweig, MD* Sujay Vora, MD Mary K. Martel, PhD, FASTRO Mihaela Rosu, PhD Eleanor M. Walker, MD Neil E. Martin, MD Christian Rube, MD Michelle Wallace, OCN, BSN, RN, CCRP Malcolm D. Mason, MD Samuel Ryu, MD Andrew Z. Wang, MD Jyoti S. Mayadev, MD Bill J. Salter, PhD Brian Wang, PhD Susan McCloskey, MD, MSHS Lakshmi Santanam, PhD Dian Wang, MD, PhD Beryl McCormick, MD, FASTRO Amit Sawant, PhD David E. Wazer, MD, FASTRO Todd R. McNutt, PhD Tracey Schefter, MD Joanne B. Weidhaas, MD, PhD Sanford Meeks, PhD Julie K. Schwarz, MD, PhD Stephanie E. Weiss, MD* William M. Mendenhall, MD Joao Seco, PhD Maria Werner-Wasik, MD** Joshua E. Meyer, MD Jan Seuntjens, PhD Julia R. White, MD Dimitris N. Mihailidis, PhD Simona Shaitelman, MD Henning Willers, MD N. George Mikhaeel, MD, MBChB Renu Sharma, MS Christopher G. Willett, MD, FASTRO Michael T. Milano, MD, PhD Michael B. Sharpe, PhD Karen M. Winkfi eld, MD, PhD Robert C. Miller, MD, MS Nathan C. Sheets, MD, MS Jennifer Y. Wo, MD James B. Mitchell, PhD, FASTRO Xinglei Shen, MD Julia S. Wong, MD Drew Moghanaki, MD** Ke Sheng, PhD Rebecca Wong, MBChB Gerard Morton, MD David J. Sher, MD, MPH Wendy A. Woodward, MD, PhD Sabin B. Motwani, MD Helen A. Shih, MD, MS, MPH Jean L. Wright, MD Benjamin Movsas, MD, FASTRO* Timothy N. Showalter, MD Qiuwen Wu, PhD Michael T. Munley, PhD Hui-Kuo George Shu, MD, PhD Ping Xia, PhD Jean L. Nakamura, MD Farzan Siddiqui, MD, PhD** Ying Xiao, PhD Ashwatha Narayana, MD** Jeff rey Siebers, PhD Lei Xing, PhD Christopher F. Njeh, PhD Charles B. Simone, MD Theodore E. Yaeger, MD Mark Oldham, PhD Ramon Alfredo Siochi, PhD Di Yan, DSc Michael O’Neill, MD Heath D. Skinner, MD, PhD Gary Y. Yang, MD Harald Paganetti, PhD** Ben J. Slotman, MD, PhD Johnny Yap, MD David A. Palma, MD, PhD William Small, MD, FASTRO Catheryn M. Yashar, MD, OCN Jatinder R. Palta, PhD, FASTRO DeeDee K. Smart, MD, PhD Torunn I. Yock, MD, MCH Bhupesh Parashar, MD Grace L. Smith, MD, PhD, MPH Sue S. Yom, MD, PhD Catherine C. Park, MD Danny Song, MD Ellen D. Yorke, PhD William Parker, MS William Y. Song, PhD David S. Yu, MD, PhD Upendra Parvathaneni, MD Luis Souhami, MD, FASTRO James Yu, MD Abhijit A. Patel, MD, PhD Lena Specht, MD, PhD Jennifer B. Yu, MD, PhD Shilpen A. Patel, MD Corey Speers, MD, PhD Yan Yu, PhD, MBA Arnold C. Paulino, MD* Sharon A. Spencer, MD Almudena Zapatero, MD, PhD Todd Pawlicki, PhD Matthew H. Stenmark, MD Richard Cedric Zellars, MD, DO Charles A. Pelizzari, PhD Kevin Stephans, MD Tiezhi Zhang, PhD Stephanie M. Perkins, MD Robin L. Stern, PhD Timothy C. Zhu, PhD Ivy A. Petersen, MD Gita Suneja, MD Mark H. Phillips, PhD Mohan Suntharalingam, MD, MBA Key * Track chair ** Track co-chair/vice-chair 2014 Session Reviewers
to the 2014 Thank You Session Reviewers Kaled M. Alektiar, MD Bruce G. Haff ty, MD, FASTRO Bharat B. Mittal, MD, FASTRO James Balter, PhD Carol A. Hahn, MD Benjamin Movsas, MD, FASTRO Justin Bekelman, MD James Alan Hayman, MD, MBA Andrea K. Ng, MD, MPH Jennifer R. Bellon, MD Kun (Kim) Huang, MD Catherine C. Park, MD A. Bapsi Chakravarthy, MD Geraldine Jacobson, MD, MBA, MPH, Arnold C. Paulino, MD Ronald C. Chen, MD FASTRO Ken Rosenzweig, MD Indrin J. Chetty, PhD Brian Kavanagh, MD Roy B. Tishler, MD, PhD Brian Czito, MD Patrick A. Kupelian, MD Akila N. Viswanathan, MD, MPH Bouthaina Dabaja, MD Joshua Lawson, MD Michelle Wallace, OCN, BSN, RN Shari Damast, MD Alexander Lin, MD Joanne B. Weidhaas, MD, PhD Laura A. Dawson, MD Anand Mahadevan, MD Stephanie E. Weiss, MD Theodore L. DeWeese, MD Lawrence B. Marks, MD, FASTRO Lynn D. Wilson, MD, MPH, FASTRO Jason A. Efstathiou, MD, PhD Brian Marples, PhD George D. Wilson, PhD Thomas J. Eichler, MD, FASTRO Mary K. Martel, PhD, FASTRO Suzanne L. Wolden, MD Felix Y. Feng, MD Bruce D. Minsky, MD Ying Xiao, PhD B. Ashleigh Guadagnolo, MD James B. Yu, MD
12 ASTRO 2014 / 56TH ANNUAL MEETING Join us in honoring the distinguished Gold Medal Recipients leaders in our fi eld at the The Gold Medal is ASTRO’s highest honor 2014 ASTRO bestowed on revered members who have made Awards outstanding contributions to the fi eld of Ceremony radiation oncology. Tuesday, September 16 10:15 a.m. – 11:30 a.m. 2014 GOLD MEDALISTS
MARY K. GOSPODAROWICZ, MD, FASTRO Dr. Gospodarowicz is the medical director of the Princess Margaret Cancer Centre at the University Health Network in Toronto and professor of radiation oncology at the University of Toronto. She has had a major impact on several areas of radiation oncology, including the treatment of malignant lymphomas and genitourinary cancers, global health and the use of radiation therapy treatment worldwide, and the mentoring of trainees. She is currently the president of the Union for International Cancer Control (UICC), an international organization dedicated to helping the global health community reduce the worldwide cancer burden.
LEONARD L. GUNDERSON, MD, MS, FASTRO Dr. Gunderson is an emeritus professor and consultant in the department of radiation oncology at the Mayo Clinic, as well as a former Chair of ASTRO’s Board of Directors. He has made signifi cant contributions to radiation oncology through research and clinical practice in gastrointestinal cancers (colorectal, gastric/GE junction, biliary, pancreas and anal) and soft tissue sarcomas (extremity, retroperitoneal). His research has focused on defi ning the indications for and results of external bean irradiation as a component of multi-modality treatment, alone or in conjunction with surgical resection and systemic therapy.
NANCY J. TARBELL, MD, FASTRO Dr. Tarbell is the dean for academic and clinical aff airs at Harvard Medical School in Boston and the C.C. Wang Professor of Radiation Oncology at Harvard Medical School and Massachusetts General Hospital in Boston. She is an internationally recognized expert in pediatric oncology and radiation therapy. Her research has examined ways to provide curative treatment programs for children with malignant disease and to develop eff ective strategies to decrease the late eff ects of treatment.
ASTRO 2014 / 56TH ANNUAL MEETING 13 Fellow Recipients
The ASTRO Fellow designation honors those who have been an Active or Emeritus Member of ASTRO for at least 15 years, have given the equivalent of 10 years of service to ASTRO and have made signifi cant contributions to the fi eld of radiation oncology. ASTRO PROUDLY RECOGNIZES THE 2014 CLASS OF FELLOWS
• John M. Buatti, MD, University of Iowa, Iowa City, Iowa • Thomas F. DeLaney, MD, Massachusetts General Hospital, Boston • Adam Dicker, MD, PhD, Thomas Jeff erson University, Philadelphia • Avraham Eisbruch, MD, University of Michigan, Ann Arbor, Michigan • Eduardo Fernandez, MD, PhD, 21st Century Oncology, Plantation, Florida • David Gaff ney, MD, PhD, University of Utah/Huntsman Cancer Hospital, Salt Lake City • Adam S. Garden, MD, MD Anderson Cancer Center, Houston • Katherine L. Griem, MD, Rush University Medical Center, Chicago • William F. Hartsell, MD, Radiation Oncology Consultants Ltd., Warrenville, llIinois • James Alan Hayman, MD, MBA, University of Michigan, Ann Arbor, Michigan • I-Chow Joe Hsu, MD, University of California, San Francisco • Lisa Kachnic, MD, Boston Medical Center, Boston • Brian Kavanagh, MD, MPH, University of Colorado Cancer Center, Aurora, Colorado • Timothy Kinsella, MD, MS, MA (ad eundem), Warren Alpert Medical School of Brown University, Providence, Rhode Island • Andre Konski, MD, MBA, MA, University of Pennsylvania, West Chester, Pennsylvania • Patrick Kupelian, MD, University of California, Los Angeles • Quynh-Thu Le, MD, Stanford University, Stanford, California • W. Robert Lee, MD, MS, MEd, Duke University School of Medicine, Durham, North Carolina • Stephen Lutz, MD, Blanchard Valley Regional Cancer Center, Findlay, Ohio • Chang Ming Charlie Ma, PhD, Fox Chase Cancer Center, Philadelphia • Bruce D. Minsky, MD, MD Anderson Cancer Center, Houston • Najeeb Mohideen, MD, Northwest Community Hospital, Arlington Heights, llIinois • Simon N. Powell, MD, PhD, Memorial Sloan Kettering Cancer Center, New York • Mack Roach III, MD, University of California, San Francisco • Kenneth E. Rosenzweig, MD, Icahn School of Medicine at Mount Sinai, New York • Christopher J. Schultz, MD, Medical College of Wisconsin, Milwaukee • Dennis C. Shrieve, MD, PhD, University of Utah School of Medicine, Salt Lake City • Paul W. Sperduto, MD, MPP, Minneapolis Radiation Oncology, Waconia, Minnesota • Maria Werner-Wasik, MD, Thomas Jeff erson University Hospital, Philadelphia • Jeff rey F. Williamson, PhD, Virginia Commonwealth University, Richmond, Virginia Class of 2013 Fellows
Silvia Chiara Formenti, MD, Phillip M. Devlin, MD, Peter B. Schiff , MD, PhD, Bhudatt R. Paliwal, PhD, Jonathan J. Beitler, MD, MBA, Geraldine M. Jacobson, MD, MPH, MBA, Seth Rosenthal, MD, Tariq A. Mian, PhD, Thomas J. Eichler, MD, and Stephen M. Hahn, MD Honorary Member Recipient Honorary Membership is awarded annually to a distinguished cancer researcher or leader in a discipline other than radiation oncology, radiation physics or radiobiology. 2014 HONORARY MEMBER
ANGELITA HABR-GAMA, MD, PHD Dr. Habr-Gama is internationally recognized for her work in developing and supporting selective nonoperative treatment approaches for rectal cancer. She founded the Division of Coloproctology at the University of Sao Paulo School of Medicine, and has been a member of the Board of the Oncology Foundation of Sao Paulo since 1990. Dr. Habr-Gama is a strong advocate for the role of radiation therapy in rectal cancer treatment. Dr. Habr-Gama is professor of surgery at the University of Sao Paulo School of Medicine and staff surgeon of coloproctological surgery at Hospital Alemao Oswaldo Cruz in Sao Paulo, Brazil.
ASTRO 2014 / 56TH ANNUAL MEETING 15 Annual Meeting Abstract Awards 2014 ASTRO ANNUAL MEETING AWARD RECIPIENTS RESIDENT CLINICAL/BASIC SCIENCE RESEARCH AWARD Andrew Sharabi, MD, PhD (Radiation and Cancer Biology) Madhu Sudhan Reddy Gudur, PhD (Radiation Physics) Stephanie Markovina, MD, PhD (Clinical) RESIDENT DIGITAL POSTER RECOGNITION AWARD Pranshu Mohindra, MD (Radiation and Cancer Biology) Adam Gladwish, MD (Radiation Physics) Kim Cao, MD (Clinical) RESIDENT POSTER VIEWING RECOGNITION AWARD Clinical Steven Sckolnik, MD (1st place) Jessica Zhou, MD (2nd place) Thomas Mullen, MD, PhD (3rd place) Radiation and Cancer Biology Nils Nicolay, MD, PhD (1st place) Kate Barrett, MD, BS (2nd place) Chi Zhang, MD, PhD (3rd place) Radiation Physics Paul Romesser, MD (1st place) Roohi Gupta, PhD (2nd place) Ziad Simon Fawaz, MD (3rd place) BASIC SCIENCE ABSTRACT AWARD Radiation and Cancer Biology Masayuki Matsuo, MD, PhD Everett Moding, BS Ngoc Pham, BS Corey Speers, MD, PhD Daniel Spratt, MD, BS Radiation Physics Ganiyu Asuni, PhD Jeremy Booth, PhD Fiona Hegi-Johnson, MBBS Xia Li, PhD Yana Zlateva, MS ANNUAL MEETING TRAVEL AWARD Clinical Kamran Ahmed, MD Ben Creelan, MD Clement Ho, MD, MS Anthony Paravati, MD, MBA John Vargo, MD Radiation and Cancer Biology Miran Blanchard, MD Nevine Hanna, MD, MPH Amanda Walker, MD Christopher Wright, BS Zachary Zumsteg, MD Radiation Physics Olivia Kelada, MS, BS Yilin Liu, PhD Jan Schuemann, PhD Almut Troeller, MS Stephen Yip, PhD INTERNATIONAL – U.S. ANNUAL MEETING SCIENTIFIC ABSTRACT AWARD Yun Chiang, MD ANNUAL MEETING NURSE ABSTRACT AWARD Chiaki Fujioka, RN Diane Serra, MS, RN General Information
cial Meeting App Meeting cial
Moscone Center Floor Plans Floor Moscone Center Shuttle Bus Schedule Shuttle Bus Posters Posters Industry-Expert Theater ASTROmobile – Offi Concessions General Information INSIDE: General Information www.iba-protontherapy.com/why-proton-therapy Thanks to With thesupportof in Oxford,UK.Shewasdiagnosedwithamedulloblastoma in1997. ,ZDVWROG,ZRXOG QHYHUJRWRXQLYHUVLW\« PROTON THERAPY , Mary, physicsgraduate,islivinganormallife andPineoblastoma/NCT01063114 -http://clinicaltrials.gov Clinicaltrial:ProtonBeamRadiotherapy forMedulloblastoma Vol. 58,No.3,pp.727–734, 2004 Article: St.Clairetal,Int.J.RadiationOncologyBiol.Phys., More aboutProtonTherapytreatment forMedulloblastoma resemblance to realpersons,livingordead, ispurelycoincidental. Although inspired fromrealcancerpatient stories,charactersappearing inthisworkarefictitious. Any indirect, consequential, special,exemplary, orotherdamages arisingtherefrom. by anypersonfollowingtheinformation offered orprovided. The publishers willnotbeliableforanydirect, physicians. The publishersmakenorepresentationsorwarranties withrespecttoanytreatmentoraction, The clinicalinformationprovided isindicativeandnotintendedtoreplacemedical adviceoffered by General Information
MOSCONE CENTER NORTH AND SOUTH ABSTRACTS AND EMBARGO POLICY 747 Howard St. San Francisco, CA 94103 The full text of the abstracts selected for oral and www.moscone.com poster presentation are available on the Annual Meeting Online Conference Planner and All activities take place in Moscone Center North and ASTROmobile beginning Saturday, September 13. All abstracts are published in a supplement of South unless otherwise stated. All information is the September 1, 2014, issue of the International correct as of August 14, 2014, and is subject to change. Journal of Radiation Oncology • Biology • Physics (www.redjournal.org). ATTENDEE REGISTRATION North Lobby All abstracts are embargoed and remain confi dential until the date and time of ATTENDEE REGISTRATION HOURS presentation at the Annual Meeting. If you have Saturday, September 13 8:00 a.m. - 5:00 p.m. any questions about the embargo policy, please Sunday, September 14 6:30 a.m. - 5:00 p.m. contact ASTRO’s Media Relations Manager, Monday, September 15 7:00 a.m. - 6:00 p.m. Michelle Kirkwood, at 703-286-1600 or Tuesday, September 16 7:00 a.m. - 5:00 p.m. [email protected]. Wednesday, September 17 7:00 a.m. - 2:00 p.m.
EXHIBITOR REGISTRATION South Lobby
EXHIBITOR REGISTRATION HOURS Thursday, September 11 8:00 a.m. - 5:00 p.m. Friday, September 12 8:00 a.m. - 5:00 p.m. Saturday, September 13 8:00 a.m. - 5:00 p.m. Sunday, September 14 7:00 a.m. - 5:00 p.m. Monday, September 15 8:00 a.m. - 5:00 p.m. Tuesday, September 16 8:00 a.m. - 5:00 p.m.
ASTRO 2014 / 56TH ANNUAL MEETING 19 AFFILIATE MEETINGS
38TH ASRT RADIATION THERAPY CONFERENCE September 14-16, 2014 Hilton San Francisco Union Square The 38th Annual ASRT Radiation Therapy Conference will take place at the Hilton San Francisco Union Square. ASTRO registered attendees may attend ASRT sessions by paying a reduced registration fee of $195. Proof of registration (registration confi rmation or badge) is required to receive this reduced rate. If you have not registered to attend the ASRT conference but would like to do so, please register on-site at the Hilton San Francisco Union Square.
31ST SROA ANNUAL MEETING September 14-17, 2014 Hyatt Regency San Francisco The 31st SROA Annual Meeting will take place at the Hyatt Regency San Francisco. ASTRO registered attendees may attend the SROA general sessions by paying a reduced registration fee of $210. Proof of registration (registration confi rmation or badge) is required to receive this reduced rate. If you have not registered to attend the SROA conference but would like to do so, please register on-site at the Hyatt Regency San Francisco.
C NNECT
South Lobby
ASTRO Connect is the perfect place to RECHARGE, RELAX Connect with attendees. and REVIVE. This networking lounge off ers an area to charge your devices, network with colleagues, have Tweet informal meetings, make new connections within the #ASTRO14 radiation oncology community and check in on social media sites.
Funded in part by Elekta
20 ASTRO 2014 / 56TH ANNUAL MEETING ASTRO CAREER FAIR ASTRO RESOURCE CENTER Rooms 250-262 North Lower Lobby, Outside Hall D Take advantage of the ASTRO Career Fair to connect Visit the ASTRO Resource Center, located outside Hall with candidates for employment. Equipped with D. Here you can learn about ASTRO member benefi ts computers and printers for your convenience, the and get information on new programs such as APEx: Career Fair is available for employers to conduct Accreditation Program for Excellence and RO-ILS: interviews with job applicants. Employers and Radiation Oncology Incident Learning SystemTM. You applicants must register through the online ASTRO can also pick up materials on upcoming educational Career Center in order to schedule interviews at the meetings and webinars, patient advocacy and more. on-site Career Fair. ASTRO’s knowledgeable staff will be on hand to answer any questions about ASTRO membership. A Hours of Operation: professional photographer will be available during Saturday, September 13 3:00 p.m. - 6:00 p.m. designated hours so that you can get your picture Sunday, September 14 8:00 a.m. - 6:00 p.m. taken and uploaded to the ASTRO membership Monday, September 15 8:00 a.m. - 6:00 p.m. directory. The Survivor Circle is also located in the Tuesday, September 16 8:00 a.m. - 6:00 p.m. Resource Center.
Private interview rooms are also available. These Hours of Operation: rooms are ideal if you have multiple interviews to Saturday, September 13 8:00 a.m. - 5:00 p.m. conduct or just need more privacy. A limited Sunday, September 14 8:00 a.m. - 5:00 p.m. number of meeting rooms are available for Monday, September 15 8:00 a.m. - 5:00 p.m. three-hour periods Saturday, September 13 through Tuesday, September 16 8:00 a.m. - 5:00 p.m. Tuesday, September 16. For more information, Wednesday, September 17 8:00 a.m. - 12:00 p.m. contact Todd Karstaedt at [email protected].
ASTRO PAC LOUNGE North Lower Lobby, Across from CE Central ASTRO’s political action committee (PAC) is off ering access to an exclusive lounge for all ASTRO members who have donated to the ASTRO PAC in 2014. The PAC lounge will feature Internet access, coff ee and beverages, food and a place to rest between sessions. Members who have not made their contribution yet will be able to donate on-site. ASTRO PAC provides ASTRO with the opportunity to more fully participate in government and ensure our members’ voices are being heard by key policy makers on Capitol Hill. Be sure to stop by the lounge to get the most recent legislative and election updates. For more information, please email [email protected] or visit www.astro.org/ASTROPAC.
Hours of Operation: Sunday, September 14 10:00 a.m. - 5:00 p.m. Monday, September 15 10:00 a.m. - 5:30 p.m. Happy Hour and Legislative Issue Forum (Room 114) 4:30 p.m. - 5:30 p.m. Tuesday, September 16 10:00 a.m. - 5:00 p.m.
ASTRO 2014 / 56TH ANNUAL MEETING 21 ASTROmobile – Your Annual Meeting Guide
ASTROmobile gives you access to the meeting program and the ability to customize your meeting experience with personalized maps and planners.
Search sessions by day, track or speaker. Search exhibitors by name, booth number or product/service category. Locate sessions and exhibitors with customized maps. Search and view the full abstracts. Preview general meeting information. Access “MyPlan” – your personal Annual Meeting schedule. View convention center maps. Take notes on a session or exhibitor and access your notes from your mobile device. Exchange messages with colleagues attending the meeting using Find-a-Friend. Integrates with the Online Conference Planner.
Please note that all information in the fi nal program is available on ASTROmobile.
ASTROmobile Login Instructions An account has been created for all registered attendees. Please log in as follows:
iPhone Users Droid Users Smartphone Users 1. Download 1. Download 1. Go to www.astro.org/ “ASTROmobile14” from the “ASTROmobile14” from the ASTROmobile in your mobile App Store. Google Play store. web browser.
2. Log in with the following 2. Log in with the following 2. Log in with the following credentials: credentials: credentials:
Registration ID: Badge Number Registration ID: Badge Number Registration ID: Badge Number Password: Last Name Password: Last Name Password: Last Name Email ID: Email Address Email ID: Email Address
Smartphone users can also access ASTROmobile using a QR Code reader and the QR Code to the right.
Login Tips Your badge number is located on the front of your badge. Your email address is the email that you provided at the time of registration. Your last name must match the spelling on your badge.
22 ASTRO 2014 / 56TH ANNUAL MEETING BUSINESS CENTER CE CENTRAL South Lower Lobby Outside Hall E The business center is conveniently located in the Staff from ASTRO and the ABR will be on hand South Lower Lobby of Moscone Center. The business during the meeting to answer your individual center off ers a variety of services including packing questions about continuing education and MOC and shipping, sign production, copying and offi ce requirements. supplies. CE Central computer stations allow you to: Hours of Operation: • Complete your continuing education and Saturday, September 13 8:00 a.m. - 5:00 p.m. meeting evaluation. Sunday, September 14 9:00 a.m. - 5:00 p.m. • View/print a session tracking form. Monday, September 15 9:00 a.m. - 5:00 p.m. • Search abstracts. Tuesday, September 16 9:00 a.m. - 5:00 p.m. • Search exhibitors. Wednesday, September 17 9:00 a.m. - 5:00 p.m. • Update your Online Conference Planner.
BUSINESS MEETING Hours of Operation: Tuesday, September 16, 2014 Saturday, September 13 8:30 a.m. - 6:00 p.m. 11:30 a.m. - 1:00 p.m. Sunday, September 14 7:30 a.m. - 6:30 p.m. Room 102/103 Monday, September 15 7:30 a.m. - 6:00 p.m. ASTRO voting members (Active, Affi liate, Allied or Tuesday, September 16 7:30 a.m. - 6:30 p.m. International members) are invited to attend the Wednesday, September 17 7:30 a.m. - 5:00 p.m. Business Meeting on Tuesday, September 14 from 11:30 a.m. - 1:00 p.m. Leaders of the Society will discuss topics of interest to ASTRO members. You should not miss this important meeting. Lunch will be served.
Great Meeting? Tweet #ASTRO14
ASTRO 2014 / 56TH ANNUAL MEETING 23 CONCESSIONS
A number of food concession outlets are located in CONCOURSE EXPRESSO the Exhibit Hall and in the North and South Lower North Concourse Lobbies so that attendees can grab a cup of coff ee, Concourse Expresso off ers a variety of coff ee, soft sandwich or salad. The electronic food and drinks and grab and go breakfast and lunch items. beverage card that you received with your registration materials can only be used at the food Hours of Operation: outlets in the Exhibit Hall. Saturday, September 13 7:00 a.m. - 3:00 p.m. Sunday, September 14 7:00 a.m. - 5:00 p.m. MC COFFEE Monday, September 15 7:00 a.m. - 5:00 p.m. South Lower Lobby Tuesday, September 16 7:00 a.m. - 5:00 p.m. MC Coff ee off ers a variety food and beverage items Wednesday, September 17 7:00 a.m. - 3:00 p.m. such as coff ee, soft drinks and grab and go breakfast and lunch meals. EXHIBIT HALL CONCESSIONS Halls A-C Hours of Operation: A number of concessions stands will be located Saturday, September 13 7:00 a.m. - 3:00 p.m. thoughout the Exhibit Hall. A variety of sandwiches, Sunday, September 14 7:00 a.m. - 5:00 p.m. salads, snacks and hot and cold beverages will be Monday, September 15 7:00 a.m. - 5:00 p.m. available. Tuesday, September 16 7:00 a.m. - 5:00 p.m. Wednesday, September 17 7:00 a.m. - 3:00 p.m. Hours of Operation: Sunday, September 14 10:00 a.m. - 5:00 p.m. SAVOR EXPRESS Monday, September 15 10:00 a.m. - 5:00 p.m. South Lower Lobby Tuesday, September 16 10:00 a.m. - 5:00 p.m. Savor Express off ers a variety of beverages, grab and go lunch and snack items. ELECTRONIC FOOD AND BEVERAGE CARD Hours of Operation: Attendees receive a $10 electronic food and Saturday, September 13 9:00 a.m. - 3:00 p.m. beverage card with their registration materials. This card can be used for coff ee and beverages as well MARKET SQUARE as food items located at concession stands in the South Lower Lobby Exhibit Hall. This card will not be accepted at food Market Square off ers a variety of diff erent grab and outlets outside of the Exhibit Hall. Lost cards will go salads, sandwiches, beverages and snacks. not be replaced. Hours of Operation: Sunday, September 14 8:00 a.m. - 4:00 p.m. Monday, September 15 8:00 a.m. - 4:00 p.m. Tuesday, September 16 8:00 a.m. - 4:00 p.m.
ESPLANADE COFFEE CART Esplanade Level, South Building Located near the General Session, the Esplanade Coff ee Cart off ers coff ee and other hot beverages and grab and go snacks.
Hours of Operation: Sunday, September 14 7:00 a.m. - 3:00 p.m. Monday, September 15 7:00 a.m. - 3:00 p.m. Connect with attendees. Tuesday, September 16 7:00 a.m. - 3:00 p.m. Tweet #ASTRO14 24 ASTRO 2014 / 56TH ANNUAL MEETING CYBER CAFÉ FACULTY/VIP OFFICE North and South Lobbies Room 120 ASTRO attendees can check email, browse the Faculty members and VIPs should check in at the Internet, print a boarding pass and registration Faculty/VIP Offi ce to pick up registration receipt, and much more at one of several computer materials and receive last-minute updates and stations located in the North and South Lobbies. program changes. The Faculty/VIP Offi ce is conveniently located next to the Speaker Ready Hours of Operation: Room. Faculty and VIPs are welcome in the Saturday, September 13 8:00 a.m. - 5:00 p.m. Faculty/VIP Offi ce throughout the meeting. Sunday, September 14 6:30 a.m. - 5:00 p.m. Monday, September 15 7:00 a.m. - 6:00 p.m. Faculty members include: Tuesday, September 16 7:00 a.m. - 5:00 p.m. • Educational session speakers. Wednesday, September 17 7:00 a.m. - 4:30 p.m. • Panel moderators and presenters. • Scientifi c program moderators and discussants. EXHIBIT HALL • eContouring Learning Lab presenters. Halls A-C • Presidential Symposium speakers. Learn about the latest products in cancer treatment • Keynote speakers and introducers. and care in the Exhibit Hall. • Nurses’ Program speakers. • International Symposium speakers. Hours of Operation: Note: Presenters of abstracts are not classifi ed as Sunday, September 14 10:00 a.m. - 5:00 p.m. faculty and should follow attendee registration Monday, September 15 10:00 a.m. - 5:00 p.m. instructions. Tuesday, September 16 10:00 a.m. - 5:00 p.m. Hours of Operation: EXHIBITOR PRODUCT INFORMATION Saturday, September 13 6:45 a.m. - 6:00 p.m. Sunday, September 14 6:45 a.m. - 6:15 p.m. New this year, your registration badge will include Monday, September 15 6:45 a.m. - 5:45 p.m. an Aztec code that contains your contact Tuesday, September 16 6:45 a.m. - 6:15 p.m. information. This code can be scanned by Wednesday, September 17 6:45 a.m. - 4:30 p.m. exhibitors in the Exhibit Hall so that you may request information on products and services off ered by the company. Your contact information will include your FIRST AID email address, unless you opted not to include it Across from Room 106 during the registration process. Please stop by First Aid: 415-974-4090 or ext. 4090 from a Attendee Registration in the North Lobby if you house phone would like to change your contact information. Building Emergency: Ext. 5111 from a house phone
First aid is located across from Room 106 in Moscone Center South. In an emergency, please dial ext. 5111 from a house phone, contact First Aid or go to ASTRO Registration and have a staff person contact security. Hours of Operation: Monday, September 8 8:00 a.m. - 5:00 p.m. Tuesday, September 9 8:00 a.m. - 5:00 p.m. Wednesday, September 10 8:00 a.m. - 5:00 p.m. Thursday, September 11 8:00 a.m. - 8:00 p.m. Friday, September 12 8:00 a.m. - 8:00 p.m. Saturday, September 13 7:00 a.m. - 8:00 p.m. Sunday, September 14 6:30 a.m. - 6:00 p.m. Monday, September 15 7:00 a.m. - 7:00 p.m. Tuesday, September 16 7:00 a.m. - 10:00 p.m. Sample Badge Aztec code Number Wednesday, September 17 7:00 a.m. - 8:00 p.m. Thursday, September 18 8:00 a.m. - 12:00 p.m. INDUSTRY-EXPERT THEATER* Exhibit Hall, Room 100 This activity allows companies to present their noteworthy products and services through a live presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a fi rst-come, fi rst-served basis. The Industry-Expert Theater content and views expressed therein are those of the exhibitor and not of ASTRO. *Industry-Expert Theaters are not accredited for continuing medical education credits.
SUNDAY, SEPTEMBER 14
Time: 12:15 p.m. – 1:15 p.m. Precision in Practice: Optimizing Outcomes and Expanding Applications with Accuray Company: Accuray Contact: Rebecca Byrne Phone: 408-334-7950 Box lunch provided.
MONDAY, SEPTEMBER 15
Time: 6:45 a.m. – 7:45 a.m. Time: 12:30 p.m. – 1:30 p.m. Perirectal Spacers: Emerging The Therapeutic Application of Xofi go® Technology and Impact on Future (radium Ra 223 dichloride) Injection Prostate RT Utilization Company: Bayer HealthCare Company: Augmenix Contact: Michelle Noyes Contact: Eileen Gardner Phone: 862-404-5478 Phone: 508-944-8015 Box lunch provided. Box breakfast provided.
Time: 10:15 a.m. – 10:45 a.m. Exclusive: Pre-release screening footage from the upcoming series “Cancer: The Emperor of All Maladies” by Award-Winning Executive Producer Ken Burns Company: Siemens Contact: Jeff rey Bell, Sr. Manager, Media Relations - Imaging and Therapy Systems Phone: 484-868-8346 Refreshments provided.
TUESDAY, SEPTEMBER 16 6:45 a.m. – 7:45 a.m. 11:45 a.m. – 12:45 p.m. Clinical Advancements in Patient QA and Safety in Electronic Brachytherapy for Modern Radiation Therapy Breast, Skin and Gynecological Company: ScandiDos Cancers Contact: Marni Brown Company: Xoft Inc. Phone: 608-630-9415 Box breakfast provided. Box lunch provided. INDUSTRY SATELLITE SYMPOSIUM Monday, September 15 6:00 p.m. – 9:30 p.m. Proton Therapy: Clinical Applications and Outcomes, Delivery Methods and Biologic Parameters San Francisco Jazz Center (Registration from 6:00 to 7:00 p.m.; reception to follow the conclusion of the program at 9:00 p.m.)
Accreditation: The University of Florida Target Audience: Radiation oncologists College of Medicine is accredited by the actively involved in the management of Accreditation Council for Continuing patients with cancer, physicists involved Medical Education to provide continuing in clinical medical physics, allied health medical education for physicians. care professionals including but not limited to nurses, therapists, dosimetrists, CME Credits: The University of Florida and administrators. College of Medicine designates this live activity for a maximum of 2.0 AMA PRA This activity is hosted by the University of Category 1 Credits™. Physicians should Florida and is supported by a grant from IBA. claim only the credit commensurate with the extent of their participation in the activity.
SEARCHING FOR QUALIFIED RADIATION ONCOLOGY PROFESSIONALS? Find them online on the ASTRO Career Center and in San Francisco at the ASTRO Career Fair
Find the right people for your practice when you use the ASTRO Career Center. Advance features allow you to search our resume database by education, title, location and more.e.
Located in Rooms 250-262 at the Moscone JOB SEEKERS Center, the ASTRO Career Fair is a great Indicate your availability opportunity to interview qualifi ed for an interview at the candidates. Employer interview space at the Annual Meeting by selecting Career Fair is free for ASTRO members with the Career Fair option the purchase of an online Career Center on “MyAccount” posting at www.astro.org/careercenter. in Career Center. INFORMATION DESK Hearst Parking Center North and South Lobbies 45 Third Street Have a question? Stop by the Information Desk to Entrance on Stevenson, two blocks from Moscone get your questions answered. North and South. 415-989-4000 Hours of Operation: Saturday, September 13 7:00 a.m. - 5:00 p.m. Moscone Center Garage Sunday, September 14 6:30 a.m. - 5:00 p.m. 255 Third Street Monday, September 15 7:00 a.m. - 6:00 p.m. Folsom and Howard, across the street from Moscone Tuesday, September 16 7:00 a.m. - 5:00 p.m. South’s Esplanade Ballroom. Wednesday, September 17 7:00 a.m. - 4:30 p.m. 415-777-2782 (garage) 415-538-7888 (offi ce) LOST AND FOUND North and South Lobbies Museum Parc Garage To report a missing item, to check to see if an item 300 Third Street has been turned into security or to turn in a lost Entrance on Third and Folsom Streets. item, please stop by one of the Information Desks 415-348-0304 located in the North and South Lobbies. PRESS OFFICE AND NEWS BRIEFINGS Hours of Operation: Rooms 110-111 Saturday, September 13 8:00 a.m. - 5:00 p.m. Accredited journalists are provided with a press kit Sunday, September 14 6:30 a.m. - 5:00 p.m. and access to cover ASTRO’s 56th Annual Meeting. Monday, September 15 7:00 a.m. - 6:00 p.m. For more information on-site about ASTRO’s Press Tuesday, September 16 7:00 a.m. - 5:00 p.m. Program and Policies, please contact ASTRO’s on-site Wednesday, September 17 7:00 a.m. - 4:30 p.m. Press Offi ce at 415-978-3503 or email [email protected]. LUGGAGE/COAT CHECK Hours of Operation: North Lobby Sunday, September 14 8:00 a.m. - 4:00 p.m. Luggage and coat check will be available in the Monday, September 15 8:00 a.m. - 4:00 p.m. North Lobby at Moscone Center for $2 per coat and Tuesday, September 16 8:00 a.m. - 4:00 p.m. small handbag and $3 per luggage item. Wednesday, September 17 8:00 a.m. - 12:00 p.m.
Hours of Operation: For ASTRO press information and policies, please Saturday, September 13 7:30 a.m. - 6:00 p.m. visit www.astro.org/AMpress. Sunday, September 14 6:00 a.m. - 6:30 p.m. Monday, September 15 7:00 a.m. - 7:00 p.m. REGISTRANT LOCATOR – FIND-A-FRIEND Tuesday, September 16 7:00 a.m. - 6:30 p.m. Looking to connect with an attendee at the Annual Wednesday, September 17 7:00 a.m. - 5:00 p.m. Meeting? You can now use our Find-a-Friend service with ASTROmobile, the offi cial Annual Meeting app. PARKING Find-a-Friend allows you to search for an attendee Moscone Center does not have a public parking and send messages while at the Annual Meeting. facility on the premises. Listed below are public parking garages in close proximity to the facility, each of which provide spaces reserved for use by authorized, handicapped individuals. Please note ASTRO does not validate for parking.
Fifth and Mission Parking Garage 833 Mission Street Located between Fourth and Fifth Streets, adjacent to Moscone West. 415-982-8522, ext. 18
28 ASTRO 2014 / 56TH ANNUAL MEETING Posters POSTER SETUP AND REMOVAL POSTER VIEWING RECEPTION Hall D Hall D Poster Setup Hours Monday, September 15 5:30 p.m. - 6:45 p.m. Saturday, September 13 12:00 p.m. - 5:00 p.m. Sunday, September 14 7:30 a.m. - 10:00 a.m. All conference attendees are invited to attend this poster viewing session and reception. During this Poster Removal Hours time, poster presenters are available by their poster Tuesday, September 16 5:00 p.m. - 7:00 p.m. to answer questions and discuss their research. Poster award winners are presented their awards at the beginning of this session, and will provide POSTER VIEWING a short oral presentation of their abstract in the Hall D poster presentation area within the hall. Each full New this year, digital posters and paper posters conference attendee, exhibitor and Monday one-day will be on display during the poster viewing hours conference attendee will receive one drink ticket below. Please note that digital posters will not be that can be used for one complimentary bever- available for viewing during digital poster discussion age at the Poster Viewing Session and Reception. session times as the screens will be used for these After your ticket has been redeemed, drinks will be sessions. See the schedule of events or use the available for purchase. You must be 21 years of age Online Conference Planner or ASTROmobile for the to consume alcoholic beverages. Your drink ticket digital poster session schedule. will be included with your badge in your registration materials. Poster Viewing Hours Sunday, September 14 10:00 a.m. - 5:00 p.m. Poster Categories: Monday, September 15 10:00 a.m. - 6:45 p.m. Biology Non-malignant Tuesday, September 16 10:00 a.m. - 5:00 p.m. Breast Nursing CNS Palliative Care POSTER PICKUP OFFICE Gastrointestinal Patient-reported Hall D Genitourinary Outcomes For those poster presenters who chose to use Gynecologic Patient Safety ASTRO’s poster printing service, there is a special Head and Neck Pediatrics pickup location in Hall D. Health Services Research Physics History/Education Quality of Life Hours of Operation: Informatics/Bioinformatics Sarcoma/Cutaneous Saturday, September 13 12:00 p.m. - 5:00 p.m. Lung Tumors Sunday, September 14 7:30 a.m. - 5:00 p.m. Lymphoma/Hematologic/ Monday, September 15 10:00 a.m. - 5:00 p.m. Leukemia
DIGITAL POSTER SESSIONS *NEW* Digital Poster Format Digital Poster Presenters New this year, the Digital Poster Discussion sessions Digital Poster Presenters must check-in at the Digital will have a new format and sessions will be held in Poster Discussion Check-in booth located in the the Poster Hall. Sessions will begin with 15 minutes of Poster Hall between the digital poster session rooms poster viewing on monitors located outside of the ses- at least two hours prior to your presentation. sion room. Attendees and presenters will then move Staff will be available to assist you with uploading any into the session room to hear brief four-minute oral last-minute changes and to help you prepare for your presentations from each poster presenter. The session oral presentation. Presenters are required to stand will end with discussant presentations that compare, by their poster for the fi rst 15 minutes of the session. contrast and tie the abstracts together. The sessions Once the session begins presenters should sit in the will take advantage of touch-screen technology to front row and wait for the Discussant to call you up to present more in-depth information, and the monitor the podium for your presentation. structure has been redesigned to allow for easier viewing and discussion with colleagues. PASSPORT PROGRAM (As of July 31, 2014)
A special thank you to our Survivor Circle Passport Program Participants. Through their generous donations, the Breast and Gyn Health Project and Kids Konnected received grants to help support their initiatives helping California cancer survivors.
RADIATION ONCOLOGY INSTITUTE (ROI) BOOTH
North Lower Lobby, across from the ASTRO Resource Center
All Annual Meeting attendees are invited to visit the Radiation Oncology Institute (ROI) booth, located near Hall D at Moscone Center. Learn more about ROI’s research initiatives and current projects. Our mascot, “ROI” the gorilla, will also be on hand for those wishing to accept our Gorilla Challenge. Don’t miss out on this great opportunity and show your support of the Institute!
Hours of Operation:
Sunday, September 14 8:00 a.m. - 5:00 p.m. Monday, September 15 8:00 a.m. - 5:00 p.m. Tuesday, September 16 8:00 a.m. - 5:00 p.m. Wednesday, September 17 8:00 a.m. - 12:00 p.m.
30 ASTRO 2014 / 56TH ANNUAL MEETING Shuttle Service SHUTTLE SERVICE TO MOSCONE CENTER This is preliminary information only, which is subject to change at any time without notice.
HOURS OF OPERATION SATURDAY, SEPTEMBER 13 8:00 a.m. – 6:30 p.m.
SUNDAY, SEPTEMBER 14 6:30 a.m. – 7:00 p.m. MONDAY, SEPTEMBER 15 6:15 a.m. – 7:30 p.m. TUESDAY, SEPTEMBER 16 6:15 a.m. – 7:00 p.m. WEDNESDAY, SEPTEMBER 17 6:30 a.m. – 5:00 p.m.
HOTELS AND BOARDING LOCATIONS All travel times are approximate pending time of day, day of week and traffi c conditions. Approximate one-way Frequency Route Hotel Boarding location at hotel travel time in minutes Hotel Abri On Cyril Magnin, across the street from 1 Parc 55 Wyndham San Francisco the Parc 55 7-10 10-15 PEAK MINUTES 15-20 NONPEAK
Clift Hotel At Hilton San Francisco Hilton San Francisco Union Square* Curbside on Taylor 8-12 10-15 PEAK 2 Hotel Monaco (a Kimpton property) At Hilton San Francisco MINUTES 15-20 NONPEAK Hotel Nikko San Francisco At Hilton San Francisco Serrano Hotel San Francisco At Hilton San Francisco Handlery Union Square Hotel At Westin St. Francis JW Marriott San Francisco Union Square At Westin St. Francis 9-13 1015 PEAK 3 Prescott Hotel (a Kimpton property) At Westin St. Francis MINUTES 1520 NONPEAK Villa Florence Hotel At Westin St. Francis Westin St. Francis Curbside on Post
Grand Hyatt San Francisco Check the sign in your hotel lobby upon 4 Hotel Triton (a Kimpton property) arrival in San Francisco for boarding 10-14 10-15 PEAK Marriott Union Square San Francisco location. MINUTES 15-20 NONPEAK Sir Francis Drake Hotel (a Kimpton property) Courtyard by Marriott San Francisco Downtown Hotel Palomar (a Kimpton property) InterContinental San Francisco Marriott Marquis SanFrancisco WALK Mosser Hotel, The NO SHUTTLE SERVICE PROVIDED. Palace Hotel, A Luxury Collection Hotel St. Regis Hotel San Francisco W Hotel San Francisco Westin San Francisco Market Street *ASRT is being held at the Hilton San Francisco Union Square. Attendees must ride Route #2 and from Moscone Center to access the Hilton San Francisco Union Square. Transfer point for all routes is at Moscone Center. Funded in part by Elekta ASTRO 2014 / 56TH ANNUAL MEETING 31 SAN FRANCISCO TRAVEL INFORMATION organizations featured in the Survivor Circle. Since South Lobby its inception, the Survivor Circle has raised nearly Attendees can stop by the San Francisco travel $200,000 for our partner organizations. Stop by the information desk located in the South Lobby at Survivor Circle to learn more about this year’s Moscone Center to receive restaurant Survivor Circle Grant Recipients: Breast and Gyn recommendations, San Francisco visitor guides, Health Project and Kids Konnected. maps, destination information and local directions. TRANSPORTATION Hours of Operation: San Francisco off ers a number of convenient Sunday, September 14 9:00 a.m. - 5:00 p.m. transportation options to help attendees easily get Monday, September 15 9:00 a.m. - 5:00 p.m. around the city. Tuesday, September 16 9:00 a.m. - 5:00 p.m. Airport SMOKING The San Francisco International Airport (SFO) is Moscone Center is a non-smoking facility. approximately 14 miles from Moscone Center and Union Square. Buses, shared ride and long-distance SPEAKER READY ROOM vans, taxis, and hotel and rental car courtesy vans are Room 121 located in the arrival area of each terminal. Faculty members and abstract presenters should upload their PowerPoint presentation in advance of Taxi their session in order to have it pre-loaded onto the On average, a one-way taxi ride from the San ASTRO conference network. To ensure presentations Francisco International Airport (SFO) to Moscone have been properly uploaded, faculty members Center and Union Square is approximately $45 and abstract presenters are asked to check in at the one-way (gratuity not included). Speaker Ready Room to review the information and make any last-minute edits. SFMTA SFMTA is San Francisco’s public transportation Speakers should plan to save their presentation on system that provides light rail and bus services a portable device and bring it to the Speaker Ready throughout downtown and to and from the airport. Room at least 24 hours in advance of their The fare for rail and bus is $2 and for cable car is $6. presentation or upon arrival at Moscone Center. For more information on rates and schedules, visit www.sfmta.com. Hours of Operation: Saturday, September 13 6:45 a.m. - 6:00 p.m. BART/CALTRAIN Sunday, September 14 6:45 a.m. - 6:15 p.m. BART (Bay Area Rapid Transit) is a fast, easy and Monday, September 15 6:45 a.m. - 5:45 p.m. inexpensive way to get to San Francisco and around Tuesday, September 16 6:45 a.m. - 6:15 p.m. the Bay area. Trains arrive at the San Francisco Wednesday, September 17 6:45 a.m. - 4:30 p.m. International Airport (SFO) terminal every 15 minutes. It is 30 minutes to downtown San Francisco, SURVIVOR CIRCLE and a one-way ticket from the airport to downtown ASTRO Resource Center, Outside Hall D is $8.65. In 2003, ASTRO created the Survivor Circle as a way to honor cancer survivors. Each year, ASTRO partners with two local patient support organizations and features them at the Survivor Circle at the Annual Meeting. It was our hope that by partnering with local organizations in the cities that host our meeting, we would be able to not only give back to the cities we visit, but also help raise awareness of Connect with attendees. these important organizations among our members. Through generous donations from exhibitors and Tweet attendees, ASTRO raises funds for the two #ASTRO14
32 ASTRO 2014 / 56TH ANNUAL MEETING VIRTUAL MEETING WIRELESS INTERNET ACCESS Extend your learning experience with access to Complimentary wireless Internet access is provided the 2014 ASTRO sessions long after the meeting is in all common areas and session rooms throughout over. All full conference attendees receive the Moscone Center. Please note that this does not Virtual Meeting with their registration at no include the Exhibit Hall. Attendees can bring their additional cost. You will receive streaming content laptop to check email, complete the evaluation or that has been digitally recorded live and published surf the Internet. Laptops must have a Wi-Fi card to as audio synchronized to the speaker presentations.* connect. Within two weeks after the meeting, full conference attendees will receive an email with a link providing access to the Virtual Meeting.
*Presentations are included in the Virtual Meeting as approved per faculty.
Funded in part by Varian.
ASTRO 2014 / 56TH ANNUAL MEETING 33 Floor Plans North Lobby ce/Other Offi E AND HOUSING DESK ASTRO INFORMATION ATTENDEE REGISTRATION ATTENDEE SHUTTLE DROP-OFF/PICKUP FOR ROUTES 1 AND 2 CYBER CAFE
E Luggage/Coat Check Luggage/Coat Restrooms Elevator Escalator Shuttle Bus Session Room
34 ASTRO 2014 / 56TH ANNUAL MEETING Floor Plans South Lobby
GENERAL SESSION Esplanade Ballroom
SAN FRANCISCO TRAVEL DESK
E
E
ASTRO Information Lead Retrieval Cyber Café ASTRO Connect Exhibitor Registration
SHUTTLE DROP-OFF/PICKUP FOR ROUTES 3 AND 4
Session Room E Restrooms Elevator Escalator Shuttle Bus Offi ce/Other Floor Plans Mezzanine Level ASTRO Job Interview Rooms (250-262) ASTRO Career Fair ASTRO Career ce/Other Offi 200-212 E 228/230 220-226 Restrooms Elevator Escalator Session Room Floor Plans Exhibit Level
ce/Other
Exhibit Hall Offi Halls A-C
First Aid Industry-Expert Theater
ASTRO Radio News ASTRO Interview Briefing Press Room Room Office
CE Central 130/131 132/133 ASTRO PAC Lounge ASTRO PAC ROI Lounge 121 122 Speaker Faculty/ VIP Ready Room Office
125 123/124 Center ASTRO Resource ASTRO Resource
Poster Information Poster Pickup Poster Discussion Room D-1 Poster Hall D E Poster Discussion Room D-2
Restrooms Elevator Escalator Telephone Session Room
ASTRO 2014 / 56TH ANNUAL MEETING 37 RO ILSTM RADIATION ONCOLOGY INCIDENT LEARNING SYSTEM Sponsored by ASTRO and AAPM
The only medical specialty society-sponsored incident learning system for radiation oncology.
Why participate?
Submit patient safety information in a confi dential, non-punitive environment.
Track and analyze internal incidents while contributing to a national database.
Receive summary reports, including aggregate data on events entered throughout the United States.
Opportunity to satisfy Maintenance of Certifi cation requirements.
Become a champion of safety – ENROLL NOW! www.astro.org/ROILS Schedule of Events
Contouring Learning Lab Learning Contouring Schedule of Events by Day Schedule of Events RO-ILS: Radiation Incident Oncology System Learning APEx: ASTRO Accreditation Program for Excellence for Program APEx: ASTRO Accreditation International Program Nurses’ Program Nurses’ Young Physicians’ Workshop Physicians’ Young ARRO Program Meeting Highlights Presidential Symposium Presidential e Sessions SAM Live INSIDE: Schedule of Events 2014 Corporate Ambassadors (Promotional Supporters) eContouring Learning Lab These hands-on sessions are designed to provide crucial contouring education and experience. Attendees will have an opportunity to learn about and discuss issues such as imaging, target delineation, quality assurance and accuracy. Each attendee receives access to the online cases for practice and reference. Learn more about earning MOC PQI credit for your participation at the CE Central Booth. After this session, attendees will be able to: • Identify basic anatomy in the cases presented. • Evaluate normal tissue dose constraints versus target dose constraints. • Demonstrate improvement in contouring skills in the cases presented between pre- and post-activity. • Self-assess where additional contouring skills training may be needed. • Apply newly acquired contouring skills to his/her own practice. Sarah Hoff e, MD, Program Chair Steven Finkelstein, MD, Program Vice-chair Room: 102 Schedule Saturday, September 13 Sunday, September 14
9:00 a.m. - 10:30 a.m. 8:00 a.m. - 9:30 a.m. eContouring for Gynecologic Cancers eContouring for Lymphoma Beth Erickson, MD, FASTRO, Medical College of Stephanie Terezakis, MD, Johns Hopkins University Wisconsin Joachim Yahalom, MD, FASTRO, Memorial Sloan Arno J. Mundt III, MD, FASTRO, University of Kettering Cancer Center California San Diego 10:15 a.m. - 11:45 a.m. 11:00 a.m. - 12:30 p.m. eContouring for Breast Cancer eContouring for Sarcoma Frank Vicini, MD, 21st Century Oncology Steven Finkelstein, MD, 21st Century Oncology Julia White, MD, Ohio State University Amalia DeComas, MD, The Core Institute Philip Poortmans, MD, PhD, President, ESTRO
1:00 p.m. - 2:30 p.m. 1:15 p.m. - 2:45 p.m. eContouring for Lung Cancer eContouring for Head and Neck – Billy Loo, MD, PhD, Stanford University Intermediate Avraham Eisbruch, MD, University of Michigan 2:45 p.m. - 4:15 p.m. Health Systems eContouring for GI Cancer I Matthew Stenmark, MD, University of Michigan Ravi Shridhar, MD, Moffi tt Cancer Center Health Systems Ken Meredith, MD, University of Wisconsin School of Mary Beth Cunanne, MD, Massachusetts Eye and Ear Medicine and Public Health 3:00 p.m. - 4:30 p.m. 4:30 p.m. - 6:00 p.m. eContouring for Head and Neck – eContouring for GI Cancer II Advanced Karyn Goodman, MD, Memorial Sloan Kettering Avraham Eisbruch, MD, University of Michigan Cancer Center Health Systems Corinne Winston, MD, Memorial Sloan Kettering Matthew Stenmark, MD, University of Michigan Cancer Center Health Systems Mary Beth Cunanne, MD, Massachusetts Eye and Ear
4:45 p.m. - 6:15 p.m. eContouring for Prostate Cancer Michael Zelefsky, MD, Memorial Sloan Kettering Cancer Center Live Self-Assessment Module Sessions Special sessions have been designated as Live Self-Assessment Modules (SAMs) to help physician and physicist attendees meet the requirements of the American Board of Radiology’s Maintenance of Certifi cation (MOC) program. Attendance at the Live SAM sessions is open to all attendees, but only Live SAM ticket holders are eligible to earn SA-CME credit. On-site registration is available at the registration desk if seats are still available (a $35 preregistration fee for each ticketed SAM session is required).
How to Participate On-site Live SAM registrants have two ways to participate: a personal mobile device (smartphone, tablet or laptop) or a paper assessment. All registrants will receive the same assessment and evaluation questions regardless of the method they use to participate.
1. Visit the Live SAM table outside the designated session room 15 minutes prior to the start of the session. 2. Give your Live SAM ticket to ASTRO staff at the Live SAM table. In return for your ticket, ASTRO staff will give you a two-sided handout. One side of the handout contains the Live SAM Participant Directions for both the paper and mobile options and the other side contains the required assessment and evaluation questions for those registrants wishing to use the paper method of participation. 3. Find any available seat in the session room and attend the entire session (required to earn credit). 4. At the conclusion of the session, follow the directions to complete the assessment and evaluation questions on paper or via your personal mobile device. A minimum score of 70 percent must be achieved on the assessment in order to earn credit, and the evaluation questions must be completed as well. 5. ASTRO staff will email you approximately 30 days post-meeting with your individual score and directions on how to print your certifi cate of completion from the ASTRO website.
Live SAM Policy
• Live SAM registrants MUST be in the designated Live SAM room 15 minutes prior to the start of the session. If you are not in the room at this time, your seat may be given away to another attendee. • Registrants interested in using the mobile device option will need to bring their own mobile device and are responsible for ensuring that it is charged and can connect to the Internet via Wi-Fi or a cellular network connection. • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session. Attendees who are more than 10 minutes late to the session will not be able to participate in the Live SAM component. • Registrants must earn a minimum score of 70 percent on the assessment and complete the evaluation questions to earn credit. Participants who do not earn a minimum of 70 percent on the assessment questions will NOT receive SA-CME credit and will NOT receive a refund.
If you have any questions about the Live SAM sessions, SA-CME requirements or MOC, please visit CE Central located outside Hall E.
Connect with attendees. Tweet #ASTRO14
42 ASTRO 2014 / 56TH ANNUAL MEETING Live SAM Sessions Sunday, September 14
1:15 p.m. - 2:45 p.m. Educational Session 101: Knowledge Modeling for Treatment Planning and Its Clinical Implementation Room: 104
4:45 p.m. - 6:15 p.m. Educational Session 105: Challenging Cases in Cervical and Endometrial Cancer Room: 104 Monday, September 15
7:45 a.m. - 9:00 a.m. Educational Session 206: Esophagus and Gastric Cancer: Contemporary Treatment Approaches Room: 104
7:45 a.m. - 9:00 a.m. Educational Session 208: Extranodal Non-Hodgkin’s Lymphoma: Recent Advances in the Management of CNS, Orbital and Cutaneous Lymphomas Room: 103 Tuesday, September 16
7:45 a.m. - 9:00 a.m. Educational Session 304: Cancer of the Colon, Rectum, Anus Room: 104
7:45 a.m. - 9:00 a.m. Educational Session 310: Pediatric Sarcomas and Hodgkin Lymphoma Room: 132/133
1:00 p.m. - 2:30 p.m. Educational Session 311: Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer Room: 104 Wednesday, September 17
7:45 a.m. - 9:00 a.m. Educational Session 403: Imaging Brain Tumors: Practical Primer for the Radiation Oncologist Room: 104
7:45 a.m. - 9:00 a.m. Educational Session 406: Recent Advances in Endometrial Cancer Room: 103
3:00 p.m. - 4:30 p.m. Educational Session 415: Optimizing Outcomes in Breast Cancer Patients Receiving Reconstruction and Radiation Therapy in 2014 Room: 104 ASTRO 2014 / 56TH ANNUAL MEETING 43 Presidential Symposium Local-regional Management of Breast Cancer: A Changing Paradigm September 14, 2014 8:00 a.m. - 12:15 p.m. | Room: Esplanade Ballroom 8:00 a.m. - 8:10 a.m. Welcome Richard T. Hoppe, MD, FASTRO 8:10 a.m. - 8:15 a.m. Presidential Symposium – Introduction Speaker: Bruce G. Haff ty, MD, FASTRO 8:15 a.m. - 10:00 a.m. Presidential Symposium – Session I – Local Management of Breast Cancer Moderators: Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO
Julia White, MD – Partial Breast Irradiation John Yarnold, BSc, MBBS, MRCP – Hypofractionation, Rationale, Current Status and Future Directions Reshma Jagsi, MD, DPhil – Low Risk Luminal A Tumors/Low Oncotype: Less Aggressive Treatment After Lumpectomy or Mastectomy? Jennifer R. Bellon, MD – Triple Negative: More Aggressive Treatment After Lumpectomy or Mastectomy? David E. Wazer, MD, FASTRO – Cardiac Issues in Breast Irradiation
10:00 a.m. - 10:15 a.m. Break – Exhibit Hall Opens
10:15 a.m. - 11:15 a.m. Presidential Symposium – Session II – Local-regional Treatment after Preoperative Systemic Therapy (PST) Moderators: Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO
Eric P. Winer, MD – PST: Why and When? Judy C. Boughey, MD – Surgical Issues after PST? Lori J. Pierce, MD, FASTRO – Radiation Issues after PST Wendy Woodward, MD, PhD – Infl ammatory Breast Cancer: Biologic and Other Special Considerations 11:15 a.m. - 12:15 p.m. Presidential Symposium – Session III – Regional Management of Breast Cancer Moderators: Jay R. Harris, MD, FASTRO, and Thomas A. Buchholz, MD, FASTRO
Henry Kuerer, MD, PhD, vs. Timothy Whelan, MSc, BM, BCh, FASTRO – Debate: Tangents Only or Regional Nodal Irradiation for Sentinel Node + Disease Sarah C. Darby, PhD – Update on EBCTCG for Node Positive Disease
Panel Discussion: Henry Kuerer, MD, PhD Timothy Whelan, MSc, BM, BCh, FASTRO Sarah C. Darby, PhD Lawrence B. Marks, MD, FASTRO Don’t miss the ASTRO Guidelines Highlight Session on Breast Margins on Monday See page 47 for more information.
44 ASTRO 2014 / 56TH ANNUAL MEETING Keynote Speakers Monday, September 15 9:15 a.m. - 10:15 a.m. Keynote Address I – New Horizons in Oncologic Imaging – Unraveling Pathways to Synergy Room: Esplanade Ballroom Hedvig Hricak MD, PhD, Chair, Department of Radiology, Memorial Sloan Kettering Cancer Center Introduced by Sarah S. Donaldson, MD, FASTRO, Stanford Cancer Center
Dr. Hedvig Hricak is chair of the Department of Radiology at Memorial Sloan Kettering Cancer Center. She is a member of the Molecular Pharmacology and Chemistry Program at the Sloan Kettering Institute, and is a professor at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Her publication record includes more than 380 peer-reviewed original research articles and more than 135 monographs and book chapters. Dr. Hricak has held numerous leadership positions in professional societies and has served as president of numerous societies including the Society of Uroradiology (2001-2003) and the Radiological Society of North America (2010). Dr. Hricak will speak on the topic of oncologic imaging and radiogenomics.
Imaging has always been an essential component of treatment planning and follow-up for patients undergoing radiation treatment. Increasingly, opportunities are arising to enhance the sophistication of cross-sectional imaging with molecular imaging, making possible a new level of precision in tumor targeting and the ability to tailor the treatment dose to the tumor’s biology. In addition, the capacity for very early assessment of tumor response by imaging is rapidly evolving. The new discipline of correlating imaging fi ndings with genomics – often called radiogenomics – is off ering still more insights that can help to modulate treatment planning. While the advances in these areas have been exciting, the dissemination of new technologies has been impeded by a variety of obstacles, ranging from limited resources to lack of FDA approval for new tracers and lack of oncologic imaging specialists. Dr. Hricak will discuss emerging areas of potential synergy between radiology and radiation oncology and the need for interdisciplinary collaboration in overcoming obstacles to progress.
Tuesday, September 16 9:15 a.m. - 10:15 a.m. Keynote Address II – New Approaches to Targeting K-Ras Room: Esplanade Ballroom Frank McCormick, PhD, FRS, David A. Wood Distinguished Professor of Tumor Biology and Cancer Research and Professor Emeritus, UCSF Helen Diller Family Comprehensive Cancer Center Introduced by Catherine C. Park, MD, University of California San Francisco
Dr. Frank McCormick is the David A. Wood Distinguished Professor of Tumor Biology and Cancer Research at the University of California San Francisco. He recently held the position of director of the UCSF Diller Family Comprehensive Cancer Center. Dr. McCormick will address the promise of biology and targeting in oncology, specifi cally as it relates to K-Ras proteins, which play a major role in many human cancers.
K-Ras proteins have unique biochemical properties relative to other Ras proteins that off er new opportunities for therapeutic intervention. Dr. McCormick’s lab is attempting to target K-Ras 4B, the major isoform of K-Ras, directly and indirectly. The lab has identifi ed compounds that bind covalently to the C-terminal CAAX box and prevent prenylation. In his address, Dr. McCormick will discuss the strategy of modifying these compounds through medicinal chemistry to increase specifi city for K-Ras relative to other Ras proteins. He will also discuss the work his lab has done in the various mutants of K-Ras and their diff erent biochemical properties. Tumors driven by the diff erent K-Ras mutants also have diff erent clinical outcomes that presumably relate to these functional diff erences. Dr. McCormick will discuss the results from his labs exploration of these diff erences using Ras-less MEFS rescued by introduction of individual Ras isoforms so that contributions of diff erent isoforms and diff erent mutant alleles to signaling networks can be analyzed in isolation. Wednesday, September 17 9:15 a.m. - 10:00 a.m. Keynote Address III – Human Error and Just Culture Room: Esplanade Ballroom Sidney Dekker, PhD, MA, MSc, Professor and Director, Safety Science Innovation Lab, Griffi th University Introduced by Lawrence B. Marks, MD, FASTRO, University of North Carolina
Dr. Dekker is currently a professor at Griffi th University in Brisbane, Australia, where he is director of the Safety Science Innovation Lab. He is also an honorary professor of psychology at The University of Queensland. Previously, he was professor of human factors and system safety at Lund University in Sweden. There, he learned to fl y the Boeing 737, working part-time as an airline pilot out of Copenhagen. Dr. Dekker has received worldwide acclaim for his groundbreaking work in human factors and safety, and is a best-selling author of several books on patient safety and just culture including his latest book, “Safety Diff erently” (2014). Dr. Dekker will speak on the topic of human error, safety culture and safety as it is related to medicine and, specifi cally, the fi eld of radiation oncology.
Dr. Dekker’s address will focus on several safety topics and questions, including: “When we go beyond the technical details of a radiation oncology incident, and face a ‘human error’ problem, we may be tempted to ask ‘Why didn’t these people watch out better?’ or ‘How could they miss that which is now so obvious to us?’” and “Beyond the software and hardware, can we solve our safety problems by telling people to be more careful, by reprimanding the miscreants, by issuing a new rule or procedure, by demanding compliance?” Dr. Dekker will explain that these are all expressions of “The Bad Apple Theory,” where we believe our system is basically safe if it were not for those few unreliable people in it. He will suggest that a new way of dealing with a perceived “human error” problem in the fi eld is to see “human error” as systematically connected to features of people’s tools and tasks. To begin dealing with a “human error problem,” Dr. Dekker will discuss the need to look more closely at how people create safety through practice, mostly successfully, under the pressure of resource constraints and multiple confl icting goals.
46 ASTRO 2014 / 56TH ANNUAL MEETING Meeting Highlights
Sunday, September 14 3:15 p.m. – 4:45 p.m. Clinical Trials Session Room: Esplanade Ballroom Moderators: Lynn D. Wilson, MD, MPH, FASTRO, Yale School of Medicine Benjamin Movsas, MD, FASTRO, Henry Ford Health System See page XX for full details. Monday, September 15 1:30 p.m. - 2:15 p.m. Presidential Address – Back to the Future: 30 Years in Breast Cancer Room: Esplanade Ballroom Bruce G. Haff ty, MD, FASTRO, President, ASTRO Introduced by: Lynn Wilson, MD, MPH, FASTRO, Yale School of Medicine
Join us for the Presidential Address where ASTRO President Dr. Bruce Haff ty will discuss the evolution in the treatment of breast cancer over the past 30 years. The informative presentation will cover what has changed, what hasn’t changed and projections for the future. Monday, September 15 2:15 p.m. – 3:25 p.m. Plenary Session Room: Esplanade Ballroom Moderators: Lynn D. Wilson, MD, MPH, FASTRO, Yale School of Medicine Benjamin Movsas, MD, FASTRO, Henry Ford Health System See page XX for full details. Monday, September 15 3:25 p.m. - 3:45 p.m. ASTRO Guidelines Highlight I – Breast Margins Room: Esplanade Ballroom Meena S. Moran, MD, Yale School of Medicine Monica Morrow, MD, Memorial Sloan Kettering Cancer Center Wednesday, September 17 10:00 a.m. - 10:30 a.m. ASTRO Guidelines Highlight II – Endometrial and Lung Cancer Room: Esplanade Ballroom Benjamin D. Smith, MD, MD Anderson Cancer Center Ann H. Klopp, MD, PhD, MD Anderson Cancer Center George Rodrigues, MD, PhD, London Health Sciences Centre
Great speaker? Tweet #ASTRO14
ASTRO 2014 / 56TH ANNUAL MEETING 47 ARRO Program Saturday, September 13 ARRO Annual Seminar* 10:00 a.m. - 5:00 p.m. Room: 103 Box lunch provided. Refer to page 50 for program schedule. *This session is not accredited for continuing medical education credits.
6:30 p.m. - 8:30 p.m. ARRO Reception Slide 430 Mason St. San Francisco, CA 94102
The ARRO Reception will be held at Slide, a popular nightclub ideally situated in downtown San Francisco in the historic Theater District adjacent to Union Square. Slide is located at 430 Mason St., between Geary St. and Post St., an approximate 15-minute walk from Moscone Center. Shuttle service will not be provided to the ARRO Reception.
Sunday, September 14 12:15 p.m. - 1:15 p.m. ARRO Annual Luncheon Room: 200-212 Guest Speaker: Colleen A.F. Lawton, MD, FASTRO, Chair, ASTRO Board of Directors
Monday, September 15 7:15 a.m. - 9:00 a.m. Meet the Professor Breakfast – Leadership Part 1* Room: 101 Join us for the newly revamped ARRO Meet the Professor breakfast! Registered attendees will hear best-selling author and leadership expert Courtney Lynch and a panel of world-renowned radiation oncologists speak on various aspects of leadership as it relates to residents in radiation oncology. There will be audience interaction throughout the event with plenty of time for questions and answers.
Guest Speaker: Courtney Lynch, Lead Star Panelists: Theodore L. DeWeese, MD, Johns Hopkins School of Medicine Tim R. Williams, MD, FASTRO, Lynn Cancer Institute Akila N. Viswanathan, MD, MPH, Brigham and Women’s Hospital Andrew T. Turrisi III, MD, Locum Tenens *This session is not accredited for continuing medical education credits.
48 ASTRO 2014 / 56TH ANNUAL MEETING 12:15 p.m. - 1:30 p.m. ARRO Poster Walk with a Professor Room: Poster Hall D Box lunch provided.
12:30 p.m. - 1:30 p.m. How to Review a Scientifi c Paper Workshop I* Room: 220-222 W. Robert Lee, MD, MS, MEd, Duke University Box lunch provided. *This session is not accredited for continuing medical education credits.
5:30 p.m. - 6:45 p.m. Meet and Greet – Residents and Medical Students Room: Poster Hall D Please join us in the Poster Hall during the Poster Session and Reception to meet and greet the medical students in attendance. This is a great opportunity to meet medical students and off er your help and guidance navigating the ASTRO Annual Meeting. Wednesday, September 17 12:15 p.m. - 1:15 p.m. How to Review a Scientifi c Paper Workshop II* Room: 200/212 W. Robert Lee, MD, MS, MEd, Duke University Box lunch provided. *This session is not accredited for continuing medical education credits.
ASTRO 2014 / 56TH ANNUAL MEETING 49 ARRO Annual Seminar* Saturday, September 13 10:00 a.m. - 4:30 p.m. | Room: 103 This year’s program combines a variety of timely topics for residents at all stages of training. Using the audience interactive system, presentations are intended to facilitate interaction among participants from diff erent communities. *This session is not accredited for continuing medical education credits.
10:00 a.m. - 10:15 a.m. Opening Remarks by the ARRO Executive Committee Welcome and Reminders – Seth Miller, MD, University of North Carolina at Chapel Hill Program Review – Nima Nabarizadeh, MD, Oregon Health and Science University 10:15 a.m. - 10:30 a.m. Global Health Scholar Presentations Global Health Scholar Program Awardee Presentation on Accra, Ghana – Kosj Yamoah, MD, Thomas Jeff erson University and Hospitals
How to Design a Radiation Oncology Related Project in a Developing Nation Tracy Sherertz, MD, Case Western University Hospitals 10:30 a.m. - 11:00 a.m. Radiation Oncologist Engagement in Quality and Safety in Leadership Bhisham Chera, MD, University of North Carolina at Chapel Hill 11:00 a.m. - 11:10 a.m. Break 11:10 a.m. - 12:00 p.m. Keynote Address: Physician Engagement in the Era of Value-based Health Care: A Call to Action Stephen Hahn, MD, FASTRO, University of Pennsylvania 12:00 p.m. - 1:00 p.m. Lunch (Box lunch provided)
1:00 p.m. - 2:15 p.m. Applying for Jobs: A Panel Discussion Moderator: Lisa A. Kachnic, MD, Boston Medical Center Panelists: Aaron Spalding, MD, PhD, Norton Cancer Institute Marka R. Crittenden, MD, PhD, Providence Cancer Center, The Oregon Clinic Siavash Jabbari, MD, Scripps Health Gautum Prasad, MD, PhD, Epic Care 2:15 p.m. - 2:30 p.m. Break 2:30 p.m. - 3:30 p.m. Career Development: Strategy Primer to Address Young Investigator Skill Set Gaps for Clinical Research Charles R. Thomas Jr., MD, Oregon Health and Science University 3:30 p.m. - 3:45 p.m. Prospective Review: A New Form of Submission for Manuscripts to the Red Journal Loren Mell, MD, University of California San Diego 3:45 p.m. - 4:00 p.m. Break 4:00 p.m. - 5:00 p.m. Practice Entry Survey Results Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
50 ASTRO 2014 / 56TH ANNUAL MEETING Young Physicians’ Workshop Tuesday, September 16 2:45 p.m. - 6:15 p.m. | Room: 123/124 This two-part workshop will address several key issues facing early career physicians and will provide an open forum for discussion among peers. The educational focus is targeted toward young physicians with less than 10 years in practice. Distinguished faculty will share their experiences and insights on several exciting topics. 2:45 p.m. - 4:15 p.m. Young Physicians’ Workshop – Part 1 Welcome and Introductions Eric D. Donnelly, MD, Northwestern University Feinberg School of Medicine Sudha Amarnath, MD, Cleveland Clinic
Understanding What the ABR Wants from You Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital Negotiating a Contract When You Are Established in the Field Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
Economics 101 – How Are Radiation Oncologists Compensated David C. Beyer, MD, FASTRO, Arizona Oncology Services
4:45 p.m. - 6:15 p.m. Young Physicians’ Workshop – Part 2 Welcome and Introductions – Eric D. Donnelly, MD, Northwestern University Feinberg School of Medicine, and Sudha Amarnath, MD, Cleveland Clinic
Diffi cult Conversations with Patients Moderators: Eric D. Donnelly, MD, Northwestern University Feinberg School of Medicine Sudha Amarnath, MD, Cleveland Clinic
Panelists: Nils Arvold, MD, Dana-Farber Cancer Institute, Brigham and Women’s Hospital Nancy P. Mendenhall, MD, University of Florida Danielle N. Margalit, MD, MPH, Dana-Farber/Brigham and Women’s Hospital Cancer Center, Harvard Medical School Tim R. Williams, MD, FASTRO, Lynn Cancer Institute
Case Presentation Moderators: Eric D. Donnelly, MD, Northwestern University Feinberg School of Medicine Sudha Amarnath, MD, Cleveland Clinic
Panelists: Patty Hardenberg, MD, Shaw Regional Cancer Center Grant Hunter, MD, Intermountain Healthcare Reshma Jagsi, MD, DPhil, University of Michigan Charles R. Thomas Jr., MD, Oregon Health and Science University
How to Get Involved with Your Specialty – Shilpen Patel, MD, University of Washington Nurses’ Program This year’s Nurses’ Program includes 11 sessions and a luncheon designed to address the educational needs of radiation oncology nurses. The Nurses’ Luncheon is open to all Annual Meeting nurse registrants, but the option must have been added at the time of registration; therefore, you must have a ticket to attend.
Saturday, September 13 10:00 a.m. - 11:30 a.m. Palliative Care Panel Room: 300 Tracy Balboni, MD, MPH, Dana-Farber Cancer Institute Lorraine Drapek, MSN, NP, Massachusetts General Hospital Jeannine Brant, PhD, APRN, AOCN, Billings Clinic
11:30 a.m. - 12:45 p.m. Welcome Luncheon Room: 104 Michelle Wallace, RN, William Beaumont Hospital The Annual Meeting Nurse Abstract Awards will be presented during the luncheon.
12:45 p.m. - 1:45 p.m. Room: 300 Radiation Treatment of Non-malignant Disorders Lynn Leandro, MS, MSN, RN, GNP-BC, Emory Healthcare, Winship Cancer Institute
2:00 p.m. - 3:00 p.m. Room: 300 Acute and Late Eff ects of Chemo-radiotherapy in Lung Cancer: Integrating Survivorship Craig Stevens, MD,PhD, Beaumont Health System Jeanne Parzuchowski, RN, William Beaumont Hospital
3:00 p.m. - 4:00 p.m. Room: 300 Skin Care for the Radiation Oncology Patient Dorothy Doughty, MN, RN, CWOCN, FAAN, Emory University
4:15 p.m. - 5:15 p.m. Room: 300 To Treat or Not to Treat: Decision-making and Treatment Options in Low-risk Prostate Cancer: Risk versus Benefi t Vanna Dest, MSN, APRN, AOCN, Yale New Haven Hospital, Smilow Cancer Hospital Pamela Devine, MSN, RN, Philadelphia VA Medical Center
ARONA Ticketed Event/ Nurses’ Live Interactive Separate Session SAM/ Session registration Separate required registration 52 ASTRO 2014 / 56TH ANNUAL MEETING required Sunday, September 14 8:30 a.m. - 10:00 a.m. Room: 220-226 Survivorship Panel Richard Boyajian, RN, MS, NP, Dana-Farber Cancer Institute Jeannine Brant, PhD, APRN, AOCN, Billings Clinic Carrie Stricker, PhD, RN, On Q Health Inc.
10:15 a.m. - 11:15 a.m. Room: 220-226 Know Your Patients’ Behaviors: Impact on Radiation Treatment and Outcomes Emily Moore, ND, LAC, Indiana Health Goshen Center for Cancer Care
11:15 a.m. - 12:15 p.m. Room: 220-226 Update on Protons - GI, GU and Breast Lorraine Drapek, MSN, NP, Massachusetts General Hospital
1:15 p.m. - 2:45 p.m. Room: 220-226 Rehab for RT Patients/Lymphedema from Radiation Carol Parmelee, RN, Indiana University Health
3:15 p.m. - 4:45 p.m. Room: 220-226 Revolutionary Noninvasive Surgery Procedures Michelle Manders, RN, BScN, William Beaumont Hospital Daniel Krauss, MD, Oakland University William Beaumont School of Medicine
4:45 p.m. - 6:15 p.m. Room: 220-226 Sexuality – Long Term Eff ects from Radiation – Male and Female Deborah Watkins Bruner, PhD, RN, Emory University
ASTRO 2014 / 56TH ANNUAL MEETING 53 International Program
A series of sessions have been identifi ed throughout the Annual Meeting Program as pertinent to our international attendees. The International Attendee Welcome Breakfast is open to all international attendees, and you must have an international attendee badge holder (black) to be admitted. The Foreign Language Poster Walks are ticketed events. You must be registered for these events and have a ticket to attend. Lunch will be provided at the Poster Walks for those who have tickets to attend. Saturday, September 13 1:00 p.m. - 2:30 p.m. ASTRO 2014 Chinese Language Refresher Course: Multidisciplinary Approach to Improve Quality and Safety in Radiotherapy Room: 122 Moderator: Zhongxing Liao, MD, MD Anderson Cancer Center
Speakers: Yexiong Li, MD, PhD, Chinese Academy of Medical Science Cancer Hospital Dian Wang, MD, Medical College of Wisconsin Barbara Sims, BS, RTT, Fox Chase Cancer Center W. Kenneth Zhen, MD, University of Nebraska Medical Center Jinming Yu, MD, PhD, Sandong Tumor Hospital and Institute Jinyi Lang, MD, Sichuan Tumor Hospital and Institution Feng-Ming Kong, MD, PhD, Georgia Regents University
3:00 p.m. - 6:00 p.m. ASTRO 2014 Spanish Language Refresher Course: Update and Review of Established and Modern Technologies Room: 122 Moderators: Beatriz Amendola, MD, Innovative Cancer Institute Higinia Cárdenes, MD, PhD, Indiana University
Speakers: Victor Bourel, PhD, Universidad Favaloro Naipy Perez, MS, Innovative Cancer Institute Dante E. Roa, PhD, University of California Irvine Roberto Diaz, MD, PhD, Moffi t Cancer Center Ferran Guedea, MD, University of Barcelona Beatriz Amendola, MD, Innovative Cancer Institute Juanita Crook, MD, University of British Columbia Carlos Perez, MD, FASTRO, Washington University Higinia Cárdenes, MD, PhD, Indiana University
ARONA Ticketed Event/ Nurses’ Live Interactive Separate Session SAM/ Session registration Separate required registration required
54 ASTRO 2014 / 56TH ANNUAL MEETING Sunday, September 14 6:45 a.m. – 8:00 a.m. International Attendee Welcome Breakfast Room: 104 The Internationals Abstract Award will be presented during the breakfast, along with remarks from the International Education Subcommittee Chair Kenneth Hu, MD.
1:15 p.m. – 2:45 p.m. Best of ESTRO at ASTRO* Room: 300 Moderators: Bruce G. Haff ty, MD, FASTRO, President, ASTRO Philip Poortmans, MD, PhD, President of ESTRO
Speakers: Philip Poortmans, MD, PhD, President of ESTRO Nuria Jornet, PhD, Chair, Physics Committee, ESTRO Brad Wouters, PhD, Chair, Radiobiology Committee, ESTRO * This session is not accredited for continuing medical education credits
4:45 p.m. – 6:15 p.m. UICC Panel – Inserting Radiotherapy into the Global Health Movement* Room: 300 Moderator: Mary Gospodarowicz, MD, FASTRO, Princess Margaret Hospital
Speakers: David Jaff ray, PhD, Princess Margaret Hospital Rifat Atun, MBA, Harvard University Danielle Rodin, MD, University of Toronto Gavin Yamey, MD, MPH, MA, MRCP, University of California, San Francisco * This session is not accredited for continuing medical education credits
Monday, September 15 7:45 a.m. – 9:00 a.m. Room: 300 ASTRO/ESTRO Joint Breast Symposium - Current Challenges in Radiation Therapy for Breast Cancer*
Speakers: Philip Poortmans, MD, PhD, President of ESTRO Nuria Jornet, PhD, Chair, Physics Committee, ESTRO Lawrence B. Marks, MD, FASTRO, University of North Carolina Atif Khan, MD, Cancer Institute of New Jersey * This session is not accredited for continuing medical education credits
Connect with attendees Tweet #ASTRO14
ASTRO 2014 / 56TH ANNUAL MEETING 55 10:45 a.m. - 12:15 p.m. ASTRO 2014 International Symposium: Workshop on Safe Implementation of Advanced Technologies in Radiation Oncology PART I: Practice of Advanced Radiotherapy Techniques, Clinical Implementation of IMRT, IGRT and IGART Programs Room: 125 Moderator: Jatinder Palta, PhD, FASTRO, Virginia Commonwealth University
Speakers: Patrick Kupelian, MD, University of California Los Angeles Jatinder Palta, PhD, FASTRO, Virginia Commonwealth University Jean Moran, PhD, University of Michigan Laura Dawson, MD, Princess Margaret Hospital
12:15 p.m. – 1:30 p.m. Foreign Language Poster Walks Room: Poster Hall D Foreign Language Poster Walks will be off ered in Chinese and Spanish, and will review selected abstracts based on disease site. Please note that this event is open to international attendees only. Please refer to the details below for further information.
CHINESE POSTER WALK Faculty: W. Kenneth Zhen, MD Disease Site: Head and Neck
SPANISH POSTER WALK Faculty: Adela Poitevin, MD Disease Site: Breast, CNS and Prostate
4:15 p.m. - 5:45 p.m. ASTRO 2014 International Symposium: Workshop on Safe Implementation of Advanced Technologies in Radiation Oncology PART II: Commissioning SBRT and SRS Systems; Clinical Implementation of SBRT and SRS Programs; Moderated Interactive Discussion Room: 125 Moderator: Jatinder Palta, PhD, FASTRO, Virginia Commonwealth University
Speakers: Indrin J. Chetty, PhD, Henry Ford Hospital Center Brian Kavanagh, MD, MPH, University of Colorado Jatinder Palta, PhD, FASTRO, Virginia Commonwealth University Nina A. Mayr, MD, FASTRO, University of Washington
56 ASTRO 2014 / 56TH ANNUAL MEETING ASTRO Accreditation Program for Excellence (APEx) ASTRO’s practice accreditation program highlights the Society’s commitment to safety and quality. The program uses evidence-based guidelines and consensus statements on the practice of radiation oncology to establish standards of performance. ASTRO’s practice accreditation program will provide an objective review by practicing radiation oncology professionals of essential functions and processes of radiation oncology practices, in addition to a facility visit from a multidisciplinary team. The practice accreditation program consists of fi ve key areas: the process of care, the radiation oncology team, safety, quality TM management and patient-centered care. Saturday, September 13 1:00 p.m. - 4:00 p.m. ASTRO Accreditation Program for Excellence (APEx) – Surveyor Session* Room: 200-226 Angela Nicholas, DC, MBA, ASTRO Yan Yu, PhD, MBA, Thomas Jeff erson University Prabhakar Tripuraneni, MD, FASTRO, Scripps Health Clinic Amy Nordeng, JD, ASTRO
This interactive session is designed to provide guidance on the surveyor’s role and an opportunity for surveyors to take the online orientation modules*. The target audience for this session is approved surveyors for ASTRO’s practice accreditation program.
Participants of this session will be able to: • Discuss the mission, vision and goals of the program. • Discuss the radiation oncology practice accreditation model. • Identify and discuss the program standards. • Identify the steps of the survey process. • Discuss corrective action steps when encountering diffi cult scenarios during a survey. • Discuss surveyor training requirements. *Attendees must bring their own laptop to participate in taking the online modules. Internet access and power cords will be provided.
Monday, September 15 12:30 p.m. - 1:30 p.m. ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon Room: 200-212 Prabhakar Tripuraneni, MD, FASTRO, Scripps Health Clinic James Hayman, MD, MBA, University of Michigan Hospitals Yan Yu, PhD, MBA, Thomas Jeff erson University This session will provide an overview of ASTRO’s practice accreditation program. This luncheon will provide the necessary information needed to understand the process, from application to successful accreditation. Those attending will be able to understand the expectations, steps, resources and tools to complete the process.
ASTRO 2014 / 56TH ANNUAL MEETING 57 RADIATION ONCOLOGY TM RO ILS INCIDENT LEARNING SYSTEM Sponsored by ASTRO and AAPM
RO-ILS: Radiation Oncology Incident Learning System™ provides a shared learning environment for radiation oncology providers to collect and analyze patient safety events. ASTRO contracted with Clarity PSO, a federally qualifi ed patient safety organization (PSO), to develop and administer RO-ILS. PSOs create a secure, non-punitive environment where providers can collect, aggregate and analyze data to identify and reduce the risks and hazards associated with patient care, as outlined in the Patient Safety and Quality Improvement Act of 2005. RO-ILS was also developed with the support and partnership of the American Association of Physicists in Medicine and is the only medical specialty society-sponsored incident learning system for radiation oncology. On June 19, 2014, RO-ILS became available to the full radiation oncology community. Please join us at the following sessions to learn more about RO-ILS and patient safety. RO-ILS Luncheon: Sunday, September 14 12:15 p.m. - 1:15 p.m. RO-ILS Luncheon: Lessons Learned from Medical Specialty Patient Safety Organizations Room: 101 Moderator: Adam Dicker, MD, PhD, Jeff erson Medical College of Thomas Jeff erson University
Speakers: Carrie Bosela, RN, CPC, CPC-I, Society for Vascular Surgery Patient Safety Organization Donald Tyler, MD, MBA, Executitve Director, Wake up Safe Other Sessions of Interest: Wednesday, September 17 9:15 a.m. - 10:00 a.m. Keynote Address III – Human Error and Just Culture Room: Esplanade Ballroom See page 46 for more information.
10:45 a.m. - 12:15 p.m. Educational Session 412: Improving Patient Safety and Quality of Care with the Radiation Oncology Incident Learning System (RO-ILS) Room: 134 See page 104 for more information.
58 ASTRO 2014 / 56TH ANNUAL MEETING ASTRO 2014 / 56TH ANNUAL MEETING 59 60 ASTRO 2014 / 56TH ANNUAL MEETING 61 ASTRO 2014 / 56TH ANNUAL MEETING 62 ASTRO 2014 / 56TH ANNUAL MEETING 63 ASTRO 2014 / 56TH ANNUAL MEETING
65 ASTRO 2014 / 56TH ANNUAL MEETING 66 ASTRO 2014 / 56TH ANNUAL MEETING
68 ASTRO 2014 / 56TH ANNUAL MEETING 69 ASTRO 2014 / 56TH ANNUAL MEETING 70 ASTRO 2014 / 56TH ANNUAL MEETING 71 ASTRO 2014 / 56TH ANNUAL MEETING 72 ASTRO 2014 / 56TH ANNUAL MEETING 73 ASTRO 2014 / 56TH ANNUAL MEETING 74 ASTRO 2014 / 56TH ANNUAL MEETING 75 ASTRO 2014 / 56TH ANNUAL MEETING 76 ASTRO 2014 / 56TH ANNUAL MEETING 77 ASTRO 2014 / 56TH ANNUAL MEETING 78 ASTRO 2014 / 56TH ANNUAL MEETING 79 ASTRO 2014 / 56TH ANNUAL MEETING 80 ASTRO 2014 / 56TH ANNUAL MEETING 81 ASTRO 2014 / 56TH ANNUAL MEETING 82 ASTRO 2014 / 56TH ANNUAL MEETING 83 ASTRO 2014 / 56TH ANNUAL MEETING 84 ASTRO 2014 / 56TH ANNUAL MEETING 85 ASTRO 2014 / 56TH ANNUAL MEETING 86 ASTRO 2014 / 56TH ANNUAL MEETING 87 ASTRO 2014 / 56TH ANNUAL MEETING 88 ASTRO 2014 / 56TH ANNUAL MEETING 89 ASTRO 2014 / 56TH ANNUAL MEETING 90 ASTRO 2014 / 56TH ANNUAL MEETING 91 ASTRO 2014 / 56TH ANNUAL MEETING 92 ASTRO 2014 / 56TH ANNUAL MEETING 93 ASTRO 2014 / 56TH ANNUAL MEETING 94 ASTRO 2014 / 56TH ANNUAL MEETING 95 ASTRO 2014 / 56TH ANNUAL MEETING 96 ASTRO 2014 / 56TH ANNUAL MEETING 97 ASTRO 2014 / 56TH ANNUAL MEETING 98 ASTRO 2014 / 56TH ANNUAL MEETING 99 ASTRO 2014 / 56TH ANNUAL MEETING 100 ASTRO 2014 / 56TH ANNUAL MEETING 101 ASTRO 2014 / 56TH ANNUAL MEETING 102 ASTRO 2014 / 56TH ANNUAL MEETING 103 ASTRO 2014 / 56TH ANNUAL MEETING 104 ASTRO 2014 / 56TH ANNUAL MEETING 105 ASTRO 2014 / 56TH ANNUAL MEETING 106 ASTRO 2014 / 56TH ANNUAL MEETING 107 ASTRO 2014 / 56TH ANNUAL MEETING 108 ASTRO 2014 / 56TH ANNUAL MEETING 109 ASTRO 2014 / 56TH ANNUAL MEETING 110 ASTRO 2014 / 56TH ANNUAL MEETING 111 ASTRO 2014 / 56TH ANNUAL MEETING 112 ASTRO 2014 / 56TH ANNUAL MEETING 113 ASTRO 2014 / 56TH ANNUAL MEETING 114 ASTRO 2014 / 56TH ANNUAL MEETING 115 ASTRO 2014 / 56TH ANNUAL MEETING 116 ASTRO 2014 / 56TH ANNUAL MEETING 117 ASTRO 2014 / 56TH ANNUAL MEETING notes
60 ASTRO 2014 / 56th Annual Meeting notes
60 ASTRO 2014 / 56th Annual Meeting notes
60 ASTRO 2014 / 56th Annual Meeting
Poster Presentations
Poster Viewing Hours Viewing Poster 14 September Sunday, 15 September Monday, p.m. a.m. - 5:00 10:00 16 September p.m. a.m. - 6:45 Tuesday, 10:00 p.m. - 5:00 a.m. 10:00 Poster Presentations Poster INSIDE: Poster Presentations PROMOTIONAL SUPPORTERS Special thankstoASTRO’s MeetingPromotional 56thAnnual Supporters 2014 CIVCO Hologic Solutions Medical Sun Nuclear Vertual, Ltd. ANNUAL MEETING (AS OF AUGUST 4, BRONZE COPPER SILVER GOLD 2014) 2014) Poster Presentations by Track
BREAST CANCER 2009 Edward Yu 2020 Miriam Knoll Male Breast Cancer Prognostic Factors: Dose to Organs at Risk (OAR) When 2001 Naoto Shikama Similarity to Female Counterparts With Covering the Internal Mammary Nodes Acute Toxicities Associated With Propensity Scores and Matched-Pair in Breast Cancer Patients: A Quantitative Three-Dimensional Conformal Analysis Comparison of VMAT, Partially-Wide External-Beam Accelerated Partial Tangents (PWT), and Photon-Electron Breast Irradiation in a Prospective 2010 Delnora Erickson (P-E) Phase 2 Trial Axillary Coverage During Radiation Therapy to the Breast With Tangents 2021 Yun Ding 2002 Bartosz Urbanski Alone Comparison of the Volume and Eff ectiveness and Toxicity of Localization of Lumpectomy Cavity Intraoperative Radiotherapy (IORT) 2011 Marciana-Nona Duma Delineated by Clips and Seroma Based Given as a Boost During Breast Tangential Field Technique for Breast on 4DCT Scan for External-Beam Partial Conserving Surgery (BCS) Followed by Cancer: The Dose to the Heart and Breast Irradiation After Breast Adjuvant Whole Breast Radiotherapy Heart Subvolumes Conserving Surgery (WBRT) 2012 Chikao Sugie 2022 Guy Jones 2003 Andrzej Wojcieszynski Effi cacy of the Dynamic Jaw Mode in Are the Conclusions of Z11 Relevant to Toxicity From Breast Cancer Treatment Helical Tomotherapy With Static Ports Community Practice? Using Helical Intensity Modulated for Breast Cancer Radiation Therapy With an 2023 Ugo de Paula Incorporated Boost 2013 Tamer Refaat Full Local Control With Accelerated Hyperthermia and Radiation Therapy Partial Breast Irradiation (APBI) by 2004 Kimberley Mak for Local Advanced or Recurrent Breast Tomotherapy After Breast-Conservative Dosimetric Inhomogeneity Predicts Cancer: Long Term Outcomes and Surgery for Patients Suitable, or Not, for Long-Term Breast Pain Following Adverse Events According to ASTRO 2009 Consensus Breast-Conserving Therapy Statement: Interim Report After 2 Years 2014 ZhaoZhi Yang Follow-Up 2005 Malolan Rajagopalan Age and Her-2 Subtype Predict The Risk Utilization of Hypofractionated of Ipsilateral Breast Tumor Recurrence 2024 Madeera Kathpal Radiation Therapy for Early Stage Breast After Breast Conservative Therapy in Deep Inspiration Breath Hold (DIBH) Cancer in the Elderly Population - Chinese Breast Cancer Patients With Electromagentic Surface A National Cancer Data Base Analysis Transponder Confi rmation of Chest Wall 2016 Charles Leonard Position for Adjuvant Therapy of Left 2006 Norman Williams Clinical Utility of the 12-Gene Ductal Breast Cancer Cosmetic Outcome Before and After Carcinoma In-Situ (DCIS) Score Assay: External Beam or Intraoperative Impact on Treatment (tx) 2025 Jonathan Wallach Radiotherapy for Early Breast Cancer Recommendations Correlation of Pathological Features of Within One Year of Breast Conserving Ductal Carcinoma in Situ (DCIS) and Surgery: An Objective Assessment of 2017 Mariko Kawamura Oncotype DCIS Score Patients From a Randomised Controlled Development of the Breast Trial Immobilization System in Prone Setup: 2026 Yasser Abo-Madyan The Eff ect of Bra in Prone Position to Breast Radiotherapy (RT) Using 2007 John Cuaron Eliminate the Breast Setup Error Simultaneous Integrated Boost (SIB): Outcomes and Early Toxicity in Patients Which Is The Optimal Intensity Treated With Proton Therapy for Breast 2018 Kitwadee Saksornchai Modulated RT (IMRT) Technique? Cancer Local Recurrence and Overall Survival Rate After Hypofractionated Irradiation 2027 Aaron Falchook 2008 Marco Trovo With Concomittant Boost in Early Breast Adoption of Intensity Modulated Hypofractionated Radiotherapy for Cancer Radiotherapy (IMRT) in Early-Stage Partial Breast Irradiation Based on a Breast Cancer Patients Receiving Novel NTCP Model for Severe Fibrosis: 2019 Olga Vujovic Hypofractionated and Conventionally Clinical Results Comparison of Two Radiation Fractionated Radiation in the US Schedules in The Adjuvant Treatment of Early Stage Breast Carcinoma With Long Term Follow-Up
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 123 2028 Mina Shenouda 2039 Merrylee McGuffi n 2049 Whitney Hitchcock Contralateral Breast Cancer: Risk Breast Cancer Patient Preferences for Cherenkoscopically Visualized Factors, Characteristics and Prognostic Adjuvant Radiotherapy Post- Superfi cial Dose and Radiation Implications Lumpectomy: Whole Breast Irradiation Dermatitis During Breast Radiotherapy Vversus Partial Breast Irradiation - 2029 Kumiko Karasawa Preliminary Results 2050 Jose Bazan Carbon Ion Radiotherapy for Stage I Chestwall/Breast and Regional Nodal Breast Cancer 2040 Elisa Cordova Irradiation: A Feasibility Study of Polymorphic Variant TP53 (R72P) May Achieving the Normal Tissue 2030 Ravi Chandra Suggest Acute Radiotoxicity in Breast Constraints on NSABP B51/RTOG 1304 Radiotherapy Risk Factors for the Cancer Patients Undergoing Development of Lymphedema in Conventional Radiation Treatments 2051 Rosanna Yeung Patients Treated With Regional Lymph Visually Monitored Deep Inspiration Node Irradiation for Breast Cancer 2041 Elia del Cerro Penalver Breath Hold Technique in Left-Sided Single Fraction HDR Brachytherapy Breast Cancer Patients Treated With 2031 Sunpreet Rakhra After Conservative Surgery and Whole Adjuvant Radiotherapy: Reproducibility Review of Outcomes After Breast Hypofractionated Breast Radiotherapy and Reliability Conserving Surgery and Intraoperative Radiotherapy and Risk Factors Leading 2042 May Lin Tao 2052 Dean Shumway to Breast Complications for Early Stage Long Term Results of Breast Development of a Photonumeric Scale Breast Cancer Conservation Therapy for Patients With for Acute Radiation Dermatitis in Breast Early Stage Breast Cancer: A Large Cancer Patients 2032 David Woolf Community Based Experience and Biological Dosimetry With γ-H2AX Foci National Norms 2053 Michael Yassa Using Radiotherapy for Breast Cancer Regional Nodal Radiotherapy in Breast as a Model 2043 Zaker Rana Cancer Patients With Positive Nodes Factors Improving Skin Sparing, Rib Who Convert to Negative Nodes After 2033 Jason Duelge Sparing, and D95 Coverage in Neoadjuvant Chemotherapy A Simple Low Cost Deep Inhalation Accelerated Partial Breast Irradiation Breath Hold System That Can Be Across Five Catheter Subtypes 2054 Rosanna Yeung Implemented at Your Clinic Evaluation of Cardiac Dose Reduction 2044 Erin Healy With Deep Inspiration Breath Hold in 2034 Eva Ambroa Rey Compliance With Hormonal Therapy in Patients With Left-Sided Breast Cancer Which Are the Best Dose/Volume Elderly Women With Early Breast Cancer Receiving Adjuvant Radiotherapy Constraints in 3D-CRT Breast Cancer? Who Were Not Treated With Adjuvant Radiation Following Lumpectomy 2055 Sua Yoo 2035 Li Zhang Delivered Dose for Preoperative Single Dose Coverage of Axillary Levels I-III and 2045 Michael Stauder Fraction Partial Breast Radiotherapy the Sentinel Lymph Node Area With Post-Mastectomy Radiotherapy After Inverse-Planned Intensity Modulated Positive Sentinel Lymph Node Biopsy 2056 Hadley Sharp Radiotherapy in Patients With Breast and Completion Axillary Lymph Node Extent of Regional Nodal Irradiation in Conserving Surgery Dissection the Breast-Conservation Setting Following a Positive Sentinel Lymph 2036 Paola Pinnaro 2046 Wei Wang Node Biopsy: Network Practice Patterns Whole Breast Hypofractionated Comparison of Orthogonal Kilovolt in a Large Multi-Site Cancer Center Radiation Therapy After Conservative X-Ray Plain Film and Cone-Beam CT Surgery: A Phase 2 Study Matching Results in Setup Error Assess- 2057 Andrew Wong ment and Correction for EB-PBI During A Comparative Review of Three 2037 Sandi Bosnic Free Breathing Methods for Scoring Late Breast A Retrospective Study of the Prone Cosmesis in Patients Treated With Breast Technique: Analysing Dosimetry, 2047 Zeliang Shi Lumpectomy and Radiation Therapy Breast Volume, Breast Separation and Radiation Increase Invasive and (RT) Acute Skin Toxicity Metastatic Potential of Breast Cancer Cells Through Activating Mmp-2 2058 Lauren Herman 2038 Li Zhang Daily Two Millimeter Chest Wall Bolus Dose Distribution Analysis of the 2048 Gul Alco Provides Adequate Dose Build-Up With Sentinel Lymph Node Area During Replacement of Tumor Bed After Acceptable Skin Toxicity for Field-in-Field Forward-Planned Oncoplastic Breast Conserving Surgery Post-Mastectomy Radiation Therapy Intensity Modulated Radiotherapy to With Immediate Latissimus Dorsi Breast Mini-Flap
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
124 ASTRO 2014 / 56TH ANNUAL MEETING 2059 Erin Gillespie 2070 Brandi Page 2080 Mami Ogita Pathologic Response After Neoadjuvant Leptomeningeal Failure in Patients With Randomized, Prospective Trial of Chemotherapy Predicts Locoregional Breast Cancer Receiving Stereotactic Moisturizer Effi cacy for the Treatment Control in Patients With Triple Negative Radiosurgery for Brain Metastases of Skin Dryness Following Radiotherapy Breast Cancer After Breast-Conserving Surgery 2071 Suzhen Wang 2060 Budhi Yadav Comparison of Clinical Treatment Eff ect 2081 Lesley Jarvis Outcome Following Postmastectomy Between Sib-IMRT and Late-Course Cherenkoscopy Is a Novel Imaging Internal Mammary Node Radiation in Boost-IMRT for Early Breast Cancer After Technique With the Potential to Patients With Breast Cancer - A Long Breast-Conserving Surgery Improve Accuracy and Detect Term Follow Up Study Radiotherapy Misadministrations 2072 Suzhen Wang During Whole Breast Radiotherapy 2061 Yazid Belkacemi Comparison of Acute Radiation Injury Tangential Fields (TGF) Breast of the Skin and Cosmetic Outcome 2082 Leonid Zamdborg Radiotherapy (RT): Prospective Between Sib-IMRT and Late-Course Dosimetric Predictors of Cosmesis Evaluation of the Dose Distribution Boost-IMRT for Early Breast Cancer After in Whole Breast Irradiation: A Novel in the Axilla and the Sentinel Lymph Breast-Conserving Surgery Clincally-Applicable Constraint Node Area (SLNA) Determined Intra Operatively by Clip Placement 2073 Pratap Reddy 2083 Jacob Shin To Study Whether Curcumin and The Impact of Race in Male Breast 2062 Jean Wright Piperine Sensitize Breast Cancer Cells Cancer Outcome in the United States: Black Patients Treated With PMRT Are and Breast Cancer Initiating Cells to A Population-Based Analysis of 4,279 More Likely Than Others to Develop Radiation Patients Moist Desquamation in a Prospective Skin Toxicity Study 2074 Weiwei Li 2084 Yazid Belkacemi IMRT Versus 3D-CRT for Post- Patterns of Practice of Nodal 2063 Xiaofeng Yang Mastectomy Irradiation of Chest Wall Radiotherapy in Breast Cancer: Results Ultrasound Texture Features as and Regional Nodes: A of the Eortc “Nora” Survey Potential Early Imaging Biomarkers for Population-Based Comparison of Normal-Tissue Toxicity in Breast-Cancer Normal Lung Dose 2085 Kristina Mirabeau-Beale Radiotherapy Quality of Life (QOL) in Women With 2075 Jiayi Chen Breast Cancer Enrolled on a Prospective 2065 Robert Mutter Outcome of Brain Metastases From Lymphedema Screening Protocol Single Field Spot-Scanning (SFSS) is Her2-Positive Breast Cancer: Diff erence Dosimetrically Superior to Two Field in Survival Benefi t From Anti-Her2 2086 Sahaja Acharya Intensity Modulated Proton Therapy Treatment After WBRT With Regard to Ductal Carcinoma In-Situ Treated With (IMPT) for Proton Post-Mastectomy Prior Targeted Therapy Accelerated Partial Breast Irradiation: Radiotherapy (PMRT) An Analysis of Ipsilateral Breast Tumor 2076 WITHDRAWN Recurrence and Contralateral Breast 2066 David Wazer Cancer A Phase 1 Trial of a Novel Photodynamic 2077 Shuai Li Therapy for Chest Wall Recurrent Breast Risk Factors for Supraclavicular Nodal 2087 Sui Shen Cancer Following Prior Radiation Failure in Chinese Breast Cancer Patients Variation in Boost Dose to Breast Cancer Therapy With One to Three Positive Axillary Tumor Bed in Deep Inspiration Nodes Treated With Breast Conserving Breath-Hold Radiotherapy Evaluated 2067 Lior Braunstein Surgery Without Supraclavicular Nodal With Feedback-Guided CBCT Invasive Lobular Carcinoma (ILC) of Radiation the Breast: Local Recurrence (LR) After 2088 Tara Hansen Breast-Conserving Therapy (BCT) by 2078 Jason Ye Accelerated Partial Breast Irradiation Subtype Approximation Triple Negative Receptor Status and Using the Strut-Adjusted Volume Other Predictors of Lymph Node Implant: A Single Institution Review of 2068 Yolanda Tseng Positivity in Small (T1) Breast Cancers: A Toxicity and Cosmetic Outcome Association Between Breast Cancer National Registry Study Biological Subtype and Risk of 2089 Mary Lopresti Locoregional Recurrence After 2079 T. Jonathan Yang Lack of Breast Cancer Screening in Mastectomy in Node-Negative Patients Characteristics and Outcomes of Breast Women at High Risk After Supra Cancer Patients Who Received Diaphragmatic Irradiation for Pediatric 2069 Lu Cao Immediate Reconstruction and Malignancies Hormone Receptor Status and TN Postmastectomy Radiation Following Stage Infl uence the Locoregional Neoadjuvant Chemotherapy Benefi t From Trastuzumab in Patients With HER2 Positive Breast Cancer After Adjuvant Radiotherapy Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 125 2090 Qian Zhang 2100 Kristina Demas 2110 Valentina Vanoni The Impact of Serum IL-8 Level on Treatment of Ductal Carcinoma in Situ Extrernal Beam Radiotherapy Versus Acute Radiation-Induced Skin With Adjuvant Accelerated Partial Breast Intraoperative Radiotherapy for Breast Toxicity in a Prospective Trial Irradiation: A Surveillance, Conserving Therapy: A Large Single Comparing Concomitant or Sequential Epidemiology, and End Results Based Institution Matched-Pair Evaluation Anastrozole With Postoperative Patterns of Care Analysis Radiotherapy in Postmenopausal 2111 Masako Kato Women With Receptor Positive Breast 2101 Clare Suttie Evaluating Radiation Dose to the Heart Cancer Dosimetric Implications of Tissue and the Left Anterior Descending (LAD) Expanders in Post-Mastectomy Coronary Artery With Left Whole Breast 2091 Asal Rahimi Irradiation, and Oncoplastic Radiation Therapy to Japanese Women Phase 1 Dose Escalation Trial Using Reconstruction Outcomes Stereotactic Body Radiation Therapy 2112 Hyunsoo No (SBRT) for Partial Breast Irradiation (PBI) 2102 Charlotte Dai Kubicky Breast Cancer Radiotherapy (RT) in Impact of Molecular Subtypes and Developing Countries: A Technique for 2092 Rebekah Young Pathologic Response on Locoregional Simple Prone Treatment Planning Evaluation of Oncotype DX DCIS Usage Recurrence (LRR) and Survival in Breast Among Minority Women: A Single Cancer Patients Treated With 2113 Eunjin Jwa Institutional Review Neoadjuvant Chemotherapy Retrospective Analysis of Risk Factors for Regional Recurrence for pN1 Patients 2093 Linna Li 2103 Shihfan Lai After Breast Conserving Surgery Squamous Cell Carcinoma of the Breast: Eff ect of Immunohistochemically An Analysis of a Rare Tumor Type in the Biological Expression on Clinical 2114 Kruti Patel SEER Database Outcome for Patients With Breast Comparison of Coronary Vessel Cancer and Brain Metastases After Brain Contouring Using Non-Contrast Cardiac 2094 Timothy Lymberiou Radiotherapy Gated CT VersusCT Angiogram Predictors of Breast Radiotherapy Plan Modifi cations: Quality Assurance 2104 Jae Myoung Noh 2115 Jonathan Verma Rounds in a Large Cancer Center Prognostic Signifi cance of Internal Breast Cancer Subtype and Mammary Node Involvement in Locoregional Outcomes in Locally 2095 Trang Pham Patients With Clinical Stage IIIc Breast Advanced Breast Cancer Left-Sided Breast Cancer Loco-Regional Cancer Who Received Neoadjuvant Radiotherapy With Deep Inspiration Chemotherapy, Surgery, and 2116 Ivy Petersen Breath-Hold (DIBH): Does Volumetric Radiotherapy What Is Normal? - Cooperative Pooled Modulated Arc Therapy (VMAT) Reduce Database to Establish Typical Heart and the Cardiac Dose Further When 2105 Tao Wu Lung Doses for Modern Breast Compared to Tangential Intensity Improved Locoregional Control For Radiation Therapy Modulated Radiotherapy (T-IMRT)? Patients With T1-2n1 Triple-negative Breast Cancer Treated With 2117 Maria Almudena 2096 Grace Lee Radiotherapy Following Modifi ed Cascales Garcia Identifying Anatomic Features in Radical Mastectomy Borderline and Malignant Phylloides Women at Risk of Cardiac Exposure in Tumors of the Breast: A Retrospective Whole Breast Radiotherapy Treatments 2106 Celine Bourgier Analysis of 37 Cases Bilateral Cancer Breast Irradiation by 2097 Yoonsun Chung Volumetric Modulated Arc Therapy 2118 Elizabeth Nichols Dummy Run Study of Quality Assurance (VMAT): Early Clinical Experience Prospective Evaluation of Preoperative Program in KROG 08-06 Study, Phase 3d Conformal Accelerated Partial Breast 3 Randomized Trial to Investigate the 2107 Gabriele Simontacchi Irradiation (3dcrt-apbi) Shows Role of Internal Mammary Lymph Node Comparison of Static Fields IMRT and Promising Early Results Irradiation for Breast Cancer Patients Helical IMRT for Accelerated Partial Breast Irradiation 2119 Efrat Shekel 2098 Shuai Li Is Contouring the Left Anterior Interim Analysis of 354 Breast Cancer 2108 Karolien Verhoeven Descending (LAD) Artery Necessary for Patients Randomly Treated With Boost Delineation in Breast Left Breast Patients? A Hyperfractionated or Conventional Radiotherapy: Isotropic Versus Retrospective Comparison Between Fractionated Radiotherapy After Breast Anisotropic Margin Expansion Treated and Revised Plans Conserving Surgery 2109 Diana Tuano 2120 Julian Johnson 2099 Louis Keiler The Impact of Contouring the Axillary Repeat Sentinel Lymph Node Mapping EBRT Versus APBI: Patient Satisfaction Lymph Nodal Levels in Achieving in Patients With Post Mastectomy Chest Adequate Doses for Tangential Wall Recurrence: Infl uence on Radiation Chestwall Irradiation Treatment Fields and Outcome
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
126 ASTRO 2014 / 56TH ANNUAL MEETING 2121 Anna Lee 2131 Stuti Ahlawat 2142 Brent Rose Inter- and Intra-operator Reproducibility Accelerated, Hypofractionated Whole Eff ect of Involved Lymph Node Size on of Cutaneous Toxicity Measurements Breast Radiotherapy in Women With Cancer-Specifi c Mortality in Women Using Quantitative Ultrasound Breast Cancer: A Phase II Trial With Node-Positive Breast Cancer
2122 Julia Manzerova 2132 Carole Massabeau 2143 Daniel Petereit Predicting Potential Radiation- Outcome of pN0 Triple Negative Breast The Impact of Breast Patient Navigation Associated Cardiac Risks for Left Breast Cancers With and Without Lymph Node on Breast Preservation Rates Cancer Patients Treated With Irradiation Post-Mastectomy or Breast and 2144 Laura Warren Regional Nodal Radiation Therapy 2133 Richard Hymas Infl ammatory Breast Cancer: Patterns Dosimetric Predictors of Toxicity and of Failure and the Case for Aggressive 2123 Daniel Trifi letti Cosmesis in Women Treated With Local-Regional Management A Comparative Analysis of 3-D Hypofractionated Whole Breast Conformal and Intensity Modulated Irradiation 2145 Justin Rineer Radiotherapy During Deep Inspiratory Patterns of Progression in Hormone Breath Hold for Left Sided Whole Breast 2134 Jon Strasser Receptor Positive Metastatic Breast Irradiation Outcomes for APBI With Strut-Based Cancer - An Argument for Local Therapy Brachytherapy: 596 Patients With 39 2124 Nalini Rao Month Median Follow-Up 2146 Richard Cedric Zellars Can Tangential Fields Designed for Two Phase 1/2 Trials of Partial Breast Whole Breast Coverage in Early Breast 2135 Christy Goldsmith Irradiation (PBI) With Concurrent Cancer Adequately Irradiate Limited Clinical Outcome of Stereotactic Chemotherapy Regimens: Late Node Positive Disease, Not Treated Radiotherapy for the Treatment of Toxicity, Cosmetic Outcome and With Alnd? Oligometastatic Breast Cancer Disease Recurrence
2125 Benjamin Lok 2136 Jean Wright 2147 Linda Smith Age, Tumor Subtype and Racial and Ethnic Disparity in Stage at Improved Targeting of the Locoregional Recurrence in Operable Breast Cancer Diagnosis: Changes in Lumpectomy Cavity Using a Spiral Breast Cancer Patients Treated With Minority Populations in Florida From 3-D Marker Adjuvant Therapies 1981-2009 2148 Nisha Patel 2126 Malcolm Mattes 2137 Peter Chen Dosimetric Deviations in Partial Breast Breast Cancer Molecular Subtype as a Propensity-Score Matched-Pair Analysis Irradiation During the Treatment Predictor of Lymph Node Metastasis of Interstitial Multicatheter Versus course due to Random and Systematic Balloon-Based Accelerated Partial Uncertainties 2127 Adavikolanu Kesava Breast Irradiation, Stratifi ed by ASTRO Ramgopal Guidelines 2149 Nathan Tonlaar Postmastectomy Chest Wall Radiation Outcomes of African American Women of Left Sided Breast Cancer Patients 2138 María Ríos Pozo Undergoing APBI for Early Stage Breast With Single Energy Electron-beam Locoregional Recurrence of Early Breast Cancer: A Matched Pair Analysis Versus Three Dimensional Conformal Cancer According to Intrinsic Subtype Radiotherapy With Photons- Analysis of 2150 WITHDRAWN Dosimetric Parameters 2139 William Hartsell Proton Beam Therapy for Locally 2151 Jennifer Chang 2128 Randy Wei Advanced Breast Cancer: Dosimetric Evolution of Heart Dose Over Time in Association Between Breast Cancer and Results and Acute Toxicity Patients Treated for Left-Sided Breast Glioblastoma Multiforme in Women: A Cancer California Cancer Registry 2140 Jessica Wobb Population-Based Analysis Comparison of Chronic Toxicities 2152 Richard Cedric Zellars Between Brachytherapy-Based Identifi cation of Molecular Markers of 2129 Catheryn Yashar Accelerated Partial Breast Irradiation Radiation-Induced Toxicity in Patients Outcomes for APBI With Strut-Based and Whole Breast Intensity Modulated Undergoing Breast Conserving Therapy Brachytherapy: First 200 Accrued Radiotherapy Patients (52 Month Median Follow-Up) 2153 James Snider III 2141 Grant Ognibene Theoretical Improvements in Cosmetic Three-Dimensional Conformal External Outcomes Utilizing a Novel Breast 2130 Melis Gultekin Beam Accelerated Partial Breast Stereotactic Radiotherapy (BSRT)- Radiation Induced Hypothyroidism and Irradiation: The Stanford Experience Device Compared to 3-Dimensional Related Dosimetric Parameters in Breast Partial Breast Irradiation Using IMRT Cancer Patients (IMRT PBI): A Dosimetric Analysis
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 127 2154 Carolina Fasola 2164 Abhilasha Patel 2174 Naomi Nakajima Local Recurrence Among Patients With Population Based Analysis to Determine Pretreatment Fluid-Attenuated Early Stage Breast Cancer Treated With Conditional Survival in Patients with Inversion Recovery (FLAIR) High Intraoperative Radiotherapy: The Eff ect Gliomas Treated With Radiation Intensity Volume on Magnetic of Systemic Therapy Resonance Imaging Correlate With 2165 Alin Chirindel Clinical Outcome in Who Grade 3 2155 Michael Eblan Multi-Reader Evaluation of Manual Gliomas Eff ect of Internal Mammary Vessel Tumor Delineation for Recurrent Irradiation on Outcomes of Free Flap Glioblastoma on FET-PET Scan - Impact 2175 Naomi Nakajima Breast Reconstruction in Patients of PET Windowing Settings High Subventricular Zone Radiation Treated With Mastectomy and Radiation Dose Correlates With Progression-Free Therapy for Breast Cancer 2166 Anthony Rizzo Survival in Glioblastoma Patients After Investigating the Relationship Between Concurrent Temozolomide 2156 Morteza Dowlatshahi Radiation Dose to Neural Stem Cell Administration and Extended Focal Favorable Cosmesis and Local Control Niches and Survival in GBM Radiotherapy for Single-Lumen and Multi-Lumen Applicators for Accelerated Partial 2167 Melissa Azoulay 2176 Naomi Nakajima Breast Irradiation for Early Stage Breast Hypofractionated Radiotherapy With Clinical Outcomes and Prognostic Cancer or Without Temozolomide Compared Factors in Patients With High Grade to Standard of Care in the Treatment Glioma Treated With Surgery of Glioblastoma: Results From a Single Followed by Concurrent Temozolomide CENTRAL NERVOUS SYSTEM Institution Administration and Extended Focal Radiotherapy 2157 James Marsh 2168 Julie Carlson Involvement of the Neural Stem Cell Hypofractionated-Intensity 2177 Michael Kucharczyk Compartment by Pediatric and Adult Modulated Radiotherapy (hypo-IMRT) Evaluation of Pseudoprogression in Gliomas: A Retrospective Review of and Temozolomide (TMZ) With and Patients With Glioblastoma (EPPIG) 377 Cases Without Bevacizumab (BEV) for Glioblastoma Multiforme (GBM): A 2178 Fen Zhao 2158 Lova Sun Comparison of Two Prospective Phase Prognostic Value of 3’-deoxy-3’- Next Generation Nanoparticles for 2 Trials 18f-fl uorothymidine Pet in Patients With Enhanced Radiation Therapy and Recurrent Malignant Gliomas: Diagnostic Imaging of Brain Tumors 2169 Julie Carlson Comparison With Contrast-Enhanced A Phase 2 Trial of MRI 2159 Jimmy Caudell Hypofractionated-Intensity Radiosensitivity Molecular Signature Modulated Radiation Therapy 2179 Joseph Bovi is Predictive of Overall Survival in (hypo-IMRT) Combined With Treatment of Recurrent Glioblastoma Glioblastoma Temozolomide (TMZ) and Bevacizumab With Bevacizumab With or Without (BEV) for Patients With Newly Re-irradiation Using a Pulsed Low Dose 2160 Quincey LaPlant Diagnosed Glioblastoma Multiforme Radiotherapy Technique: A Single Radiographic Features, Patterns (GBM) Institution Experience of Treatment Failure, and Clinical Outcomes in 56 Cases of Molecularly 2170 Dayssy Diaz Pardo 2180 Xin Li Subtyped Glioblastoma Multiforme Re-irradiation for Recurrent Gliomas: Extravasation Rate Constant Estimation Patients Comparison of Multiple Fractionation From Pharmacokinetic First Principles Schedules to Improve Dynamic Susceptibility 2161 Toshihiko Iuchi Contrast MRI Characterization of Brain Risk and Benefi t of Irradiation for 2171 Hiroshi Igaki Tumors Subventricular Zone in the Treatment of Patterns of Recurrence in Malignant Patients With Glioblastoma Glioma Patients: Association With 2181 Grace Kusumawidjaja Neurogenic Niche and Radiotherapy Dose Escalated Intensity Modulated 2162 Michelle Kim Dose Radiotherapy and Increased Radiation A Phase 1 Dose-Escalation Study of Doses to Subventricular Zones in Gemcitabine Plus Standard Radiation 2172 Brijal Desai Treatment Outcomes of Patients With Therapy for Malignant High Grade Overall Survival (OS) and Toxicity Glioblastoma Multiforme Gliomas Outcomes Following Large-Volume Re-irradiation Using Proton Therapy 2182 Nobumasa Fujitani 2163 Andrew Elson (PT) for Recurrent Glioma Applicability of the Linear-Quadratic Evaluation of Pre-Radiotherapy Model to Radiotherapy at a High Dose Apparent Diff usion Coeffi cient (ADC): 2173 Christopher Anker per Fraction In Vivo Patterns of Recurrence and Additional Treatment Margin Beyond Progression Free Survival Analysis in Edema Provides No Benefi t in the Patients with GBM Radiation of Glioblastoma Multiforme Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
128 ASTRO 2014 / 56TH ANNUAL MEETING 2183 Rifaquat Rahman 2194 Amol Narang 2205 William Kennedy Toxicity, Hospitalization Burden, and Mr Enhancement as a Predictor for Proton Therapy for Pituitary Adenoma Survival Among Glioblastoma Patients Malignant Degeneration in Progressive Receiving Chemoradiation Low-Grade Gliomas: An Update With 2206 Khusraw Sabit Survival Analysis Volumetric Growth Measurements of 2184 Charlotte Debus Pituitary Macroadenomas Following The Battle Between Amino Acid PET 2195 David Randolph Surgical Resection and Indications for and Functional MRI: Precision of Tumor Does Delay of Start of Radiation Aff ect Early Adjuvant Radiotherapy Delineation Examined by Glioma Clinical Outcomes of Glioblastoma Progression Pattern After Radiotherapy 2207 Michael Dyer 2196 Evan Osmundson Quality of Life in Patients Treated With 2185 Mekhail Anwar Relative Monocytopenia, a Proposed Surgery Alone versus Surgery and Determining Voxel Response to Correlate of Decreased Vasculogenesis, Radiation for Nonfunctioning Pituitary Radiotherapy in Glioblastoma Using is Associated With Improved Survival in Adenomas Integrated Dosimetry, Diff usion, Patients With Glioblastoma Multiforme Perfusion and Spectra 2208 Ryan Rhome 2197 Ru xin Wong Long Term Outcomes and Toxicities 2186 Jordan Holmes Outcome of Patients With Acoustic of Growth Hormone (Somatotroph)- Genomic Predictors of Infi eld and Neuroma Treated With Conventionally Secreting Pituitary Macroadenomas Marginal Failure for Glioblastoma Fractionated Stereotactic Therapy: An Treated With Adjuvant Fractionated Treated With Concurrent Radiotherapy Institution Experience Stereotactic Radiation Therapy (FSRT) and Temozolomide: A Step Towards Personalized Radiation Fields? 2198 Kurt Meyer 2209 Jennifer Jeff eris Predictors of Symptomatic Edema After Minimal Acute Toxicities Following 2187 Barbara Diletto Treatment of Intracranial High-Dose Proton Therapy for Spinal Prognostic Value of Age and Meningiomas With Single Fraction Tumors Comorbidities in Elderly Glioblastoma Stereotactic Radiosurgery Patients: Analysis From Three 2210 Zain Ahmed Prospective Phase 2 Trials 2199 Ariel Marciscano Spine Stereotactic Radiosurgery in the Long-term Follow Up of Adaptive Management of Sarcoma Metastasis 2188 Silvia Chiesa Multi-Stage Stereotactic Radiosurgery Including Edema or Not in for Treatment of High Grade 2211 Cliff ord Robinson Glioblastoma? Analysis From Sequential Arteriovenous Malformations Comparison of Spinal Cord Motion Prospective Phase 2 Studies Versus Vertebral Body Motion During 2200 Nikhil Joshi Magnetic-Resonance Imaging-Guided 2189 Vikram Jairam Staged Gamma Knife Radiosurgery for Radiation Therapy (MR-IGRT) Change in Radiotherapy Treatment Large Volume Arteriovenous Volumes With Initial Alkylating Malformations: A Single Institution 2212 Michael Virk Chemotherapy in WHO Grade 3 Retrospective Review and Initial Results Symptomatic Vertebral Body Gliomas Compression Fractures Requiring 2201 Xin Wang Intervention Following Single Fraction 2190 John Hardie Hypofractionated Stereotactic Stereotactic Radiosurgery for Spinal Evaluation of RANO Response Criteria Radiotherapy for Giant Cavernous Sinus Metastases Compared to Clinician Evaluation in Hemangiomas in Close Proximity to Grade 3 Anaplastic Astrocytoma (AA): Optic Nerves and/or Optic Chiasm 2213 Prachi Jain Implications for Clinical Trial Reporting Radiographic, Neurological and Clinical 2202 Gregory Russo Assessment of Fractionated Stereotactic 2191 Jiayi Huang Evolving Trends in Stereotactic Radiosurgery in the Treatment of Clinical Outcomes of Small Cell Radiosurgical Treatment of Meningioma Metastatic Epidural Spinal Cord Glioblastoma or Glioblastoma With Compression at a Single Institution Oligodendroglioma Component 2203 Jeff rey Kittel treated With Radiotherapy and Adjuvant Radiation May Not be Neces- 2214 Eric Chang Temozolomide sary Following Gross Total Resection of Long-Term Outcomes after Proton an Atypical Meningioma Beam Radiation Therapy for Intraocular 2192 Julie Jung Kang Vascular Tumors High-Dose Radiation to the 2204 Jillian Maclean Subventricular Zone Does Not Alter the Simultaneous PET/MRI for Target 2215 Gaurav Marwaha Patterns of Recurrence in GB Volume Defi nition in Meningiomas: Ruthenium Eye Plaques for Uveal Feasibility and Impact on Interobserver Melanoma: Long-Term Clinical 2193 Magali Lecavalier- Variability Outcomes Barsoum Prognostic Factors of Survival for Aanaplastic Gliomas Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 129 2216 Puyao Li 2228 Bruce Pollock 2239 Hilary Bagshaw Radiation Tolerance of the Optic Single Fraction Stereotactic Local Control of Melanoma Brain Pathway After Fractionated Proton Radiosurgery of Meningeal Metastases by Metastatic Lesion Radiation Therapy Hemangiopericytomas 2240 Jennifer Chang 2217 Christopher Barker 2229 Shyamal Patel Estimation of the Incident Probability Ruthenium-106 Plaque Brachytherapy Does Systemic Therapy Matter After of Brain Metastases in Hippocampal- for Uveal Melanoma: Factors Associated Stereotactic Radiosurgery for Brain Sparing Whole Brain Radiation With Local Tumor Recurrence Metastases From Lung Cancer? 2241 Kamran Ahmed 2218 Sean Szeja 2230 Akifumi Miyakawa Outcomes Following Fractionated Clinical Eff ect of UV radiation on Ocular Low-Dose (GK) Radiosurgery Plus Stereotactic Radiotherapy in the Melanoma: SEER Investigation Whole-Brain Radiotherapy (WBRT) Management of Radioresistant and Versus GK Alone for Multiple Brain Radiosensitive Brain Metastases 2219 Alexei Polishchuk Metastases: a Matched Case-Control Tumor and Dosimetric Predictors of Study 2242 Zachary Seymour Long-Term Visual Outcomes After Surgical Resection and Brain Proton Beam Therapy of Uveal 2231 Akihiro Hayashi Brachytherapy With Permanent Melanoma Study on the Optimal Field Width in Iodine-125 Seeds for Brain Metastases Helical Tomotherapy With the New 2220 Lukas Stalpers Dynamic Jaws Technology for Small 2243 Gerald Fogarty Late Eff ects of Radiotherapy for Optic Metastatic Brain Tumors Randomised Trial of Whole Brain Nerve Sheath Meningioma (ONSM) Radiotherapy in Melanoma Brain 2232 Samuel Shin Metastases- First Interim Analysis 2221 Samantha Price Updated Results of Involved Field MRI-Based Verifi cation of Plaque Radiation Therapy After Resection 2244 Seohee Choi Positioning and Treatment Planning for of Single Brain Metastases - A Single Treatment Outcome and Prognostic Episcleral Brachytherapy Institution Experience Factors of Supratentorial PNET : Follow-Up Results of a Single Institute 2222 Bradford Perez 2233 Hideyuki Harada Uveal Melanoma Treated With Cranio-Spinal Irradiation for 2245 Maria Leticia Silva Iodine-125 Episcleral Plaque According Leptomeningeal Carcinomatosis: A Analyses of 600 Patients With Brain to the COMS Trial Is Associated With pilot study Metastases Treated With Whole Brain Worsened Visual Acuity Change and Radiotherapy: Prognostic Features and Increased Risk of Chronic Toxicity 2234 Rovel Colaco Comparison With DS-GPA Prognostic Compared to Lower Prescription Doses Systemic Treatment and Radiation Features - A 16-year Institutional Review Necrosis Following Gamma Knife 2223 Aiko Nagai Radiosurgery in the Treatment of Brain 2246 Ching-Chieh Yang Hypofractionated Stereotactic Metastases Frameless Hypofractionated Robotic Radiotherapy Using Helical Radiosurgery for Cerebral Arteriovenous Tomotherapy for Single or Multiple 2235 Rovel Colaco Malformations : Early Clinical Report Brain Metastases Dose Selection Algorithm for Gamma on Obliteration Rate, Bleeding Risk and Knife Treatment of Cerebral Toxicity 2224 Keisuke Tamari Metastases- Preliminary Results Non-invasive Stereotactic Radiosurgery 2247 Andrew Huang for Brain Metastases of Lung Cancer 2236 Jean-Baptiste Clavier Factors Associated With Delineation of Brain Metastases for Leptomeningeal Failure in Patients Who 2225 Prince Mathew Stereotactic Radiotherapy: An Underwent Surgical Resection Alignment Accuracy & Intrafraction Interobserver Contour Comparison Followed by Cavity-Directed Motion Analysis in Frameless Functional Stereotactic Radiosurgery for Brain Image Guided Radiosurgery 2237 Kamran Ahmed Metastases Fractionated Stereotactic Radiotherapy 2226 James Bates to the Postoperative Cavity for Brain 2248 John Lucas Effi cacy of Stereotactic Radiosurgery Metastases A Propensity Score Adjusted Analysis of (SRS) in the Treatment of Brain Patients Receiving Up-Front SRS Versus Metastases From Melanoma and Renal 2238 David Shultz WBRT: Does the Use of Upfront WBRT Cell Carcinoma (RCC) Repeat Stereotactic Radiosurgery (SRS) Really Aff ect Neurologic Death? For New Brain Metastases Following 2227 Stefanie Lazow Initial Srs: Accumulated Tumor Volume 2249 Jacob Raber Comparison of Clinical Outcomes And Graded Prognostic Assessment Eff ects of Acute Radiation Exposure on After Intracavitary Cesium-131 (Cs-131) (GPA) Score Calculated at Each Course Extinction of Previously Conditioned Brachytherapy Versus Stereotactic Correlate With Overall Survival Fear in Mice Radiosurgery for Resected Brain Metastases Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
130 ASTRO 2014 / 56TH ANNUAL MEETING 2250 Rebecca Levin-Epstein 2262 Ashish Jani 2274 Joel Broomfi eld Stereotactic Radiation Therapy The Eff ect of Energy Index on Brain Stereotactic Radiosurgery for Refractory Demonstrates Improved Tumor Control Metastases Local Control with Trigeminal Neuralgia Versus Whole Brain Radiotherapy in Stereotactic Radiosurgery Breast Cancer Brain Metastasis for all 2275 Ryan Lanning Receptor Subtypes 2263 Andrew Song Clinical Outcomes of Salvage Partial Adult Medulloblastoma: Does Brain Radiation Therapy for Local 2251 Rupesh Kotecha Craniospinal Dose Matter? Recurrence After Stereotactic Management of Brain Metastasis in Radiosurgery in the Setting of Brain Patients With Neuroendocrine 2264 Saif Althaqfi Metastases Carcinomas of the Lung Use of CT Cisternograms in Target Defi nition for Trigeminal Neuralgia 2276 Karin Lindberg 2252 Tony Wang Radiosurgery Outcome After SBRT of Adrenal Gland Lung Cancer Mutation Status and Metastases - A Multicenter Targeted Therapy Predict for Outcomes 2265 Amandeep Taggar Retrospective Analysis of 60 Adrenal in the Setting of Brain Metastasis Outcomes From First Three Years of Metastases Treated With Stereotactic Radiosurgery Frameless Stereotactic Radiosurgery in Treating Brain Metastases 2277 Kyle Arneson 2253 Luluel Khan A Phase 1 Trial of Concurrent Sorafenib Outcomes With Hypofractionated 2266 Taro Murai and Stereotactic Radiosurgery for Stereotactic Radiotherapy (hfSRT) in Stereotactic Radiotherapy for Brain Patients With 1-4 Brain Metastases Patients With Intact Brain Metastases Metastases From Advanced Non-Small and Post-Operative Surgical Cavities Cell Lung Cancer With or Without 2278 Leslie Modlin Endothelial Growth Factor Receptor Repeat Resection Cavity Stereotactic 2254 Vinai Gondi (EGFR) Mutations: Infl uence of Gefi tinib Radiosurgery (SRS) for Brain Metastases Real-Time Pre-Treatment Review Limits Treatment Locally Recurrent Following Initial Unacceptable Deviations: Quality Resection Cavity Boost Assurance (QA) Results of RTOG 0933 2267 Yaser Hasan Factors Aff ecting Post-Operative 2279 Mira Shah 2255 Paulo Moraes Surgical Cavity Volume and Surface Parotid Gland Dose in Whole Brain Outcome of Cerebral Arteriovenous Area Dynamics Specifi c to Brain Radiation Therapy Patients Malformation After Linear Accelerator Metastases Radiosurgical Retreatment 2280 Anthony Pham 2268 Jason Chan Evaluation of Mini-Mental Status 2257 Lukas Stalpers Re-treatment of Brain Metastases Using Examination Score in a Prospective Estimation of the Incidence of Brain Stereotactic Radiosurgery Study of Neurosurgical Resection and Metastases and Patterns of Care in The Intra-Operative Cesium-131 Netherlands 2269 Hong-Qing Zhuang Radioisotope Brachytherapy in Analysis of Risk and Predictors of Patients With Newly Diagnosed Brain 2258 Guy Savir Brain Radionecrosis After Robotic Metastases Comparison of Fractionated Radiosurgery Stereotactic Radiosurgery and 2281 Reshma Munbodh Single-Fraction Stereotactic 2270 Eduard Schreibmann Radiation Induced Toxicity in Patients Radiosurgery for the Treatment of Automated Population-Based Planning Treated for Brain Tumors With Photon Brain Metastases for Whole Brain Radiation Therapy or Proton Radiotherapy
2259 Daniel Gorovets 2271 Bree Eaton 2282 Christopher Abraham Improving Patient Selection for Single Fraction Radiosurgery versus Dosimetric Variables Predictive of Local Stereotactic Radiosurgery as the Initial Hypofractionated Radiosurgery for Control Following Stereotactic Radiotherapy Approach for Brain the Treatment of Resected Large Brain Radiosurgery (SRS) for Non-Small Cell Metastases Metastases: A Comparison of Lung Cancer (NSCLC) Brain Metastasis Complications and Local Tumor Control 2260 Priya Jayachandran 2283 Neil Estabrook Repeat Stereotactic Radiosurgery (SRS) 2272 Nikolai Mickevicius Quantifying the Optimum Number of for Brain Metastases Locally Recurrent Eff ects of Whole Brain Radiation Proton Fields in Treatment of Midline Following Initial SRS Therapy on Resting State Connectivity: Tumors Using a Marginal Cost Analysis A Case Study 2261 Jeff rey Burkeen 2284 Matthew Johnson Lower-Dose Stereotactic Radiosurgery 2273 Jared Giem Brain Metastases Treated With Surgical for Small Brain Metastases: Local Control Evaluation of Treatment Plan Quality of Resection Followed by Frame-Based and Toxicity Single and Multiple Isocenter Stereotactic Radiosurgery Stereotactic IMRT for Multiple Intracranial Tumors Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 131 2285 Colette Shen 2296 Hunter Boggs 2306 Kazushige Atsumi Repeat Stereotactic Radiosurgery is an Primary Gross Tumor Volume is an Utility of an Artifi cial Neural Network Appropriate Approach for New/ Important Prognostic Factor in Locally for Prediction of Survival in Patients Recurrent Brain Metastases Advanced Esophageal Cancer Patients With Esophageal Cancer Treated With Treated With Trimodality Therapy Radiotherapy 2286 Shahed Badiyan Outcomes Following a Second Course 2297 Jin Wang 2307 Takuro Ariga of Stereotactic Radiosurgery (SRS) for Detecting The Variations of the Spatial Clinical Outcomes of Defi nitive Locally Recurrent Brain Metastases Position and Overlap Ratio for Primary Chemo-Radiotherapy for T4 Esophageal Thoracic Esophageal Cancer Target Cancer 2287 Robert Press During Radiotherapy Based on Clinical Predictors of Distant Brain Repeated Four-Dimensional CT Scans 2308 Ted Ling Failure and Early Salvage Whole Brain Protons Off er Reduced Radiation Therapy after LINAC-Based 2298 Jin Wang Cardiopulmonary Exposure for Patients Stereotactic Radiosurgery for Brain Detection of Tumour Volume Receiving Radiation Therapy for Metastases Regression and Motion Changes During Esophageal Cancer Radiotherapy for Primary Thoracic 2288 Ryan Abel Oesophageal Cancer Based on 4DCT 2309 Rei Umezawa Stereotactic Radiosurgery to the Scans Long-Term Results of Resection Cavity for Brain Metastases: Chemoradiotherapy for Stage 2-3 Prognostic Factors and Outcomes 2299 Stephanie Servagi Thoracic Esophageal Cancer: Vernat Comparison of Three Protocols 2289 Alexander Masino Chemoradiotherapy for Oesophageal Fractionated Stereotactic Radiosurgery Cancer in Elderly Patients 2310 Jun Tan for the Treatment of High-Risk Brain Suggestion on Modifi cation of Metastases 2300 Mariko Kawamura Postoperative Radiation Therapy Safety and Effi cacy of Endoscopic Volumes for Thoracic Esophageal 2290 Jennifer Chang Evaluation During Chemo-Proton Squamous Cell Carcinoma in Stage 3 or Estimation of the Incident Probability Therapy of Esophagus Cancer: Initial Positive Lymph Nodes of Brain Metastases in Hippocampal- Result of 6 Month Follow-Up Sparing Whole Brain Radiation 2311 Miyako Myojin 2301 Yuji Murakami The Signifi cance of 3DCRT/VMAT Hybrid Results of Neoadjuvant Plan to Reduce Pericardial Toxicity After GASTROINTESTINAL CANCER Chemoradiotherapy Followed by Chemoradiation for Thoracic Surgery for Locally Advanced Esophageal Cancer 2291 Shuhei Sekii Esophageal Squamous Cell Carcinoma Intrafraction Esophageal Motion for 2312 Jun Tan Clinically T1 Esophageal Cancer 2302 Melody Xuanlu Qu Results and Prognostic Factors for Management and Outcomes of Esophageal Cancer Treated With 2292 Liu Di Elderly Patients Treated for Cancer of Intensity-Modulated Radiotherapy Shall We Treat Small Cell Esophageal Esophagus Carcinoma (SCEC) Like Small Cell Lung 2313 Mao-Bin Meng Cancer (SCLC)? Comparison of the 2303 Yasumasa Nishimura Multimodality Therapy Is Expression Profi les of SCEC, SCLC and Clinical Outcome of Radiotherapy for Recommended for Limited-Stage Esophageal Carcinoma (EC) Esophageal Cancer between 2004 and Combined Small-Cell Esophageal 2008: Second Survey Carcinoma 2293 Mary Dean Defi nitive Contemporary 2304 Nima Nabavizadeh 2314 Peng Zhang Chemoradiation With Dose Escalation Preoperative Carboplatin and Detection of Radiation-Induced Heart for Esophageal Cancer Paclitaxel-Based Chemoradiotherapy Disease by Gated Myocardial Perfusion for Esophageal/Gastroesophageal Imaging in Patients With Esophageal 2294 Yoshiko Doi Carcinoma: Results of a Modifi ed Cross Cancer During-RT Four-Dimensional Assessment of the Regimen Within a Multidisciplinary Internal Motion of Esophagus in Upper Foregut Malignancy Program at 2315 Yanluan Guo Early-Stage Esophageal Cancer Patients a NCI-Designated Cancer Center Defi ning Target Volumes for Radiation Using Metal Markers Treatment of Primary Esophageal 2305 Yoshinori Ito Cancer: A Comparison of Four 2295 Annemarie Fernandes Phase 2 Study of Neoadjuvant Dimensional CR and 18FDG PET-CT Clinical Outcomes of Proton Beam Chemoradiotherapy With Cisplatin Re-Irradiation for Esophageal Cancer Plus 5-Fluorouracil and Elective Nodal Irradiation for Stage 2/3 Esophageal Squamous Cell Carcinoma
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
132 ASTRO 2014 / 56TH ANNUAL MEETING 2316 Yanluan Guo 2326 Ikuno Nishibuchi 2336 Amanda Chofl et Geometrical Diff erences in Target Tolerability and Outcome of Defi nitive Nutritional Factors Predict Survival in Volumes Between 18FDG PET-CT and Chemoradiotherapy for Elderly Patients Patients Receiving Concurrent Four Dimensional CT Mip Images of With Esophageal Cancer Chemoradiotherapy for Locally Primary Esophageal Cancer for Advanced Esophagus Cancer Radiation Treatment 2327 Junxin Wu Treatment and Prognosis of 73 Cases 2337 Tetsuo Nonaka 2317 Yanluan Guo With Limited Stage Primary Esophageal Radiation Therapy for Squamous Cell Detection of the Factors That Infl uence Small Cell Carcinoma Carcinoma of the Cervical Esophagus the Correlation of Target Volumes for Primary Esophageal Cancer Based 2328 Hui Liu 2338 Arjun Sahgal on Pet-CT and End-Expiration Phase Concurrent Chemoradiotherapy A Multi-Institutional Study Evaluating of Four-Dimensional CT in Radiation Associated With Enteral Nutrition the Reliability of the Spinal Instability Treatment Support: A Radical Treatment Option for Neoplastic Score (sins) Among Esophageal Squamous Cell Carcinoma Radiation Oncologists for Spinal 2318 Feng-Ming Hsu Patients With Malignant Fistulae Metastases Clinical Application of the Seventh UICC-AJCC TNM Staging System in 2329 Tawfi k Giaddui 2339 Mark Zaki Patients Treated With Trimodality Inter Observer Variability in Esophageal PET SUVmax as a Predictor of Pathologic Therapy for Esophageal Squamous Cell Contours for Patients With Non-Small Complete Response to Neoadjuvant Carcinoma Cell Lung Cancer Treated With Chemoradiation Therapy in Patients Defi nitive Chemoradiotherapy: RTOG With Carcinoma of the Esophagus 2319 Lan Wang 0617 Experience The Relationships Analysis of CT Based 2340 Jinsong Yang Gross Tumor Volume(GTV) and 2330 Sarah James The Important Prognostic Value of Prognosis for Esophageal Carcinomas Potential Presurgical Predictors for Pretreatment Stage in Patients Received 3DCRT or IMRT Treatment Pathologic Response in Patients With Achieving Pathologic Complete Advanced Esophageal Carcinoma Response After Neoadjuvant Therapy of 2320 Dali Han Treated With Trimodality Therapy Esophageal Cancer Risk Factors of Lymph Node Micro-Metastasis in Negative Node of 2331 Ethan Ludmir 2341 Judit Boda-Heggemann Esophageal Squamous Cell Carcinoma Defi nitive Chemoradiotherapy for Dose-Dependent Changes in Renal Detected by Conventional Pathological Cervical Esophageal Carcinoma: A 1H-/23Na-MRI After Adjuvant Technique, and Its Relationship With Single-Institution Experience Radiochemotherapy for Gastric Cancer Primary Tumor FDG PET/CT Uptake 2332 Yun Chen 2342 Jessica Cheng 2321 Chun Han Specifi c Lymphocytes Subsets are Radiotherapy Patterns of Care in Gastric The Application of Volumetric Associated With Stage and Overall Adenocarcinoma: A Single Institution Modulated Arc Therapy(VMAT)in Survival of Esophageal Squamous Experience Esophageal Carcinoma Cell Carcinoma Patients Treated With Radiotherapy 2343 Guichao Li 2322 Melanie Machiels An Interim Analysis of a Phase 2 Feasibility of Endoscopic Guided 2333 Talha Shaikh Clinical Trial of Preoperative Placement of Markers in Patients With Histology Predicts Response to Chemoradiotherapy Improving the Esophageal Tumors Chemoradiation (cRT) Regimen In Resection Rate for Potential Resectable Patients Undergoing Esophagectomy Gastric Cancer Patients 2323 Kazuki Ishikawa for Locally Advanced Esophageal Clinical Results of Defi nitive Cancer 2344 NingNing Lu Chemoradiotherapy for T4 Esophageal Prospective Phase 2 Trial of Cancer 2334 Takashi Kawanaka Nimotuzumab and Concurrent Salvage Chemoradiation Therapy With Capecitabine and Radiotherapy for 2324 Jinsong Yang Triple-Drug Combination (Docetaxel, Patients With Locally Advanced Dosimetric Analysis and Clinical 5-FU And CDDP) for Postoperative Inoperable or Relapsed/ Residual Outcome of Prophylactic Intensity Locoregional Recurrence of Esophageal Gastric Cancer: Final Analysis Modulated Radiation Therapy in Cancer pT3N0M0R0 Esophageal Cancer 2345 Ravi Patel 2335 Matthew Thau Increased Survival Associated With 2325 Hitoshi Ishikawa Signifi cant Weight Loss in The Post-Operative Radiation in Gastric Proton Beam Therapy Combined With Neoadjuvant Setting Is Predictive of Cancer Before and After MAGIC Trial: A Concurrent Chemotherapy for Whether Patients Undergo Surgery Population Based Study Esophageal Cancer Following Chemoradiation for Locally Advanced Esophageal Cancer
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 133 2346 Kyle Cuneo 2358 Talha Shaikh 2368 Ryan Lutz A Pilot Study of Diff usion Weighted MRI Defi ning the Optimal Sequencing of Pre-treatment Neutrophil to in Patients Undergoing Neoadjuvant Chemotherapy (Cx) and Radiation (RT) Lymphocyte Ratio (NLR) is Prognostic in Chemoradiation for Pancreatic Cancer in Patients (pts) With Locally Advanced Resectable Pancreatic Cancer Pancreatic Cancer 2347 Tobin Strom 2369 Omar Mian Worse Overall Survival With 2359 Ted Ling Dosimetric Parameters Predicting Late Preoperative Biliary Drainage in Evaluation of Normal Tissue Exposure Toxicity in Stereotactic Body Resectable Pancreatic Cancer Patients in Patients Receiving Radiotherapy for Radiotherapy (SBRT) for Pancreatic Pancreatic Cancer based on RTOG 0848 Cancer 2348 Lauren Colbert The Use of MRI for GTV Delineation 2360 Lora Wang 2370 Yun Liang In Borderline and Locally Advanced Dose Escalation With a Vessel Boost Preliminary Study of Daily Pancreatic Cancer Increases Local in Borderline Resectable Pancreatic Gastrointestinal Filling Impact on Tumor Control in Patients Treated With Adenocarcinoma Treated With Targeting During Radiotherapy for Intensity Modulated Radiation Therapy Neoadjuvant Chemoradiation Pancreatic Cancer Patients
2349 Takahiro Kishi 2361 Matthew Abrams 2371 Hua Gan Impact of Pretreatment Modifi ed Safety and Effi cacy of Capecitabine as a Monte Carlo Dose Evaluation for Glasgow Prognostic Score on Survival in Radiosensitizer in Adjuvant Pancreatic Stereotactic Body Radiation Chemoradiotherapy for Locally Chemoradiotherapy for Pancreatic Therapy Advanced Pancreatic Cancer Adenocarcinoma 2372 Michael Bernstein 2350 Norifumi Kennoki 2362 Eric Mellon Chemotherapy Alone Versus Preliminary Results of Feasibility and Stereotactic Body Radiation Therapy Chemoradiation for Unresectable Toxicities In Intensity Modulated for Locally Advanced and Borderline Pancreatic Cancer: A Meta-Analysis Radiotherapy With Gemcitabine And Resectable Pancreatic Cancer: Updated S-1 for Pancreatic Cancer Outcomes and Toxicity in Over 100 2373 Roland Teboh Forbang Patients Patient Setup Management for 2351 Jessica Freilich Pancreatic Stereotactic Body Radiation Age and Resected Pancreatic Cancer 2363 David Sherr Therapy: Inter-Fraction Adjustment Outcomes Is Marital/Partner Status Associated Between Spine Alignment and the With Survival in Patients With Pancreatic Fiducial During Breath-Hold 2352 Jinluan Li Resectable Pancreatic Cancer Treated Kv Imaging Comparison of CT and MRI-Based Gross With Adjuvant Post-Operative Tumor Volume and Organ at Risk Multi-Modality Therapy? Results of 2374 Shalini Moningi Delineation for Pancreatic Cancer Secondary Analysis of RTOG 97-04 Interpreting Baseline and Follow-up Patients Undergoing Neoadjuvant 18Flurodeoxyglucose-PET Total Lesion Stereotactic Body Radiotherapy 2364 Andrew Baschnagel Glycolysis in Patients With Locally The Eff ects of Neoadjuvant Chemora- Advanced and Borderline Resectable 2353 Entesar Dalah diation on Gene Expression Patterns of Pancreatic Cancer Delineation of Spatially-Varied High-Risk Pancreatic Ductal Adenocarcinoma GTV in Pancreatic Adenocarcinoma 2375 Kujtim Latifi Using MRI-ADC Maps 2365 Yong Yue Metabolic Tumor Volume (MTV) is Prognostic Modeling of Locally a Predictor of Survival in Borderline 2354 Takeo Kasuya Advanced Pancreatic Cancer Treated Pancreatic Cancers Treated With Feasibility of Respiratory-Gated PET/ With Radiotherapy Using [18F] FDG-PET Neoadjuvant Therapy CT for Pancreatic Tumors: A Preliminary Features and CA-19-9 Result 2376 Esengul Kocak 2366 Thomas Hayman Paraneoplastic Thrombocytosis is a 2355 Gang Ren Pancreatic Cancer Outcomes in Signifi cant Independent Prognostic Dosimetric Study on Dose Escalation Resected Age ≥ 70 Patients Are Factor for Overall and Progression Free in Internal Target of Pancreatic Cancer Comparable to Younger Patients Survival in Locally Advanced Pancreatic With Helical Tomotherapy Cancer 2367 Carla Hajj 2356 Antonino Romeo Chemotherapy and Intensity- 2377 Joshua Palmer Loco-Regional Hypofractionated Modulated Radiation Therapy for Modern Clinical Outcomes of Radio-Chemotherapy for Unresectable Locally Advanced Pancreatic Cancer Periampullary Cancer Following Nonmetastatic Pancreatic Cancer Achieves Prolonged Survival Pancreaticoduodenectomy and Adjuvant Chemoradiotherapy: A 2357 Nicolas Peguret Single-Institution Pancreatic Cancer Individualized Gated Stereotactic Body Registry Radiation Therapy for Pancreatic Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
134 ASTRO 2014 / 56TH ANNUAL MEETING 2378 Joshua Palmer 2388 Yusuke Iuzuka 2398 Joshua Niska Patterns of Failure in Periampullary Evaluation of Dose Distribution and Impact of Intravenous Contrast Cancer Following Tracking Accuracy in Dynamic Enhancement Phase on Target Pancreaticoduodenectomy and Tumor-Tracking Irradiation for Liver Defi nition for Hepatocellular Carcinoma Adjuvant Chemoradiotherapy With Tumors Using a Gimbaled Linac (HCC) and Intrahepatic Implications on Radiation Treatment Cholangiocarcinoma (IHC): Planning 2389 Shigeyuki Takamatsu Observations from Patients Enrolled on Focal Liver Reaction After Proton Beam a Prospective Phase 2 Trial 2379 David Horowitz Therapy for Hepatocellular Carcinoma Use of Adjuvant Radiation Therapy in Examined With Gadoxetate 2399 Ann Raldow the Management of Acinar Cell Disodium-Enhanced Hepatic MRI: Initial Tolerability of Liver Re-irradiation With Carcinoma of the Pancreas: Results Results Stereotactic Radiation Therapy From the Survival, Epidemiology, and End Results Database 2390 Shigeyuki Takamatsu 2400 Iris Ernst Early Experience With Proton Beam Detection of Target Motion for Liver 2380 Shalini Moningi Therapy for Hepatocellular Carcinoma SBRT by 4 D List Mode PET/CT - an Surgical Outcomes Following Analysis based on Phantom Chemotherapy and Stereotactic Body 2391 Shirin Sioshansi Measurements, Interfractional Cone Radiation Therapy in Patients With Tolerance Dose of the Diaphragm With Beam CT Scans and 510 Clinical Data Borderline and Unresectable Pancreatic Liver SBRT Cancer 2401 RyoongJin Oh 2392 Jonathan Klein Tolerance of Liver as a Predictor of 2381 Camille Berriochoa Prospective Longitudinal Assessment Hepatic Dysfunction In Stereotactic Preoperative Chemoradiation for of Quality of Life for Liver Cancer Body Radiotherapy Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Improves Margin Negativity and Nodal Radiotherapy 2402 Eun Kyung Paik Involvement at Resection Stereotactic Ablative Radiotherapy 2393 Vijay Kudithipudi Combined With Incomplete 2382 Terence Williams Liver Stereotactic Radiotherapy (SRT) Transarterial Chemoembolization in Caveolin-1 Confers a Multi-Modality With Functional Treatment Planning Hepatocellular Carcinoma Therapy Resistance Phenotype in for Patients With Intermediate Stage Pancreatic Cancer Cells Hepatocellular Carcinoma (HCC) 2403 Ben Goodman Safety and Effi cacy of Stereotactic Body 2383 Yo-Liang Lai 2394 Smith Apisarnthanarax Radiotherapy for Hepatic MELD Score is a Predictor of Early Quantitative Imaging of Global Oligometastases: 10-year Update Deterioration of Liver Function and Variability and Regional Heterogeneity Overall Survival in Patients With in Liver Function With 99mTC-Sulfur 2404 Jenny Shaff er Hepatocellular Carcinoma Receiving Colloid SPECT/CT in Hepatocellular Pooled Analysis of Liver Stereotactic Radiotherapy Carcinoma Patients Body Radiotherapy for Colorectal Metastases: Results From 5 Institutions 2384 Wei Huang 2395 Uranchimeg Tsegmed The Risk Factors Of HBV Reactivation Functional Image-Guided Stereotactic 2405 Daniel Chang After Conformal Radiotherapy in Body Radiotherapy Planning Using the Pooled Analysis of Liver Stereotactic Patients With Hepatocellular Carcinoma Intensity Modulated Radiation Therapy Body Radiotherapy for Hepatocellular Technique for Patients With Carcinoma: Results From a 2385 Amar Kishan Hepatocellular Carcinoma Multi-Institution Study Dosimetric Comparison Between an MRI-Guided Tri-Cobalt-60 Teletherapy 2396 Tiziana Comito 2406 Marta Scorsetti System and VMAT for Liver SBRT Stereotactive Ablative Radiotherapy The Challenge of Inoperable (sabr) in Inoperable Oligometastatic Hepatocellular Carcinoma (HCC): 2386 Yaoru Huang Disease From Colorectal Cancer: A Safe Results of a Single-Institutional Risk Factors of Hepatic Failure After and Eff ective Approach Experience on Stereotactic Body Re-irradiation for Recurrent Hepatocel- Radiation Therapy lular Carcinoma 2397 William Hall Abdominal MRI Radiographic to 2407 Karin Muller 2387 Kimberly Keene Pathologic Agreement in Patients With Reduced Tumor Dose Coincides With Stereotactic Body Radiation Therapy Resected Cholangiocarcinoma Compromised Local Control of Liver Followed by Sorafenib Improves Metastases Treated With fSRT Survival Without Increasing Toxicity 2408 Taiki Takaoka Helical Tomotherapy for Chemo-Refractory Multiple Liver Metastases: A Pilot Study Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 135 2409 Reena Engineer 2419 Michael Chuong 2430 Kim Ann Ung Neoadjuvant Chemoradiation Can Radiation Dose Versus Activity as a Treatment Dilemmas for Synchronous Downstage and Improve Resectability Prognostic Factor in Metastatic and Metachronous Prostate and Rectal Rates In Locally Advanced Unresectable Colorectal Cancer Patients Who Cancers Gall Bladder Cancers Received Selective Internal Radiation Therapy to the Liver Using Yttrium-90 2431 Ning Li 2410 Mary Feng Resin Microspheres Repeated Endorectal Unexpected Geometric Changes of the Ultrasonographies Predict The Tumor Gall Bladder During Liver Stereotactic 2420 Krista Bota Response Of Preoperative Body Radiation Therapy Dosimetric Comparison of Volumetric Chemo-radiotherapy In Rectal Cancer Modulated Arc Therapy, Tomotherapy 2411 Haoming Qiu and Intensity Modulated Radiation 2432 Rafal Suwinski SBRT for Hepatocellular Carcinoma: Therapy for Radiation Dose Escalation Randomized Clinical Trial on 8 Year Experience from a Regional of Hepatic Malignancies Hyperfractionated versus Transplant Center Hypofractionated Preoperative 2421 Evan Osmundson Radiotherapy for Rectal Cancer: Subset 2412 Daniel Wahl Dosimetric Modeling of Central Liver Analysis and Evaluation of the SBRT Provides Equivalent Local Control Toxicity After SBRT to the Liver Prognostic Factors for Overall Survival Compared to RFA for the Treatment of and Loco-regional Control Hepatocellular Carcinoma With Minimal 2422 Brandon Dyer Toxicity Laboratory Evaluation of Hepatic 2433 Karine Benezery Synthetic Function as a Predictor of The Role Of Contact Brachytherapy Xray 2413 Neha Bhooshan Ethiodol Retention During Transarterial 50 Kv (cbx) For Organ Preservation In Pre-Treatment Tumor Volume as a (Chemo)Embolization in Hepatocellular Rectal Cancer: A Series Of 61 Patients Prognostic Factor in Metastatic Carcinoma (HCC) Colorectal Cancer Patients Who 2434 Ching-Chieh Yang Received Selective Internal Radiation 2423 Xin Wang Importance of Tumor Regression Therapy to the Liver Using Yttrium-90 Adjuvant Radiotherapy May be Grading in Predicting the Outcome Coated Resin Microspheres Necessary for High Risk Patients With for Patients With Rectal Cancer After Stage 2 or 3 Upper Rectal Cancer After Preoperative Chemoradiotherapy 2414 Michael Chuong Total Mesorectal Excision Radiographic Tumor Volume Change as 2435 Esther Jimenez-Jimenez a Prognostic Factor for Overall Survival 2424 Virginia Morillo Macías Improvement Of Rectal Boost in Metastatic Colorectal Cancer Patients Surgical Interval After Neoadjuvant Contouring By Comparing Colonoscopy Who Received Selective Internal Treatment in Rectal Cancer: Impact on (CL) and MRI With Planning CT (PCT) Radiation Therapy to The Liver Using Response and Outcome Findings Yttrium-90 Resin Microspheres 2425 Marzieh Lashkari 2436 Jae-Sung Kim 2415 Edward Mannina The Eff ect Of Neoadjuvant Intraluminal The Role Of Postoperative Adjuvant Radiologic Versus Pathologic Brachytherapy and Chemotherapy After Radiotherapy In Patients With Stage II Assessment of Response in Conventional Neoadjuvant and III Upper Rectal and Recto-sigmoid Hepatocellular Carcinoma Treated With Chemoradiation On Pathologic Cancer: A Propensity Score Matched Stereotactic Body Radiotherapy Response In Patients With Locally Analysis Advanced Rectal Cancer: A Phase 2 2416 Seth Blacksburg Nonrandomized Clinical Trial 2437 Lijun Shen Characterizing Radiographic and Validation of a Rectal Cancer Outcome Pathologic Outcomes After Stereotactic 2426 Shilo Lefresne Prediction Model in Routine Chinese Body Radiation Therapy (SBRT) in the Management of Stage II and III Rectal Patients Management of Primary Hepatocellular Cancer: Is There A Rural-urban Carcinoma (HCC) Diff erence? 2438 Yan Zhang Role Of 18F-FDG PET-CT In 2417 Jenny Shaff er 2428 Chun-Ming Huang Postoperative Surveillance Of Colorectal Pooled Analysis of Stereotactic Body Preoperative Image-Guided versus Cancer Patients With Diff erent Radiotherapy for Liver Tumors: Results Conventional Pelvic Radiation Therapy Carcinoembryonic Antigen From 5 Institutions for Locally Advanced Rectal Carcinoma: Concentrations Comparison of Clinical Outcomes and 2418 Aditya Halthore Toxicity 2439 Lijun Shen Radiographic Outcomes of Yttrium-90 Baseline Neutrophil-lymphocyte Radioembolization in Patients With 2429 Esther Yu Ratio as a Prognostic Factor for Locally Hepatocellular Carcinoma Comparison Of EUS Versus Pelvic Mri Advanced Rectal Cancer Undergoing For Radiation Treatment Planning In Neoadjuvant Chemoradiation Locally Advanced Rectal Cancer
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
136 ASTRO 2014 / 56TH ANNUAL MEETING 2440 Daniel Glick 2450 Yu Tang 2461 Shyam Tanguturi Gastrointestinal Toxicity in Patients With Phase I Study Of Postoperative Outcomes With Full Dose Re-irradiation Infl ammatory Bowel Disease Treated Capecitabine With Concurrent With Curative Intent for Secondary With Pelvic Radiotherapy Radiotherapy In Elderly Patients With Anorectal Cancers Following Prostatic Rectal Cancer Radiotherapy 2441 Ashley Weiner Neoadjuvant Rectal Cancer (NAR) Score 2451 Tae Ryool Koo 2462 Malgorzata Kozak Applied to Phase II Trial of Short Course Prognostic Factors In Lymph Node The Prognostic Signifi cance Of Radiation (RT) and FOLFOX as Positive Rectal Cancer After Surgery Pre-treatment Hematologic Parameters Preoperative Therapy for Rectal Following Neoadjuvant In Patients Undergoing Resection For Cancer Supports a Total Neoadjuvant Chemoradiotherapy Colorectal Cancer Approach 2452 Yali Shen 2463 Benjamin Moeller 2442 Hiroo Sato High Dose Hypo-fractionated Outcomes and Quality of Care for Anal HLA class I Expression Its Alteration by Stereotactic Body Radiotherapy (SBRT) Cancer Patients Treated With IMRT in a Preoperative Hyperthermo- For Isolated Lung Metastasis from Large Multi-Site Cancer Center Chemoradiotherapy in Patients With Colorectal Cancer: Preliminary Results Rectal Cancer 2464 Berardino De Bari 2453 Helen Chen Helical Intensity-Modulated Radiation 2443 Hyeon Woo Lim Outcomes and Prognostic Facors Therapy With Daily Image Guidance in Is Elective Inguinal Radiotherapy of Rectal Cancer Patients Receiving the Treatment of Anal Canal Cancer Necessary for Locally Advanced Rectal Neoadjuvant Chemoradiation With and Cancer Involving Anal Canal? Without Planned Surgery 2465 John Longo Pelvic Insuffi ciency Fractures in Anal 2444 Tae hyung Kim 2454 Lee Jeongshim Canal Cancer Patients Treated With The Eff ectiveness of Off -Protocol Involved-fi eld Radiotherapy Integrated Helical Tomotherapy: Can We Identify Upfront Chemotherapy and In The Management Of Isolated Demographic, Clinical, or Dosimetric Preoperative Short-course Retroperitoneal Nodal Recurrence From Risk Factors? Radiotherapy followed by Delayed Colorectal Cancer Surgery for Patients With Locally 2466 Jennifer Wo Advanced Rectal Cancer and 2455 Khinh Ranh Voong Dosimetric Analysis of Proton Pencil Synchronous Metastases Radiation Therapy for High Grade Beam Scanning Radiotherapy versus Neuroendocrine Carcinoma of the Dose Painted Intensity Modulated 2445 Robert Weir Rectum and Anal Canal Radiation Therapy for Squamous Cell L5/S1 as the Superior Border of Carcinoma of the Anal Canal Radiation Therapy Fields in Rectal 2456 Abhijeet Bhirud Cancer Misses Internal Iliac Lymph Does Bladder Filling Aff ect Rectum 2467 David Grew Nodes Position? Signifi cantly Worse Colostomy-free Survival In Human Immunodefi ciency 2446 Lucas Resende Salgado 2457 Nathan Bennion Virus Positive Patients After Defi nitive Outcomes of Oligometastatic Rectal Comparing Supine vs. Prone Positioning Chemoradiation For Anal Cancer Cancer Treated With Extended Course and Contouring Methods in Patients Pelvic Irradiation Undergoing Preoperative 2468 Raima Amin Chemoradiation for Rectal Cancer Impact of HIV Status and Protease 2447 Yaacov Lawrence Inhibitor Use on Blood Counts During Severe Gastro-Intestinal Complications 2458 Zachary Morris Concurrent Chemoradiation Of Radiation Therapy In Rectal Cancer: Increased Pathologic Complete Quantifying The Eff ect of Age Response to Neo-adjuvant Radiation in 2469 Nadia Saeed Rectal Cancer Patients Taking an Pre-treatment Neutrophil-Lymphocyte 2448 Qin Xiao Angiotensin Converting Enzyme Ratio (NLR) Does Not Predict Worse Phase II trial of Preoperative Inhibitor or Angiotensin Receptor Outcomes in Anal Cancer Chemoradiotherapy With Oxaliplatin Blocker and Capecitabine for 137 Patients With 2470 Rebecca Muirhead Locally Advanced Rectal Carcinoma: 2459 Eric Anderson A Tumour Control Probability Model for Outcome and Failure Pattern Statin Use As A Predictor Of Outcome In Anal Squamous Cell Carcinoma Colorectal Cancer 2449 Xin Lei 2471 Craig Baden The Individual Californium(cf)-252 2460 Aman Anand Patterns of Failure in Squamous Cell Neutron Intracaviatry Brachytherapy Robust Scanned Proton Treatment Plans Carcinoma of the Anal Canal - A after Concurrent Chemo-radiation Provide Large Reductions In Bone Comparison between Intensity Predicted the Radio-sensitivity for Marrow Exposure For Pelvic Modulated Radiation Therapy and Low-lying Rectal Adenocarcinoma: The Radiotherapy For Anal Cancer 3-Dimensional Conformal Radiation 3 year result for 62 T2 and T3 patients Therapy Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 137 2472 Christopher Spencer 2482 Yachiro Hashimoto 2491 Henry Park Outcomes After Imrt Compared To Hypofractionated Image-Guided-IMRT Eff ect Of Primary Treatment Modality 3dcrt For Squamous Cell Carcinoma Of For Clinically Localized Prostate On The Association Between Statins The Anus Cancer - A Total Dose Of 66 Gy And Prostate Cancer Recurrence: An Delivered At 3 Gy Per Fraction Thrice Updated Meta-Analysis 2473 Abhilasha Patel A Week Comparison of Conditional Survival in 2492 Takuma Nomiya Patients With Gastrointestinal 2483 Ovidiu Marina Phase I/II Trial of Defi nite Carbon Ion Malignancies Treated With Radiation: A Prognostic Value Of Diagnostic Prostate Radiotherapy for Prostate Cancer: Population-based Analysis Biopsy Percent Carcinoma Volume (pcv) Evaluation of hypofractionated And Percent Positive Cores (ppc) On treatment of 12 fractions over 3 weeks 2474 Duygu Sezen Treatment Outcomes Following Robotic Stereotactic Body Radiation Radiotherapy (rt): A Retrospective 2493 Zachary Seymour Therapy In Patients With Recurrent Or Analysis Of 1731 Patients Dose-Volume Analysis of Urinary Metastatic Abdominopelvic Tumors: A Toxicity following SBRT Monotherapy Single Institute Experience 2484 Hiroyuki Ogino for Prostate Cancer Transperineal Approach Versus 2475 Manisha Palta Transrectal Approach For Fiducial 2494 Joseph Evans Intensity Modulated Radiotherapy Marker Placement In Proton Beam Comparative Eff ectiveness Analysis of Utilization in the Treatment of Therapy Of Prostate Cancer: A Patient Reported Quality of Life (QOL) Gastrointestinal Malignancies between Prospective Comparison After Stereotactic Body Radiotherapy 2000 and 2009 in the SEER Medicare as Compared to Intensity Modulated Population 2485 Joen Sveistrup Radiotherapy or Low Dose Rate Prospective Assessment of Urinary, Brachytherapy up to 2 years after Gastrointestinal and Sexual Symptoms Treatment GENITOURINARY CANCER Before, During and After Image Guided Intensity Modulated Radiotherapy for 2495 WITHDRAWN 2476 John Mikell Prostate Cancer Low-Dose Aspirin Mitigates Acute 2496 Felipe Counago Radiation-Induced Genitourinary 2486 Tobin Strom 3T Multiparametric MRI (3T mMRI) With Toxicity in Patients With Prostate A Dosimetric Study of Polyethylene a Phased-array Torso Coil in Staging Adenocarcinoma Glycol Hydrogel in 200 Prostate Cancer of Prostate Cancer Patients (PCP) Prior Patients Treated With High-Dose-Rate to Radical Prostatectomy: Preliminary 2477 Matthew Hall Brachytherapy ± Intensity Modulated Results Improved Overall Survival in Prostate Radiation Therapy Cancer With Increasing Dose 2497 Felipe Counago 2487 Benjamin Spieler Correlation between apparent diff usion 2478 James Ying Salvage Radiation for Biochemical coeffi cient (ADC) and gleason score Long Term Outcome of Prostate Cancer Failure Following Radical (GS) in prostate cancer patients (PCP) Patients Who Fail Salvage Radiation Prostatectomy: Improved Outcomes by using 3.0 Tesla multiparametric MRI Therapy and Radical Prostatectomy With Early Treatment (3T mMRI)
2479 Minh-Phuong Huynh-Le 2488 Eunpi Cho 2498 Amar Kishan Discrepancies In Toxicity Grading Of A Phase II Trial of External Beam Pelvic Nodal Dosing With Registration Rectal Bleeding: A Survey Of Radiation Radiotherapy (RT) And Abiraterone (ABI) to the Prostate: Implications for Oncologists Who Treat Prostate Cancer In Men With Localized Prostate Cancer High-Risk Prostate Cancer Patients (PCa): A Safety And Pharmacodynamics Receiving SBRT 2480 John Phillips Assessment The Impact of Diff ering Gleason Scores 2499 Jim Rose at Biopsy on the Odds of Upgrading 2489 Yvonne Pham Androgen Deprivation Therapy in and the Risk of Death from Prostate Improved Biochemical Control after Intermediate Risk Prostate Cancer Cancer Permanent Prostate Seed Implantation Patients Treated With Low Dose Rate for Large Prostate Glands >60 Grams Brachytherapy: A Multi-institutional 2481 Boris Naydich Compared to Smaller Glands Propensity Score Matched Pair Analysis Capricious Psa Dynamics After Prostate Seeds Brachytherapy Complicates 2490 Steven Finkelstein 2500 Arpit Chhabra Interpretation Of Outcome In Over 40% Impact of Prior Radiation Treatment Impact Of Race On Both Pathologic Of Patients on Sipuleucel-T Product Parameters in Extent Of Disease And Administra- PROCEED Patients tion Of Adjuvant Radiation Therapy In A Cohort With Clinical Low Risk Prostate Cancer Undergoing Radical Prostatectomy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
138 ASTRO 2014 / 56TH ANNUAL MEETING 2501 Daniel Krauss 2511 Joelle Helou 2523 Aaron Nelson Favorable Toxicity Profi les for Low Stereotactic Radiotherapy Versus Evaluation of an Atlas-Based and Intermediate Risk Prostate Cancer External Beam + High Dose Rate Segmentation Method for Prostate MRI Patients Treated With Single Fraction Brachytherapy Boost in the Treatment High Dose Rate Brachytherapy of Localized Prostate Cancer: A Quality 2524 Jonathan Cheng of Life Analysis Intensity-Modulated Radiation Therapy 2502 Sandrine van de Pol and Daily Image Guidance Therapy for Low Acute Toxicity in Prostate Cancer 2512 Lindsay Jensen Localized Prostate Cancer: Clinical Patients Treated With Hypofractionated Higher Delivered Bowel Doses Due Outcome and Toxicity from a External Beam Radiotherapy and Single To Lower Bladder Volumes In Patients Multi-Institutional Retrospective Cohort Fraction HDR Brachytherapy Receiving Post-prostatectomy Salvage Study Radiotherapy 2503 Colin Murphy 2525 Curtis Bryant Identifi cation of Groups at Increased 2513 Joelle Helou Proton Therapy in the Management of Risk of Prostate Cancer (PCa) Death Dosimetric and Patient Correlates of High-Risk Prostate Cancer after Salvage Radiation Therapy (sRT) Quality of Life after Prostate Stereotactic using Recursive Partitioning Analysis Ablative Radiotherapy (RPA) - Results from an NCI-designated 2526 Michael Hughes Comprehensive Cancer Center 2514 Jack Bagley The Long Term Eff ects of Salvage High Performance Status and Comorbidities Dose IG-IMRT after Prostatectomy in a 2504 Hyun-Cheol Kang in Patients Treated with External Beam Community Setting Whole Pelvic Irradiation for Patients Radiation for Intermediate-Risk Prostate With Prostate Cancer With a Cancer 2527 Waleed Mourad Biochemical Relapse Following Radical Dose-escalated Post-prostatectomy Prostatectomy: The Era of Robot- 2515 Yutaka Shiraishi Salvage Radiation Therapy: Is 81 Gy Safe assisted Minimally Invasive Surgery Prostate Postimplant CT With Metal And Eff ective? Artifacts Reduction For Improvement 2505 Josh Mason Of Seed Localization 2528 Roger Huang Delivering Multi-Parametric MRI-guided Long-Term Outcome of Dose Escalated High Dose Rate Brachytherapy Boost in 2516 Ananya Choudhury Hypofractionated Intensity Modulated Non-Metastatic Prostate Cancer Simultaneous Cone Beam Computed Radiation Therapy (IMRT) for Localized Tomography (CBCT) Acquisition Prostate Cancer. 2506 Amber Orman During Arc Radiotherapy (SCART): A A Phase III Randomized Trial of Comparison Of Volume Delineation On 2529 Joshua Sifuentes MRI-Mapped Dose-Escalated Salvage Simultaneous And Standard CBCT In Evaluating The Distribution Of Prostate Radiotherapy Post-Prostatectomy: Prostate Radiotherapy Cancer In Prostatectomy Specimens To The Maps Trial, An Initial Dosimetric Determine Eligibility For Focal Therapy Assessment 2517 F. J. Pos Introduction Of VMAT, IGRT And IMRT 2530 Waleed Mourad 2507 Gregory Warrell Reduced Acute GI Toxicity In Prostate Androgen Deprivation Therapy (ADT) Computationally-Obtained Thermal Cancer Patients With 75.6-81 Gy Conformal External Distributions for LDR Beam Irradiation (EBRT) Improves Thermobrachytherapy Seeds in Clinical 2519 Benedikt Engels Biochemical Progression Free Survival Implants Impact Of Planning Target Volume (BPFS) In Gleason Score 7 (GS7) Margins And Rectal Distention On Intermediate Risk Prostate Cancer 2508 George Rodrigues Biochemical Failure In Image-guided Comparison of LDR Brachytherapy Radiotherapy Of Prostate Cancer 2531 Christopher Straka Versus External Beam Radiation Therapy Early and Multiple PSA Bounces Can for Low and Intermediate-Risk Prostate 2520 Haruo Inokuchi Occur Following High Dose Prostate Cancer: A Propensity-Score Matched Long-term Genitourinary Toxicity Up Stereotactic Body Radiation Therapy: Analysis To 7-years After High Dose Subset Analysis of a Phase I/II Trial Intensity-modulated Radiotherapy In 2509 Albert Edwards Patients With Localized Prostate Cancer 2532 Anusha Kalbasi A Competing Risks Analysis of Clinical Low Rates of Adjuvant Radiation in Outcomes of Prostate LDR 2521 Tamara Smith Non-Metastatic Prostate Cancer Brachytherapy at a Single Institution Impact of Change from CTCAE Version Patients With Pathologic Risk Factors 3 to CTCAE Version 4 on Urologic 2510 Donald Fuller Toxicity Scores in Prostate Cancer 2533 Rupesh Kotecha HDR-like SBRT For Post-radiotherapy A Comparison Of Long-term Treatment- Locally Recurrent Prostatic Carcinoma: 2522 Caitlin Gomez related Toxicities Between Moderately PSA Response, DFS And Toxicity Dosimetric Parameters Predict Quality Hypofractionated And Conventionally Assessment of Life Outcomes for Patients Receiving Fractionated Radiation Therapy For Stereotactic Body Radiation Therapy for Localized Prostate Cancer Prostate Cancer
ASTRO 2014 / 56TH ANNUAL MEETING 139 2534 Nevine Hanna 2545 Jonathan Yang 2556 David Crawford Treatment of Adenocarcinoma of Evaluation of PSA Patterns in Patients CCP Score Stratifi es Risk For Prostate Prostate Using HDR Interstitial With Localized Prostate Cancer Treated Cancer Patients At Biopsy: Initial Brachytherapy Along With External With Radiotherapy and Androgen Commercial Results Beam Radiation - Long Term Follow-up Deprivation Therapy Results 2557 Yuta Shibamoto 2546 Thomas Nabhani Dose-volume Histogram Analysis for 2535 Andrew Loblaw Biochemical Progression-Free Survival the Urethra to Predict Urinary Stereotactic Ablative Radiotherapy (BPFS) for Gleason Score (GS) 7 Prostate Complications in Carbon-ion Versus Low Dose Rate Brachytherapy: Adenocarcinoma Treated With External Radiotherapy of Prostate Cancer A Propensity Matched Analysis of Beam Radiation (RT) ± Prostate Seed Canadian Data Implant (SI) 2558 Felipe Counago Role of 3.0 Tesla multiparametric 2536 Sarah Hamilton 2547 Martin Dolezel MRI (3TmMRI) in local staging and in The Incidence Of Second Malignancies Interfraction Variation In Prostate decision-making for treatment planning Following Low Dose Rate Cancer - Analysis Of 11726 Cone-beam in prostate cancer (PC) Brachytherapy For Prostate Cancer Ct And Implication For Treatment Planning 2559 Robert Kattevilder 2537 Joseph Safdieh Time Trends in Urinary Toxicity after Long Term Tolerance and Outcomes for 2548 Shane Lloyd Radiotherapy Treatment for Prostate Dose Escalation in Early Salvage Robotic Stereotactic Body Radiotherapy Cancer Post-Prostatectomy Radiation Therapy for Prostate Adenocarcinoma 2560 Ferran Ferrer 2538 Kentaro Ishii 2549 Didem Oksuz External Beam Radiotherapy Plus Comparison of Dosimetric Parameters Seminal Vesicle Interfraction High Dose Rate Brachytherapy in the and Acute Toxicity after Whole-pelvis Displacement and Dose Variations Treatment of Locally Advanced Prostate Versus Prostate-only Volumetric- Throughout the CBCT-guided Cancer modulated Arc Therapy With Daily Radiotherapy for Prostate Cancer Image Guidance for Prostate Cancer 2561 Hirofumi Asakura 2550 Christina Son Response of Pelvic Lymph Nodes to 2539 Seth Miller Bladder Dose-Volume Parameters Neoadjuvant Hormonal Therapy in Change in Prostate Biopsy Pathology Predict for Urinary Incontinence After Prostate Cancer Patients: Computed Reading on a Second Pathology Review Post-operative Radiation for Prostate Tomography for Radiotherapy at an Academic Medical Center Cancer Treatment Planning as “Second Look” Imaging 2540 Dominika Hempel 2551 Harold Wallace Testicular Dose Contributed by Transperineal Ultrasound for Image 2562 Antoine Simon Image-Guided Intensity-Modulated Guidance in the Treatment of Prostate Quantifi cation of The Diff erences Radiotherapy (IMRT) in Prostate Cancer Cancer: A Comparison to Fiducial-Based Between Planned and Delivered Doses Patients CT Imaging in The Bladder in Prostate IGRT
2541 Alexandra Stewart 2552 William Jackson 2563 Melpomeni Kountouri Findings of the Royal College of A Phase II Trial of Salvage Radiation and Dose Escalation with Two Sequential Radiologists (UK) national audit of Concurrent Weekly Docetaxel After Twice-Weekly Hypofractionated Prostate Cancer Brachytherapy Rising PSA post Radical Prostatectomy Schedules for Localized Prostate Cancer: A Comparative Study of Long 2542 Yu-Wei Lin 2553 Phillip Gray Term Toxicity and Outcome The 4-Year Result of Stereotactic Body Recent Trends in the Management of Radiotherapy for Localized Prostate Localized Prostate Cancer: Results from 2564 Kenshiro Shiraishi Cancer the National Cancer Data Base Volumetric Modulated Arc Therapy (VMAT) in the Treatment of Localized 2543 Cheng Hong 2554 Eric Vigneault Prostate Cancer: Initial Experience in Infl uence Of Zonal Dosimetry On Comparison Of Permanent Seed 200 Patients Prostate Brachytherapy Outcomes Implant Monotherapy With Combined Ebrt Plus Hdr Boost In Intermediate Risk 2565 Magali Lecavalier- 2544 Daniel Shasha Prostate Cancer Barsoum Brachytherapy Boost For Gleason (GS) 7 Pelvic Lymph Nodes Displacement Intermediate Risk Prostate 2555 Andrew Chiang in High-risk Prostate Cancer Patients Adenocarcinoma Yields Excellent Stereotactic Body Radiotherapy (SBRT) Treated With Image-guided IMRT With Biochemical Control And May Eliminate Boost to Mimic High-Dose Rate (HDR) Two Independent Target Volumes Therapeutic Benefi t Of Hormonal Brachytherapy for Intermediate-Risk Therapy Prostate Cancer: A Phase I Study
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
140 ASTRO 2014 / 56TH ANNUAL MEETING 2566 Piotr Milecki 2576 Derek McHaffi e 2585 Shu-Ya Lisa Grimm Importance Of Psa Level Post Observations from Early Adoption Comparison Of The Ipss Score Changes Neoadjuvant Androgen Deprivation of Radium 223 (Ra-223) in Heavily One Year Post High Dose Radiation Therapy (adt) For Patients With Prostate Pretreated Patients With Metastatic Between Good Bladder Fillers And Poor Cancer (pc) Treated With External Beam Castration-Resistant Prostate Cancer Bladder Fillers Radiotherapy (ebrt) And Brachytherapy (mCRPC) Hdr Boost 2586 Zhiyuan Zheng 2577 Justyna Chalubinska- A Description Of The Failure Patterns 2567 Xin Qi Fendler Of High-risk Prostate Cancer In The Optimal Clinical Target Volume for the Impact Of Intensity Modulated United States: Useful But Incomplete Seminal Vesicles in Localized Prostate Radiotherapy And Hypofractionated Information From The National Cancer Cancer Radiotherapy: Using CT to Radiotherapy On Overall Survival In Database Include the Segments Recommended Prostate Cancer by Pathological Examination 2587 Joseph Weiner 2578 Peter Agoston A Novel Perineal Shield for Low-dose 2568 Xin Qi Quality of Life After Permanent Rate Prostate Brachytherapy Neo-adjuvant Hormonal Therapy on Implantation Prostate Brachytherapy Seminal Vesicles Reduction: Optimal Based On Prospective Questionnaire 2588 Moshe Meister Clinical Target Volume for the Seminal Data Clinical Experience of Full-Dose External Vesicles in Localized Prostate Cancer Beam Radiation in Prostate Cancer Radiotherapy 2579 Jeff Michalski Patients Failing Initial Treatment With Impact of Prior Docetaxel, Extent of Prostate Brachytherapy 2569 Lara Hathout Disease (EOD), and Prior Dose To The Bladder Neck Is A Strong Bisphosphonates (Bp) on Hematologic 2589 David Harris Predictor For Acute Toxicity After (Heme) Safety of Radium-223 Dichloride Acute and Late Toxicity of Prostate Combined Ldr Brachytherapy And (Ra-223) From ALSYMPCA Radiotherapy Utilizing Fiducial versus External Beam Radiation Therapy For Cone-Beam Computed Tomography Prostate Cancer: Implications For New 2580 Paul Nguyen Daily Alignment Dose Constraints Impact of a Genomic Classifi er of Metastatic Risk on Post-prostatectomy 2590 Gilles Crehange 2570 Frederic Commandeur Treatment Recommendations by The Relationship Between The Gradient Collinearity Method For Radiation Oncologists and Urologists Occurrence Of Bone Metastases Prostate Mri To Ct Registration And Dose/volume Of Prior Prostate 2581 Steven Oh Radiotherapy In Patients With Localized 2571 Cory Hogue Outcomes in Organ Transplant Patients Prostate Cancer Optimum Frequency of Cone Beam With Prostate Cancer Treated With Computed Tomography (CBCT) for Radiotherapy 2591 Brandon Mahal Intact Prostate IMRT Racial Disparities in the Management of 2582 Michael Lovelock African American Men With 2572 Razvan Galalae Continuous Monitoring and Intermediate to High-Risk Prostate High-Dose-Rate Brachytherapy For Intra-Fraction Target Position Cancer Radical Dose Escalation In Patients With Correction during Treatment is Essential Localized Prostate Cancer - A for Patients Undergoing SBRT Prostate 2592 David Marcus Longitudinal Comparative Study Of Therapy With Tight Target Margins The Impact of Radiation Therapy Three Historical Protocols Oncology Group Consensus Clinical 2583 James Kavanaugh Target Volume Guidelines on Outcomes 2573 Monica Shukla Initial Evaluation of the First in Patients Undergoing Post- Early Salvage Pelvic Radiotherapy For Commercially Available Prostatectomy Radiation Therapy Lymph Node Positive Prostate Cancer Knowledge-Based Planning Software Following Prostatectomy 2593 James Melotek 2584 Young Kwok Urinary, Bowel, and Sexual Quality of 2574 Christophe Blay Long-Term Follow-up of a Prospective Life Is Not Worse After Whole Pelvic Prostate CT CBCT Registration Quality Trial of Neoadjuvant Chemotherapy Post-Prostatectomy Radiation Assessment and Androgen Deprivation Followed by Prostatectomy and Adjuvant Radiation 2594 Hima Musunuru 2575 Xiaofeng Yang in High Risk Prostate Cancer Comparison of Active Surveillance, Low Integration of MR Images into Dose Rate Brachytherapy, Stereotac- Ultrasound for 3D Doppler Imaging of tic Ablative Body Radiotherapy and the Neurovascular Bundle in Prostate Standard External Beam in Low Risk Radiotherapy: A Pilot Study Prostate Cancer
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 141 2595 Dorota Kazberuk 2606 Fan Ye 2616 Alan Pollack High-Dose-Rate Interstitial Comparison of Patient versus Physician Prostate Cancer Phase I Lattice Brachytherapy As Monotherapy In Reporting of Comorbidities in Localized Extreme Ablative Dose (LEAD) Trial: Prostate Cancer Patients Prostate Cancer Patients, Results from Feasibility and Acute Toxicity the Population-Based NC ProCESS 2596 Brandon Mahal Cohort 2618 Ashwin Ram The Impact of Race on Prostate-Cancer Prognostic Value Of Psa Nadir In Specifi c Mortality Among Men With 2607 Alfredo Urdaneta Patients Undergoing Defi nitive Low-risk Disease: Potential Implications Long-term Follow-up after Radiation For Prostate Cancer for Active Surveillance MRI-Directed Regional Salvage Brachytherapy for Locally Recurrent 2619 Garrett Green 2597 Zvi Symon Adenocarcinoma of the Prostate Dose Volume Relationship of Acute Does Choline PET/CT Change the and Late Small Bowel Toxicity From Management of Prostate Cancer 2608 David Ziehr Radiation Therapy for Prostate Cancer: Patients With Biochemical Failure? Exogenous Insulin Therapy Is a Veteran Aff airs Study Associated With Increased Prostate 2598 Albert Chang Cancer Mortality in Men With Type 2 2620 David Asher Long-Term Outcomes of Patients With Diabetes Mellitus The Emergence Of New Late Radiation High-Risk Prostate Cancer Treated With Toxicities Beyond The Traditional 5 HDR Brachytherapy Boost 2609 Alexander Engelman Years Of Follow-up After Low-dose The Effi cacy and Toxicity Outcomes Rate Prostate Brachytherapy 2599 Florian Sterzing of HIV-Infected Patients With Prostate Impact of 68Ga-PSMA PET/CT in Cancer Treated With Defi nitive 2621 Sergio Faria Staging of Prostate Cancer Patient Prior Radiation Therapy Radiotherapy-induced Castration In to Radiotherapy Men With Advanced Prostate Cancer. 2610 Ross Zeitlin Results Of A Prospective Phase I Study 2600 Thirupandiyur The Dosimetric Impact of Small Udayakumar Smearing and PTV Margin Reductions 2622 Parvesh Kumar Radiation Mediated Inhibition of IFN on DVH Values for OAR in Recently Updated Preliminary Results Signaling Sensitizes VSV Resistant Imaged-Guided Therapy for Localized Of An On-Going Phase I/II Trial Using Prostate Cancer Cells Prostate Cancer Tri-modality Therapy In Patients With Post-prostatectomy High Risk 2601 Abhishek Solanki 2611 Hardev Singh Pathologic (p) T2-3N0M0 Prostate Biochemical and Survival Outcomes in Impact of Endorectal Balloon and Saline Cancer Patients With T3 Prostate on Translational Shift in Prostate Cancer Adenocarcinoma Treated With Patients Treated With Proton Therapy 2623 Moses Arunsingh Brachytherapy Dosimetric Correlates for Acute 2612 Kevin Blas Toxicity in Prostate Cancer Treated 2602 Ann Henry Long-Term Clinical Outcomes for With Hypofractionated Impact of D90 on PSA outcomes in men Patients Treated With Adjuvant Versus Radiotherapy - Absolute Volumes treated With Low Dose Rate Prostate Early Versus Delayed Salvage are Better Predictors than Relative I125 Monotherapy Radiotherapy in the Post-Prostatectomy Volumes Setting 2603 John Lukens 2624 William Hartsell Oncologic and Toxicity Outcomes after 2613 Ashwin Ram Multi-institutional Prospective Prostate Brachytherapy for HIV-Positive Multiple Intermediate-Risk Factors as a Evaluation Of Quality Of Life Patients: A Matched Cohort Analysis Prognostic Tool For Men With Outcomes In Patients Treated With Localized Prostate Cancer Proton Therapy For Prostate Cancer 2604 George Yang Prostate Volumes >50 cc Do Not 2614 Amol Narang 2625 Samuel Cooper Preclude Dosimetric Coverage of the End of Treatment PSA as a Novel Comparison of Intraoperatively Built Prostate With High-Dose-Rate Prognostic Factor in Patients Custom Linked (IBCL) Seeds to Free Brachytherapy Undergoing Defi nitive Radiation for Seeds for LDR Prostate Brachytherapy Prostate Cancer 2605 Fabio Ynoe Moraes 2626 Sindy Magnan Trial Sponsorship, Self-reported 2615 Atchar Sudhyadhom Androgen Deprivation Therapy for Confl icts Of Interest Of Authors (coi) IPIP: A Planner Independent Approach Patients With Localized Prostate And Non-drug Related Randomized to HDR Prostate Brachytherapy Cancer Treated With High-Dose-Rate Clinical Trial (rct) In Prostate Cancer Brachytherapy Boost
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
142 ASTRO 2014 / 56TH ANNUAL MEETING 2627 Donald Fuller 2636 Khaled Zaza 2647 Norio Katoh Factors That Predict Gu, Gi And Sexual Patterns of Referral to Radiation Japanese Multi-institutional Study of Quality Of Life (QoL) Outcomes 3 Years Oncology Among Patients Who Stereotactic Body Radiation Therapy For After Stereotactic Body Radiation Undergo Cystectomy for Invasive Renal and Adrenal Tumors Therapy (SBRT) For Early Prostate Bladder Cancer in Ontario: A Popula- Cancer, Results From A Multi- tion-Based Study 2648 Christopher Tinkle institutional Phase 2 Trial Comparison of Stereotactic Body 2637 Marisa Kollmeier Radiotherapy and Conventional 2628 Magali Quivrin Image-guided Intensity-modulated External Beam Radiotherapy in Renal Post-implant Multiparametric Mri-based Radiation Therapy (IMRT) for Bladder Cell Carcinoma Dosimetry After Permanent Iodine Seed Cancer: Toxicity and Early Outcomes Prostate Brachytherapy: The Impact Of 2649 Fabio Cury The Dose Delivered To The Dominant 2638 Deborah Whalley Renal Tolerance to Stereotactic Body Intra-prostatic Lesion On Prostate Accelerated IMRT With Image Guidance Radiotherapy - an Assessment of Specifi c Antigen Bounce For Bladder Cancer Volume and Anatomical Site Irradiated
2629 Scott Robertson 2639 Catherine Thompson 2650 Sophia Kamran Prognostic and Therapeutic Tolerability Of Neoadjuvant Risk of Testicular Cancer Following Implications of PNI in Prostate Cancer Chemotherapy And Concurrent Childhood Cancer Testicular Radiation Patients Undergoing Defi nitive Chemoradiotherapy With Gemcitabine Radiation In Muscle Invasive Bladder Cancer: 2651 Clair Beard Physician And Patient Reported Variation in patterns of care in the 2630 Skyler Johnson Outcomes United States for clinical Stage I A Comprehensive Assessment Of The seminoma - Results from the National Prognostic Utility Of The Stephenson 2640 Fulya Agaoglu Cancer Data Base (1998-2011) Nomogram For Salvage Radiotherapy Bladder Preservation Therapy for Post-prostatectomy Muscle Invasive Bladder Cancer 2652 Marco Carlone CT Imaging for Penile Brachytherapy 2631 Dean Shumway 2641 David Raleigh Is the Fear of Post-Prostatectomy Gold Fiducial Marker Tracking To 2653 Abhilasha Patel Radiotherapy Justifi ed? An Analysis of Optimize Radiotherapy For Conditional Survival in Patients With Patient-reported Quality of Life Organ-Preserving Treatment Of Genitourinary Malignancies Treated Following Adjuvant or Salvage Muscle-Invasive Bladder Cancer With Radiation: A SEER Based Analysis Radiation 2642 Paula Doyle 2654 Brett Cox 2632 Amber Orman In Vivo Assessment Of Radiation Single Institution Experience With Automated Prostate Bed Lesion Damage To Murine Urothelium Using Radium-223 Dichloride (Ra-223) for Detection: The Next Step in Salvage Chondroitin Sulfate Labeled With Texas Metastatic Castrate-Resistant Prostate Radiotherapy Dose Escalation Red Cancer (mCRPC)
2633 Nirdosh Gogna 2643 William MacKillop USANZ And TROG Inter-group Phase III The Outcomes of Radiotherapy and GYNECOLOGIC CANCER Trial (TROG 02.03) Concurrent Weekly Surgery for Bladder Cancer: A Cisplatin Plus Radiation Therapy In Population-Based Study 2655 Ying Zhang Localised Muscle Invasive Bladder Rethinking For Pathological Risk-factors Cancer: Compliance< Toxicity< Quality 2644 Ariel Lederman Of Patients With Figo Stage I And Ii Of Life And Overall Results Treatment of Adrenal Metastases Using Cervical Cancer Hypofractionated Stereotactic Body 2634 BaoQing Li Radiosurgery 2656 Fei Yang The Role Of Post-cystectomy Radiation Standardized Spatial Heterogeneity In Treatment Of Squamous Cell 2645 Ryan Hughes Of Baseline Intratumoral 18F-FDG Carcinoma Of The Bladder: A Seer Predictors of Locoregional and Accumulation For Outcome Prediction Analysis Intravesical Recurrence Among Patients Of Concurrent Chemoradiotherapy in Treated With Nephroureterectomy for Cervical Cancer 2635 Tim Lautenschlaeger Urothelial Tract Carcinoma Novel Predictive Micro-RNA Signature 2657 Lauren Tait In The Setting Of Selective Trimodality 2646 Aaron Sabolch The Diff erence in Dose to the Bladder Preservation Therapy Toxicity of Concurrent Radiotherapy Parametria Using Image Guided With Mitotane Compared to Brachytherapy As We Move Away from Radiotherapy Alone in the Adjuvant Point A Treatment of Adrenocortical Carcinoma
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 143 2658 Grant Clark 2667 Elizabeth Kidd 2677 Hong In Yoon Quantifying Organ-at-Risk and Comparison of Outcomes for Cervical The Long-term Follow-up Result Of Applicator Movement During the Time Cancer Patients Treated with Radiation Extended-fi eld Radiotherapy For Between Treatment Planning and and Concurrent Weekly Cisplatin versus Uterine Cervical Cancer With Positive Delivery of 3-D Image Guided High Cisplatin and 5-Fluorouracil Para-aortic Lymph Nodes: Does The Ad- Dose Rate Intracavitary Brachytherapy dition Of Chemotherapy Have Survival for Cervical Cancer 2668 Matthew McKeever Benefi t? Radioablative Dose for Pelvic and 2659 John Ma Paraaortic Lymph Node Metastases 2678 Fumiaki Isohashi The Impact of Total External Beam from Cervical Cancer Dose-volume Analysis Of Predictors For Radiation Therapy and Brachytherapy Acute Hematologic Toxicity In Patients Package Duration on the Outcome of 2669 Seok Ho Lee With Cervical Cancer Treated With Cervical Cancer Treated with Radiation Assessment Of Tumor Volume And Postoperative Pelvic Radiation Therapy alone or with Concomitant Serum Tumor Marker Levels During And Concurrent Nedaplatin-based Chemotherapy Chemoradiation Therapy For Cervix Chemotherapy Cancer 2660 Karen Xu 2679 Vinita Takiar Extended Field Intensity-Modulated 2670 Primoz Petric PD-1 Levels Correlate with Lymph Node Radiation Therapy for Gynecologic A Tool For Pre-treatment Estimation Of Positivity in Patients with Squamous Cancers: Is the Risk of Duodenal Toxicity Brachytherapy Dose Contribution To Cell Carcinoma of the Cervix High? Pelvic Lymph Nodes In Cervix Cancer 2680 Mitchell Kamrava 2661 Marc Mahe 2671 Sean Quinlan-Davidson Clinical Outcomes Of High-dose-rate Early Clinical Outcomes In Cervical A Prospective Comparative Analysis Of Interstitial Gynecologic Brachytherapy Cancer Treated With Extended Field Three Methods Of Rectal Retraction For For Primary Locally Advanced Cervical Helical Tomotherapy To Paraaortic High-dose-rate Brachytherapy In Cancer Lymph Nodes Cervical Carcinoma: Eff ect On Organs At Risk 2681 Kazuhiko Hayashi 2662 Hanmanth Neboori Total Rectal Dose Estimated From Is Quantifying the D2cc to Bowel 2672 Claire Dempsey Radical External Beam And Necessary During Defi nitive HDR The Changing Nature Of HDR Intracavitary Radiotherapy For Uterine Brachytherapy for Patients with Invasive Brachytherapy For Cervix Cancer: How Cervical Cancer Using Deformable Cervical Carcinoma? The Clinical Target Volume Aff ects The Image Registration Method Historical Prescription Dose 2663 Kawngwoo Park 2682 Keiko Murofushi Clinical Outcome of Isolated Para-aortic 2673 Gamze Ugurluer Early Outcomes And Dose-volume Lymph Node Recurrence Treated With Bone Complications after Pelvic Parameters For CT Based Treatment Salvage Chemoradiotherapy for Uterine Radiation Therapy: Evaluation With MRI Planning In Brachytherapy For Cervical Cervical Cancer Cancer With Severe Vaginal Invasion Or 2674 Yongsook Lee Vaginal Cancer 2664 Goro Kasuya Variation In High Dose Rate Impact Of Bladder Volume And Uterine Brachytherapy Dose Contribution 2683 Henrik Hansen And Vaginal Geometric Factors On Among Pelvic Lymph Node Groups In Introducing PET/CT in Cervical Cancer The Irradiated Dose To The Bladder Locally Advanced Cervical Cancer Staging Procedures Leads to Stage And Small Intestine In Cervical Cancer Migration and Selection Bias Patients Treated With Image-guided 2675 Francesco Cellini Brachytherapy FDG-PET Can Predict Overall 2684 Akiko Kubo Recurrence And Disease Free Survival Contribution Of Imaging In Diagnosis 2665 Yusung Kim After Defi nitive Irradiation And Of Local Recurrence After Radiation Overall Rectum and Bladder doses Mri-guided Adaptive Brachytherapy In Therapy For Cervical Cancer (D2cc and D0.1cc) when integrated Uterine Cervix Cancer EBRT and HDR Brachytherapy Doses 2685 Cameron Swanick for Cervical Cancer by Accounting for 2676 Jun-ichi Saitoh Impact of Normal Tissue Motion on Organ Deformations Eff ectiveness of Bisphosphonate Dose to Critical Structures during against Radiation-induced Decrease of Intracavitary Brachytherapy 2666 Shira Felder Bone Mineral Densities in Irradiated and The Addition Of Brachytherapy To Non-irradiated Bone after Pelvic 2686 John Boyle Adjuvant External Beam Radiation Radiation Therapy in Patients with Simultaneous Integrated Boost to Pelvic Improves Survival In Cervical Cancer Uterine Cervical Cancer and Paraaortic Nodes from Cervical Patients Following Surgery Cancer Improves the Dosimetric Therapeutic Ratio
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
144 ASTRO 2014 / 56TH ANNUAL MEETING 2687 Emily Dunn 2698 Dominique Rash 2708 Chris McClinton PET/CT and MRI After Chemoradiation Prospective Evaluation of Patient Comparison of Four Diff erent for Cervical Cancer: Comparing the Satisfaction Following the Use of Optimization Methods for Cervical Predictive Value for Recurrence Education Materials for Cervical Cancer Brachytherapy in the Era of 3D Planning Brachytherapy 2688 Valentine Guimas 2709 Puja Venkat Trendelenburg Position Can Reduce 2699 Anthony Michaud F18-FDG PET/CT as a Prognostic Small Bowel Dose In Brachytherapy Of Prospective Analysis of the Treatment Indicator of Clinical Outcomes for Cervix Carcinoma Planning Process for Gynecologic Image Cervical Cancer Treated With Guided High Dose Rate Brachytherapy MRI-Guided Brachytherapy 2689 Lilie Lin Initial Report of the Clinical Feasibility 2700 Rajni Sethi 2710 Himanshu Nagar and Acute Toxicities Associated with A Multi-Institutional Study of Lymph Treatment with Adjuvant Pelvic Pencil Beam Scanning Whole Pelvis Node Positive Cervical Cancer Patients Radiation Therapy ± Vaginal Proton Therapy for Gynecologic Treated in the Modern Era of Brachytherapy in Patients with Cancers Chemoradiation High-Risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and 2690 Mei Li 2701 Xin Wang High-Grade Endometrioid Carcinoma The Comparison between Reporting Long-term Follow-up Results Of Doses per GEC ESTRO and Estimation Simultaneous Integrated Or Late 2711 Christine Chang- from Deformable Dose Accumulation Course Accelerated Boost With Ebrt Halpenny To Vaginal Stump In Intermediate Risk Early Stage Pure and Mixed Endometrial 2691 Henrik Hansen Cervical Cancer Patients After Radical Clear Cell Carcinoma: Outcomes and Radiotherapy without Cisplatin for Hysterectomy Patterns of Recurrence Elderly Cervical Cancer Patients 2702 Jennifer Croke 2712 Angeles Rovirosa 2692 Tony Eng Vaginal Dose And Patient Reported Comparative Results of Vaginal Relapses Treatment Outcome of Patients With Sexual Adjustment With MR-guided and Toxicity of Two Protracted 192-Ir Advanced Cervical Carcinoma After Brachytherapy For Cervical Cancer HDR brachytherapy (BT) Schedules in Concurrent Chemotherapy and External Postoperative Endometrial Carcinoma Beam Radiation Therapy Plus 2703 Angela Lin (EC) High-Dose-Rate (HDR) Brachytherapy A Retrospective Review Of Patient Outcomes Following High-Dose-Rate 2713 Gustavo Ferraris 2693 Gregory Treharne Brachytherapy In The Treatment Of Ki-67 Expression as a Prognostic Factor Cervical Cancer Patients Presenting Cervical Cancer of Outcome After Adjuvant Irradiation with Para-aortic Lymph Node in Endometrial Carcinoma Involvement have Distinctly Diff erent 2704 Baozhou Sun Survival Compared to Patients 3d Dose Accumulation In Pseudo-split- 2714 Lucas Sapienza Presenting with Metastatic Disease fi eld Imrt And Bt For Locally Advanced Isolated Brachytherapy for Cervical Cancer Endometrial Cancer with Disease 2694 Ryan Best Restricted to Uterus - Oncologic Results Dosimetric Study Of Two Utrecht-style 2705 Rebekah Young and Toxicity Analysis Applicators For Cervical Brachytherapy Is Point A Still Relevant?: Does Prescribing to Tumor Volume Vs Point A 2715 Sebastia Sabater 2695 Ebru Karakaya Correspond to Equivalent Outcomes Body Mass Index And Doses At Organs Is Pretreatment Neutrophil To Among Cervical Cancer Patients At Risk Evaluated By CT In A Lymphosite Ratio A Predictive Factor Undergoing T&O Brachytherapy? Mediterranean Postoperative Vaginal For Cervical Cancer Control? Cuff Brachytherapy (VCB) Cancer 2706 Alex Herskovic Population 2696 Jihoon Lim Is There A Diff erence In Cause Specifi c The Impact of Substance Use on Survival And Overall Survival In 1b1 2716 Himanshu Nagar Incidence and Survival in Locally Squamous Cell Carcinoma And Tolerability of Concurrent Advanced Cervical Cancer Treated with Adenocarcinoma Of The Uterine Cervix? Chemotherapy and Vaginal Radiation Therapy Seer Database: 2004-2008 Brachytherapy for Treatment of Early Stage High Grade Endometrial Cancer 2697 Feng Mei 2707 Puja Venkat Prognostic Factors For Toxicity And Outcome Assessment of Dose 2717 Sharon Lu Survival In Advanced Cervical Cancer Adaptation of MRI-Guided Cervical Single Institution Comparison of Patients Treated With High Dose Rate Cancer Brachytherapy “Sandwich” versus Sequential Adjuvant (hdr)-intracavitary Brachytherapy Chemotherapy and Radiation for Stage (icbt) Combined With Complementary III Endometrioid Uterine Carcinoma Intensity Modulated Radiotherapy (imrt)
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 145 2718 Mohamed Elshaikh 2728 Arya Amini 2739 Larissa Lee Quantifi cation of the Air Gaps Around Should we customize PTV expansions Local-Regional Recurrence in Node High-Dose Rate Brachytherapy Cylinder. for BMI? Daily Cone Beam Positive Vulvar Cancer: Clinical Factors, A Prospective Study to Correlate Air Computerized Tomography to Assess RT Fields and Dose Gaps with Optimal Cylinder Size Organ Motion in Postoperative Endometrial and Cervical Cancer 2740 Carminia Lapuz 2719 Sean Vance Patients Determination of Standardized Failure Patterns of Type II Endometrial Objective and Constraint Settings for Cancer With and Without Adjuvant RT 2729 Joseph Dise Inverse Planning using IPSA and HIPO Development and Evaluation of an for HDR Brachytherapy Multi-channel 2720 Nicolas Bauer Automatic Interstitial Catheter Vaginal Cylinders Vaginal Vault High-dose-rate Digitization Tool for HDR Brachytherapy Brachytherapy Alone as Adjuvant of Gynecologic Cancers 2741 Megan Mezera Treatment of Early-stage Endometrial Intensity Modulated Radiotherapy Cancer: a Retrospective Study on 119 2730 Jennifer Ma Utilizing Dose-Escalated Integrated Patients Lymphovascular Invasion as a Poor Simultaneous Boost to PET Avid Gross Prognostic Factor in Uterine Cancer Nodal Disease in Gynecologic 2721 Mehmet Ufuk Abacioglu Malignancies: Analysis of Disease Comparison of Target Volume and 2731 Thatcher Heumann Response and Toxicity Organ At Risk Doses With Multi-channel Survival Outcomes and the Role of vs. Single Channel Cylinder for Vaginal Adjuvant Therapy Sequencing in Type II 2742 Sujith Baliga Brachytherapy Uterine Cancer After Defi nitive Surgery Stereotactic Body Radiation Therapy in Recurrent, Persistent, or Oligometastatic 2722 Christina Chapman 2732 Kaveh Maghsoudi Gynecological Tumors Assessing the Need for Dose Salvage Radiation Therapy Including Calculations to Organs at Risk Using MRI High Dose Rate Brachytherapy for 2743 Jessica Zhou Planning in Vaginal Brachytherapy Isolated Vaginal Recurrences of Radiation Dosimetry of Pelvic Floor and Endometrial Cancer Non-Reproductive Sexual Organs in 2723 Josephine Chen External Beam Radiation Therapy for Comparing the Use of the Full 2733 Joseph Syh Gynecologic Cancers Dose-Volume Histogram (DVH) Curves A Dosimetric Study by Using a with Point Dosimetric Indices to Multichannel Cylinder in High Dose 2744 Ryan Bair Characterize External-Beam Treatment Rate Brachytherapy Treatment of the Radiopaque Polymer Hydrogel used Plans for Endometrial Cancer Vaginal Cuff as a Fiducial Marker in Gynecologic Brachytherapy 2724 Neil Desai 2734 Sang-June Park Comparison Of Early Stage Uterine Is It Better to Treat from Inside Out or 2745 Melis Gultekin Papillary Serous Carcinoma (upsc) And Outside In for Vaginal Cuff Determination of Optimal Planning Carcinosarcoma Treated With Adjuvant Radiotherapy? Target Volume Margins in Patients with Carboplatin/taxane Chemotherapy And Gynecologic Cancer Intravaginal Radiotherapy (ivrt) 2735 Rebekah Maymani Vaginal Cancer: Importance of 2746 Nicolette Taku 2725 Vikram Velker Response to EBRT and Medical Quantifying Vaginal Motion Associated Adjuvant Treatment of Stage IA Type II Contraindications to Interstitial With Daily Endorectal Balloon During Endometrial Cancers: Is Observation a Brachytherapy Whole Pelvis Radiotherapy For Valid Strategy? Gynecologic Cancers 2736 Jim Rose 2726 Philip Poorvu Transvaginal Ultrasound-Guided “Loops” Versus “Bowel Bag”: Which Is Interstitial Brachytherapy For Vaginal HEAD AND NECK CANCER Better For Bowel Contouring In Tumors: A Fixed Template Technique Gynecologic Cancer Patients Receiving 2747 Rangarajan Ramya IMRT To The Paraaortic Nodes? 2737 Yuan Rao Comparison of Clinical Profi le of Oral Analysis of Survival after Cancers in Young And Elderly - A Single 2727 Julia Manzerova Brachytherapy for Vulvar Cancer Using Institution Series From a Developing Treatment Regimens Incorporating the SEER Registry country Adjuvant Radiation Therapy Improve Survival of Patients with Carcinosar- 2738 Kathy Han 2748 Ryuji Murakami coma of the Uterus: a SEER Study What Is The Optimal Treatment For Prognostic Impact of the Nodal Level Patients With Sentinel Node-positive Involvement in Advanced Oral Cancer Vulvar Cancer? Treated with Preoperative Concurrent Chemoradiation Therapy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
146 ASTRO 2014 / 56TH ANNUAL MEETING 2749 Zachary Nicholas 2759 Ken Takeda 2771 Shlomo Koyfman A Dosimetric Evaluation of Oral Tongue Clinical Factors with respect to Cervical Intensity Modulated Radiotherapy Sparing to Reduce Dysgeusia in Head Body Volume Reduction During (IMRT) Reduces Late Toxicity in Patients and Neck Cancers Defi nitive External Beam Radiation with Human Papillomavirus Associated Therapy for Oropharyngeal Squamous (HPV+) Oropharyngeal Carcinoma 2750 Eli Scher Cell Carcinoma Treated with Chemoradiotherapy (CRT) Evaluation Of Primary Treatment Technique For Squamous Cell 2760 Omar Gayar 2772 Sophia Kamran Carcinoma Of The Buccal Mucosa: A Compliance with Quality Assurance Weekly On-treatment MRIs During Single Center Experience Measures for Improving Oropharyngeal Radiotherapy (RT) In Head And Neck Cancer Patient Care Squamous Cell Carcinoma (HNSCC) 2751 Sean Quinlan-Davidson Patients To Monitor Treatment Postoperative IMRT for Patients with 2761 Esengul Kocak Response Oral Cavity Carcinoma Beam Path Toxicity In Candidate Organs at Risk: Assessment Of Radiation 2773 William Magnuson 2752 Kathryn Hitchcock Emetogenesis For Patients Receiving Potential Infl uence of ACE Inhibitors Retromolar Trigone Squamous Cell Head And Neck Intensity Modulated and Angiotensin Receptor Blockers on Carcinoma Treated with Radiotherapy Radiotherapy Outcome in Patients with Oropharynx Alone or Combined with Surgery: A Cancer Treated with Radiotherapy 10-Year Update 2762 Daniel Yeung Reducing Toxicity from Oropharyngeal 2774 Anthony Pham 2753 Richard Cassidy Cancer Therapy with IMPT: A Dosimetric Signifi cantly Improved Local Control Squamous Cell Carcinoma of the Oral Analysis With The Use Of Cesium-131 Tongue: Exploring New Trends Brachytherapy In High Risk And 2763 Francesco Ricchetti Recurrent Head And Neck (hn) Cancers: 2754 Jeff rey Vainshtein Parotid Gland Shrinkage during IMRT for Long Term Results Of A Pilot Study Matted Lymph Nodes: An Indication Oropharyngeal Cancer and Xerostomia for Intensifi cation of Chemotherapy in 2775 Marianne Feen Roenjom Human Papillomavirus-Related (HPV+) 2765 Florence Keane A Validation Study Of Normal Tissue Oropharyngeal Cancer (OPC)? The Prognostic Signifi cance Of T-stage Complication Probability (NTCP) And N-stage In Patients With Squamous Models For Radiation-induced 2755 Jerry Liu Cell Carcinoma Of The Oropharynx Hypothyroidism (HT) Prognostic Value Of Radiographic (OPSCC) In The HPV Era Extracapsular Extension In Locally 2776 Scott Glaser Advanced Head And Neck Squamous 2766 Mauricio Gamez A Dosimetric Analysis of Adjuvant Cell Cancers Unilateral Radiotherapy for Radiation Therapy Following Transoral Node-Positive HPV-Positive Squamous Robotic Surgery (TORS) for Oropharyn- 2756 Moein Alizadeh-Kashani Cell Carcinoma of the Tonsil: Analysis of geal Cancer Compared to Defi nitive Phase I-ii Study Evaluating Reduced a Prospective Cohort Chemoradiation (CRT) Radiation Volume And Dosage Using Comprehensive Tomotherapy And 2767 Jerry Liu 2777 Enrique Izaguirre Concurrent Chemotherapy For Is Radiographic Extracapsular Dose Dependent Response of Tonsil Oropharyngeal Carcinoma Extension Prognostic In Human Cancers to Radiation Therapy and Papillomavirus-related Oropharyngeal Concurrent Chemotherapy: A 2757 John Ma Cancers? Retrospective Analysis of Change of Three-year Clinical Outcome and Gross Tumor Volume Quality of Life Interim Analysis of a 2768 Jacob Rasmussen Phase II Trial to Examine Use of Temporal Stability And 2778 Philip Schaner Post-Chemotherapy Volumes after Reproducibility Of FDG-PET-based Dose Intensity Modulated Radiation Therapy Neo-adjuvant Treatment of Squamous Painting Targets In Head And Neck Decreases the Risk of Long Term Cell Carcinomas of the Head and Neck Cancer Gastrostomy Tube Dependence in Curative Intent Treatment for Squamous 2758 Pirus Ghadjar 2769 Ganesh Narayanasamy Cell Carcinoma of the Oropharynx Impact Of Weight Loss On Survival After Radiobiological Evaluation of IMRT Chemoradiation For Locally Advanced Treatment Of Head And Neck Patients: 2779 Natalie Logie Head And Neck Cancer. Secondary Multi-Institutional Study The Impact Of Treatment Delays In Results Of A Randomized Phase 3 Trial Oropharyngeal Cancer Patients Treated (SAKK 10/94) 2770 Stephen Rosenberg With Surgery Followed By (chemo) HPV Positive Oropharyngeal Cancers: radiation Mid-treatment PET During Radiotherapy And Implications For Treatment De-escalation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 147 2780 Joshua Weir 2791 Musa Altun 2801 Wing Lun Mui Reduced Toxicity of Induction Radiation Infi eld Second Tumors in Dosimetric Eff ect of Binary Multi-leaf Chemotherapy with Omission of 5FU Nasopharyngeal Carcinoma Patients Collimator in Helical Tomotherapy to and Response Rates by RTOG 0129 Risk Optic System in Treating Group 2792 Rafael Manon Nasopharyngeal Carcinoma Retrospective Study Of Hippocampal 2781 Susie Chen Sparing In The Treatment Of 2802 Emily Tanzler Use of 18-FDG PET in Determination of Nasopharyngeal Cancer Are Blind Biopsies of the Nasopharynx, Disease Extent in HPV/p16 Positive Pyriform Sinus, and Contralateral Tonsil Oropharyngeal Squamous Cell 2793 Faqiang Ma Necessary in the Work-Up of Unknown Carcinoma Effi cacy and Factor Aff ecting Outcome Primary Squamous Cell Carcinoma of of Induction Chemotherapy Combined the Head and Neck? 2782 Takeshi Kodaira Concurrent Chemoradiation Therapy in Clinical Effi cacy Of Helical Tomotherapy 263 Patients with locally 2803 Chengtao Wang For Nasopharyngeal Cancer Treated advancednasopharyngeal carcinoma Metabolic Tumor Volume (MTV) and With Defi nite Concurrent Maximum Standardized Uptake Value Chemoradiotherapy 2794 Chan Woo Wee (SUVmax) as Predictive Factors in A Single Physician Experience of Locally Advanced Nasopharyngeal 2783 Vincent Wu Intensity-Modulated Radiotherapy for Cancer Treated with Defi nitive Radiation Induced Changes On Locoregionally Advanced Chemoradiotherapy Temporo-Mandibular Joint In Nasopharyngeal Carcinoma Treated Nasopharyngeal Cancer Patients After with Concurrent Chemoradiation 2804 Ozlem Ozkaya External Beam Radiotherapy - A Akagunduz Preliminary Study 2795 Lai Tan Evaluation of the Radiotherapy Induced Quality of Life in Nasopharyngeal Optic Nerve and Chiasm Injuries by 2784 Yong Chen Cancer (NPC) Patients: Study of Salivary Electrophysiological Tests and Optic Prognostic Signifi cance of Maximum Flow Recovery Pattern on Coherence Tomography in the Patients Primary Tumor Diameter in Xerostomia Improvement for IMRT with Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma (Intensity Modulated Radiation Therapy) vs VMAT (Volumetric Modulated Arc 2805 Emma Holliday 2785 Ning Zhang Therapy) Gastrostomy Tube Rates Decrease by Primary Tumor Regression Speed After Over 50% in Patients with Radiotherapy And Its Prognostic 2796 Weixin Liu Nasopharyngeal Cancer Treated with Signifi cance In Nasopharyngeal Nasopharyngeal Carcinoma in Intensity Modulated Proton Therapy Carcinoma: A Retrospective Study Childhood and Adolescence: A Single (IMPT): A Case-Control Study Institution’s Experience of 158 Patients 2786 Tsung Min Hung The Dose of Elective Neck Irradiation 2797 Qichao Zhou 2806 Miranda Kim as 46 Gy is Feasible in Nasopharyngeal Prognostic Factors Of Local Control Sequential Versus Concurrent Carcinoma treated by Intensity- After Re-irradiation With Chemotherapy For Locally Advanced Modulated Radiotherapy Intensity-modulated Radiotherapy Nasopharyngeal Carcinoma: A Of Locally Recurred Nasopharyngeal US-based Study 2787 Hongmei Ying Carcinoma Eff ectiveness And Toxicities Of 2807 Wei-Hsien Hou Intensity-modulated Radiation Therapy 2798 Xiyin Guan The Ratio Of Weight Loss To Planning For Patients With T4 Nasopharyngeal Induction Chemotherapy With Target Volume Signifi cantly Impacts Carcinoma Docetaxel And Nedaplatin Followed Setup Errors In Nasopharyngeal Cancer By Concurrent IMRT And Nedaplatin Patients Undergoing Helical 2788 Ryo Toya For Locally Advanced Nasopharyngeal Tomotherapy With Daily MVCT Radiotherapy For Nasopharyngeal Carcinoma Carcinoma: Predictability Of Treatment 2808 WeiWei Xiao Outcomes At Interim Re-assessment 2799 Ramesh Bilimagga Delineation Of the Clinical Target Role Of Stereotactic Radiosurgery In Volume in Early-stage Nasopharyngeal 2789 Lin Ma Recurrent Head And Neck Cancers: A Carcinoma Treated With Replanning Criteria and Timing Single Institution’s Experience Intensity-modulated Radiotherapy: Defi nition for Parotid Protection-based Long-term Follow-up Of A Phase 2 Adaptive Radiation Therapy in 2800 Niranjan Bhandare Study Nasopharyngeal Carcinoma Association Between Location of Nasopharyngeal Carcinoma, Pre- and 2809 Annie Chan 2790 Irene Karam Postradiotherapy Otitis Media with Refi nement and Individualization of Outcomes Following Re-irradiation For Eff usion, and Sensory Neural Hearing Clinical Target Volume Delineation in Recurrent Nasopharyngeal Carcinoma: Loss Nasopharyngeal Carcinoma: A 22-Year A Single Institutional Experience Clinical Experience Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
148 ASTRO 2014 / 56TH ANNUAL MEETING 2810 Ayal Aizer 2819 Mark Edson 2828 Kristin Plichta Assessment Of Trismus After IMRT For Organ Preservation In The Prognostic Value of Pretreatment Chemoradiation For Nasopharyngeal Hypopharynx Cancer Provides Good FDG-PET scans in Head and Neck Cancer: A Prospective, Phase 2 Trial Locoregional Control Squamous Cell Cancers Treated with Defi nitive Chemoradiation 2811 Aron Popovtzer 2820 Jacob Shin Organ Preservation for Patients with Racial Disparities In Laryngeal Cancer 2829 Kenneth Shung Hu Advanced Laryngeal Cancer Who Treatment And Outcome In The United Pre-Treatment PET Metabolic Tumor Responded to Induction Chemotherapy States: A Population-Based SEER Volume (MTV) and Maximum with Docetaxel, Cisplatin, and 5- Analysis Of 24,069 Patients Standardized Uptake Value (SUVmax) Fluorouracil (TPF) Followed by Cisplatin Predict for Organ Preservation and Concomitant with Radiation Therapy: A 2821 Matthew Ward Disease-Free Survival in Larynx Cancer Phase 2 trial Reduction of Severe Late Toxicity After Patients Treated with Concurrent Defi nitive Chemoradiotherapy (CRT) Chemoradiation 2812 Keiichi Takehana using Intensity Modulated Radiation Retrospective Analysis of Clinical Therapy (IMRT) in Non-HPV Associated 2830 Yae-eun Suh Effi cacy of IMRT Using Helical Head and Neck Squamous Cell Single Institution Outcomes Of Stage 3 Tomotherapy among Patients Treated Carcinoma (HNSCC): More than And 4 Laryngeal Squamous Cell with Defi nitive Chemoradiotherapy for Xerostomia Carcinoma Treated With Primary Hypopharyngeal Cancer (Chemo)radiation 2822 Elise Anne Jager 2813 Ken Takeda Improved GTV Delineation Of 2831 Jeppe Friborg Clinical Factors with respect to Cervical Laryngeal/Hypopharyngeal Carcinoma Loco-regional Control And Survival Body Volume Reduction During On MRI By The Use Of Delineation After Primary Radiotherapy Of Defi nitive External Beam Radiation Guidelines Hypoharyngeal Carcinoma - A Therapy for Hypopharyngeal Squamous Population-based Study Cell Carcinoma 2823 Joana Caldas Magalhaes FDG-PET Semi-automatic 2832 Lauren Kropp 2814 Zhibin Huang Segmentation Methods For GTV Radiation Therapy following Total Tumor Volume Delineation in Head and Delineation In Laryngeal And Laryngectomy for High-Risk Larynx Neck Cancer with Imaging Modalities: Hypopharyngeal Cancer and Hypopharynx Squamous Cell CT, PET, MRI, Compared with Carcinoma Pathological Tumor Volume 2824 Newton Hurst Pretreatment Computed Tomographic 2833 Bhaswanth Dhanireddy 2815 Naoyuki Kanayama Gross Tumor Volume (CT-GTV) Is The Impact of Smoking on Laryngeal Patterns of Cervical Lymph Node Prognostic for Poor Functional Preservation in Locally Advanced Metastasis in Defi nitive Radiotherapy Outcomes in Patients Undergoing Laryngeal Cancer Treated with for Hypopharyngeal Cancer: Larynx Preservation Defi nitive Chemoradiotherapy Implications for the Elective Target Volume Delineation 2825 Shahrokh Iganej 2834 Stephen Lai Triweekly Carboplatin Alone Instead of Identifi cation and Management of 2816 Jonathan Chen Cisplatin in the Defi nitive Treatment of Laryngeal Carcinoma Patients with Diff erences in Survival Outcome Locally Advanced Laryngeal Carcinoma Risk Factors for Gastrostomy Tube Between Stage 1 and Stage 2 Glottic With Concurrent Chemoradiation: One Placement Cancer: A SEER-Based Analysis Institution’s Experience and a Comparison to RTOG 91-11 Results 2835 Ozlem Ozkaya 2817 Esat Mahmut Ozsahin Akagunduz Carotid Dose Sparing in Defi nitive 2826 Lucas Sapienza Dose-Volume Eff ects of Radiation to Irradiation of Early-Stage Glottic Cancer Long-term Experience With Swallowing Function in the Using Helical Tomotherapy-Based Radiotherapy Alone For Early Stage Radiotherapy of Head and Neck Cancers Image-Guided Intensity-Modulated Squamous Cells Glottic Carcinoma: Radiotherapy Impact Of Technological Incorporation 2836 Michael Scott Comparison of Toxicity and Tumor 2818 Joseph Tung-Chieh 2827 Bhaswanth Dhanireddy Response in Early Glottic Cancer Treated Chang The Impact of Diff erent Radiation with Conventionally Fractionated (CRT) Outcome Of Residual Disease At The Therapy Techniques on Oncologic vs. Hypofractionated Radiotherapy End Of Radiotherapy For and Functional Outcomes of Locally (HRT): Retrospective Analysis of a Single Pharyngo-laryngeal Cancer Patients Advanced Laryngeal Cancer Institution Experience Received Defi nite Chemotherapy And Intensity Modulation Radiotherapy 2837 Cole Kreofsky Larynx-Preserving Intensity Modulated Radiation Therapy for Laryngeal and Hypopharyngeal Carcinoma Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 149 2838 Priyanka Bhateja 2848 Jin Ho Kim 2859 Juliette Thariat Defi nitive Chemoradiation (CRT) For Impact Of Radiotherapy Volumes On Prognosis Of Irradiated Anaplastic Organ Preservation In Locally Advanced Skull Base Recurrence In Adenoid Cystic Thyroid Carcinomas, A Rare Cancer Squamous Cell Carcinoma Of The Carcinoma In The Head And Neck Network Study Hypopharynx (SCC-HP): Oncological Outcomes And Late Toxicity 2849 Waleed Mourad 2860 Alan Monroe Durable cosmetic control with radiation Dorsal Vagal Complex of the Brainstem: 2839 Samir Patel therapy for HIV-associated Parotid Conformal Avoidance to Reduce Charged Particle Therapy for Nasal Benign Lymphoepithelial Cysts Nausea Cavity and Paranasal Sinus Malignancies: A Systematic review and 2850 Cheng-En Hsieh 2861 Srinivas Chilukuri Meta-analysis Postoperative Radiotherapy for Two Prescription Dose Levels As Safe As Submandibular Gland Carcinomas: 3-4 Prescription Dose Levels In IMRT For 2840 Nadya Shusharina What is the Optimal Elective Nodal The Treatment Of Neck Nodal Regions Evaluation of Proton Therapy for Irradiation Volume? In Head Neck Cancers Advanced Head and Neck Cancer with Respect to Changing Heterogeneity 2851 Alexandra Jensen 2862 Beth Beadle High-let Radiotherapy For Adenoid Diff erential Feeding Tube Placement 2841 Issa Mohamad Cystic Carcinoma Of The Head And and Duration with IMRT for Head and Role of Radiotherapy in Management Neck: 15 Years’ Experience With Neck Cancer: A SEER-Medicare Analysis of Nasal and Sinonasal Squamous Cell Raster-scanned Carbon Ion Therapy Carcinomas 2863 John Cuaron 2852 Petra Stegmaier Patterns of Failure in Patients with Head 2842 Yang-Gun Suh Identifi cation of Diff erences in the and Neck Carcinoma of Unknown Treatment Outcomes of whole Saliva Baseline Proteome Profi le Primary Treated with Radiation Therapy Intensity-Modulated Radiotherapy that are Associated with Development versus Three-Dimensional Conformal of Oral Mucositis in Head and Neck 2864 Masaru Takagi Radiotherapy for Patients With Cancer Patients during Treatment with Treatment Outcomes of Proton or Maxillary Sinus Cancer in the IMRT Carbon Ion Radiotherapy for Chordoma Postoperative Setting of the Skull Base 2853 James Han 2843 Daisuke Miyawaki Weekly On-treatment MRIs During 2865 Re-I Chin Result of Multimodal Treatment Radiotherapy (RT) In Head And Neck Prognostic Signifi cance of Metabolic Including Radiotherapy for Squamous Squamous Cell Carcinoma (HNSCC) Tumor Volume after Induction Cell Carcinomas of Maxillary Sinus: A Patients To Monitor Normal Tissue Chemotherapy in Squamous Cell Retrospective Study Response Carcinoma of the Head and Neck
2844 Lawrence Younan 2854 Darwin Yip 2866 Jon Cacicedo Infl uence of Time Factors on Local Proton Beam Therapy for Utility Of 18F-fl uorodeoxyglucose Control and Survival Following Unresectable Adenoid Cystic Positron Emission Tomography (PET/ Radiotherapy for Paranasal Sinus Cancer Carcinoma of the Nasopharynx CT) In The Staging And Treatment Plan Evaluation Of Head And Neck 2845 Jay Liao 2855 Aleksandra Kuczmarska Squamous Cell Carcinoma Management and Long-Term Markedly Increased Incidence of Outcomes of Sinonasal Undiff erentiated Thyroid Cancer in Northeast Penn- 2867 Madhava Kanakamedala Carcinoma: 20-year Experience at a sylvania: A Clinical-Epidemiological Outcome Analysis Of Extracapsular Single Insitution Investigation Extension In Cervical Lymph Nodes For Locally Advanced Squamous Cell 2846 Shyamal Patel 2856 Mu-Hung Tsai Carcinomas Of Head And Neck Postoperative Radiation Therapy For A Dose-Eff ect Relationship and Parotid Pleomorphic Adenoma With Estimated Parameters for the 2868 Hugo van der Heide Close Or Positive Margins: Treatment Lyman-Kutcher-Burman (LKB) Model of Radiation-induced Volumetric Changes Outcomes And Toxicities Normal Tissue Complication Of Salivary Glands In Relation With Probability (NTCP) for Radiation Induced Mean Dose And Saliva Production In 2847 Jin Ho Kim Hypothyroidism Head-and-neck Cancer Patients Signifi cance Of Postoperative Radiotherapy On Locoregional Control 2857 Peter Zavitsanos 2869 Dayssy Diaz Pardo In T1/t2 Adenoid Cystic Carcinoma In Hürthle Cell Carcinoma of the Thyroid Head And Neck Second Primary Cancer The Head And Neck Rates In The HPV Era: A SEER Analysis 2858 Sean Sachdev Thyroid V50 Predicts Hypothyroidism in Head-and-Neck Cancer Patients Treated with IMRT Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
150 ASTRO 2014 / 56TH ANNUAL MEETING 2870 Niranjan Bhandare 2881 Sonam Sharma 2891 Stephanie Rice The Eff ect of Preexisting Diabetes Risk Factors for Prolonged Diagnosis to Skin Cancers of the Head and Neck: A 21 on the Incidence of Post-Radiation Treatment Interval (DTI) Among Patients Year Single Institution Experience Retinopathy in Head and Neck Cancer with Head and Neck Squamous Cell Patients Carcinoma (HNSCC) 2892 Vikram Manoor Maiya The Use of Xylitol for the Prevention 2871 Jessica Freilich 2882 Sean Sachdev of Xerostomia in Patients Receiving Outcomes of Mucosal Melanoma of the Age Most Signifi cant Predictor of Intensity Modulated Radiotherapy for Head and Neck Requiring Enteral Feeding in Head-and- Head and Neck Cancers Neck Cancer Patients 2872 Paolo Antognoni 2893 Ali Hosni FDG PET SUV-based Segmentation 2883 Lanting Gao IMRT with Selective Target Volume Method for Biological GTV (BTV) The Role of Adjuvant Radiotherapy in Approach in Head and Neck Squamous Delineation in Pharyngeal Cancer the Treatment of Type B3 Thymoma Cell Carcinoma of Unknown Primary Dose-Painted IMRT: Preliminary Site Retrospective Evaluation of Patterns of 2884 Timothy Waxweiler Local Relapse Safety and Feasibility Update of 2894 Michael Spiotto Olaparib, an Orally Bioavailable PARP Ace Inhibitors Predict For Acute Kidney 2873 Jesse Shulman Inhibitor, With Concurrent Cetuximab Injury During Chemoradiation For Head Long Term Follow-up of Patients and Radiotherapy in Heavy Smokers And Neck Cancer treated with Radiation Therapy for with Stage 3-IVB Squamous Cell Merkel Cell Carcinoma of the Head Carcinoma of the Head/Neck: A Phase 2895 Michael Spiotto and Neck 1 Trial Unplanned Hospitalizations Greater Than Five Days Predict For Worse 2874 Philip Gilbo 2885 Harry Quon Outcomes After Radiotherapy For Head Radiotherapy for Benign Head and Neck Eff ective Pain Management of Mucositis And Neck Cancer Paragangliomas: A 45-year Experience with Prophylactic Gabapentin in the Irradiated Head and Neck Cancer 2896 Aleksandra Napieralska 2875 Michael Cheung Patient Is Associated with Functional Cancerogenic Wind Blows Through Optimal Timing of Initial PET/CT Benefi ts the Pipe - Rare Carcinoma of Trachea as Surveillance Scan after Radiotherapy for Primary or Secondary Neoplasm Head and Neck Cancers 2886 Yvonne Mowery Changes in Tumor Volumes and 2897 Beibei Xu 2876 Rex Hoff man 18F-FDG PET characteristics during Aspiration Pneumonia After Multi-site Review Of Osteoradionecrosis Radiotherapy for HPV+ and HPV- Head Chemoradiotherapy for Head-and-Neck in the Posterior Aspect of the Mandible and Neck Squamous Cell Carcinoma Cancer Following Radiotherapy (HNSCC) 2898 Huaising Ko 2877 Jean-Claude Rwigema 2887 Yutaka Toyomasu Lhermitte’s Sign After VMAT-based 4π Noncoplanar Stereotactic Body Treatment Outcomes of Particle Radiation of Head-and-Neck Cancer: Radiation Therapy (SBRT) for Head and Therapy using Protons or Carbon Ions Incidence, Clinical Features and Neck Cancer: Potential to Improve Local for Locally Advanced Head and Neck Dosimetry Control and Late Toxicity Squamous Cell Carcinoma 2899 Madhava Kanakamedala 2878 Jakub Cvek 2888 Satish Kondaveeti Comparison Of Cisplatin Versus Hyperfractionated Accelerated Therapeutic Benefi t Of Concurrent Cetuximab With Intensity Modulated Radiotherapy 70-75Gy in 5 weeks for Radiation With Single Agent Radiation Therapy In Locally Advanced Advanced Head and Neck Nimotuzumab In Locally Advanced Squamous Cell Carcinomas Of Head Cancer - Single Institution Experiences And Recurrent Hnscc - A Retrospective And Neck-Toxicity, Patterns Of Failure Analysis And Survival Analysis 2879 Meredith Giuliani Elderly Patients With Advanced Head 2889 Isabel Prieto 2900 Shea Wilcox And Neck Cancer Less Likely To Receive Tapentadol To Alleviate Chronic Pain Cyclical Hypofractionated IMRT For Radiation Therapy Secondary to Neck Fibrosis in Head Eff ective Palliation Of Head And Neck and Neck Cancer Patients Treated With Cancers: Can Modern Techniques Off er 2880 Neal Dunlap Surgery Plus Chemo-Radiotherapy Improved Outcomes? Cyclical Hypofractionated Radiotherapy For Palliative Treatment Of Locally 2890 Taro Murai Advanced Head And Neck Cancer Hypofractionated Stereotactic Radiotherapy For Auditory Canal Or Middle Ear Cancer: 2-year Results In 30 Patients
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 151 2901 Rejnish Kumar 2910 Olgun Elicin 2920 Junjian Huang Phase IIb Randomized Trial Comparing Volumetric Regression Ratio of Tumor Low Baseline Lymphocyte Count Concurrent Chemoradiation with and Involved Lymph Nodes after May Predict Poorer Overall Survival In Weekly versus Three Weekly Induction Chemotherapy Predicts Patients With Head And Neck Cancer Cisplatinum in Locally Advanced Head the Overall Survival in Head and Neck Treated With Radiation Therapy and Neck Squamous Cell Carcinoma Cancer 2921 Kaleigh Doke 2902 Yeona Cho 2911 Abdallah Mohamed Lymphedema Therapy Improves Neck Clinical Outcome Of Eye-conserving Methods for Analysis and Reporting the Circumference, Range of Motion and Treatment With Ruthenium-106 Patterns of Loco-regional Failure in the Pain Scores in Head and Neck Brachytherapy For Choroidal Era of IMRT for Head and Neck Cancer: Radiotherapy Patients Melanoma: Experience with the fi rst 88 Deformable Image Registration Based Korean patients Quality Assurance Workfl ow 2922 Ahmad Al-Basheer Correlation Of Integral Does, White 2903 Nigel Anderson 2912 Nhu Tram Nguyen Blood Cell Counts, And Radiotherapy Gross Tumor Volume Size and Oral Head And Neck Squamous Cell Techniques For Head And Neck Cancer Cavity Dose Drive Dysphagia in Carcinoma Of Unknown Primary: Is Patients Under Radiotherapy Defi nitive (Chemo) IMRT for Head & There A Better Treatment? Neck Cancer 2923 Scott Robertson 2913 Marielle Philippens Routine Capture of Structured Data 2904 Maureen Rolfo Advances in MRI for Elective Treatment Elements (SDEs) Provides Insight into Association of 18F-FDG Metabolic of Lymph Nodes and Cranial Nerves in Unique Dose-Toxicity Relationships in Tumour Volume and Dysphagia in Head Head and Neck Cancer Irradiated Head and Neck (HN) Cancer and Neck IMRT as a Prophylactic Patients Feeding Predictor 2914 Shaakir Hasan Simultaneous Integrated Boost (SIB) for 2905 Matthew Bertke Advanced Head and Neck (H&N) Cancer HEALTH SERVICES RESEARCH HPV Status May Alter the Signifi cance May Accelerate Muscle Loss in of Extranodal Extension as a Negative Concurrent Chemoradiation as 2924 Yu Yang Soon Prognostic Factor in Post-Operative Assessed By A Validated CT-based Tool Impact Of Adoption Of Prophylactic Squamous Cell Carcinoma of the Head Cranial Irradiation On The Outcome Of and Neck 2915 Canhua Xiao Extensive Stage Small Cell Lung Cancer: Increased Fatigue is Associated with A Single Institution Retrospective Study 2906 Matthew Ward TNF and NFκB-Regulated Infl ammatory Nasogastric Enteral Feeding is Superior Signaling in Patients with Head and 2925 Nitesh Paryani to Percutaneous Gastrostomy in Neck Cancer Receiving IMRT Referral Patterns for Pediatric Proton Preventing Late Pharyngeal Therapy in Florida Dysfunction in Long-term Survivors of 2916 Abdallah Mohamed Locoregionally Advanced Head and Biological and Dosimetric Analysis of 2926 Christopher Corso Neck Squamous Cell Cancer (HNSCC) Loco-regional Failure after IMRT for Demographic Disparities in SBRT treated with Defi nitive Head and Neck Cancer Utilization for Stage I NSCLC Chemoradiotherapy (CRT) 2917 Daniel Grossi Marconi 2927 Lili Goh 2907 David Grew Head And Neck Non-melanoma Skin A Survey Of The Asian Patients’ Disease Outcomes In Human Cancer Treated By Orthovoltage Expectations And Beliefs About The Immunodefi ciency Positive Patients Radiation: An Analysis Of 1021 Cases Eff ectiveness Of Radiotherapy For Treated With Primary Or Adjuvant Incurable Cancers Radiotherapy For Head And Neck 2918 Ahmed Chaudhary Cancer Trismus after Chemoradiotherapy for 2928 Alexander Rand Locoregionally Advanced Head and Demographic Disparities in Time from 2908 Vasanthan Sakthivel Neck Cancer: A Prospective Study of the Prostate Cancer Diagnosis to Defi nitive Secondary Cancer Risk Analysis: Dose Eff ect Relationship in Accelerated Treatment in Patients at a Diverse Evaluation Of VMAT Vs Dynamic IMRT Fractionation by Concomitant Boost Academic Medical Center Planning In Treatment Of Head And with Cisplatin and Cetuximab from the Neck Cancer By Simultaneously EPIC Trial 2929 Guy Jones Integrated Boost Technique Initial Results of a Pilot Program for 2919 Peter Ahn Low-Dose CT Lung Cancer Screening 2909 Andrew Hoover Comparison Of The Eff ect Of Full-neck in a Community Radiation Oncology Head and Neck Cancer Patients with Rapidarc IMRT Versus Split-fi eld IMRT Practice False Negative Surveillance FDG PET/CT Techniques On Radiation Dose To Low Scans Show Unique Clinical Neck Structures Characteristics and Disease Recurrence Patterns Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
152 ASTRO 2014 / 56TH ANNUAL MEETING 2930 Leslie Ballas 2940 Terence Sio 2952 Raymond Mailhot Vega Radiation Therapy Utilization in Temporal and Geographic Variation Cost-eff ectiveness Analysis Of Proton Adolescent and Young Adult Oncology of Intensity Modulated Radiation Versus Photon Therapy With Respect To Patients Therapy (IMRT) Utilization in Patients Risk Of Growth Hormone Defi ciency with Colorectal Cancer: A SEER- 2931 Rishabh Kapoor Medicare Based Analysis 2953 Nataniel Lester-Coll Report on the Veteran Health Cost Eff ectiveness Analysis of Administration - Radiation Oncology 2941 Sean Maroongroge Stereotactic Body Radiotherapy for Quality and Safety Monitoring The Impact of New EMR Adoption Pulmonary Oligometastases (VHA-ROQSM) Program on the Number of Radiology Exams Ordered in a Busy Radiation Oncology 2954 Tongming He 2932 Joan Ryoo Clinic Personalized Radiation Therapy of Assessing Quality of Care (QC) Near Breast Cancers May Not Incur End-Of-Life (EOL): Use of Natural 2942 Nikola Cihoric Substantial Increase in Treatment Language Processing (NLP) to Identify Analysis of Clinical Trials in Radiation Delivery Time Brain Metastasis (BM) Cases for Oncology: A Systematic Evaluation of Radiotherapy (RT) Receipt Characterization of the Clinicaltrials.gov 2955 Merrylee McGuffi n Database The Cost Of Convenience: A 2933 Alexander Rand Cost-Eff ectiveness Analysis Comparing Impact of Breast Cancer Patient 2943 Michaela Dinan External Beam Radiation Therapy, Demographics and Treatment Type on Association between Diagnostic CT High-dose Rate Brachytherapy And Time from Diagnosis to Adjuvant Utilization and Radiation Therapy at the Permanent Seed Implants For Early Treatment at a Diverse Academic End of Life (EOL) in Elderly Breast and Stage Breast Cancer Medical Center Prostate Cancer Patients, 2002-2007 2956 Hayeon Kim 2934 Mark Waddle 2944 Usama Mahmood Cost-eff ectiveness Analysis of 3D Which Prostate Cancer Patients Receive Impact Of Insurance Status On Image-Guided Brachytherapy Multidisciplinary Consultation? Findings Treatment Selection For Localized Compared to 2D Brachytherapy in the from the Population-Based NC Process Prostate Cancer In The United States Treatment of Locally Advanced Cervical Cohort Cancer 2945 Kimberley Foley 2935 Amy Harrison Measuring The Quality Of Personal 2957 Matthew Schutzer Radiation Quality and Safety: A Patient’s Care In Prostate Cancer Radiotherapy: Time Driven Activity Based Costing: Perspective What Aspects Of Care Are Important an Economic Analysis of Whole Breast To Patients? Radiotherapy versus Balloon-Based 2936 Gaurav Bahl Brachytherapy in the Management of A National Analysis of Gender and 2946 Arash Naghavi Early Stage Breast Cancer Ethnocultural Diversity Within the Outcomes Following Radiotherapy Canadian Radiation Oncology Physician For Head And Neck Cancer Of A High 2958 Thomas Lanni Workforce Volume Center Vs Low Volume Center Comparing the Cost Eff ectiveness of Low Dose Rate Brachytherapy, High 2937 Daniel Yang 2947 Naichang Yu Dose Rate Brachytherapy and Impact Of Three Decades Of Screening Automatic Monitoring of Patient Chart Hypofactionated Intensity-Modulated On Racial Disparities In Cervical Cancer Status Improves Workfl ow for External Radiation Therapy for the Treatment of Incidence Beam Radiotherapy Low/Intermediate Risk Prostate Cancer
2938 Jeremy Harris 2948 David Schreiber 2959 Alexander Louie Factors Contributing to the Use of Comparative Eff ectiveness of Radical Estimating the Population Impact of Intensity Modulated versus 3D Prostatectomy versus Dose Escalated Introducing Stereotactic Ablative Conformal Radiation Therapy for Stage Radiation Therapy in a predominantly Radiotherapy for Stage I NSCLC in III Non-Small-Cell Lung Cancer: A African American Population Canada SEER-Medicare Study 2949 Daniel Grossi Marconi 2960 Anand Shah 2939 Apar Gupta The Reliability Of Automatic Cost-Eff ectiveness Analysis of Eff ect of Patient Demographics and Segmentation For Lung Volumes In Stereotactic Body Radiotherapy, Radiation Timing on PSA Reduction in Breast, Lung And Esophageal Cancers Conventional Single-Fraction Patients Treated With Defi nitive Radiotherapy, and Medical Radiation Therapy for Prostate Cancer 2951 Daniel Trifi letti Management Alone for a Painful Reconsidering Adjuvant Versus Salvage Localized Spine Metastasis Radiotherapy For Prostate Cancer Using An Individualized Decision Analysis With Genomic Classifi er Scores
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 153 2961 Jason Ye 2972 Tatiana Conrad 2983 Steve Braunstein Cost-eff ective Analysis Of Malignant Epidural Spinal Cord Tobacco Cessation Perspectives and Hypofractionated Versus Standard Compression: Prognostic Factors Practice Among U.S. Radiation 30-fraction Imrt In Patients With Poor Predicting Need for Surgery Oncology Residents Prognosis Glioblastoma Multiforme 2973 Jose Lopez 2984 Audrey Tetreault 2962 Patrick Richard Computerized Decision Support System Impacts of Software-based Development of a Multi-Parametric and NaïVe Bayes Models for Predicting Management of Radiation Treatment Cost Eff ectiveness Model for the Risk of Relapse in Breast Cancer Interruptions Comparison of Therapeutic Modalities in Defi nitive Radiotherapy for Stage III 2974 Michael Lock 2985 Giang Hong Non-Small Cell Lung Cancer (NSCLC) Identifi cation of Patients with Liver Monitoring Neutron Exposure of Cancer that will Not Benefi t from Radiation Therapists on 15 Mv Linear 2963 Dimitri Dimitroyannis Radiation Accelerators Favorable Cost-Eff ectiveness is a Hallmark of Modern Hypofractionated 2975 Mark Mishra 2986 Neil Martin Radiotherapy: the case of early-stage Is Prophylactic Cranial Irradiation (PCI) Defi ning a Standard Set of Patient- Lung Cancer with Hippocampal Avoidance (HA) Centered Outcomes for Men With Justifi ed in Limited Stage Small Cell Localized Prostate Cancer 2964 Shlomo Koyfman Lung Cancer (LS-SCLC)? Intensity Modulated Radiotherapy 2987 Max Dahele (IMRT) Reduces Late Toxicity Without 2976 Muhammad Qureshi A Snapshot of the Practice of Increasing Cost Compared to Preoperative Multiparametric Mri Stereotactic Body Radiotherapy from 30 Conventional 3D-RT in Patients with Accurately Predicts For Extracapsular Centers in 6 Countries Human Papillomavirus Associated Extension In A Diverse Patient (HPV+) Oropharyngeal Carcinoma Population Undergoing Prostatectomy Treated with Chemoradiotherapy (CRT) HISTORY 2977 Aaron Kusano 2965 Anthony Wong Preoperative Short Course Radiation 2988 Debra Yeboa Physicians’ Beliefs about the Benefi ts for Locally Advanced Rectal Cancer: A Historical Trends of Radiotherapy Use in and Risks of Adjuvant Therapies for National Opinion Survey Prevalent Malignancies Stage II and Stage III Colorectal Cancer 2978 Shauna Campbell 2989 Ankit Agarwal 2966 Caroline Patton Factors Infl uencing One Year Survival in A Ten-year Analysis of the American Choosing Wisely: The American Society Early Stage Non-Small Cell Lung Cancer Society for Radiation Oncology Political for Radiation Oncology’s Top 5 List (NSCLC) Patients Receiving Stereotactic Action Committee Body Radiotherapy (SBRT) 2967 Beant Gill 2990 Daniel Golden Quantitative Evaluation of Radiation 2979 Tangel Chang Implementation and Evaluation of a Oncologists’ Adaptability to Phase II Prospective Trial of Triphasic Multi-institutional Radiation Oncology Cost-Eff ective Treatment Programs PET/CT: Primary Site Infl ammation Clerkship Curriculum: A Report from the versus Cancer at 3 Months After Radiation Oncology Education 2968 Clayton Hess Completion of Radiation for Head and Collaborative Study Group Current Attitudes of Practicing Neck Squamous Cell Carcinoma Physicians Regarding Ethical Dilemmas 2991 Gurleen Dhami in Radiation Oncology: Findings From a 2980 Paul Wallner Mentorship of Radiation Oncology National Survey Promises and Pitfalls: Development of a Residents: An Unmet Need National Brachytherapy Registry 2969 Laurie Pilote 2992 Nikhil Thaker Is Radiation Oncology Living Up To The 2981 Corey Hobbs Improving the Quality of Radiation Standards Of Informed And Shared Cancer Mortality Based on Income and Oncology Education through an Decision Making? Radiotherapy Availability: a Correlation Innovative Medical Student Treatment Analysis and Implications for Planning Curriculum 2970 Christine Lauro Developing Countries Breast Cancer Risk Assessment and 2993 Nicholas Zaorsky Chemoprevention: Results of a Survey 2982 Harold Agbahiwe A National Assessment of Medical Increased African-American Enrollment Student Knowledge in Radiation 2971 Bhartesh Shah in Breast Cancer Clinical Trials: A Single Oncology and Comparison to Primary Analysis of Decision Making at a Institution Experience Care and Radiation Oncology Attending Multidisciplinary Head and Neck Tumor Physicians Board Incorporating Evidence Based NCCN Guidelines
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
154 ASTRO 2014 / 56TH ANNUAL MEETING 2994 Crys Curkendoll 3005 Takashi Shintani 3015 Nima Aghdam Use of WikiBooks in Radiation Oncology Stereotactic Body Radiotherapy As A Robotic Stereotactic Body Radiation Education Part Of Defi nitive Treatment For Therapy (SBRT) with Fiducial Tracking Synchronous Double Primary Lung for Inoperable Peripheral Stage I 2995 Aaron Kusano Cancer Non-small Cell Lung Cancer (NSCLC): Integrity of the Radiation Oncology Four-Year Disease Control and Survival National Resident Matching Program: 3006 Atsushi Motegi Outcomes Applicant Perspectives Acute Toxicities and Dose Volume Histogram Parameters for Organ at Risk 3016 Shigeo Takahashi 2996 Shannon Byler in Proton Beam Therapy for Stage Iii The Relationship between Mean Lung Student Oncology Society: A Radiation Non-small Cell Lung Cancer Dose and Pulmonary Complications Oncologist Led Approach To after Neoadjuvant Chemoradiotherapy Exploring Careers In Oncology For 3007 Katsuyuki Shirai followed by Surgery for Lung Cancer Medical Students The Maximum Standardized Uptake Value (SUVmax) on FDG-PET Predicted 3017 Leah Katz 2997 Jasbir Jaswal Overall Survival and Progression Free Clinical Outcomes Of Alternative Uses Evaluating the Impact of a Canadian Survival for Stage I Non-Small-Cell For Stereotactic Body Radiotherapy In Anatomy and Radiology Contouring Lung Cancer Treated with Carbon Ion Non-small Cell Lung Cancer: Thinking (ARC) Bootcamp for Radiation Radiotherapy Beyond Defi nitive Treatment For Early Oncology Residents Disease 3008 Aruna Turaka 2998 Wilfred Ngwa Correlation of PET/CT Response To The 3018 Aruna Turaka Radiation Oncology in Resource-Poor Mediastinal Down Staging In Operable Can PET/CT Predict Pathological Settings: Challenges and NSCLC: Impact Of RT Dose Response For Operable NSCLC Patients Opportunities for Humanitarian or Treated With Dose-escalated Radiation Collaborative Cancer Care, Research 3009 Lin Zhou Therapy (DE-RT) In Trimodality Setting and Education Phase I Trial of Icotinib Combined With Whole Brain Radiotherapy for 3019 Ben Fischer-Valuck 2999 Brian Koottappillil EGFR-mutated Non-Small Cell Lung Correlation Of A Qualitative Visual Evaluation of a Radiation Oncologist Cancer Patients With Brain Metastases Based FDG-PET/CT Scale And The Led Dedicated Oncology Block in the -Updated Results Semi-quantitative SUVmax in Predicting Preclinical Medical School Curriculum Overall Survival In Patients With 3010 Kimberley Mak Early-stage NSCLC Following SBRT 3000 Paris-Ann Ingledew Patterns of Local Recurrence for Caught In The Web: The Quality Of Mesothelioma Patients Treated with 3020 Connie Yip Online Resources For Cancer Patients Extra-Pleural Pneumonectomy and A Prospective Study Of Bevacizumab Radiation Therapy Using the & Platinum-based Chemotherapy In 3001 Evan Thomas Electron-Photon Technique: The NSCLC: Comparison Of The Development of a Structured Education Dosimetric Challenges of Prognostic Value Of Early Imaging and Evaluation Program to Standardize Electron-Photon Match Lines and Response Assessment Criteria And and Improve Target and Organ-at-risk Blocks Intratumoral Heterogeneity Analysis Contouring Ability among Radiation Oncology Residents 3011 Aiko Nagai 3021 Daniel Tandberg Effi cacy And Toxicities Of Invasive Sampling of PET Positive 3002 Heather Warkentin Intensity-modulated Stereotactic Body Aortopulmonary Window Lymph Effi cacy and Effi ciency of a Tumor Radiotherapy Using Helical Nodes in Patients with Right-Sided Group Model in Clinical Physics Tomotherapy For Lung Cancer And Non-Small Cell Lung Cancer is Not Instruction of Residents Lung Metastases Always Necessary to Guide Treatment
3012 Michael Herman 3022 Feifei Teng LUNG CANCER SBRT for Oligometastatic Non-Small Cell The Infl uence Of Response To Initial Lung Cancer Chemotherapy On Optimal Timing 3003 Tsuyoshi Takanaka Of Radiotherapy Administration For Breath-hold Volumetric Modulated Arc 3013 Qi Wang Limited-disease Small-cell Lung Cancer Stereotactic Body Radiation Therapy Can Abnormalities on High-resolution For Early-stage Lung Cancer Guided By CT Predict Early radiation Pneumonitis 3023 Byounghyuck Kim Real-time Fluoroscopy after Thoracic Radiation Therapy Role of Postoperative Radiotherapy After Curative Resection and Adjuvant 3004 Marco Trovo 3014 Adam Olson Chemotherapy for Patients With SBRT for Re-irradiation of Persistent or Normal Tissue Toxicity Risk Assessment Pathological Stage N2 Non-Small Cell Recurrent Locally Advanced NSCLC with Interim 18F-FDG PET-CT in Patients Lung Cancer: A Propensity Score with Non-Small Cell Lung Cancer Matching Analysis (NSCLC) Undergoing Radiotherapy Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 155 3024 John Heinzerling 3034 Yili Duan 3043 Nathan Cannon Stereotactic Ablative Body Radiosurgery Comparison Of Primary Target Volumes Neutrophil-lymphocyte And (SABR) In Early Stage Lung Cancer: Can Based On Four-dimensional CT And Platelet-lymphocyte Ratios As Results of Advanced Cancer Care in Fluorodeoxyglucose Positron Emission Prognostic Factors Following an Innovative De-Centralized Cancer Tomography CT Images Of Stereotactic Radiation Therapy For Institute Replicate Favorable Clinical Non-small-cell Lung Cancer Early-stage Non-small Cell Lung Cancer Trial Results? 3035 Gitte Persson 3044 Brandon Disher 3025 Meixiang Zhou Deep Inspiration Breath-hold Lateral Electron Disequilibrium (LED) Salvage Concurrent Paclitaxel-based Radiotherapy For Locally Advanced in Lung Cancer Patients Treated With Chemo-radiotherapy for Post-surgical Non-small Cell Lung Cancer: Is Dose To Stereotactic Body Radiation Therapy: Microscopic Residual Tumor At The The Mediastinal Structures Reduced? Assessing the Potential for Underdosing Bronchial Stump (R1 Resection) In Non-small Cell Lung Cancer 3036 Shankar Siva 3045 Andrew Barsky Feasibility of IMRT Planning to Reduce Prophylactic Irradiation of Surgical Tract 3026 Takaya Yamamoto Dose to Functional Lung Using Sites in the Era of Radical Pleurectomy Impact of Tumor Attachment to the Respiratory Gated (4D) Gallium-68 for Malignant Pleural Mesothelioma Pleura Measured by a Pretreatment Perfusion PET/CT CT Image on Outcome of Stage I 3046 Ritsuko Komaki NSCLC Treated With Stereotactic Body 3037 Sung-Ja Ahn Predictors of Brain Metastasis after Radiotherapy Surgical Salvation after Full-dose Prophylactic Cranial Irradiation for Concurrent Chemoradiation in Patients Limited-Stage Small Cell Lung Cancer 3027 Nitesh Paryani With Locally Advanced Non-small Cell Outcomes And Patterns Of Failure With Lung Cancer (NSCLC) 3047 Benjamin Mou Stereotactic Body Radiotherapy In The Stereotactic Body Radiotherapy For Treatment Of Primary And Metastatic 3038 Quynh Nguyen Central Lung Tumors: Outcomes And Lung Nodules In Elderly Patients The fi ve-year outcome for patients Toxicity diagnosed with Locally Advanced 3028 Joe Chang Non-Small Cell Lung Cancer treated 3048 Xiong Wei Clinical Implementation Of with defi nitive concurrent Nadir White Blood Cell, Absolute Intensity-modulated Proton Therapy In Chemotherapy and Proton Beam Neutrophil And Absolute Lymphocyte Thoracic Malignancies Therapy Counts During Concurrent Chemoradiation Therapy Are 3029 Chad Tang 3039 Yukinori Matsuo Associated With Worse Outcomes In Lymphopenia Association With Low Comparison of Long-term Survival Patients With Limited-stage Small Cell Lung Dose And Its Eff ects On Non-small Outcomes between Stereotactic Body Lung Cancer Cell Lung Cancer Patient Outcomes Radiotherapy and Sublobar Resection for Stage I Non-small Cell Lung Cancer 3049 Mohammadreza 3030 Chad Tang in High-risk Operable Patients: Negahdar Predictors Of Site-specifi c Distant Propensity Score Match Analysis Non-Invasive Pulmonary Nodule Metastasis After Defi nitive Radiotherapy Elastometry by CT and Deformable In Non-small Cell Lung Cancer, And 3040 Yoshihiko Manabe Image Registration The Impact Of Metastatic Location On Helical and Static-port Tomotherapy Survival Using the Newly-developed Dynamic 3050 Mohammadreza Jaws Technology for Lung Cancer Negahdar 3031 Gregory Videtic First in Human High-Resolution 5 Years And Beyond: Characterizing 3041 Mustafa Adli Imaging of Regional Lung Function by Long Term Survivors After Stereotactic Erythrocyte Membrane Na+/K+-Atpase Single Energy Xenon CT Compared to Body Radiotherapy (SBRT) For Early Activity In Locally Advanced Non-Small Ventilation SPECT Stage Lung Cancer Cell Lung Cancer Patients Treated With Chemoradiotherapy 3051 Yyki Takeuchi 3032 Noriyoshi Takahashi 45 Gy Versus 54 Gy Of Accelerated Even Local Control of Metastatic Lung 3042 Tzung-Chi Huang Hyperfractionated Radiotherapy For Tumors is Worse Than That of Primary Motion Freeze For Respiration Motion Patients With Limited-stage Small-cell Lung Cancer in Patients Treated With Correction In PET/CT: A Preliminary Lung Cancer: A Retrospective Analysis Stereotactic Body Radiation Therapy Investigation With Lung Cancer Patient Of A Seven-year Experience Data 3033 Qingsong Pang The Interval Time Between First Diagnosis and Brain Metastasis for Limited Small-cell Lung Cancer Without Prophylactic Cranial Irradiation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
156 ASTRO 2014 / 56TH ANNUAL MEETING 3052 Marina Heskel 3062 Joanne Zhung 3072 Neal Bhatt Safety and Effi cacy of Stereotactic Body Patterns Of Regional Failure & Evaluation of Prognostic Variables in Radiotherapy (SBRT) Reirradiation for Evaluation of LN dose In Early Stage Patients With Small Cell Lung Cancer: New or Recurrent Pulmonary Nsclc Treated With Sbrt The Role of Volumetric Response to Malignancies Following Previous Initial Therapy in Determining the In-fi eld Conventionally Fractionated 3063 Jackie Wu Benefi t of Prophylactic Cranial Thoracic Radiotherapy (CFRT) Predictive Models for Assuring Quality Irradiation and Consistency of Lung IMRT Plans 3053 Karl Wurstbauer Across Institutions in Cooperative 3073 Inaya Ahmed Dart-bid (diff erentiated Accelerated Group Trials Impact of Metformin Use on Survival Radiation Therapy- 1.8 Gy Twice Daily) in Non-small Cell Lung Cancer Treated For Locoregionally Advanced NSCLC: 3064 Jiraporn Setakornnukul with Defi nitive Radiation Therapy Mature Results Of A Novel Therapeutic Target Volume Delineation for Lung Approach Stereotactic Body Radiotherapy (SBRT): 3074 Inaya Ahmed Utility of PET/CT for Lesions Centrally Survival Benefi t with Carboplatin-based 3054 Marina Heskel Located or Close to the Chest Wall Induction Chemotherapy for Bulky Stereotactic Body Radiation Therapy for Stage II & III Inoperable Non-small Cell Oligometastatic Pulmonary Lesions 3065 Hubert Pan Lung Cancer A Prospective Analysis of Cardiac 3055 Kristin Higgins Biomarkers and Electrocardiogram 3075 Ning Liu A Phase I Study Examining a Abnormalities in Patients Receiving Metabolic Tumor Volume Change Stereotactic Boost in Combination with Thoracic Radiation Therapy with During Radiotherapy and Late-course Chemoradiation for Patients with Stage High-Dose Heart Exposure Adaptive Radiotherapy in Patients With III Non-Small Cell Lung Cancer Non-small Cell Lung Cancer 3066 Wei Jiang 3056 Damodar Pokhrel Intensity-modulated Stereotactic Body 3076 Ellen Kim Clinical Evaluation of RTOG 0813 Radiotherapy For Medically Inoperable Comparison of Overall and Cause Dosimetric Criteria for Lung SABR Using Stage I non-small Cell Lung Cancer Specifi c Survivals of Stage 3 Non-Small XVMC Monte Carlo Algorithm Cell Lung Cancer (NSCLC) Treated With 3067 Anna Maria Ascolese Carboplatin or Cisplatin Based 3057 Adil Akthar Concurrent Chemo-radiotherapy In Concurrent Chemoradiation Therapy Incidence of Occult N1 Disease in Patients With Locally Advanced NSCLC: using SEER-Medicare Data (1992-2007) Patients with Clinical Stage I Non-Small Toxicity And Clinical Assessment Using Cell Lung Cancer: Implications for VMAT Tecnique 3077 Justin Mann Patients Considered for Stereotactic Accelerated Hypofractionated Body Radiotherapy 3068 Qurrat Mehmood Radiotherapy with Concurrent Predicting Esophagitis During Radical Chemotherapy in Locally Advanced 3058 Tomoki Kimura Lung Radiotherapy Using 18-FDG-PET Non-Small Cell Lung Carcinoma A Prospective Study Of Functional Image-guided Radiotherapy Planning In 3069 Kyung Su Kim 3078 Wen Feng Lung Cancer Patients Treatment Outcomes Of Limited-stage The Emerging Outcome of Small-cell Lung Cancer Patients Treated Postoperative Radiotherapy for Stage 3059 Jason Samuelian With Concurrent Chemoradiotherapy: IIIA(N2) Non-Small Cell Lung Cancer: Curative Treatment of Stage I A Comparative Analysis Of Diff erent Basing on 3D Conformal Techniques Non-Small-Cell Lung Cancer Using Radiation Dose Fractionation Schedules and Institutional Standard Clinical Robotic Stereotactic Radiation in In A Single Institution Target Volume Patients with COPD: A VA Population Study 3070 Hiromitsu Iwata 3079 Shankar Siva A Phase I Study Of Stereotactic Body Infl ammatory Cytokine Expression as 3060 Derek Bergsma Radiotherapy With Real-time Tumor Prognostic Biomarkers of Toxicity Temporal Variation in Total Lung Tracking Using A Robotic Radiosurgery During Radiation Therapy of Patients Volume and Lung V20 in Lung Cancer System Based On The Monte Carlo with Non-Small Cell Lung Cancer Patients Treated With Radiotherapy Algorithm For Lung Tumors: The First Report In Japan 3080 Mei Ling Yap 3061 Stephen Bowen Adaptive Dose-escalation Using Serial Negative Correlation Between 3071 Kitty Huang 4D-PET/CT Scans During Radiotherapy Quantitative FDG PET/CT And MAA Stereotactic Ablative Radiotherapy For Locally Advanced Non-small Cell SPECT/CT Blood Perfusion Imaging (SABR) and Pulmonary Re-Irradiation: A Lung Cancer Parameters In Thoracic Malignancy Systematic Review of the Patients Literature Assessing Safety and Oncologic Outcomes
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 157 3081 Nami Ueki 3092 Jeremy Kilburn 3103 Siddharth Saraiya Comparison Of Four-dimensional Which Lung Tumors Shrink During Evaluation Of Diff usion Weighted Mri Doses And Three-dimensional Doses Fractionated Radiation And How Does To Diff erentiate Atelectasis From Lung In Dynamic Tumor Tracking Irradiation This Infl uence Outcome? Appropriately Cancer In Radiotherapy Planning For Lung Tumor Using A Gimbaled Selecting Tumor And Treatment X-ray Head Characteristics For Adaptive 3104 Masahiro Morimoto Radiotherapy Protocols Overall Treatment Time of Accelerated 3082 Fumiya Baba Hyperfractionated Radiotherapy at 45 Analysis of Changes in Dose 3093 Stefan Jeppesen Gy in 30 Fractions for Limited Small Cell Distribution due to Respiration in A comparison of Stereotactic Body Lung Cancer is A Signifi cant Prognostic Respiratory-Gated Stereotactic Body Radiation Therapy (SBRT) vs. No Factor Radiotherapy (SBRT) for Lung Tumors Treatment in medical inoperable using 4D-CT patients with early-stage Non-Small Cell 3105 Kevin Kelley Lung Cancer (NSCLC) Medically Inoperable Early Stage 3083 Marco Trovo Peripheral versus Central Lung Cancer Extended Pleurectomy/Decortication 3094 Lindsay Rowe Treated with Stereotactic Body or Surgical Biopsy in the Era of High Dosimetry and Survival from an Radiation Therapy Doses of Radiation Therapy for Adaptive Radiotherapy Clinical Trial for Malignant Pleural Mesothelioma? Limited-stage Small Cell Lung Cancer 3106 Monika Blake Loco-regional Control and Toxicity After 3084 Eileen Harder 3095 Jian Sun Treatment With Intensity Modulated ACE Inhibitors Decrease the Risk of Gross Target Volume as the Predictor for Radiotherapy (IMRT) to The Thoracic Radiation Pneumonitis Following SBRT the Overall Survival for Stage III Cavity in Patients With Non-metastatic Non-Small Cell Lung Cancer Malignant Pleural Mesothelioma (MPM). 3085 Aaron Allen A Feasibility Study 12Gy*5 is a Safe and Eff ective Dose for 3096 Suchit Patel Centrally Located Lung Tumors Pattern Of Failure In Metastatic 3107 Jing Liu EGFR-mutant NSCLC Treated With Exploring Spatial Overlap Of High 3086 Eileen Harder Erlotinib: A Role For Upfront Uptake Regions Derived From Dual The Eff ect of Diabetes and Antidiabetic Radiotherapy? Tracer PET/CT Imaging Using 18F-FDG Drugs on Outcomes after Pulmonary And 18F-FLT In NSCLC Patients SBRT 3097 Hotaka Nonaka Re-stereotactic Body Radiotherapy 3108 Yoshiyuki Shioyama 3087 Marciana-Nona Duma (SBRT) for Local Recurrence of Lung Stereotactic Body Radiotherapy for SBRT For Lung Metastases: Should We, Cancer Previously Treated With SBRT 90 years or Older Patients with Stage I Should We Not? Non-small-cell Lung Cancer 3098 Suchit Patel 3088 Prashoban Bremjit Risk Of Brain Metastasis In EGFR-mutant 3109 Tadamasa Yoshitake Is Overall Treatment Time A Predictive NSCLC Treated With Erlotinib: A Role For Incidence Of Radiation Pneumonitis Factor In Radiation Therapy For Prophylactic Cranial Irradiation? After Multiple Courses Of Stereotactic Non-small Cell Lung Cancer? Body Radiation Therapy For Lung 3099 Tarun Podder Cancer Patients 3089 Matthew Nyfl ot Is Lack Of Dosimetric Coverage Accuracy Of 4D Cone Beam CT And 4D Responsible For Post-sbrt Tumor 3110 Lipin Liu Fan Beam CT For Thoracic Radiotherapy Recurrence? Outcome of Concurrent Simulation And Verifi cation Imaging Chemoradiotherapy for Stage III Non- 3100 Andre Dekker small Cell Lung Cancer 3090 Scott Lester Rapid Learning In Practice: A Lung An Evaluation Of Toxicity Using Cancer Survival Decision Support 3111 Song Gao Accumulated Total Dose Based On Eqd2 System In Routine Patient Care Data A Pilot Study On Imaging Of Integrin For Thoracic Reirradiation Incorporating αvβ3 With Rgd Pet/ct In Suspected At Least One Course Of Sbrt 3101 Gordon Guo Lung Cancer Patients Local Treatment Improves Survival In 3091 H Fazilet Dincbas NSCLC Patients With Synchronous Brain 3112 Mitsuhiko Oguri Is Deformable PET/CT Registration For Oligometastases The factors which Infl uence Acute Contouring Target Volume Superior to Exacerbation on Patients Recieving Rigid Image Registration in Lung Cancer 3102 Dandan Zheng Stereotactic Body Radiation Therapy for Radiotherapy? Is PTV Still Appropriate for Prescription Lung Cancers with “Interstitial Change” Specifi cation in Monte Carlo SBRT Lung Planning? 3113 Adam Smith Stereotactic Body Radiotherapy for Recurrent or Second Primary Non-Small Cell Lung Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
158 ASTRO 2014 / 56TH ANNUAL MEETING 3114 Gerrit Blom 3125 George Rodrigues 3135 Matthew Wheatley VMAT Planning For Large Volume Stage Is Intermediate Radiation Dose Defi ning a Novel Cardiac III Lung Cancer Escalation with Concurrent Contouring Atlas for NSCLC Using Chemotherapy for Stage III Non-Small Cadaveric Anatomy 3115 Jason Edwards Cell Lung Cancer Benefi cial? A Stereotactic Body Radiation Therapy In Multi-Institutional Propensity-Score 3136 Maria Antonia Gomez Patients With Immune Suppression Matched Analysis Volumetric Modulated Arc Therapy For Non-Small Cell Lung Cancer Stage III: 3116 Sanath Kumar 3126 Angela Mohr Early Results In Our Institution Prognostic Biomarkers In Non-small Evaluation Of Automatic Segmentation Cell Lung Cancer Patients Treated With Tools For Thoracic Organs In 3137 Samantha Brigotti Radiotherapy Radiotherapy Planning The Infl uence of Hematological Parameters on Tumor Control and 3117 WITHDRAWN 3127 Liyi Xie Survival in Lung SBRT SBRT For Lung Cancer Appears To 3118 Steen Mortensen Provide Superior Local Control To 3138 Stephen Bowen Use Of A Novel Liquid Fiducial Marker Wedge Resection: Is This Due To The Impact of Functional Lung Imaging Injected With Endoscopic Ultrasound Therapeutic Eff ects Of Low Dose using Ventilation/Perfusion SPECT/ Equipment, For Use In Image Guided Peripheral Radiation? CT on Planning Objectives in Thoracic Radiotherapy Of Thoracic Tumors Radiation Therapy (Porcine Model) 3128 Luke Miller Primary Tumor Volume, Bulky 3139 Charles Simone 3119 Hideomi Yamashita Adenopathy and Number (But Not Stereotactic Body Radiotherapy (SBRT) Stereotactic Body Radiotherapy For Location) of Involved Nodal Stations for Stage I Non-small Cell Lung Cancer Patients With Pulmonary Interstitial Predict Outcome in N2-N3 NSCLC (NSCLC): Outcomes by Fractionation, Change Treated With Defi nitive Tumor Stage and Location, and Patient Chemoradiotherapy Operability 3120 Judi Van Diessen Prognostic Parameters For Primary 3129 Laura Kollar 3140 Ying Hou Tumor And Lymph Node Failure In Is the Ipsilateral Lung a Superior Outcomes And Toxicity After Lung Locally Advanced NSCLC Patients Predictor than Total Lung in the Stereotactic Body Radiation Therapy Treated With Concurrent Development of Grade 3 or Greater (SBRT) In Patients (Pts) With A History of Chemoradiation Therapy Pneumonitis? Prior Lung Resection or Radiofrequency Ablation (RFA) 3121 Richard Cattaneo 3130 Supriya Jain Stereotactic Body Radiation Therapy Monte Carlo-Based Treatment Planning 3141 Gurleen Dhami After Surgical Resection of Primary May Increase Chest Wall Pain and Rib Anatomic Variations in Pulmonary Lung Cancers Fractures in Lung Stereotactic Body Perfusion and Ventilation Per Radiotherapy (SBRT) Patients Treated Quantitative MAA and DTPA SPECT/CT 3122 Nan Bi According to RTOG 0915 Protocol in Patients Receiving Thoracic Radiation The Potential Predictive Value Of Therapy Urinary Metabolomic Changes In 3131 Tatiana Rabin Locally Advanced Non-small Cell Lung Pre-clinical Studies Of Metformin Reveal 3142 Zhilei Shen Cancer Patients Treated With Celecoxib Radiosensitization For Human Small Clinical Evaluation of a Novel And Chemoradiotherapy Cell Lung Cancer In Vitro But Apparent Exponential Weighting Algorithm for Antagonism In Vivo 4DCT Reconstruction 3123 Baosheng Li Phase III Study Of Concurrent LCAHRT 3132 Camille Berriochoa 3143 Chiara Valentini With Pemtrexed Or Vinorelbine For Lung SBRT For Tumors With Chest Wall Validation Of A Pre Release Commercial Unresectable Stage III NSCLC Involvement: Safe And Eff ective Autosegmentation Software For Sbrt And 4drt Purposes In Lung Cancer: 3124 Andreas Rimner 3133 Heike Peulen Ready (research Program In Auto Stage III Non-Small Cell Lung Cancer Prognostic Model For Progression Free Delineation System)-lung-01: Proof Of Treated Without Concurrent Survival In Patients With Stage III Concept Chemotherapy: What is the Optimal Non-small Cell Lung Cancer Treated Radiation Dose? With Concurrent Chemoradiation 3144 Jason Hayes Risk of Pneumonitis after Stereotactic 3134 Katsuyuki Karasawa Body Radiation Therapy for Non-Small Stereotactic Body Radiation Therapy Cell Lung Cancer in Patients With Prior and Hypofractionated 3-dimensional Anatomic Resection Non-coplanar Conformal Radiotherapy for Solitary Metachronous Second Primary Non-small Cell Lung Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 159 3145 Bertram Maidment III 3155 Xin Ming LYMPHOMA/LEUKEMIA Dosimetric Comparison Of Cardiac Toxicity in Intensity-Modulated VMAT-based Lung SBRT Treatments Radiation Therapy, Dynamic Conformal 3165 Jonathan Farr With And Without A Flattening Filter: Arc Therapy and Volumetric Modulated Potential Organ Dose Reduction From An Inter-institutional Study Arc Therapy of Lung Cancers Intensity Modulated Proton Therapy For Pediatric Hodgkin’s Disease Patients 3146 Michael Schmuecking 3156 Christina Speirs Receiving Consolidative Involved-node Is Molecular Remission As Detected Comprehensive Analysis Of Dosimetric Intensity Modulated Photon Therapy By 18F-FDG PET/CT And Regression Predictors Of Overall Survival For Stage Grade After Neoadjuvant Treatment In III Non-Small Lung Cancer (NSCLC) 3166 Bouthaina Dabaja The Primary Tumor And The Involved Treated With Defi nitive Radiotherapy Hodgkin’s Lymphoma Treatment: Mediastinal Lymph Nodes A Prognostic Modern Radiation Therapy, Lower Factor In Patients With NSCLC Stage III? 3157 Tithi Biswas Dose, Smaller Field, But The Risk Of Is There Any Disparity In Treatment Lhermitte’s Sign Is Still There 3147 Nhu Tram Nguyen And Outcome Of Stage I Non-small Tracheal Tumours Treated With Cell Lung Cancer (nsclc): A Study From 3167 George Mikhaeel Endotracheal Brachytherapy Alone: Single Cancer Registry? Patterns of Mediastinal Lymph Node Experience From A Single Institution (MLN) Involvement by Lymphoma 3158 William Chance Using International Association for the 3148 Eduardo Fernandez Postoperative Hemithoracic Intensity Study of Lung Cancer (IASLC) Stereotactic Ablative Radiotherapy Modulated Radiation Therapy (IMRT) Classifi cation (sabr) For Early Stage Lung Cancer In with an Optional Integrated Boost for The Multi-center Community Setting Malignant Pleural Mesothelioma: 3168 Carlo Furlan Toxicity, Patterns of Failure, and a The German Hodgkin Study Group 3149 Jay Paul Reddy Matched Survival Analysis Stratifi cation Scheme For Newly Infl uence of Surveillance PET/CT on Diagnosed Hodgkin’s Lymphoma Is Detection of Early Recurrence 3159 Hani Al-Halabi Useful For Predicting Outcome Of Following Chemoradiation in Stage III A Contralateral Esophagus Sparing Patients Receiving Radiotherapy After Non-small Cell Lung Cancer Technique To Limit Severe Esophagitis Autologous Self Cell Transplant In Associated With Concurrent Relapsed/refractory Hodgkin 3150 Jolinta Lin Chemoradiotherapy In Lung Cancer Lymphoma Large Tumor Size Increases the Risk Patients of Developing Symptomatic Pleural 3169 Shane Lloyd Eff usions Following Stereotactic Body 3160 Julip Jung Hodgkin Lymphoma With Bulky Radiation Therapy for Lung Cancer Lung Tumor Motion Tracking using Mediastinal Disease: A Comparison of Sequential Inter-phase Deformable AP/PA, IMRT, and Volumetric Arc Plans 3151 Weili Wang Registration in 4D CT Images for Autoantibodies against p16 Radiation Treatment Planning 3170 Maximilian Spickermann Protein-derived Peptides Predict How Reliable Is Cone Beam Computed Radiation Pneumonitis in Patients With 3161 Yun Hee Lee Tomography (CBCT)? - A Quality Control Non-small Cell Lung Cancer Treated Tumor Volume Changes Assessed with Of Intensity-modulated Radiotherapy With Defi nitive Radiotherapy High Quality KVCT in Lung Cancer And Intensity-modulated Arc Therapy Patients Undergoing Concurrent For Patients With Hodgkin’s Lymphoma 3152 Yu Chen Chemoradiotherapy Post-induction Infl ammatory Status 3171 Jordan Torok Predicts Complete Pathologic Response 3162 Anshu Jain Low-Dose Consolidation Radiation In Non-small Cell Lung Cancer Patients A Pilot Study of FLT-PET as an Early Therapy for Early-Stage Unfavorable Undergoing Induction Chemoradio- Imaging Biomarker in the Tri-modality Hodgkin Lymphoma therapy Treatment of Patients with Thoracic Malignancies 3172 Marianne Aznar 3153 Yankhua Fan Breathing Adapted Radiotherapy In Radiation Dose-Volume Eff ect in Lung: 3163 Feng-Ming Kong Hodgkin Lymphoma: Do We Need The A Functional Subunits Based Normal Immunomodulating Cytokines May Staging Pet/CT In Deep Inspiration Tissue Complication Probability Model Improve Overall Survival Prediction Breath Hold? and Its Application to 3DCRT and SBRT After Radiotherapy In Patients With Locally Advanced Non-small Cell Lung 3173 Suzanne Sachsman 3154 Eric Kemmerer Cancer Impact on Dose to Abdominal Organs Local Failures After Lung SBRT and with the Use of Proton Therapy in the Dosimetric Analysis of Potential Surgical 3164 Ankit Mangla Management of Diaphragmatic and Resection Lung Volumes The Association Of Pre-chemotherpay Infradiaphragmatic Hodgkin Neutrophil-lymphocyte Ratio With Lymphoma Survival In Non-small Cell Lung Cancer Patients Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
160 ASTRO 2014 / 56TH ANNUAL MEETING 3174 Ali Mazloom 3185 Susan Hiniker 3195 Christopher Kelsey Survival Benefi t of Radiotherapy in Prognostic Factors, Treatment, And Cardiopulmonary Exercise Testing Patients With Stage III Classical Hodgkin Outcomes Of Limited-Stage Diff use Prior To Myeloablative Allogeneic Stem Lymphoma: An Analysis of the Large B-cell Lymphoma (DLBCL) In The Cell Transplantation Using Total Body Surveillance, Epidemiology, and End Rituximab (R) Era Irradiation: A Feasibility Study Results (SEER) Database 3186 Arisa Harada 3196 Josef Hammer 3175 Christopher Wilke Primary Radiation Therapy For Localized Total Body Irradiation (TBI) by Role Of Consolidative Radiotherapy Duodenal Follicular Lymphoma Volumetric Modulated Arc Following Autologous Stem Cell Therapy - First Experiences and Transplantation For Relapsed Or 3187 Kazunari Miyazawa Perspectives Refractory Hodgkin’s Lymphoma Low Cataract Incidence Of Electron Beam Therapy With Hanging Lens Block 3197 John Plastaras 3176 Michio Iwabuchi For Conjunctival MALT Lymphoma Risk Factors for Radiation Pneumonitis Treatment of Primary Central Nervous in Patients With Lymphoma Treated System Lymphoma (PCNSL): 3188 Jian Zang With Chemotherapy and Photon or Comparison between Whole-brain Better Outcome In Stage I-II Nasal-type Proton Radiotherapy Radiotherapy and Partial-brain Of Nk/t Cell Lymphoma Treated With Radiotherapy Radiotherapy Followed By etoposide 3198 Naoya Ishibashi and/or L-asparaginase Containing Prospective Study Of Total Body 3177 Bouthaina Dabaja Chemotherapy Regimen Irradiation As Pretreatment For Defi nitive Radiation Therapy For Stage Hematopoietic Stem Cell I And II (MALT) Mucosa Associated 3189 Bo Chen Transplantation Lymphoid Tissue Lymphoma: Report Of Failure Distribution Of Early Stage A Prospective Study Upper Aerodigestive Tract NK/T-cell 3199 Douglas Kelly Lymphoma After Treatment Dosimetric Evaluation of Helical 3178 Bouthaina Dabaja Tomotherapy Low Dose Total Body Follicular Lymphoma of the Skin: 3190 Sameer Jhavar Irradiation (TBI) for Mini Allogeneic Diff erent Therapies Similar Outcome Role of Radiation Therapy in Early Stage Transplants Diff use Large B-Cell Lymphoma (DLBCL) 3179 Joohwan Lee in Elderly The Role of Radiotherapy in Localized NON-MALIGNANT Nongastric and Nonorbital 3191 Ophelie Cassuto Mucosa-associated Lymphoid Tissue Comparison Between Short Course 3200 Steven Sckolnik Lymphoma (Single Fraction) And Long Course Frameless LINAC Image Guided (Multiple Fractions) On Pain Relief In Radiosurgery for Primary and Recurrent 3180 Kotoha Tatekawa Patients With Bone Localization Of Trigeminal Neuralgia Clinical Outcome of Radiation Therapy Multiple Myeloma for Ocular Adnexal Mucosa-Associated 3201 Waleed Mourad Lymphoid Tissue Lymphomas 3192 Ehsan Balagamwala Higher Energy Megavoltage Photon Spine Stereotactic Radiosurgery for and Split Beam technique Minimize 3181 Saiji Ohga the Treatment of Multiple Myeloma, an the Testicular Dose during Radiation Treatment Outcome of Primary Institutional Series Prophylaxis of Heterotopic Ossifi cation Ocular Adnexal Malt Lymphoma by Radiotherapy - Prognostic Eff ect of the 3193 Thatcher Heumann 3202 Zachary Lopater Ajcc Tumor-Node-Metastasis Clinical Total Skin Electron Irradiation (TSEI) Treatment of Dupuytren’s Staging System for Ocular Adnexal Malt Using Rotational Technique For Contracture and Ledderhose’s Disease Lymphoma Cutaneous T- Cell Lymphoma with Radiation
3182 Lior Braunstein 3194 Jeff rey Wong 3203 Adriana Blakaj Predictive Factors for Ophthalmic Phase I Dose Escalation Trial of Total Metallothioneins in Fibrosis: Toxicity in Patients Receiving Marrow and Lymphoid Irradiation Implications for Radiation-induced Radiotherapy for Ocular Adnexal or (TMLI) Using Helical TomoTherapy Fibrosis Periorbital Lymphoma Combined with Etoposide (VP16) and Cyclophosphamide (CY) in Patients with 3204 Nisha Ohri 3184 Chelsea Pinnix Refractory Acute Leukemia A Renewed Application of Intracoronary The Outcome of Limited Stage Undergoing Allogeneic Hematopoietic Brachytherapy for In-Stent Restenosis of Plasmablastic Lymphoma Treated With Cell Transplant Drug-Eluting Stents and Without Radiation Therapy: A Single Institutional Experience
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 161 3205 Divya Arora 3215 Chiaki Fujioka 3225 Tetsuo Saito Dosimetric Analysis Of Brainstem Optimal Bladder Volume at Treatment Physicians’ Reluctance to Choose Dose Constraints For Linac Based Planning for Prostate Cancer Patients Radiotherapy over 1 to 2 Weeks for Pain Radiosurgery For Medical Management Receiving Volumetric-modulated Arc Relief in Patients With Bone Metastasis Refractory Trigeminal Neuralgia Therapy and a Poor Prognosis
3206 Shen Jie 3216 Therese Porzio- 3226 Matthew Cheney Hypofractionated Electron-Beam Kwiecinski Re-irradiation for Spinal Metastases: Radiation Therapy for Keloids: Temporary Displacement of the Bowel A Single Institution Series Examining Retrospective Study of 568 cases with during Treatment of Sacral Tumors With Radiation Myelopathy and Disease 834 lesions Stereotactic Body Radiation Therapy Outcomes
3207 Stella Yoo 3217 Olivier Maisonet 3227 Christina Henson Radiation Therapy for Prophylaxis of Implementation of a Quality Assurance Outcomes in Patients Treated with Heterotopic Ossifi cation at the Elbow: A Protocol for Patients With an Implanted Whole Brain Radiotherapy Versus Single-Institution Retrospective Study Cardiac Device Undergoing Treatment Stereotactic Radiosurgery for Brain With Radiation Metastases Secondary to Non-Small Cell 3208 Terence Sio Lung Cancer Radiation Toxicity in Patients With Scleroderma, Discoid and Systemic PALLIATIVE CARE 3228 Woo Joong Rhee Lupus Erythematosus: A Retrospective Vertebral Compression Fractures after 26-Year Single-Institutional Study 3218 Drew Moghanaki Spine Irradiation Using Conventional Availability Of Single-fraction Palliative Fractionation in Patients with 3209 Nathan Tennyson Radiotherapy For Cancer Patients Metastatic Colorectal Cancer Patient Reported Outcome after Receiving End-of-life Care Within The Electron Radiation Treatment for Veterans Healthcare Administration 3229 Pierfrancesco Franco Early-Stage Palmar and Plantar Palliative Radiotherapy for Painful Bone Fibromatosis 3219 Shane Lloyd Metastases From Solid Tumors Radiation Oncologists’ Opinions about Delivered With Static Ports of 3210 Claudia Carvajal Palliative Radiation Therapy for Patients Tomotherapy Postoperative Radiotherapy in the on Hospice Care Management of Keloids 3230 Hidetoshi Kobayashi 3220 Ian Poon Radiation Therapy for A Multi-National Report on Symptomatic Bone Metastases: The NURSING Image-Guided Stereotactic Body Eff ect of Calculated Dose And Dose Radiotherapy for Oligometastases - Distribution on Intensity of Pain Relief 3211 Patries Herst Patient Selection and Follow-Up and Time of Pain Relief Prophylactic Use Of Soft Silicone Film Prevents Radiation-induced Moist 3221 Shohei Kawashiro 3231 Tetsuo Saito Desquamation In Breast Cancer Patients Reirradiation of Spinal Metastases With Painful Diseases Other than Bone Intensity Modulated Radiation Therapy Metastasis are More Frequently Treated 3212 Colleen Schaidle with Radiotherapy than Bone Metastasis The Role of the Non-physician 3222 Robert Olson Practitioner (Advanced Practice Nurse Impact of Program Wide Dissemination 3232 Mareike Held and Physician Assistant) in Radiation of the Inconsistent Utilization of Single A System to Determine Suitable Oncology Fraction Radiotherapy for Bone Candidates for Expeditious On-board Metastases across a Provincial Program CBCT Dose Planning and Delivery 3213 Diane Serra Guided Imagery Improves Head and 3223 Mark Barnes 3233 Ken Harada Neck Cancer Patients’ Satisfaction Radiotherapy Fractionation Schedules Factors Infl uencing upon Pain and Quality of Life during Defi nitive Prescribed are Dependent on the Reduction: Bone Metastases from Renal Radiation Therapy with or without Distance a Patient Travels to Receive Cell Carcinoma (RCC) Treated With Chemotherapy Treatment Radiation Therapy
3214 Florence Yuen 3224 Naoki Nakamura 3234 Layth Mula-Hussain Management of Moist Desquamation in Neuropathic Pain Features In Patients Palliative Radiotherapy to Metastatic Radiation Oncology Patients With Bone Metastases Breast and Lung Cancers in The Middle East Region: 5 Years Experience at A Tertiary Center In Iraq
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
162 ASTRO 2014 / 56TH ANNUAL MEETING 3235 Saif Aljabab 3246 Hiroshi Tanaka 3256 Alan Kiang Hemostatic Radiotherapy in Advanced An International Multi-institutional Long-term Trajectory of Quality of Life Bladder Cancer A Single Institution Planning Study Evaluating Treatment in Nasopharyngeal Cancer Patients Review Planning And Plan Acceptability Metrics For Spine Stereotactic Body 3257 Jennifer Woo 3236 Omar Mian Radiotherapy (SBRT) Stereotactic Body Radiation Therapy for Reduced Lymphocytopenia Following Prostate Cancer: What is the Stereotactic Body Radiation Therapy 3247 Vladimir Avkshtol Appropriate Patient-Reported Outcome (SBRT) For Spine Metastases Compared Lacrimal Gland Radiation Dose and for Clinical Trial Design? With Conventional Radiation Therapy Toxicity After Whole Brain Radiation (CRT) 3258 Shrinivas Rathod 3248 Daniel Tan High-precision Conformal Radiotherapy 3237 Sara Alcorn Hypofractionated Stereotactic In Head-neck Cancers: Longitudinal Analysis of Factors Complicating Radiosurgery For The Treatment Of Changes In Quality-of-life And Treatment for Bone Metastases: Why Large Brain Metastases Temporal Time-Trends Are Patients Not Receiving Single-fraction Radiotherapy? 3249 Heather Curry 3259 Adriana Valderrama Utilization of Hypofractionated Health State Utilities Among Metastatic 3238 Yu-Ming Wang Regimens for the Treatment of Bone Castrate-resistant Prostate Cancer Heart Rate Variability as a Novel Metastases Before and After Initiation of Patients With and Without Prognosticator in Patients with Brain ASTRO’s ”Choosing Wisely” Campaign Symptomatic Skeletal Events Metastasis - A Pilot Study 3250 Francesco Cellini 3260 Andra Krauze 3239 Tai Chung Lam Virtual Simulation Procedure’S Diffi culty Assessment of Ten Years of Quality of Adverse Outcomes After Palliative Level Assessed By New Score System: Life Research Presented at Major Radiation Therapy For Pain Level Aff ects Duration Of American Clinical Oncology Meetings Uncomplicated Spine Metastases: Role Procedures Better Than Technical Of Spinal Instability And Single Fraction Complexity 3261 Jennifer Woo Radiation Therapy Comparing Patient-reported Outcomes 3251 C.M. Charlie Ma In Patients With And Without Late 3240 Bevan Ly Quality Assurance for MR Guided Urinary Flare Following Stereotactic Dose Escalation Using Conventional Focused Ultrasound Treatment of Bone Body Radiation Therapy (SBRT) For Versus IMRT Planning for Metastasis - A Clinical Experience Localized Prostate Cancer Hypofractionated Radiation of Lumbosacral Metastases 3252 Jessica Schuster 3262 Matthew Mason A Compassionate Care Palliative Patient Reported Outcomes: Correlation 3241 Yasushi Hamamoto Radiotherapy Program for Cancer of MDASI-HN and Clinical Support Prognoses Of Patients Who Received Patients Enrolled in Hospice - Off ering Required for Patients Receiving Curative Palliative Intent Radiotherapy In Recent Reduced-Cost Palliative Radiotherapy in Head and Neck Chemoradiotherapy Years the Same Day as Evaluation 3263 Terence Sio 3242 Jason Lee 3253 Amir Zahra Baseline Patient-Reported Quality- A Multi-institution Pooled Analysis of Pain Response and Local Control of of-life Is Not Related to Overall Survival Oligometastatic Patients Treated with Bone Metastases for Renal Cell in Patients Receiving Stereotactic Body SBRT Carcinoma with Conventional Radiation Therapy for Thoracic Fractionation Radiation Therapy Malignancies: A Preliminary Report 3243 Kyle Arneson Patterns Of End Of Life Care In Patients 3264 Einsley-Marie Janowski With Metastatic Melanoma Requiring QUALITY OF LIFE Dysuria Following Stereotactic Body Whole Brain Radiation Radiation Therapy for Prostate Cancer 3254 Hong Ye 3244 Natalie Logie Quality Of Life in Patients With Brain 3265 Jae Lee Dose Fractionation Schedule Correlates Metastasis Treated With Frame-Based Clinically-Relevant Body Composition With Survival In Whole Brain Stereotactic Radiosurgery Alone Using Changes in Head and Neck Cancer Reirradiation: An International Pooled the EORTC QLQ-C30 and QLQ-BN20 Patients Undergoing Chemoradiation Analysis 3255 Daniel Joh 3266 Andrew Rossetti 3245 Benjamin Lok Proctitis Following Stereotactic Body The Impact Of Music Therapy On Palliative Head and Neck Radiotherapy Radiation Therapy for Prostate Cancer Anxiety and Distress In Patients with the Quad Shot Regimen for Undergoing Simulation For Radiation Incurable Primary or Metastatic Cancers Therapy (RT)
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 163 3267 Marie Gurka 3277 Andrew Lee 3288 John Groarke Gross Hematuria after Stereotactic Body The Impact Of Hormone Therapy Negative Correlation Between Coronary Radiation Therapy (SBRT) for Prostate On Long-term Quality Of Life In Men Flow Reserve And Mean Radiation Dose Cancer Receiving Proton Therapy For Prostate To The Heart Cancer 3268 Isabelle Thibault 3289 Lisa Kachnic Quality of Life in Patients Treated With 3278 Jessica Zhou Perceptions And Practices Regarding Stereotactic Ablative Body Patient Reported Outcomes for Quality Women’s Vaginal Health Following Radiotherapy (SABR) for Liver of Life (QOL) By Expanded Prostate Radiation Therapy Metastases Cancer Index (EPIC) 15 Years Post Treatment 3290 Robert Olson 3269 Leszek Miszczyk Feasibility of Population Based Split-Course Accelerated, 3279 Zaker Rana Collection of Patient Reported Hyperfractionated Irradiation Factors Aff ecting Patient Reported Outcome Measures in a Provincial (CHA-CHA) as a Sole Treatment for Outcomes Following Robotic Radiotherapy Program Advanced Head and Neck (H&N) Cancer Radiosurgery Stereotactic Body Patients - Randomized Clinical Study. Radiotherapy for Prostate Cancer 3291 Arisa Shimizu Quality of Life (QOL) Evaluation Correlation of The Incidence of 3280 Amy Leatherwood Hypothyroidism and the Dose-Volume 3270 David Elliott What is the Impact of Survivorship Histogram in Head and Neck Cancer Medical Marijuana Use in Patients with Visits? Preliminary Analysis from a Patients Treated With Intensity- History of Head and Neck Squamous NCI-Designated Cancer Center Modulated Radiotherapy Cell Carcinoma Treated with Radiation Oncology Program Radiotherapy 3292 Luis Larrea 3281 Meredith Giuliani Stereotactic Body Radiation Therapy In 3271 Devarati Mitra Identifi cation of Unmet Survivorship The Elderly Does Adding Vaginal Brachytherapy Needs in Primary Lung Cancer Patients: (VB) To External Beam (EB) Increase A High Burden for Younger Patients 3293 Ashish Patel Rectal Bleeding? Comparing Results Pitfalls and Predictors of Poor Press Of Combined EB+VB To The PORTEC-2 3282 Andrew Barsky Ganey Patient Satisfaction Scores Data For EB Alone And VB Alone Radiation-Induced Malignant Mesothelioma: Frequency and 3272 Yu-Hsuan Lai Prognosis PATIENT SAFETY Analysis of Health-Related Quality of Life in Breast Cancer Patients Receiving 3283 Sara Samiee 3327 Sarah Gwynne Adjuvant Radiotherapy Colorectal Cancer Screening In Cancer Prospective Review Of Outlining In The Survivors Treated with Radiation Uk Neoscope Oesophageal Trial 3273 Joost Nuyttens Therapy Quality of Life during 5 Years after 3328 Hiral Fontanilla Stereotactic Radiotherapy in Stage I 3284 Miriam Knoll Individual Patient Based Peer-review At Non-Small Cell Lung Cancer Long Term Urinary and Rectal Tolerance A Proton Center in Prostate Cancer Survivors Treated 3274 Anuj Goenka with Defi nitive Conformal Radiotherapy 3329 Wai Wang Lam The Impact of Prostate Size on Patient Dosimetric Impact of Dose Servo Assessed Quality of Life Following 3285 Devarati Mitra Control on Long Helical Tomotherapy Proton Beam Radiotherapy Lymphedema: Is It Associated With Treatment Delivery Lymph-node Involvement In 3275 Zaker Rana Endometrial Cancer? 3330 Sarah Gwynne Improved Irritative Voiding Symptoms Progress Towards Prospective Real Time Three Years After Stereotactic Body 3286 YoungsSeok Seo Review Of Outlining In GI Trials At A UK Radiation Therapy For Prostate Cancer Stereotactic Body Radiotherapy Based Radiotherapy Quality Assurance Centre Strategy For Oligo-recurrent Cancer In 3276 Shariq Khwaja The Para-aortic Area Patient Reported QOL Outcomes From A Prospective Phase II Trial Of Short 3287 Christine Hill-Kayser Course Radiotherapy Followed By Patient Reported Outcomes after Chest FOLFOX Chemotherapy As Preoperative Radiation for Hodgkin (HL) and Treatment For Rectal Cancer Non-Hodgkin Lymphoma (NHL)
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
164 ASTRO 2014 / 56TH ANNUAL MEETING 3331 Jialu Yu 3342 Yutao Gong 3354 Samuel Chao Investigation Into A New Quality Variation Of Cardiac Contours Using One Year Experience with the Workfl ow Assurance Tool For Radiotherapy Diff erent Heart Defi nitions For NSCLC Enhancement (WE) Team: Does Structure Delineation: Atlas-based Patients Enrolled On Rtog 0617 Continuous Improvement Have to be Automatic Segmentation (ABAS) Of Continuous? Cardiac Structures For Non-small Cell 3343 Lukasz Matulewicz Lung Cancer From RTOG 0617 Evaluation of Transit Dosimetry 3355 Rohan Deraniyagala Software For Helical Tomotherapy Usability Study of the EduMod 3332 Tomas Dvorak eLearning Program: Head and Neck Assessment Of Radiation 30-Day Mor- 3344 Yuvaraj Sekar Nodal Station Contouring tality Based On ACR Continuous Quality Evaluation of a Novel 2D Detector Array Improvement Process for Patient Plan Verifi cation in 3356 Nataliya Kovalchuk Conventional and Flattening Filter Optimizing Effi ciency and Safety in 3333 Timothy Meier Free (FFF) Photon Beams in Clinical Radiation Oncology Department A Rapid Large Increase in Patient Visits Conditions through the Use of Aria 11 Visual Care Can Compromise Quality and Safety in Path (VCP) Radiation Oncology Treatment Delivery 3345 Yu Chen Tomotherapy Patient Specifi c Delivery 3357 Seiichi Ota 3334 Kelly Kisling QA Using Exit Detector Array Feasible Strategy For Reduction Of Evaluation of a System for Independent Individual Human Failures In External Treatment Plan and Delivery Verifi cation 3346 Xiaohu Mo Radiation Therapy Workfl ow A Delivered Dose Based Record and 3335 Joshua Mathews Verify System in the Era of IGRT 3358 Ryan Jones A Liquid Ion Chamber For Clinical The Improvement of a Novel Stereotactic Output Measurements 3347 Brian Liszewski Radiotherapy Workfl ow by Failure Mode A National System for Incident and Eff ects Analysis 3336 Sarah Hamilton Reporting in Radiation Therapy: A National Survey on Peer Review: Development of a Taxonomy and 3359 Shalini Moningi Canadian Radiation Oncologists’ Views Severity Classifi cation Management of Task Saturation in Regarding the Benefi ts, Practical a Pancreatic Multidisciplinary Clinic: Workload Implications and Legal 3348 Andrea McNiven Using a Novel Operations Management Liability Multicenter Collaborative Quality Methodology to Increase Effi ciency Assurance Program in Ontario: Second and Reduce Unnecessary Downstream 3337 Lucas Vitzthum Year Results Encounters Identifying and Implementing Factors that will Reduce Treatment Package 3349 Gustavo Kertzscher 3360 Karl Fritscher Time for Cervical Cancer Patients Fast, Simple And Accurate: In Vivo A 3d Patient Specifi c Collision Requiring Defi nitive Radiotherapy: Dosimeter Calibration For Hdr/pdr Avoidance System for Radiotherapy AQuality Improvement Eff ort Brachytherapy Treatment Planning
3338 Yoshiyuki Katsuta 3350 Raj Varadhan 3361 Chihray Liu Plan Quality Assurance of VMAT for VMAT Head & Neck Treatment Designing a Patient Treatment prostate cancers in a Digitally Delivery-Benchmarking Accuracy of Workfl ow Management and Analysis Integrated and Controlled Linear Patient DVH based QA with Radiological System in a Department of Radiation Accelerator Using Log Files Physics Center (RPC) Head and Neck Oncology Phantom Results 3339 Charles Able 3362 Byong Yong Yi A Model for Preemptive Maintenance of 3351 Shalini Moningi Determination of Risk-Based Target Medical Linear Accelerators - Predictive A Comparison of Incident Learning in Margins: A Failure Mode and Eff ect Maintenance the Academic and Community Analysis (FMEA) Proof of Principle Radiation Oncology Setting 3340 Kara Leonard 3363 Seth Blacksburg Developing a Process for Radiation 3352 Guilherme Pavan Operations Management in Radiation Oncology Specifi c Apparent and Root Dosimetric Evaluation Of Treatment Oncology: Identifying Workfl ow Cause Analyses Planing System On High Dose Rate Parameters that Portend for Simulation (hdr) Brachytherapy Using Monte Carlo Delay 3341 Ruijie Yang Method And Radiochomic Film Implementation of Incident Learning in 3364 Matthew Peter Mumber the Safety and Quality Management of 3353 Thomas Mullen Eff ect of Mindfulness Training on Radiotherapy: the Primary Experience What’s the Hold-Up? Late Work Events Mindfulness Level in The Workplace in a New Established Program with in Radiation Oncology Reveal and Patient Safety Culture as a Part of Advanced Techniques Opportunities for Improved Patient Error Prevention in Radiation Oncology Care and Safety Practice: A Pilot Study Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 165 3365 Bin Yang 3296 Ange Wang 3308 Waqar Haque Application of Expectation- Impact of Molecular Sub-type and Radiation Therapy Provides Favorable Maximization Method in kV X-ray Craniospinal Irradiation (CSI) Dose on Outcomes as Defi nitive Treatment for Spectrum Estimation From Relapse of Medulloblastoma Ewing’s Sarcoma Transmission Measurements 3297 Joanna Chin 3309 Jun Liang 3366 Kyle Delaney Incidence of Optic Nerve Involvement Primary Mediastinal and Thoracic Neutron Activation of Indium Foils in Pediatric Intracranial Germ Cell Liposarcomas: Clinical Analysis of 25 Irradiated During Passively Scattered Tumors Cases Proton Therapy and Implications on the Treatment of Pacemaker Patients 3298 Kristin Redmond 3310 Barbara Roeper Diff usion Tensor Imaging (DTI) and High-precision Involved-Lesion 3368 Jona Hattangadi Proton MR Spectroscopy (MRS) Radiation Therapy (IL-RT) to all A 25-Year Epidemiologic Study of Detected Region Specifi c Injury to Metastatic Sites in Multifocal Pediatric Medical Malpractice Claims in Radiation White Matter in Children Treated with Sarcoma Oncology Cranial Irradiation 3311 Ozlem Ozkaya 3369 Shereef Elnahal 3299 I-Chun Lai Akagunduz Identifying Predictive Factors for Treatment Results and Prognostic The Eff ect of Radiotherapy in the Local Treatment Variance Events in Patients Factors for Intracranial Non- Control of the non-Extremity Ewing’s Receiving Radiation Therapy: germinomatous Germ Cell tumors: Sarcomas Comparative Results from a Single Institute Experience Comprehensive Safety Variance 3312 Eleanor Osborne Database 3300 Melis Gultekin Survival And Toxicities Following Whole Reirradiation of Pediatric Tumors with Abdominopelvic Radiotherapy As Part 3370 Prithima Mosaly Robotic Stereotactic Radiosurgery Of Multimodality Treatment For Patients Objective Assessment of Mental With Desmoplastic Small Round Cell Workload With Pupillary Monitoring 3301 Jinsoo Uh Tumor During Routine Clinical Tasks: The Eff ects of Surgery and Proton Therapy Impact of Cross Coverage on Cerebral White Matter of 3313 Robert Kirkland Craniopharyngioma Patients Stratifying Pulmonary Tumor Burden 3371 Kinley Taylor in Patients with Stage IV Wilms Tumor A Case Study of the Use of A3 Thinking 3302 Sara Alcorn (WT): Implications for Treatment and in Radiation Oncology Predictors of Setup Accuracy in Disease Outcome Image-Guided CNS Radiotherapy: 3372 Prithima Mosaly Prospective Data from a Multi-national 3314 Ronica Hazariwala Assessing the Applicability and Pediatrics Consortium Cardiopulmonary Outcomes for Reliability of the Human Factors Concurrent Versus Sequential Lung Analysis and Classifi cation System 3303 Oren Cahlon and Abdominal Irradiation in Stage IV (HFACS) to the Analysis of Good Craniospinal Radiotherapy May Not Be Wilms Tumor Catches in Radiation Oncology Necessary for Localized Nongerminomatous Germ Cell Tumors 3315 Vanessa Salinas 3373 Jonathan Grant (NGGCT) Incidence of Cataracts in Lens Sparing Secondary Neutron Production is vs Whole Eye Radiation Therapy Predictive of Implantable Cardiac 3304 Geoff rey Ray Technique in Retinoblastoma Patients Device Reset in Patients Receiving Pediatric Central Nervous System Radiotherapy Reirradiation and Tolerance of the 3316 Nikhil Thaker Brainstem to High Cumulative Dose Evolution of Proton Therapy and Advanced Radiation Techniques for PEDIATRIC CANCER 3305 Susan McGovern Retinoblastoma Proton Therapy For Pediatric AT/RT of 3294 Anita Mahajan the CNS 3317 Fauzia Shaikh Neurocognitive Outcomes in Modeling Radiation Induced Vascular Relationship to Hippocampal and Brain 3306 Rachel Jimenez Eff ects of High Dose Versus Standard Doses after Partial Brain Proton Proton Radiotherapy for Pediatric Dose Radiation in an Orthotopic Mouse Radiotherapy in Children Craniopharyngioma Model of High-Risk Neuroblastoma
3295 Roshan Sethi 3307 Radhika Sreeraman 3318 Brandon Imber Patterns Of Failure Following Proton Mid-Treatment Magnetic Resonance Biomarker Modulations in Children with Therapy In Medulloblastoma; LET Imaging in Pediatric Intracranial Neuroblastoma Following Treatment Distributions And Rbe Associations For Low-Grade Giomas Treated with Proton with 131I-mIBG Relapses Beam Therapy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
166 ASTRO 2014 / 56TH ANNUAL MEETING 3319 Carl DeSelm 3550 Dan Ruan 3561 Javier Torres-Roca Optimum Radiation Treatment for CNS Development of a Clinical Information Correlation Between Tumor Intrinsic Recurrent Neuroblastoma Management System With Logical Radiosensitivity and Immune Activation Organization for Improved Accuracy in Solid Tumors 3320 Nikesh Shah and Inheritance Total Body Radiotherapy Dose 3562 Shuang Zhao Comparison in Pediatric Patients 3551 Dan Ruan Identifi cation and Validation of a with Relapsed Acute Lymphoblastic Listening To Sinogram: Detecting And Metastasis Signature in Human Breast Leukemia Estimating Actual Discrepancy During Cancer Treatment 3321 Clayton Hess 3563 Florentino Rico Outcomes of Pre-Operative Versus 3552 Shuai Zheng Supervised Learning Methods for the Post-Operative Radiation for Patient Treatment and Prognosis Prediction of Tumor Radiosensivity to Heterotopic Ossifi cation Prevention Information Extraction with Adaptive Preoperative Radiochemotherapy in Pediatric Patients with Cerebral Self Learning Medical Form Generating Palsy Undergoing Proximal Femoral System 3564 Russell Rockne Resection An Evaluation of Multi-institutional 3553 Johannes Kraft Data-Transfer to Facilitate Personalized 3322 Dana Casey Evaluation and Comparison of Computational Modeling Second Cancer Risk in Childhood Segmentation Algorithms in Low Cancer Survivors Treated with Contrast FET-PET Scans for Gross Tumor 3565 Timothy Robinson Intensity-Modulated Radiation Therapy Volume Delination Hypoxia Induces mRNA 3’UTR (IMRT) Truncation in Multiple Cell Types In Vitro 3554 Kevin Albuquerque 3323 Christine Hill-Kayser Development and Experience With an Factors Associated With Event EMR Based Radiation Oncology Toxicity RADIATION AND CANCER Reporting in the Pediatric Radiation Recording Instrument (ROTOX): Bench- BIOLOGY Oncology Population Using an marking and Quality Improvement Electronic Condition Reporting System 3414 Andrew Vaughan 3555 Weiguo Lu Infl uence Of Chromatin Structure On 3324 Josefi ne Stahl Kornerup In-vivo Verifi cation and Adaptive The Induction Of Radiation-induced The Impact Of Diff erent PTV Margins In Evaluation for Every Patient, Every Chromosome Aberrations VMAT And IMPT For Adolescents With Treatment Nasopharyngeal Carcinoma 3415 Brandon Stone 3556 Mark Phillips Gene Expression Patterns in Pancreatic 3325 Benjamin Farnia Development of a Probabilistic Model Neuroendocrine Tumors Suggest Dosimetric and Toxicity Analyses of For Therapy Plan Error Checking Resistance to Radiation Therapy Reirradiation for Recurrent Pediatric Brain Tumors 3557 Andres Parra 3416 Kristina Young Automatic Detection of the Foci of TGFβRI Inhibition Prior To Radiation 3326 David Barron Residual or Recurrent Disease in the Enhances Effi cacy In A CD8 Dependent The Role of Radiotherapy in Prostate Bed after Prostectomy using Fashion Epstein-Barr Virus-Related Dynamic Contrast Enhanced-MRI Lymphoproliferative Disorder 3417 Elena Muraro 3558 Kevin Moore Stereotactic Ablative Radiotherapy Suboptimal Treatment Planning Adds (SABR) for Oligometastatic Breast Can- INFORMATICS/ Substantial Risk of Normal Tissue cer Patients: Investigating the Immune BIOINFORMATICS Complication: A Secondary Study on Profi le to Identify Predictive Biomarkers RTOG 0126 3547 Nhu Tram Nguyen 3418 Azadeh Fahim Blinded Evaluation Of Sinogram 3559 Javier Torres-Roca Golestaneh Affi rmed Iterative Reconstruction In Large-Scale Evaluation of a Molecular Identifying Molecular Mechanisms Radiotherapy Planning Images Signature of Tumor Intrinsic Radiosensi- Of Tumor Radio-resistance Via High tivity in Solid Tumors Throughput In-vivo Microrna Knock 3548 Tobias Fechter Down Screen Evaluation Of An Integrated Minimall 3560 Christopher Betzing Interactive Tool For The Segmentation Identifi cation of Critical Pathways 3419 Chung Man Leung Of Relevant Oar In Lung Cancer Altered by Radiation Exposure and Drug Ionizing Radiation Exposure Modulates Target Analysis MicroRNA Expression In Human Cancer 3549 Anant Gopal Cells An Electronic Medical Record Search Engine for Clinical Outcome Research
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 167 3420 Sophia Bornstein 3432 Amit Maity 3442 Michael Epperly Role of Non-canonical Wnt5a Signaling PI3K/Akt Inhibition Decreases Oxygen Intraoral GS-Nitroxide JP4-039 In in Metastatic Oral Cavity Squamous Cell Consumption In Tumor Cells By Novel F15 Emulsion Ameliorates Carcinoma Phosphorylating And Inactivating Irradiation-Induced Mucositis In Tumor Pyruvate Dehydrogenase (PDH) E1a Bearing Fanconi Anemia (FA) (Fancd2-/-) 3421 Jessie Tao Subunit C57BL/6 Mice A549 Lung Cancer Cells Up-Regulate Proto-Oncogene Expression in 3433 David Dadey 3443 Frank Giordano Mesenchymal Stem Cells Inhibition of the PERK Arm of the Impact of Flattening-Filter-Free (FFF) Endoplasmic Reticulum Stress Response Radiation on the Clonogenic Survival of 3422 Aadel Chaudhuri Attenuates VEGF Production in Astrocytoma Cell Lines MicroRNA-125b Represses IRF4 to Irradiated Glioblastoma Cell Lines Induce Acute Myeloid Leukemia 3444 Takeshi Nishioka 3434 Shyam Rao X-ray Irradiation Induces Mitophagy 3423 Michael Koukourakis Sphingolipid Signaling with High Single And Cancer Metabolic Reprogramming Autophago-Lysosomal Flux Following Dose SBRT/SRS Exposure of Endothelial Cells And 3445 Gerben Borst Fibroblasts to Ionizing Radiation 3435 Arta Monjazeb Genetically Enigineerd Mouse Models Radiation Induced Changes In And High Precision Fractionated 3424 Mariko Sato Chemokine Expression Promote Natural Radiotherapy To Unravel Mechanisms How Can We Overcome Hypoxia- and Killer Cell Homing Of Irradiation Escape Radiation-Induced EMT? - Contribution of Blockade on HIF-1 and JNK 3436 Jonathan Schoenfeld 3446 Hiromitsu Iwata Phospholyration With LW6 Response of Extra-cranial Lesions After Oxygen Enhancement Ratio Of Proton Treatment of Metastatic Melanoma with Beams: The Precise Report Of The Same 3425 Marjan Rafat Cranial Radiation and Ipilimumab Institution’s Experiments Using The Normal Tissue Irradiation Promotes Clinical Equipments Tumor Cell Migration 3437 Yoshiyuki Suzuki Carbon-ion Beam And X-ray Irradiation 3447 Trevor Leong 3426 Catherine Park Increase A Release Of An Immune Gamma-H2AX as a Predictive Biomarker Tensional Properties Of Extracellular Mediator Protein High Mobility Group of Individual Radiosensitivity Matrix (ecm) Modulate Radiation Box 1 (HMGB1) In Various Human Resistance Via Yes Associated Protein Cancer Cell Lines 3448 Katarzyna (YAP) Zielinska-Chomej 3438 Marlon Veldwijk Alternating Electric Fields (TTFields) 3427 Minsi Zhang A Potential Role for Non-targeted Inhibit Repair Of Dna Damage Induced Hif-1α Regulates Radiation Resistance Biological Eff ects in Cellular Inactivation By Ionizing Radiation And Sensitize In Primary Sarcomas In A Tumor-cell after Ionizing Irradiation with Large Glioma And Non-small Cell Lung Cancer Autonomous Mechanism Single Doses Cells To Radiation
3428 Bryan Allen 3439 Timothy Illidge 3449 Samuel Bakhoum Assessing Superoxide Levels in Human Radiation Therapy Induces An Adaptive Dna Damage Response During Mitosis NSCLC and Normal Lung Epithelium Upregulation Of PD-L1 On Tumour Cells Induces Cancer Chromosomal Which May Limit The Effi cacy Of The Instability 3429 Hyun Yoo Anti-tumour Immune Response But Can Gefi tinib Inhibits Radiation-induced Be Circumvented By Anti-PD-L1 3450 Fen Xia Skin Fibrosis By Inhibition Of Stat1 Increasing the Synthetic Lethality of Expression 3440 Vishruth Reddy PARP Inhibition in Glioblastoma Cells by BVES Loss is Protective In Radiation Depletion of Nuclear BRCA1 3430 Eun-Jung Lee Enteritis Radiation-Induced Eosinophil 3451 Alexander Spektor Recruitment Promotes Th2 response via 3441 Michael Epperly Micronuclei-induced DNA Damage And IL-33 production in Irradiated Skin Eff ects of Radiation Mitigators JP4-039 Mutagenesis In Cancer and MMS350 on Gene Transcripts in 3431 Sibo Tian Radiosensitive Fanconi Anemia 3452 Li Yuan Zhang The Role Of Fibronectin On Spatial Fancd2-/- (C57Bl/6) Bone Marrow Minocycline-mediated Improvement Of Organization In 3-d Culture: A Model Stromal Cells Cognitive Impairment Induced By For Wound Healing After Radiation Irradiation Involves Preventing Therapy Immature Neurons From Apoptosis
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
168 ASTRO 2014 / 56TH ANNUAL MEETING 3453 Piotr Widlak 3464 Michael Dominello 3476 Gregory Gan Radiotherapy-induced Changes In Radioprotection of Normal Esophageal Radiation Dose Uncertainty in a Mouse Serum Lipidome Of Head And Neck Tissue by Soy Isofl avone Treatment Head and Neck Irradiation Model Cancer Patients 3465 Jeff rey Buchsbaum 3477 Jia Yang 3454 Michael Epperly Improving the Delivery and Safety of Histopathologic Validation of 3’- Radiosensitivity of Human Induced Proton Beam Therapy Deoxy-3’-18F-Fluorothymidine PET for Pluripotent Stem Cells Compared to Detecting Tumor Repopulation During Parental Fibroblasts 3466 Napapat Amornwichet Fractionated Radiotherapy of Human Evaluation Of DNA Damage Response FaDu Squamous Cell Carcinoma 3455 Soichi Odawara After Carbon-ion Beam Irradiation In Polaprezinc Protects Intestinal P53-mutant Cancer Cells 3478 Daniel Spratt Epithelium from Radiation-induced 89zr-mstp2109a, A Novel Antibody Damage in Mice 3467 Naoko Okano Based Radiotracer To Evaluate And In Vitro Determination Of The Relative Guide The Clinical Translation Of 3456 Fan Xingwen Biological Eff ectiveness Of Carbon-ion Antibody-drug Conjugates Targeting Electroacupuncture Ameliorates Beam Irradiation In Cells Derived From Steap1 Irradiation-induced Cognitive Human Normal Lung Tissues Impairment in Rats via Multiple 3479 Olga Volotskova Pathways 3468 Bin Wang Cerenkov Radiation Energy Transfer Pulsed Low Dose Rate External Beam (cret) As Novel Strategy For Tumor 3457 Diana Yi Zhao Radiotherapy: An in vivo Study On Imaging And Delineation Pharmacological Inhibition And Genetic Prostate Cancer Ablation Of The Egr1 Transcription 3480 Masayuki Matsuo Factor Radioprotects The Mouse 3469 Sei Sai Pulsed Electron Paramagnetic Hippocampus And Small Intestine Eff ects of Carbon Ion Beam Alone or in Resonance Imaging For Evaluation Of Combination with Gemcitabine and/ Reoxygenation In Murine Tumors: A 3458 Xiaorong Dong or Cisplatin on Cholangiocarcinoma New Reoxygenation Imaging For Nemo Modulates Radiation Induced Stem-Like Cells Radiation Therapy Human Umbilical Vein Endothelial Cells Senescence Via Nf-κB Signal Pathway 3470 Peng Zhang 3481 Makoto Hosono Local Tumor Control And Normal Heterogeneity of Intratumoral Hypoxia 3459 Heinz Schmidberger Tissue Toxicity Of Pulsed Low Dose Rate on FMISO PET/CT in Association with gamma-H2AX: A Sensitive Biodosimeter Radiotherapy (plrt) For Recurrent Lung Local Control in Radiation Therapy in Radiotherapy? Cancer: An In Vivo Study 3482 Zhenhua Gao 3460 Ippei Takahashi 3471 Pervin Hurmuz Comparison Of Tumor Volumes As KH-3, a Transcriptional Modulator of The Eff ect Of Dose Rate Per Fraction On Determined By Pathologic Examination p53, Protects Mice from Lung Toxicity And Flt-pet/ct Images Of Non-small-cell Radiation-Induced Gastrointestinal Lung Cancer: A Pilot Study Syndrome 3472 Sreeja Sarojini Experimental Radiation (2400 MU/min/ 3483 Martin King 3461 Lisa Abernathy 50cGy) In Vitro Achieved Signifi cant Evaluation Of A Gamma Rejection Soy Isofl avones Inhibit Increase In Apoptosis On Melanoma Strategy For CCD-based Beta Particle Radiation-Induced Macrophage and Cells With Superior Survival Of Normal Imaging Neutrophil Activation and Promote Cells When Compared To 400 MU/min Ly6C+Ly6G- Suppressive Monocytes 3484 Andrea Laruelo Resulting in Lung Radioprotection 3473 Masatoshi Hasegawa Towards Accurate and Robust MRSI Changes of Cancer Stem Cell Markers in Quantifi cation to Improve the 3462 Rafi Kabarriti Human Ependymoblastoma Following Radiotherapy Treatment of GBM Co-transplantation Of Liver Sinusoidal Carbon Ion Beam Irradiation Endothelial Cells Promotes 3485 Brian Marples Repopulation Of Transplanted 3474 Anil Pyakuryal Evaluating Low-Dose Pulsed Radiother- Hepatocytes Following Hepatic Radio-biologic Evaluation of apy in Murine Model of Neuroblastoma Irradiation Simultaneously Integrated Boost (SIB) IMRT Methods in Head and Neck 3486 Vaishali Kapoor 3463 Jae Ho Cho Cancer: Multi-Institutional Study Monoclonal Antibody 2C6F3 Against Time, Dose And Volume Response In Radiation-inducible Cell Surface Tip-1 The Mouse Pulmonary Injury Model 3475 Marjan Rafat As A Novel Agent For Imaging And After Ablative Irradiation Impact of Very Rapid Irradiation on Targeting Tumors Clonogenic Survival
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 169 3487 Jessica Perez 3498 Mohamed Khattab 3509 Qian Dong Fluorescence Endomicroscopy as a Tool PSMA-targeted Low Molecular Weight Human Positive Cofactor 4 (PC4) is a to Assess Radiation-Induced Lung Urea-siRNA Conjugates for Targeted Promising Target to Improve the Damage, Protection and Regeneration Knockdown of DNA-PK and Radiotherapy Eff ect of Esophageal Radiosensitization of Prostate Cancer Squamous Cell Carcinomas 3488 Keum Sil Lee Cell Lines Impact of Optimally-Gated PET on 3510 Xi Tian Tumor Localization And Quantifi cation 3499 Peter Huber Preclinical Evaluation Of Promitil, A Stepwise Combination Of Novel Nanoparticle Formulation Of 3489 Kuei Lee Multi-pathway Blockade In Addition To Mitomycin C, In Chemoradiotherapy Glucose Metabolism Gene Expression Radio-chemotherapy For Glioblastoma Patterns and Tumor Uptake of 18F-FDG 3511 Seong-Yun Jeong Following Radiation Treatment 3500 Nils Nicolay Ibulocydine Sensitizes Human Cancers Multi-pathway Inhibition As A Novel to Radiotherapy by Induction of 3490 Moiz Ahmad Strategy To Attenuate Mitochondria-Mediated Apoptosis X-ray Fluorescence CT As A Novel Radiation-induced Pulmonary Fibrosis Imaging Modality For Improved 3512 Seong-Yun Jeong Radiation Therapy Target Delineation 3501 Uma Raju The Combination Of Hyperthermia, Inhibition of IGF-1R Signaling Enhances Radiation And Chemotherapy For 3491 Dominik Naczynski the Head and Neck Tumor Tumor Suppression Using Hollow Gold Development Of X-ray Luminescent Radioresponse But Fails to Further Nanoparticles Infrared Probes For Tumor Imaging Improve Tumor Response to Cetuximab and Radiation Therapy In Vivo 3513 Masao Nakayama 3492 Shunsuke Furutani Dose Estimation Of Normal Brain Tissue MEK Inhibition by Selumetinib 3502 Ping Li Tolerance For Microbeam Radiation Enhances the Antitumor and Photothermal Eff ect By Rgd-conjugated Therapy Anti-Metastatic Eff ects of Gold Nanorods Enhances The Effi cacy Chemoradiation Therapy in Orthotopic Of Radiotherapy In Melanoma Cancer 3514 Manuela Felix Human Lung Cancer Models Cells Converting A Standard Micro-CT Into An IGRT-competent Small Animal 3493 Shin-ichiro Masunaga 3503 Szu-Yuan Wu Irradiation Device Signifi cance of Administering Combination Of Metformin And Statins Bevacizumab Combined with Boron Signifi cantly Enhanced The Local 3515 Yunguang Sun Neutron Capture Therapy in terms of Radio-therapeutic Eff ect And Igfbp3 Promotes Cell Death and Local Tumor Control and Lung Attenuated The Lung Metastasis Of Sensitizes Cisplatin and Radiation Metastatic Potential Lewis Lung Carcinoma (LLC) Animal Treatments in Lung Cancer Cell Models Model 3494 Noriyuki Okonogi 3516 Yunguang Sun Therapeutic Impact Of 3504 Yuji Seo Nit1 Is a Novel Therapeutic Target Intravenous-injection Of Microglia On Systematic Linear-Quadratic Analysis for for the Sensitization of Chemo- and Radiotherapy For Malignant Glioma Radiosensitization in vitro: Implications Radiotherapy in Kras Mutant Lung Arising In S100beta-v-erbB Transgenic for Hypofractionated Radiotherapy in Cancer Models Rat the Combined Modality Approaches 3517 Ana Kiess 3495 Satoshi Harada 3505 Edina Wang Targeted Molecular Auger Radiotherapy Tumor Imaging, Antitumor Action, and Nanoparticle Formulations of HDAC for Micrometastatic Prostate Cancer Inhibition of Metastasis Using Targeted Inhibitors as Radiosensitizers Anti-CD47 siRna Nanoparticles and 3518 Tao Wang Radiotherapy 3506 Dong Wook Nathan Kim Disruption Of Erk1/2 Sensitizes Validated Tumor Graft Model Reveals Radiation Resistance Prostate Cancer 3496 Chi Zhang Delayed Local Recurrence of Renal Cell Cells To Paclitaxel And Ionizing Genotype-dependent Tumor Inhibitory Tumors after High Dose Single Fraction Radiation Eff ects of Metformin in Glioblastoma Ablative Radiation Therapy Cells 3519 Peter Liu 3507 Darrion Mitchell A Zebrafi sh Drug Screen Repositions 3497 Zhenhuan Zhang Epithelial-to-Mesenchymal Transition as FDA-Approved Compounds for PTIP Down-regulation Enhances a Therapeutic Target in Prostate Cancer Radiochemotherapy Radiation-induced Tumor Cell Suppression In Vitro and on CAM 3508 Ligang Xing Improve The Eff ect Of Radiotherapy For Recurrent Esophageal Squamous Cell Carcinoma With Sodium Glycididazole
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
170 ASTRO 2014 / 56TH ANNUAL MEETING 3520 Thomas Quinn 3531 Kate Barrett 3541 Jonathan Thompson Immunophenotype of B16-F10 Genetic Polymorphisms Associated Toll-like Receptor-9 Expression Does Melanoma After Combination Therapy with Toxicity are Associated with Not Predict for Breast Cancer Specifi c With Radiation and Systemic, Overall Survival Following Curative Outcome in African-American RGD-targeted, Adeno-associated Virus Radiation for Non-Small Cell Lung Triple-Negative Breast Cancer Patients Phage-TNF Cancer 3542 Jessica Wobb 3521 Tithi Biswas 3532 Jinyi Lang The Signifi cance of 18FDG PET and Combining Pemetrexed with Early Changes In Adc Involved In Related Glucose Metabolism Biomarkers Methoxyamine to Enhance the Mmp-9 Expression Predict The in HPV Positive and Negative Head and Radiosensitization of Non-Small-Cell Response Of Tumor To Irradiation On Neck Squamous Cell Carcinomas Lung Cancer (NSCLC): Preclinical Studies Mice Bearing U14 Cervical Cancer in vivo 3544 Richard Tuli 3533 Maria Teresa Bortolin Correlation of Methylation Patterns 3522 Ralph Vatner Multiplexed Plasma Cytokine and Gene Expression with Radiation Macrophage-Targeting Agents to Chemokine and Growth Factor Profi ling Response of SMAD4-Characterized Stimulate Anti-Tumor Immunity Elicited in Early-Stage Non-Small Cell Lung Pancreatic Cancer Xenografts by Radiotherapy Cancer Patients Undergoing Stereotactic Body Radiotherapy 3545 John Grecula 3523 Arta Monjazeb Dynamic-Contrast Enhanced MR and Radiation Enhances Innate Immune 3534 Leslie Modlin Volume Regression rate as a Recognition Of Cancer Stem Cells In Circulating Tumor DNA Concentrations preoperative predictive assay in Solid Tumors Refl ect Metabolic Tumor Volume in patients with Non Small Cell Lung NSCLC Cancer 3524 Tu Dan The Eff ect Of Nutrigenomics In 3535 Reza Masoud Rahbari 3546 Evan Osmundson Augmenting Radiation Therapy For Enhanced Rad21 Cohesin Expression Circulating Tumor DNA as a Biomarker Breast Cancer Confers Poor Prognosis And Resistance for Pancreatic Adenocarcinoma To Chemotherapy In High Grade 3525 Jia Yang Luminal, Basal And Her2 Breast Cancers Eff ect Of Celecoxib On Inhibiting Tumor RADIATION PHYSICS Repopulation During Radiotherapy In 3536 Ana Ruiz-Alonso Human Fadu Squamous Cell Carcinoma Prognostic Biomarkers in Tongue 3566 Justin Linam Squamous Cell Carcinoma No Need to Wait: Fiducial Migration in 3526 Michael Epperly Immediate Versus Delayed Simulation Disparate Gene Transcript Patterns 3537 Ting Xu for Prostate IGRT Between Radiosensitive Bone Marrow Nanopore-peptidomics To Predict Stromal and Radioresistant Response To Chemoradiotherapy For 3567 Nzhde Agazaryan Hematopoietic Cell Lines From Fanconi Lung Cancer Dosimetric Impact Of Positioning Errors Anemia (FA) (Fancd2-/-) C57BL/6 Mice For Spinal Radiosurgery Patients: A 3538 Yipeng Song Planning Tool Proposition 3527 Meetha Medhora Association of Radiation Pneumonitis Mitigation Of Radiation-Induced Injuries Related Single Nucleotide 3568 Elisabeth Weiss To Multiple Organs In Rats By Polymorphisms and Changes in Is there a Need for Reassessment of Fda-approved Drugs And Supportive Pulmonary Function in Patients with Internal Target Volumes (ITV) During Care Non-small Cell Lung Cancer after Radiotherapy for Locally Advanced Defi nitive Concurrent Chemoradiation Lung Cancers? 3528 Michael Epperly Organ Specifi c Levels of MnSOD in 3539 Anwen Liu 3569 Mitsuhiro Nakamura Tet-Inducible Manganese Superoxide Serum CRP Is Predictive Of Survival In Improving The Target Estimation Dismutase Mice Non-small-cell Lung Cancer Patients Accuracy In Infrared Marker-based Treated With Defi nitive Dynamic Tumor Tracking With a 3529 Thomas Enke Chemoradiotherapy Gimbaled Linac Molecular Radiotherapy In Experimental Model of Advanced 3540 Steve Walston 3570 Judit Boda-Heggemann Prostate Cancer Using Internalizable Papillomavirus E2 Protein As A Breath-Hold Cone Beam Ct (CBCT): Monoclonal Antibody Biomarker For Radiation Sensitivity In Improved Image Quality With HPV Associated Head And Neck “Stop-and-go” Breathhold-only 3530 Michael Epperly Squamous Cell Carcinoma Acquisition Versus Repetitive Reduced Radiation Pulmonary Fibrosis Breathhold During Continuous Rotation in Toll-Like Receptor-4 (TLR4) Deletion Recombinant Negative Mice 3571 Mami Akimoto 3583 Allen Li 3594 Yoshihiro Ueda Baseline Correction of a Correlation A Comparison of Six IGRT Modalities Setup Evaluation of Two Model In Infrared Marker-Based Used for Soft-Tissue Sarcoma of the Immobilization Systems For Stereotactic Dynamic Tumor Tracking With a Extremity in RTOG 0630 Body Radiotherapy Gimbaled Linac 3584 Madeera Kathpal 3595 Bernard Jones 3572 Laura Padilla Margins for Deep Inspiration Breath Adaptive Motion Mapping in Pancreatic Patient-Specifi c Collision Detection Hold (DIBH) With Electromagentic SBRT Patients using Fourier Transforms Package Using Surface Imaging Surface Transponder Confi rmation of Chest Wall Position for Adjuvant 3596 George Noid 3573 Youngjun Kim Therapy of Left Breast Cancer Feasibility of Using Ultrasound to Is Surface Registration Accurate Enough Monitor Intrafraction Motion During For Patient Setup In Head-and-neck 3585 Kathryn Mittauer Radiation Therapy for Pancreatic Cancer Radiation Therapy? Variation of Controlled Breath Hold from CT Simulation to Treatment and its 3597 Hao Zhang 3574 Shingo Oohira Dosimetric Impact for Left-sided Breast The Accuracy Of Intra-fraction Tumor Couch-height Based Patient Set-up For Radiotherapy with a Real-time Optical Motion Modeling With Respiratory Abdominal Radiation Therapy Tracking System Surrogates Using Supervised Learning
3575 Pengpeng Zhang 3586 Olivier Gayou 3598 Guanzhong Gong Setting Action Levels For Abdominal Imaging A Moving Tumor With To Study the Feasibility and Potential Stereotactic Body Radiation Therapy Megavoltage CBCT Benefi t of Defi ning the Internal Gross Monitored With Frequent KV Imaging Tumor Volume (ITV) for Surveillance 3587 Niranjan Bhandare Hepatocellular Carcinoma (HCC) Comparing DVH Parameters of 3D Applying the Contrast-enhanced 4D-CT 3576 Winky Wing Ki Fung Inverse Planning Simulated Annealing Obtained by Deformable Registration Eff ect of Residual Non-Rigid Errors on (IPSA) with Manual-graphical Technology Actual Delivered Dose in Prone Breast Optimization in the Treatment of Tomotherapy Uterine Cervix with HDR Brachytherapy 3599 Benjamin White using a Tandem-and-ring Applicator Motion Assessment of the Left Anterior 3577 Manuel Blessing Descending Aorta during Clinical 4DCT Image Guided Radiotherapy Using 3588 Jean Peng Ultrafast Kv-mv Cbct: End-to-end Test Assessment Of Setup Variability For 3600 Alon Witztum Results Of The Finalized Prostate Patients With Rectal Balloon Dosimetric Eff ect Of Setup Errors On Implementation By 3D CBCT And Real-time Surface Multiple Isocenter Volumetric Imaging Modulated Arc Radiotherapy For 3578 Anna Arns Craniospinal Axis Matching Accuracy of Ultrafast 3589 Etienne Letourneau Kilovoltage-Megavoltage (kV-MV) Organ Dose Reduction While Using 3601 Bo Zhao Cone-Beam CT for Image Guided In-house CBCT Patient-specifi c Comparison Of Deep Inspiration Breath Radiotherapy Protocols Based on OSL Dosimetry Hold Left Breast Tangents With Active Breath Hold And Voluntary Breath Hold 3579 John Park 3590 Martin Hojgaard Using 3d Surface Image Guidance Clinical Analysis of Patient Setup on Deep Inspiration Breath-hold Radiation Image-Guided Frameless Stereotactic Therapy Reduces Heart Radiation Dose 3602 Paul Keall Radiosurgery for Acoustic Neuromas In Gastric Radiotherapy Clinical Process and Quality Assurance Practices for the Clinical 3580 Karen Mooney 3591 You Zhang Implementation of Kilovoltage Determining The Internal Margin (IM) Lung 4D-CBCT Reconstruction using Intrafraction Monitoring (KIM) for For Lung And gastrointestinal Tumors Prior Information and Limited-angle Real-Time Image-Guided Prostate Based On Real-time Measurements Projections - Phantom and Patient Cancer VMAT Studies 3581 William Plishker 3603 Dengwang Li Retrospective Assessment of Image 3592 Casey Abing Multi-resolution Liver Segmentation For Mask Box Sizing for Automatic Patient Intra-Fraction Position Management CT By Hybrid Method Positioning Post-Cone Beam CT Using Stereoscopic X-ray Verifi cation for Stereotactic Body 3604 Clare Suttie 3582 Mirza Ali Radiotherapy Lung Treatment Surgical Clips in Breast Tumor Cavity Study of Inter Fraction Movements Photon Boosts: Impact on CTV Size, and of Tongue During Radiation Therapy 3593 Hui Cheng Utility in Image Verifi cation Using in Cases of Tongue Malignancy using Utrecht Intertitial Applicator Shifts And Non-orthogonal KV Imaging Volumetric KV Cone Beam CT (CBCT) Organ Movements In 3d Ct-based Hdr Imaging Brachytherapy Of Cervical Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
172 ASTRO 2014 / 56TH ANNUAL MEETING 3605 George Chiu 3617 Martina Hurwitz 3628 Jeho Jeong Acute Skin Reaction of Whole Breast Investigation of a Respiratory Motion Investigation of Temporally Varying Irradiation in Supine and Prone Position Model Based on an External Surrogate Fractionation in Radiation Therapy Using Tomotherapy Signal With a Digital Phantom and Using a Resource-Conservation Tumor Realistic Patient Breathing Response Model 3606 Ti-Hao Wang Margin Assessment and Optimization 3618 Shane Stecklein 3629 Ruben Carmona in Prostate Irradiation by Quantitative Dosimetric Eff ects of Respiratory Longitudinal Study Of Fat Analysis of Daily Mega-Voltage Motion and Interfraction Setup Composition Changes In Bone Marrow Computed Tomography Variation on Internal Mammary Node During Chemotherapy And Irradiation Radiotherapy For Pelvic Malignancies 3607 Jessica Scholey Development Of Image Registration 3619 William Watkins 3630 Caspar Van Leeuwen For Novel Megavoltage Topogram For Automated Evaluation of Deformable Meta-Analysis Of Tumor Fractionation Patient Localization In Tomotherapy Image Registration using Physical Tissue Sensitivities Based On Clinical Data Characteristics 3608 John Van Sornsen 3631 Piotr Pater de Koste 3620 Shidong Li Estimation of DNA Damage Yields Due Markerless Tracking Of Lung Tumors On Live Video Imaging Guided to Low Energy Electrons Continuous Kv Images Radiotherapy of Breast Cancer 3632 Norma Ybarra 3609 Susannah Hickling 3621 Yong Yang Impact Of Mesenchymal Stem Cells Feasibility Of X-ray Acoustic Computed Optimization of Dosimetric Margins Delivery Routes On Recovery From Tomography As A Tool For Non-Invasive for CBCT-Guided Prostate Volumetric Radiation-induced Lung Injury Using Ct Volumetric In Vivo Dosimetry Modulated Arc Therapy (VMAT) Densitometry: Preclinical Investigation
3610 Joshua James 3622 Caroline Chung 3633 Scott Merrick Quantifi cation of PTV Margin When Clinical Evaluation of a Novel Creation of a More Comprehensive Using a Robotic Radiosurgery System to Thermoplastic Mask System with Target Volume for Esophageal Cancers Treat Lung Tumors With Spine Tracking Intrafraction Motion Monitoring using by Combining Respiratory Gated IR Tracking and Cone-beam CT for Simulation and Daily Image-Guided 3611 Rojano Kashani Dedicated Cobalt Radiosurgery Unit Radiation Therapy (IGRT) Feasibility of Gating Using a Magnetic-Resonance Image-Guided 3623 Miranda Risberg 3634 Daniel Cho Radiation Therapy (MR-IGRT) System A Prospective Trial Of Kv Stereoscopic Predicting Radiotherapy Outcome for X-rays With Fiducials Versus Ultrasound Head and Neck Cancer Patients using 3612 Mikael Antoine For Daily Image Guidance In Prostate Artifi cial Neural Network (ANN) Geometrical Analysis Of Organs Motion Cancer For Preoperative Helical Tomotherapy 3635 Feng Mei Of Retroperitoneal Liposarcomas 3624 Arta Monjazeb Ct Number Changes Observed During Analysis of Daily Setup Variation with Ct-guided Radiotherapy For Head And 3613 Per Poulsen Image-Guided Treatment of Soft-Tissue Neck Cancer, A New Indicator For Performance Improvement of MLC Sarcomas Treatment Response Tracking Investigated with an Experimentally Validated Tracking 3625 Angelo Bergamo 3636 Ke Sheng Simulator Hypofractionated Liver Stereotactic Detecting Prostate Focal Lesions In Ct Body Radiation Therapy: Biological Images 3614 Jonathan Lischalk Eff ective Dose Correlated Radiation Correlation Of Fiducial Motion In 4D-CT Induced Liver Disease 3637 Phillip Prior Planning Scans With Real-time Fiducial Normal Tissue Complication Tracking During Fractionated SBRT Of 3626 Florian Kamp Probability Modeling For Chest Wall Upper Gastrointestinal Malignancies Predicting the Relative Biological Pain In Stereotactic Body Radiaton Eff ectiveness of Carbon Ion Therapy: An Analysis Of Compiled 3615 Louise Fanchon Radiotherapy Beams using the Clinical Data Spatially Accurate Ground Truth For Pet Mechanistic Repair-Misrepair-Fixation Segmentation Verifi cation From Biopsy (RMF) Model and Nuclear Fragment 3638 Maria Thor Specimens Extracted Under PET/CT Spectra Identifying Groups Of Patient-reported Guidance Gastro-intestinal Symptoms Using 3627 Daniel Simpson Factor Analysis 3616 Wu Liu A Novel Multi-institutional Database for Optimized Prostate Intrafraction Motion Tracking and Reporting Dose-Volume Management IGRT Strategy for 3mm Data and Normal Tissue Eff ects Margin Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 173 3639 John Kang 3650 Eelco Lens 3660 Leonard Kim A Free Multi-model Program For Dosimetric Benefi ts Of Using A Fast, High-Resolution, 3-D Imaging of Comparing Linear-quadratic And Mid-ventilation Or Breath-hold Tissue Blocks Using Optical Coherence Non-linear Quadratic Models In TCP Approach As An Alternative To Internal Tomography: Visualizing Microscopic Prediction Of SABR-treated NSCLC Target Volume For Pancreatic Cancer Disease for Clinical Target Volume Patients Design 3640 Victoria Yu A Dual Compartment Linear-Quadratic 3651 Kristofer Kainz 3661 Roxana Draghici Model of Cell Survival Validation Of A Technique To Derive A Volumetric Modulated Arc Therapy For Virtual Phase-specifi c PET Contour From Bilateral Breast Carcinoma: Dosimetric 3641 Tiziana Rancati Free-Breathing PET Analysis and Immediate Tolerance An In-Silico Experiment Model to Iden- tify the Best Predictors of Radioinduced 3652 Michael Altman 3662 Danita Kannarunimi Late Toxicity Addressing The Issues Limiting Rapid Dose Analysis of MRI-Based Planning Contour Evaluation To Facilitate Effi cient Techniques Using Volumetric 3642 Wilfred Ngwa On-line Adaptive Radiation Therapy Modulated Arc Therapy in Brain Tumors Radiotherapy Biomaterials For Response (OL-ART) With MR-IGRT Assessment And Nodal Detection 3663 Guillem Pratx (brand) 3653 Di Yan First Demonstration of Medical Evaluation of Image Guidance & Radiation Treatment Beam Monitoring 3643 Louise Murray Adaptive Radiotherapy Techniques for via Air Scintillation Imaging Risk Of Second Malignancy Following H&N Cancer Prostate Radiotherapy Using 3664 Yuri Jeong Contemporary Radiotherapy 3654 Kyoung Jun Yoon A Dosimetric Comparison of Volumetric Techniques Evaluation Of CBCT based Dose Modulated Arc Therapy (VMAT) and Calculation in an Enhanced CBCT Non-coplanar Intensity Modulated 3644 Jagdeep Raince System Radiotherapy (IMRT) for Nasal Cavity Integrated Deformable Registration and Paranasal Sinus Cancer and Biologic Modeling to Compare 3655 Raj Varadhan Dose Distributions of High Dose IMRT Applicability and Limits of Dose 3665 Ludovic Bedos and Combination IMRT-Brachytherapy Warping: Are There Islands of CT Number Accuracy Assessment Of A (combo-RT) in Localized Prostate Deformation that Fail to Depict Dose New Metal Artifact Reduction Cancer Painting? Algorithm For CT Simulations In Radiation Therapy 3645 Omar Ishaq 3656 Lotte Fog Dosimetric Comparison between Split Towards A Criterion For Selective 3666 Suhong Yu Ring and Tandem & Ovoid HDR Adaptive Radiotherapy In Head And Application Of Cone Beam CT For Brachytherapy Applicators in Cervical Neck Cancer Patients Adaptive IMRT Treatment Planning Cancer Treatment 3657 Aaron Judith 3667 Peter Balter 3646 Rebecca Howell Impact Of Breathing Motion On Imrt A Framework for Dose Based IGRT: Toward Developing Survivorship Care (intensity Modulated Radiation Therapy) Validation of Dose Cloud Shift Plans For Breast Cancer Patients at High Of The Chest Wall In Post-mastectomy Assumption Risk for Radiation-related Cardiac Eff ects Breast Cancer Patients: A Dosimetric Comparison With 3d 3668 Masakuni Kawakami 3647 Eric Paulson Conformal Radiotherapy Development of Error Estimating Rapid Evaluation of Radiotherapy Program for IMRT Dose Delivery using Response using Multi-Parametric Image 3658 Kwun-Ye Chu Dynamic MLC Log Files Treemaps Impact of Weight Change on Dose Delivery In Pancreatic Intensity- 3669 Kenji Matsumoto 3648 Seha Hwang Modulated Radiotherapy Statistical Process Control For Epid Study On The Sensitivity Of Dosimetry In The Quality Assurance Gamma-index Evaluation Methods To 3659 Jesus Olivera Of IMRT Positioning Errors Of High-defi nition Localized Prostate Cancer: Volumetric MLC Of True Beam STx In VMAT Quality Modulated Arc Therapy (VMAT) Versus 3670 Lisa Tachiki Assurance For SBRT Intensity Modulate Radiation Therapy Deformable Contour Propagation of (IMRT): Which one is better? Organs-At-Risk in Adaptive Head and 3649 Yujiro Fujita Neck Radiation Therapy Potential Uncertainty as to 3D Image Registration in Thoracic Image-Guided Radiotherapy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
174 ASTRO 2014 / 56TH ANNUAL MEETING 3671 Shiv Srivastava 3682 Shirish Jani 3692 Rob Tijssen The Eff ect of Slice Thickness on Target On Clinical Utility of Orthopedic Metal A Combined Breath Hold and Free and Organs at Risk Volumes, Dosimetric Artifact Reduction (OMAR) Software in Breathing Protocol is not Feasible for Coverage and Radiobiological Impact In CT Simulation and Treatment Planning Locoregional Radiation Therapy of IMRT Planning Left-sided Breast Cancer 3683 Suk Lee 3672 Ahmad Amoush Development of 3D Dose Evaluation 3693 David Thomson Potential Systematic Errors in IGRT Solution for Off -line Dose Guided Automatic Segmentation to Defi ne When Diff erent Reference Images are Adaptive Radiotherapy in Organs at Risk (OARs) for Function used for Pancreatic Tumors Multi-modality IMRT Techniques Sparing Head and Neck IMRT
3673 Fengxiang Li 3684 Kwang Hwan Cho 3694 Yong Hum Na Quantifying Internal Target Volume Dosimetric Evaluation Using MVCT VMAT Treatment Planning Using Cloud Uncertainties Derived From Images For Adapted Plan-dose Computing Three-Dimensional CT and Monitoring In Tomotherapy Four-Dimensional CT for Radiation 3695 Christian Fiandra Therapy of Non-Small-Cell Lung Cancer 3685 Pascal Fenoglietto Planning Dose Recalculation on Cone Metal Artifact Reduction (mar) Beam CT Images for Hypo-fractionated 3674 Fengxiang Li Algorithm For Head And Neck With SBRT in Prostate Cancer: Dose Tracking Evaluation of Movement of Peripheral Dental Prosthesis Comparison with and without the Non-small-cell Lung Cancer using use of Seed Markers for a daily online Four-dimensional CT 3686 Kenton Thompson Repositioning Process Feasibility of PTV and OAR Overlap as a 3675 Wenyang Liu Predictive Planning Tool 3696 Sophia Edwards- Four-dimensional CT-based Evaluation Bennett Of Intrafractional And Interfractional 3687 Suk Lee Utilization of a Novel Adaptive Dose Anastomosis Motion During Which Is An Optimizing Modality For Recalculation Tool in the Delivery of Postoperative Radiotherapy in Gastric Imrt Prostate Case In Linac Step And High Dose Radiation for Intermediate to Cancer: A Prospective Study Shoot, Tomotherapy, Rapidarc, Vamt, High-Risk Prostate Cancer And Proton Using New Plan Evaluation 3676 Nicholas Serrano Scoring Index And Dosimetric Physical 3697 Neil Kirby Correlation Of Three Imaging Modalities Index? The Potential for Patient-Specifi c, For Pre-treatment Alignment In Head Automated Evaluation of Deformable And Neck Imrt 3688 Young-nam Kang Image Registration Accuracy The Feasibility Study Of MRI-based 3677 Jorge Alpuche Aviles Dose Calculation With Look Up Table In 3698 Wensha Yang Commissioning Of A Prostate Model Radiation Treatment Planning Overlap Volume Analysis using 4DCT: Created Using Knowledge Based Implications for Gating in SBRT of the Planning As A Tool To Guide The 3689 Stefania Pallotta Lung and Pancreas Planning Process Treatment of Moving Lesions with Helical Intensity-Modulated 3699 Evan White 3678 Jun Lian Radiotherapy (HIMR): A Phantom Study Optimization Index: A Tool for Prostate Deformation from Rectal Quantitative Comparison of Radiation Balloon and Dosimetric Eff ects in 3690 Gulay Karagoz Treatment Plan Quality Prostate Brachytherapy Evaluation of MLC Leaf Position Accuracy for Static and Dynamic IMRT 3700 Antonio Damato 3679 Ben J.M. Heijmen treatments Using DAVID In Vivo Changes in Kidney Position and Dose Fully Automatic IMRT and VMAT Dosimetric System Due to Respiratory Motion in Treatment Planning in Routine Clinical Gynecologic Patients Receiving Practice 3691 Akira Sakumi Extended Field Intensity Modulated Impact Of A Low Transmission Multileaf Radiation Therapy 3680 Joel Castelli Collimator on The Parotid Grand Impact Of Weekly Re-Planning To Spare Dose In Head And Neck Volumetric 3701 Guangjun Li The Parotid Glands In Head And Neck Modulated Arc Therapy Planning - A Daily Delivery Accuracy Of Volumetric Cancer Radiotherapy Dose Volume Histogram Comparison Modulated Arc Therapy Treatments Between Two-step Adaptive And Using Linac Log Files 3681 Takeshi Kamomae Simultaneously Integrated Boost Dosimetric Infl uence of Dental Crowns Techniques on IMRT and VMAT for Head and Neck Cancer: Correlation Between Planned Radiation Doses and Measured Dose Enhancements
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 175 3702 Francisco Clemente 3714 Ziad Fawaz 3724 Vangipuram Shankar Gutierrez Intrafraction Cone Beam Computed Deformable Dose Accumulation on 4-D 3D Secondary Verifi cations for VMAT Tomography Imaging Evaluation CBCT static derived series In Oligofrac- Prostate Treatments Based in During Stereotactic Body Radiation tionated Lung SABR - Trigger Tool For DVH-metrics and 3D Gamma Analysis Therapy For Lung Tumors and Adaptive Replanning? Metastatic Tumors to the Spine 3703 Eric Paulson 3725 Chunhui Han Rapid Evaluation of Radiation Treatment 3715 Teh Lin Mobile Gross Target Volume Variations Plan Quality using Interactive Treemaps Comparative Assessment of Adaptive In Computed Tomography Images For Radiation Therapy on Partial Bladder SBRT Treatment Of Early-stage Non- 3704 Xiangrong Qi Cancer Treatment between CT-on-Rails small Cell Lung Cancer Patients Using Assessment of Volumetric and (CTOR) and KV Cone Beam CT (CBCT) Abdominal Compression Dosimetric Variations for Image Guided Stereotactic Body Radiation Therapy 3716 Dewayne Defoor 3726 Rodney Ellis Treatment On The Evaluation Of Patient Specifi c Comparative Analysis For Renal IMRT QA Using EPID, Dynalog Files and Stereotactic Body Radiotherapy (sbrt) 3705 Andre Vieira Patient Anatomy Using Robotic Radiosurgery (RR), Quality Assessment Of Vmat Plans For A Protons, And Linac Based Treatment Linac Unity Using The AAPM-tg119 Tests 3717 Weiguang Yao Planning Techniques Approach to Obtaining Optimal 3706 Marta Adamczyk Combination of MLC Transmission Ratio 3727 Simon Lo The Infl uence of Various VMAT and Dynamical Leaf Gap for IMRT/VMAT A Multi-National Report on Technical Optimization Strategies on Final Plan Dose Calculation in TPS Factors of Stereotactic Body Quality in the Treatment of Prostate Radiotherapy for Oligometastases Cancer 3718 Xiaojian Chen Interfractional Variation Of Cardiac Dose 3728 Lijun Ma 3707 Aaron Nelson During Whole Breast Irradiation Clinical Realization of Sector Beam Comparison Of Two Atlas-based Intensity Modulation for Gamma-Ray Segmentation Methods For Head And 3719 Kelly Erickson Based Radiosurgery Neck Cancer With Rtog-defi ned Lymph A Technique To Quantify And Reduce Node Levels Backscatter Due To Metallic Dental 3729 Anna Simeonova Restoration In Head And Neck Automatically Gated CBCT-controlled 3708 Xiangfei Chai Radiotherapy Fast Breath-hold SBRT Is Dosimetrically A Web-based Image Processing and Robust and Facilitates Precision Plan Evaluation Platform (WIPPEP) for 3720 Robert Reynolds Treatments For Patients With Lung Future Cloud-Based Radiotherapy Initial Experience with VMAT Plan and Cancer Delivery Verifi cation using a DICOM-RT 3709 Rachel Tuohy Framework and Linac Delivery Log Files 3730 Chuxiong Ding Strategies For Evaluation of Daily Multistage Stereotactic Radiosurgery Delivered Dose Using Cone Beam CT 3721 Chang Liu for Large Intracranial Arteriovenous (CBCT) Delivered Target And Organ Dose Malformations: Focused Cobalt-60 Estimation Using Deformable Image Radiosurgery Versus Robotic 3710 Jason Li Registration On Cone-beam Computed Radiosurgery Dose Delivery Accuracy of VMAT with Tomography (cbct) Scans For Head And Frequent Interruptions Neck Radiotherapy 3731 Kohei Okawa Comparison Of 3-d And 4-d Plans In 3711 Silvia Chiesa 3722 Joong Yeol Woo The Radiotherapy For Lung Cancer The Dosimetric Consequences Of A Evaluation Of Fast Adaptive Planning Using Real Time Tumor Tracking System Rotational Positioning Correction In Method Using Deformable Image IGRT Prostate Volumetric Modulated Registration And Gpu Based Rtp For 3732 Jan-Erik Palmgren Arc Therapy (VMAT) Treatment Using A Lung Cancer Patients With Concurrent Robotic Stereotactic Radiotherapy 6 DOF Robotic Couch Chemoradiotherapy. Compared To 3d Mr Image Guided Hdr Brachytherapy In The Treatment Of 3712 Qiong Xu 3723 Ralph Vatner Cervical Cancer On-board CBCT Imaging Using 2.5 MV Salvage Radiotherapy (RT) for Beam On A Radiotherapy Linac For Recurrence in the Brain After Surgical 3733 Joerg Rottmann Metal Artifact Reduction Resection and Involved Field Radiation Verifi cation Real-Time Image Therapy (IFRT) for Single Brain Metasta- Acquisition System (VERITAS) 3713 James Robar ses: VMAT Versus Matched Lateral Fields Compensation for Imaging Dose in Low-Z Target Volume-of-Interest CBCT
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
176 ASTRO 2014 / 56TH ANNUAL MEETING 3734 Yutaka Naoi 3745 Murshed Hossain 3756 Joanne Zhung Accuracy of Hypofractionated Respiratory Motion-Encompassing Evaluation Of Interfraction Changes In Intracranial Stereotactic Radiotherapy Planning Target Volume (ME-PTV) for Tumor Volume To Predict Long Term under Cone-beam Computed Stereotactic Body Radiation Therapy Outcomes Of Sbrt In Early Stage Nsclc Tomography Image Guidance with a (SBRT) of Lung Cancer Six Degrees of Freedom Robotic Couch 3757 Benedicte Henriques and Mask System 3746 Ravindra Yaparpalvi Use Of FDG-PET To Guide Dose Characterization of Target Dosimetry in Prescription Heterogeneity In 3735 Jessica Molinier Lung SBRT Stereotactic Body Radiation Therapy For Is Tracking Better Than Free Breathing Lung Cancers With Volumetric For Lung Stereotactic Treatments? A 3747 Rabia Nergiz Dagoglu Modulated Arc Therapy: A Study Of Dosimetric Comparison Stereotactic Body Radiotherapy (SBRT) Feasibility for Pelvic Recurrence from Colorectal 3736 WITHDRAWN Cancer 3758 Cinzia Talamonti Novel Epitaxial Silicon Array for Quality 3737 Thierry Gevaert 3748 Dariusz Michalski Assurance in Radiotherapy Investigation Of The Optimal Dynamic System Theory for Lung Prescription Isodose For Stereotactic Cancer Patient Breathing 3759 John Lucas Radiosurgery Of Vestibular Safety Assessment, Artifact Reduction Schwannomas 3749 Marcus Sonier and Description of Geometric Evaluation Of Immobilization On Target Distortion Associated with 3738 Femke Steenbeke Localization For Image-guided Kidney/ Diff usion Imaging (DWI) with Rigid Targeting Accuracy Of A Stereotactic Adrenal SBRT Head Frame Immobilization for Frameless Radiosurgery Technique For Stereotactic Radiosurgery Arteriovenous Malformation 3750 Jin-Song Ye Does MLC with Finer Leaf Width 3760 Guang Li 3739 Alexander Louie Improve the Treatment Plan Quality in Clinical Experience With Two Cranial Dosimetry, Image Guidance And Stereotactic Body Radiation Therapy of Frameless Stereotactic Radiosurgery Clinical Outcome Of Sub-centimeter Lung Cancers (fSRS) Systems Lung Tumors After Stereotactic Ablative Radiotherapy 3751 Jianzhou Wu 3761 Markus Oechsner Duty Cycle Selection of Gating in Lung Respiratory-Gated Lung Stereotactic 3740 Bevan Ly SBRT with Flatting-Filter-Free Beams Body Radiotherapy: a Planning Study of A Comparative Study of Robotic and 3D-CRT vs VMAT Linac-based Stereotactic Body 3752 Thomas Zilli Radiation Therapy for Metastatic Urethra-sparing Stereotactic Body 3762 Rafael Pineiro Retif Thoracic Spinal Tumors Radiotherapy For Localized Prostate Local Control Evaluation In Bone Cancer: Dosimetric Results From A Metastases Treated With Stereotactic 3741 Alireza Fotouhi Ghiam Prospective Multicenter Randomized Body Radiation Therapy: Initial Dosimetric Impact of Combined Phase II Trial Experience Rotational and Translational Setup Errors on Spinal Cord Dose in Patients 3753 Huan-Huan Wang 3763 Christopher Estes Treated With Spine Stereotactic Feasibility And Effi cacy of Stereotactic Comparative Analysis of Monte Carlo Body Radiotherapy (SBRT) For Spinal Body Radiation Therapy Using Robotic and Pencil Beam Algorithm-Derived Metastasis Radiosurgery as Curative Treatment for Dose Distributions for Tumors and Metastatic Thyroid Carcinoma Normal Tissue in Lung Stereotactic 3742 Winnie Li Ablative Radiotherapy Impact of Immobilization on 3754 Zsolt Gabos Intra-Fraction Motion for Dedicated A Planning Comparison of 3D 3764 Phuong-Di Dang Cobalt Radiosurgery Unit Using Conformal Multiple Static Field, Intra-fraction Setup Verifi cation During Cone-Beam Computed Tomography Conformal Arc and Volumetric Stereotactic Body Radiotherapy for Modulated Arc Therapy for the Delivery Localized Prostate Cancer Using Rectal 3743 Randi Cohen of Stereotactic Body Radiotherapy for Balloons Pre-Treatment SBRT Imaging Correlates Lung Cancer Equally Well with Multi-Phase 4DCT and 3765 Rajesh Rajan Averaging of 4DCT Simulation 3755 Hyun Kim Dosimetric Impact Of Intrafraction Dosimetric Comparison of Gamma Motion In Spine SABR 3744 Ruggero Ruggieri Knife and VMAT Radiosurgery for Comparison Of Computed 88% TCP Vestibular Schwannoma Dose For SBRT Of NSCLC From Diff erent Models
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 177 3766 Tonghe Wang 3777 Tomi Ogunleye 3788 Umar Masood Motion Eff ects on Organ Dose in Comparison of Linear Accelerator (linac) Development of a Novel Compact Respiratory Gated Stereotactic Body and Cobalt-60 Based SRS Dosimetric Particle Therapy Facility with Laser Radiation Therapy Indices in the Radiosurgical Treatment driven Ion Beams via Gantry Systems Of Cerebral AVM Patients based on Pulsed Magnets 3767 Steven Babic Cone-Beam CT (CBCT) Based Evaluation 3778 Misbah Gulam 3789 Paul Romesser of a Non-Invasive Stereotactic Head Single Isocenter Lung SBRT for Multiple Proton Beam Radiation Therapy (PBRT) Frame Equipped With a Vacuum PTV Lesions Results in Signifi cantly Reduced Acute Fixation Bite-Block for Radiosurgery Toxicity Rates Compared with 3779 Enid Choi Intensity-Modulated Radiation Therapy 3768 Johan Cuijpers Application of a Survival-Predicting (IMRT) When Treating the Ipsilateral A Predictive Model for Radiosurgery Nomogram Based Primarily on Whole Neck for Head and Neck Cancer Plan Quality and VMAT Planning Brain Radiotherapy-Treated Patients Objectives for Multiple-Brain with Brain Metastases Yields Signifi cant 3790 Yuichi Akino Metastases Underestimates for Radiosurgery- Respiratory Motion Management of Treated Patients Liver Cancer in Uniform Scanning 3769 Pauline Rochefort Proton Beam Therapy Local Control And Role of Fractionation 3780 Houda Bahig in Stereotactic Body Radiation Therapy Quantitative MRI Changes Post- 3791 Jorrit Visser For Adrenal Gland Metastasis Stereotactic Ablative Radiotherapy Of Robust Proton Versus Photon Dose The Spine Escalated Chemoradiation as Primary 3770 Qinghui Zhang Treatment for Oesophageal Cancer Dosimetric Eff ect of Prescription 3781 Tejas Telivala Isodose Line Selection on Normal Linac with Flattening Filter Free (FFF) 3792 Dongxu Wang Tissues in SRS and SRT Treatment mode based Virtual HDR treatment for The Impact of Body Weight Change Planning localized Prostate Cancer: A Dosimetric on the Dose Distribution of Intensity- Feasibility Study modulated Proton Therapy for Cervical 3771 Joel Broomfi eld Cancer Stereotactic Ablative Radiotherapy for 3782 Fiori Alite Gynaecological Malignancies in the Impact of Monte Carlo Treatment 3793 Witold Matysiak Oligometastatic Setting Planning on Local Control in Lung SBRT Evaluation of the RangeShifter model in a commercial Proton Therapy Planning 3772 Ricardo Wang 3783 Bo Zhao System Comparison of Whole Brain Integral Lowering Dose Prescription from the Dose between Whole Brain 85% to 60% Isodose Lines may Reduce 3794 Terence Sio Radiotherapy and Stereotactic Radiation Necrosis in Intracranial A Dosimetric Planning Feasibility Study Radiosurgery of Multiple Brain Tumors after Linac-based Radiosurgery for Spot-scanned Stereotactic Body Metastases Proton Therapy (SBPT) for Unresectable 3784 Yi Rong Pancreatic Tumors 3773 Bin Han Evaluation of Fiducial Migration in Development of a High-Resolution and Stereotactic Body Radiotherapy for 3795 Erik Tryggestad High-Effi ciency Dosimetry Strategy for Lung Patients Aggregated Plan Robustness Analyses Robotic Radiosurgery QA for Spot-Scanned Pancreatic 3785 Andreea Pennington Stereotactic Body Proton Therapy 3774 Gozde Yazici Stereotactic Body Radiotherapy (SBRT) The Dosimetric Impact of Implants on using Robotic Radiosurgery for Lung 3796 Jedediah Johnson the Spinal Cord Dose in Stereotactic Cancer - Comparison of Treatment Plans Modeling the Dosimetric Eff ects of Body Radiotherapy using Ray Tracing (RT) and Monte Carlo Repainting in Respiratory-gated Spot (MC) Algorithm Scanning Proton Treatment Plans 3775 Allan Chen Six-Dimensional Setup Variations and 3786 John Cuaron 3797 Bruce Faddegon Intra-Fraction Corrections in Coverage Of Posterior Supraclavicular A Sub-millimeter Experimental Image-Guided Frameless Stereotactic Fossa With Post-mastectomy Proton Benchmark Of A 67.5 Mev Proton Depth Radiosurgery for Trigeminal Neuralgia Therapy For Breast Cancer: A Dosimetric Dose Curve In Water Comparison Study And Implications For 3776 Zhong Su Target Defi nition 3798 Tony Wong SBRT/SRS Experience Using a Vero Linac Evaluation Of Treatment Plan for Oligometastases 3787 John Cuaron Robustness With Adaptive Re-planning Dosimetric Comparison Of Skin Surface For Recurrent Lung Cancer Patients Dose In Patients Undergoing Proton Treated With Protons And Photon Radiation Therapy For Breast Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
178 ASTRO 2014 / 56TH ANNUAL MEETING 3799 Shinichi Shimizu 3811 Kwanghyun Jo 3823 Ileana Iftimia Realization of the Cone-beam CT by A Reusable Proton Range Compensator Sensitivity Analysis of Rotation Eff ects Fpds that Mounted on the Spot- And Verifi cation Of Its Functionality with the Miami Multi-channel HDR scanning Dedicated Proton Beam Treatment Technique Gantry 3812 Bryan Ager Hounsfi eld Unit Correction for Dental 3824 David Craft 3800 Sreekrishna Murty Implant Materials in Intensity 3D Planning With Low Segment Goddu Modulated Proton Therapy of Head Multi-criteria IMRT Software Novel Method for Range Validation of and Neck Cancer: A Quality Assurance Proton Beams in Biological Tissues Benchmark Study 3825 Ergun Ahunbay Applicability Of An Aperture-morphing 3801 Aiping Ding 3813 Heng Li Based Replanning Algorithm For An EPID-based Dosimetric Verifi cation Minimizing Dose Uncertainty For Spot Flattening-fi lter-free Beams Tool for Electron Beam Therapy Scanning Proton Therapy Of Moving Tumors By Optimization Of The Spot 3826 Jong In Park 3802 Vania Batista Delivery Sequence Optimal Design and Evaluation of Planning Strategies And Inter- And Electron Beam Energy Degrader for Intra-fractional Motion Robustness 3814 Bin Cai Breast Boost Irradiation For Pancreatic Patients Treated With Eliminate the Scattering Component Scanned Carbon Ion Therapy in Smearing Margin with Modern 3827 Huiting (Christine) Feng Treatment Planning System in Proton Simultaneously Integrated Boost (SIB) 3803 Jaeman Son Therapy Improves Sparing of Normal Tissues in Development Of Proton Dosimetry Locally Advanced Cervical Cancer While System Using Fiber-optic Array 3815 Aman Anand Reducing Overall Treatment Time Including Real-time Analysis Software Spot Scanned Proton Treatment Could Tool Potentially Reduce Hemotoxicity In 3828 Dae Yup Han Patients Being Treated With Radiation Direction Modulated Brachytherapy 3804 Chuan Zeng For Endometrial And Cervix Cancer (DMBT) for Cervical Cancer Proton Pencil Beam Scanning for Mediastinal Lymphoma: Dosimetric 3816 Yuanshui Zheng 3829 Nicolas Depauw Evaluation and 4-dimensional Minimizing Treatment Planning Errors in A Novel Proton Pencil Beam Scanning Robustness Assessment Proton Therapy Using Failure Mode and Technique For Post-mastectomy Chest Eff ects Analysis Wall Irradiation 3805 Paige Summers Compilation of Proton Therapy Data 3817 Juliane Daartz 3830 Deepak Gupta from the Approval Process for Technical Aspects Of A Proton Real Time Gall Bladder Motion And NCI-funded Clinical Trials Stereotactic Radiosurgery Program Deformation During Fractionated Stereotactic Body Radiotherapy 3806 Oscar Casares Magaz 3818 James Welsh Evaluation Of The Stability Of The FFAG Accelerators for Next-Generation 3831 Ruijiang Li Water Equivalent Path Length In Proton Ion Beam Therapy Systems Non-isocentric Treatment Strategy For Therapy Of Lung Tumors Using 4D-CT Breast Radiotherapy Images 3819 Mehran Zaini Radiation Physics of a New Electronic 3832 Phillip Prior 3807 Li Zhao Brachytherapy System for Treating Skin Eff ect Of Electron Density Assignment Adaptive Re-planning For Proton Lesions On MRI-based Imrt Planning Treatment of Lung Cancer Using 4D Planning 3820 Anna Dinkla 3833 Bianey Palma Validation of a Novel User-friendly Optimization Of Beam Parameters For 3808 Jerimy Polf Approach to Inverse Optimization for Very High-energy Electron Verifying Proton Treatment Delivery Stepping Source Prostate Radiotherapy: A Lung Cancer Case Using Prompt Gamma Imaging Brachytherapy Treatment Planning 3834 Andre-Guy Martin 3809 Patrick Richard 3821 Samuel Shin Robotically Guided Prostatic Fiducial Phantom Analysis of Dental Filling Use of Simultaneous Integrated Boost Marker Insertion Under Direct MRI Materials: Impact on Head and Neck Regimen with Flexible Infl atable Guidance: A Proof Of Concept In A Live Tumor Visualization and Proton Beam Multi-Channel Versus Single Channel Canine Subject Dosimetry and Syed Applicator in the Management of Gynecologic Cancer 3835 Guanzhong Gong 3810 Drosoula Giantsoudi Is It Necessary To Inhale Oxygen Symptomatic Treatment Change in 3822 Juha Korhonen Applying Active Breathing Control In Medulloblastoma Patients after Proton MRI-only Based RTP Workfl ow for Radiotherapy Of Cancer? RT: LET Distributions and RBE Prostate Cancer Patients Associations Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 179 3836 Jiancheng Li 3848 Uma Goyal 3859 George Hajdok The Analysis Of Esophageal Tumor Prone Lead Shield to Reduce Scatter Large, Half-Beam, Flattening Filter Free Mobility During Normal Respiration Radiation to the Contralateral Breast Volumetric Modulated Arc Therapy With Four-Dimensional Computed During Radiotherapy For Breast Cancer: for Head and Neck Cancer Radiation Tomography Physics Results Therapy
3837 Tianfang Li 3849 Liangzhong Xiang 3860 Xing Liang Density Eff ect on Monte Carlo Dose High Precision Focal Brachytherapy of Proton PBS Plan Design and Robustness Calculation for Lung Robotic Prostate Cancer Guided by Dual-Mode Evaluation for Head and Neck Cancer Radiosurgery Photoacoustic and Ultrasound Imaging 3861 Nava Paudel 3838 Daniel Santos 3850 Jessica Lowenstein Leif Free Radical Generation Under the Tangential Volumetric Modulated The Credentialing Process for the Conditions of Nanoparticle-aided Radiotherapy Is Superior To NSABP B-51/RTOG 1304 Phase 3 Microwave Hyperthermia Brachytherapy For Large Scalp Lesions: Randomized Clinical Trial A Case Study In Lentigo Maligna 3862 Arya Amini 3851 C.M. Charlie Ma Dose Painting to Treat Single Lobe 3839 Magdalena Bazalova Pulsed Low Dose Rate Radiotherapy Prostate Cancer Using Targeted External Treatment-Planning Study For Very (PLDR) For Recurrent Cancers: Beam Radiation Therapy: Is It Feasible? High-Energy Electron Beam Treatment Planning Strategies for IMRT Radiotherapy: Integral Dose Reduction and VMAT For Pediatric Patients SARCOMA AND CUTENEOUS 3852 Bill Salter TUMORS 3840 Yu Ra Cho Hybrid Modulated Arc Therapy (HMAT) Dosimetric evaluation of Polymer Gel on an Artiste Linac 3374 Jennifer Pretz Dosimeter using Saccharide in Clinical Localized Adult Ewing Sarcoma (ES): Radiotherapy System 3853 Katarzyna Balasz Improved Outcomes With Ifosfamide Total Lymphoid Irradiation: A and Etoposide (IE) Added to 3841 Pietro Mancosu Comparison of the Dose Distributions Cyclophosphamide, Doxorubicin, and Robustness and In Vivo Dosimetry for of Four Irradiation Techniques Vincristine (CAV) Chemotherapy (CT) Total Marrow Irradiation With VMAT 3854 Maryam Moteabbed 3375 Dana Casey 3842 Nan Zhao Robustness of Proton Therapy Versus Ewing Sarcoma in Adults Treated With A Novel Integrated VMAT/IMRT IMRT to Interfractional Variations for Modern Radiotherapy Techniques Technique For the Treatment of Prostate Cancer Treatments Non-Small Cell Lung Cancer 3376 Stephanie Casey 3855 Houari Korideck Use of Protoporphyrin Fluorescence to 3843 Nan Zhao Intratracheal Delivery of Gold Determine Clinical Target Volumes for A Novel Integrated VMAT/IMRT Nanoparticles for Radiotherapy in Non-Melanotic Skin Cancers Treated Technique for the Treatment of Murine Lung Adenocarcinoma With Primary Radiotherapy Nasopharyngeal Carcinoma 3856 Evan Thomas 3377 Jianyang Wang 3844 Panagiotis Tsiamas Fast-Awitching Dual Energy Computed Comparison of Postoperative A Simplifi ed Craniocaudal Modulated Tomography Mitigates the Eff ects of Intensity-Modulated Radiation Therapy Arc Technique for Total Body Irradiation High-Z Streak Artifact in Radiation With Two-dimensional Radiotherapy Treatment Planning in Patients With Soft Tissue Sarcoma of 3845 Wilko Verbakel Extremities and Trunk An Automated Volumetric Modulated 3857 Baotian Huang Arc Therapy Optimization Solution for Optimizing Dose Delivery Strategies 3378 Dana Casey Head and Neck Treatment Planning in Stereotactic Body Radiotherapy of Whole Lung Irradiation for Adults With Early Stage Non-Small-Cell Lung Cancer Pulmonary Metastases From Ewing 3846 Roohi Gupta With RapidArc and Flattering Filter Free Sarcoma In vivo Pharmacokinetics and Beams Biodistribution of Drug-Loaded 3379 Matthew Cheney Nanodroplets for Treating Prostate 3858 Michael Rutenberg 18F-FMISO PET/CT Visualization of Cancer Using Focused-Ultrasound Dosimetric Advantages of an Adaptive Tumor Hypoxia in Patients With under MR-Guidance Strategy Using Dual-Plan Superposition Chordoma of the Mobile and for Whole Pelvis Radiotherapy in High Sacrococcygeal Spine 3847 Danique Barten Risk Prostate Cancer Evaluation of Organ at Risk Sparing and Robustness for Diff erent Proton Planning Techniques for Head-and- Neck Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
180 ASTRO 2014 / 56TH ANNUAL MEETING 3380 Meritxell Arenas 3392 Darwin Yip 3404 Hina Saeed Hypofractionated High Dose Rate Review of Experience and Outcome Impact Of 3dcrtvs Imrt On Brachytherapy in Non-melanoma Skin of Dural Plaque Brachytherapy from Post-operative Wound Complications Cancer Treatment 2000-2013 3405 Bindu Manyam 3381 Amar Kishan 3393 Laura Kollar Inferior Outcomes in Feasibility of MRI-guided Tri-Cobalt-60 Does Post-Neoadjuvant Therapy PET Immunosuppressed Patients With High IMRT for Preoperative Radiotherapy of Response Predict Pathologic Outcomes Risk Cutaneous Squamous Cell Soft Tissue Sarcomas in the Treatment of Sarcomas? Carcinoma of the Head and Neck Treated With Surgery and Radiation 3382 Michael Cheung 3394 Franel Le Grange Therapy Acute Skin Toxicity using High Dose Late Eff ects of Radiotherapy in Rate Electronic Brachytherapy for Extremity Sarcoma 3406 Christopher Tinkle Non-Melanoma Skin Cancer Oncologic Surgery and Intraoperative 3395 Hesham Gayar Radiation Therapy (IORT) in 3383 Sanghyuk Song Results of Novel Multi-Channel HDR Management of Unplanned Excision of Eff ects of Adjuvant Radiotherapy in Brachytherapy Applicators in the Extremity Soft Tissue Sarcoma (STS) Patients With Synovial Sarcoma Treatment of Non-Melanoma Skin Cancer 3407 Christopher Wilke 3384 Aryavarta Kumar Radiologic And Pathologic Response HDR Brachytherapy for Resected 3396 Julian Johnson After Neoadjuvant Radiotherapy For Retroperitoneal Sarcoma in the Primary Single Institutional Series of Myxoid Liposarcoma Of The Extremities and Recurrent Setting Intraoperative Radiotherapy (IORT) for Primary and Recurrent Retroperitoneal 3408 Kenneth Merrell 3385 Haotong Wang and Pelvic Sarcomas Outcomes And Prognostic Factors Of Prognostic Factors in Alveolar Soft-Part Stereotactic Body Radiotherapy For Soft Sarcoma: A Seer Analysis 3397 Christopher Barker Tissue Sarcoma Metastases Locally Advanced and Unresectable 3386 Ajay Bhatnagar Cutaneous Squamous Cell Carcinoma: 3409 Joseph Pennington Electronic Brachytherapy for the Outcomes of Concurrent Cetuximab Does a Post-operative Boost in Patients Treatment of Non-Melanoma Skin and Radiotherapy With Low Necrosis Scores Improve Cancer: Results up to 4 Years Local Control in High Grade Extremity 3398 Katsuyuki Karasawa Sarcomas? 3387 Tobias Chapman IMRT for Angiosarcoma of the Scalp Myxoid Liposarcomas Demonstrate a Using TomoTherapy: Planning Study 3410 Oren Cahlon Profound Response to Neoadjuvant and the Initial Results Hypofractionated Preoperative Radiation Therapy: An MRI Based Radiation Therapy to a Partial Tumor Volumetric Analysis and Pathological 3399 Michael Hadsell Volume in Retroperitoneal Sarcomas Correlation Tangential Modulated Arc Therapy: A (RPS): A Dosimetric Comparison Novel Technique for the Treatment of Between Intensity Modulated Radiation 3388 Anthony Crimaldi Superfi cial Disease Therapy (IMRT) and Uniform Scanning Eff ects of Radiation Therapy in Adult Proton Therapy (PT) Soft Tissue Sarcomas (STS) of the 3400 Omeed Moalikyar Extremities (Ext): A 20 Year Adjuvant Radiation Therapy for 3411 Aashish Bhatt Retrospective Review Sarcomas of the Head and Neck: A High Dose Proton Beam Boosted Single Institution Experience Radiation Therapy in the Management 3389 Pin-I Huang of Non-Skull Base Chondrosarcomas Outcomes Of Head And Neck 3401 Masahiro Kenjo Osteosarcoma: 10-year Experience At A Long Term Results of Postoperative 3412 James Snider III Single Institution Three Dimensional High Dose Rate Use of “Virtual” High Dose Rate (HDR) Brachytherapy for Soft Tissue Sarcomas Brachytherapy via Spatially 3390 Silvia Rodriguez Villalba Fractionated GRID Radiation Therapy HDR Valencia Applicator in Non- 3402 Christopher Tinkle (SFGRT) as Part of Neoadjuvant Therapy Melanoma Skin Cancer: Clinical Intraoperative Radiation Therapy in Poor Prognosis, Bulky Sarcomas Outcomes (IORT) in the Management of Recurrent Extremity Soft Tissue Sarcoma (STS) 3413 Sean Szeja 3391 Upendra Parvathaneni Clinical Eff ects of Ultraviolet Exposure A Novel Single-fraction Radiotherapy 3403 Alex Jacobson on Cutaneous Melanoma for White Approach For Metastatic Merkel Cell Outcomes of Patients With Synovial Americans in SEER Carcinoma Is Well Tolerated And Sarcomas Treated With Multimodality Demonstrates Strong Effi cacy Linked To Therapy: A Single Institution Review Intact Cellular Immunity
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2014 / 56TH ANNUAL MEETING 181 “A prestigious teaching faculty has been assembled to promote dialogue, provide multidisciplinary viewpoints and interact with participants. –Karen Kelly, MD, Symposium Chair ”
CCHICAGO H I C A GO MULTIDISCIPLINARY SYMPOSIUM in TTHORACICHORACIC OONCOLOGYNCOLOGY RADIATION THERAPY SURGERY CHEMOTHERAPY October 30-November 1, 2014 Chicago Marriott Downtown Magnifi cent Mile | Chicago
• Hear multidisciplinary speakers addressing topics relevant to everyday practice. • Participate in case-based presentations and post-session discussions on future directions for cancer treatment. • NEW IN 2014: Tumor board sessions on early disease and metastatic disease cases submitted by attendees.
Register by October 1 for advance rates: www.thoracicsymposium.org
This live activity has been approved for AMA PRA Category 1 Credit™.
CO-SPONSORED BY:
® INSIDE: Index by Author Index by Track Indexes Indexes
Tuesday, September16, 9:00a.m.-12:00p.m. Sunday andMonday, September14and15, 9:00a.m.-5:00p.m. and ConcourseStop by Center, oftheMoscone the SanAntonio boothintheNorth Want toknowmore? October 18-21,2015•HenryB.GonzalezConventionCenterSanAntonio AND, THE LOCATION FOR ASTRO’S 57TH ANNUAL MEETING! • Site oftheworld famousAlamo. • oftheAmericanCowboy. Birthplace • suchasSeaWorld, familyattractions, Aplace withwonderful SanAntonio Zoo • Hometo more than25museumsincludingtheMcNay, ranked4thintheUSfor • city, walkable withthefamousRiver Avery Walk, featuring 15milesofpaths • Easyto getto, fl withdirect • The seventh inthe United largest States. city • is: Did you Antonio know thatSan Deep intheHeartofTexas! Annual MeetingMoves ASTRO 20 ASTRO and Aquarium, SixFlags andseveral water parks. art. 19th and20thcentury lined withshops, cafes andbistros. 15 ights from 34cities. Index by Author (Abstracts only)
Amoush, Ahmad 3672 Bauer, Nicolas 2720 Bowen, Stephen 3138 A Anand, Aman 3815 Baumann, Brian 260 Bowen, Stephen 3061 Abacioglu, Mehmet Ufuk 2721 Anand, Aman 2460 Baumann, Brian 290.5 Boyle, John 2686 Abazeed, Mohamed 224 Anderson, Bradley 182 Bazalova, Magdalena 3839 Boyle, John 170 Abel, Ryan 2288 Anderson, Eric 2459 Bazan, Jose 2050 Bradley, Jeff rey 317 Abernathy, Lisa 3461 Anderson, Nigel 2903 Beadle, Beth 2862 Bradshaw, Tyler 6 Abing, Casey 3592 Andreassen, Christian 328 Beard, Clair 2651 Braunstein, Lior 3182 Able, Charles 3339 Anker, Christopher 2173 Bedos, Ludovic 3665 Braunstein, Lior 2067 Abo-Madyan, Yasser 2026 Anne, Pramila, Rani 90 Bekelman, Justin 132 Braunstein, Lior 1030 Abraham, Christopher 2282 Antognoni, Paolo 2872 Belcaid, Zineb 79 Braunstein, Steve 2983 Abramowitz, Matthew 286 Antoine, Mikael 3612 Belkacemi, Yazid 2084 Braunstein, Steve 32 Abrams, Matthew 2361 Anwar, Mekhail 2185 Belkacemi, Yazid 2061 Bremjit, Prashoban 3088 Acharya, Sahaja 2086 Apisarnthanarax, Smith 2394 Benezery, Karine 2433 Brenneman, Randall 1045 Adam, Jean-François 26 Arenas, Meritxell 3380 Bennion, Nathan 2457 Brigotti, Samantha 3137 Adamczyk, Marta 3706 Ariga, Takuro 2307 Berbeco, Ross 1098 Broomfi eld, Joel 3771 Adli, Mustafa 3041 Arneson, Kyle 2277 Bergamo, Angelo 3625 Broomfi eld, Joel 2274 Advani, Sunil 1038 Arneson, Kyle 3243 Bergom, Carmen 97 Brower, Jeff rey 107 Agaoglu, Fulya 2640 Arns, Anna 3578 Bergsma, Derek 3060 Bryant, Curtis 2525 Agarwal, Ankit 2989 Arora, Divya 3205 Berk, Lawrence CT-07 Buchsbaum, Jeff rey 3465 Agazaryan, Nzhde 3567 Arunsingh, Moses 2623 Berman, Abigail 1117 Burkeen, Jeff rey 2261 Agbahiwe, Harold 2982 Asakura, Hirofumi 2561 Bernard, Mark 1110 Byler, Shannon 2996 Ager, Bryan 3812 Ascolese, Anna Maria 3067 Bernstein, Michael 2372 Aghdam, Nima 3015 Ashamalla, Hani 1127 Berriochoa, Camille 2381 Agoston, Peter 2578 Asher, David 2620 Berriochoa, Camille 3132 C Aguilera, Todd 1008 Ashworth, Allison 134 Bertke, Matthew 2905 Cacicedo, Jon 2866 Ahlawat, Stuti 2131 Ashworth, Allison 168 Best, Ryan 2694 Cahlon, Oren 3410 Ahmad, Moiz 3490 Asuni, Ganiyu 31 Betzing, Christopher 3560 Cahlon, Oren 3303 Ahmed, Inaya 3073 Atsumi, Kazushige 2306 Bhandare, Niranjan 2800 Cai, Bin 3814 Ahmed, Inaya 3074 Avkshtol, Vladimir 3247 Bhandare, Niranjan 2870 Caldas Magalhaes, Joana 2823 Ahmed, Kamran 2237 Ayala-Peacock, Diandra 275 Bhandare, Niranjan 3587 Campbell, Shauna 2978 Ahmed, Kamran 2241 Aznar, Marianne 3172 Bhateja, Priyanka 2838 Cannon, Nathan 3043 Ahmed, Kamran 35 Azoulay, Melissa 2167 Bhatnagar, Ajay 3386 Cao, Kim 1014 Ahmed, Merina 7 Bhatt, Aashish 3411 Cao, Lu 2069 Ahmed, Zain 2210 Bhatt, Neal 3072 Cardenas, Michael 65 Ahn, Peter 2919 B Bhirud, Abhijeet 2456 Carlone, Marco 2652 Ahn, Sung-Ja 3037 Balasz, Katarzyna 3853 Bhooshan, Neha 2413 Carlson, Julie 2168 Ahunbay, Ergun 3825 Baba, Fumiya 3082 Bi, Nan 3122 Carlson, Julie 2169 Aizer, Ayal 2810 Babic, Steven 3767 Bilimagga, Ramesh 2799 Carmona, Ruben 3629 Akimoto, Mami 3571 Baden, Craig 2471 Bishop, Andrew 197 Carvajal, Claudia 3210 Akino, Yuichi 3790 Badiyan, Shahed 2286 Biswas, Tithi 3157 Casares Magaz, Oscar 3806 Akram, Kothwal 1018 Bagley, Jack 2514 Biswas, Tithi 3521 Cascales Garcia, Maria A. 2117 Akthar, Adil 3057 Bagshaw, Hilary 2239 Bitterman, Danielle 64 Casey, Dana 3378 Al-Basheer, Ahmad 2922 Bahig, Houda 3780 Blacksburg, Seth 3363 Casey, Dana 3375 Albuquerque, Kevin 3554 Bahl, Gaurav 2936 Blacksburg, Seth 2416 Casey, Dana 3322 Alco, Gul 2048 Baig, Nimrah 71 Blakaj, Adriana 3203 Casey, Stephanie 3376 Alcorn, Sara 177 Bair, Ryan 2744 Blake, Monika 3106 Cassidy, Richard 2753 Alcorn, Sara 3237 Bakhoum, Samuel 3449 Blanchard, Miran 118 Cassuto, Ophelie 3191 Alcorn, Sara 3302 Balagamwala, Ehsan 3192 Blas, Kevin 2612 Castelli, Joel 3680 Aleman, Berthe 138 Baldini, Elizabeth 253 Blay, Christophe 2574 Castelnau-Marchand, Al-Halabi, Hani 3159 Baliga, Sujith 2742 Blessing, Manuel 3577 Pauline 1066 Ali, Mirza 3582 Ballas, Leslie 2930 Block, Alec 313 Caster, Joseph 342 Alite, Fiori 3782 Balter, James 1104 Blom, Gerrit 3114 Cattaneo, Richard 3121 Alite, Fiori 1011 Balter, Peter 3667 Boda-Heggemann, Judit 2341 Caudell, Jimmy 2159 Alizadeh-Kashani, Moein 2756 Bar Ad, Voichita 165 Boda-Heggemann, Judit 3570 Caudell, Jimmy 1060 Aljabab, Saif 3235 Baral, Shweta 1054 Boehling, Nick 244 Cellini, Francesco 3250 Allen, Aaron 3085 Barker, Christopher 2217 Boelke, Edwin 152 Cellini, Francesco 2675 Allen, Bryan 3428 Barker, Christopher 3397 Boggs, Hunter 2296 Chai, Xiangfei 3708 Alpuche Aviles, Jorge 3677 Barnes, Mark 3223 Bohoudi, Omar 276 Chalubinska-Fendler, Althaqfi , Saif 2264 Barrett, Kate 3531 Booth, Jeremy 42 Justyna 2577 Altman, Michael 3652 Barron, David 3326 Bornstein, Sophia 3420 Chan, Annie 2809 Altun, Musa 2791 Barsky, Andrew 3045 Borst, Gerben 3445 Chan, Jason 2268 Ambroa Rey, Eva 2034 Barsky, Andrew 3282 Bortolin, Maria Teresa 3533 Chance, William 3158 Amin, Raima 2468 Barten, Danique 3847 Bosnic, Sandi 2037 Chandra, Ravi 2030 Amini, Arya 3862 Baschnagel, Andrew 2364 Bota, Krista 2420 Chang, Albert 2598 Amini, Arya 2728 Bates, James 2226 Bourgier, Celine 2106 Chang, Daniel 2405 Amornwichet, Napapat 3466 Batista, Vania 3802 Bovi, Joseph 2179 Chang, Eric 2214
ASTRO 2014 / 56TH ANNUAL MEETING 185 Chang, Jennifer 2240 Chuong, Michael 2414 De Paula, Ugo 2023 Ellis, Rodney 3726 Chang, Jennifer 2290 Chuong, Michael 2419 De Rose, Fiorenza 1034 Elnahal, Shereef 3369 Chang, Jennifer 2151 Cifuentes Gaitan, Jidney 1080 Dean, Mary 2293 Elshaikh, Mohamed 2718 Chang, Joe 3028 Cihoric, Nikola 2942 Debus, Charlotte 2184 Elson, Andrew 2163 Chang, Joseph Tung-Chieh 2818 Citrin, Deborah 332 Decker, Roy 1144 Eng, Tony 2692 Chang, Kenneth 221 Clark, Grant 2658 Defoor, Dewayne 3716 Engelman, Alexander 2609 Chang, Tangel 2979 Clavier, Jean-Baptiste 2236 Dekker, Andre 3100 Engels, Benedikt 40 Chang-Halpenny, Christine 2711 Clemente Gutierrez, Del Cerro Penalver, Elia 2041 Engels, Benedikt 2519 Chao, Samuel 3354 Francisco 3702 Delaney, Kyle 3366 Engineer, Reena 2409 Chapman, Christina 2722 Coates, James 43 Demas, Kristina 2100 Enke, Thomas 3529 Chapman, Tobias 3387 Cohen, Randi 3743 Dempsey, Claire 2672 Epperly, Michael 331 Chaudary, Naz 1072 Colaco, Rovel 2235 Den, Robert 347 Epperly, Michael 3454 Chaudhary, Ahmed 2918 Colaco, Rovel 2234 Depauw, Nicolas 3829 Epperly, Michael 3442 Chaudhuri, Aadel 3422 Colbert, Lauren 100 Deraniyagala, Rohan 3355 Epperly, Michael 3441 Chaudhuri, Aadel 1007 Colbert, Lauren 2348 Desai, Brijal 2172 Epperly, Michael 3526 Chen, Aileen 301 Colvill, Emma 310 Desai, Neil 2724 Epperly, Michael 3530 Chen, Allan 3775 Comito, Tiziana 2396 DeSelm, Carl 3319 Epperly, Michael 3528 Chen, Bo 3189 Commandeur, Frederic 2570 Dhami, Gurleen 3141 Erho, Nicholas 348 Chen, Helen 2453 Conrad, Tatiana 2972 Dhami, Gurleen 2991 Erickson, Delnora 2010 Chen, Jiayi 2075 Conway, Jessica 172 Dhanireddy, Bhaswanth 2833 Erickson, Kelly 3719 Chen, Jonathan 2816 Cooper, Benjamin 1036 Dhanireddy, Bhaswanth 2827 Ernst, Iris 2400 Chen, Josephine 2723 Cooper, Samuel 2625 Dholakia, Avani 1048 Estabrook, Neil 2283 Chen, Peter 297 Cordova, Elisa 2040 Di, Liu 2292 Estes, Christopher 3763 Chen, Peter 2137 Corso, Christopher 2926 Diaz Pardo, Dayssy 2869 Evans, Joseph 2494 Chen, Susie 2781 Corso, Christopher 1003 Diaz Pardo, Dayssy 2170 Evans, Joseph 193 Chen, Xiaojian 3718 Counago, Felipe 2496 Diletto, Barbara 2187 Chen, Xinfeng 210 Counago, Felipe 2558 Dimitroyannis, Dimitri 2963 Chen, Yong 2784 Counago, Felipe 2497 Dinan, Michaela 2943 F Chen, Yu 3152 Cox, Brett 2654 Dincbas, H. Fazilet 3091 Fachal, Laura 114 Chen, Yu 3345 Craft, David 3824 Ding, Aiping 3801 Faddegon, Bruce 3797 Chen, Yun 2332 Crawford, David 2556 Ding, Chuxiong 3730 Fahim Golestaneh, Azadeh 3418 Cheney, Matthew 3379 Creelan, Ben 163 Ding, Yao 160 Falchook, Aaron 2027 Cheney, Matthew 3226 Crehange, Gilles 2590 Ding, Yun 2021 Fan, Yankhua 3153 Cheng, Hui 3593 Crehange, Gilles 1125 Dinkla, Anna 3820 Fanchon, Louise 3615 Cheng, Jessica 2342 Crimaldi, Anthony 3388 Dise, Joseph 2729 Faria, Sergio 2621 Cheng, Jonathan 2524 Croke, Jennifer 238 Disher, Brandon 3044 Farnia, Benjamin 3325 Cheng, Simon 1139 Croke, Jennifer 2702 Doi, Yoshiko 2294 Farnia, Benjamin 1017 Chera, Bisham 280 Cruz, Misael 1053 Doke, Kaleigh 2921 Farnia, Benjamin 1138 Cheung, Michael 2875 Cuaron, John 2863 Dolezel, Martin 2547 Farr, Jonathan 3165 Cheung, Michael 3382 Cuaron, John 339 Doll, Corinne 61 Fasola, Carolina 2154 Cheung, Patrick 126 Cuaron, John 3787 Dominello, Michael 17 Fawaz, Ziad 3714 Chhabra, Arpit 12 Cuaron, John 3786 Dominello, Michael 3464 Fechter, Tobias 3548 Chhabra, Arpit 2500 Cuaron, John 2007 Dong, Qian 3509 Felder, Shira 2666 Chiang, Andrew 1005 Cui, Taoran 316 Dong, Xiaorong 3458 Felix, Manuela 3514 Chiang, Andrew 2555 Cuijpers, Johan 3768 Dover, Laura 1113 Feng, Felix CT-02 Chiang, Yun 10 Cuneo, Kyle 2346 Dowlatshahi, Morteza 2156 Feng, Huiting (Christine) 3827 Chiesa, Silvia 2188 Curkendoll, Crys 2994 Doyle, Paula 2642 Feng, Mary 2410 Chiesa, Silvia 3711 Curry, Heather 130 Draghici, Roxana 3661 Feng, Wen 3078 Chilukuri, Srinivas 2861 Curry, Heather 3249 Du, Shisuo 116 Fenoglietto, Pascal 3685 Chin, Joanna 3297 Cury, Fabio 2649 Duan, Yili 3034 Fernandes, Annemarie 2295 Chin, Re-I 2865 Cvek, Jakub 2878 Duelge, Jason 2033 Fernandez, Eduardo 3148 Chino, Junzo 1063 Czito, Brian 39 Duma, Marciana-Nona 2011 Ferraris, Gustavo 2713 Chirindel, Alin 2165 Duma, Marciana-Nona 3087 Ferrer, Ferran 2560 Chiu, George 3605 Dunlap, Neal 2880 Fiandra, Christian 3695 Cho, Daniel 3634 D Dunn, Emily 2687 Finkelstein, Steven 2490 Cho, Eunpi 2488 Daartz, Juliane 3817 Durkee, Ben 137 Fischer-Valuck, Ben 3019 Cho, Jae Ho 3463 Dabaja, Bouthaina 3177 Dvorak, Tomas 3332 Fog, Lotte 3656 Cho, Kwang Hwan 3684 Dabaja, Bouthaina 335 Dyer, Brandon 2422 Fogarty, Gerald 2243 Cho, Yeona 2902 Dabaja, Bouthaina 3166 Dyer, Michael 2207 Foley, Kimberley 2945 Cho, Yu Ra 3840 Dabaja, Bouthaina 140 Fontanilla, Hiral 3328 Choe, Kevin 78 Dabaja, Bouthaina 3178 Fotouhi Ghiam, Alireza 3741 Chofl et, Amanda 2336 Dadey, David 3433 E Fowble, Barbara 92 Choi, Chihwan 103 Dagoglu, Rabia Nergiz 3747 Eaton, Bree 2271 Franco, Pierfrancesco 3229 Choi, Enid 3779 Dahele, Max 2987 Eaton, Bree 245 Freilich, Jessica 2351 Choi, Noah 1133 Dai Kubicky, Charlotte 2102 Eblan, Michael 2155 Freilich, Jessica 2871 Choi, Seohee 2244 Dalah, Entesar 2353 Edson, Mark 2819 Friborg, Jeppe 2831 Choudhung, Anaya 2516 Damast, Shari 240 Edwards, Albert 2509 Fritscher, Karl 3360 Chu, Kwun-Ye 3658 Damato, Antonio 3700 Edwards, Jason 3115 Fu, Shen 11 Chua, Melvin Lee Kiang 262 Damato, Antonio 278 Edwards-Bennett, Sophia 3696 Fujioka, Chiaki 3215 Chun, Stephen 1092 Dan, Tu 3524 Eldredge-Hindy, Harriet 1027 Fujita, Yujiro 3649 Chung, Caroline 3622 Dang, Phuong-Di 3764 Elicin, Olgun 2910 Fujitani, Nobumasa 2182 Chung, Yoonsun 2097 De Bari, Berardino 2464 Elliott, David 3270 Fuller, Donald 2510
186 ASTRO 2014 / 56TH ANNUAL MEETING Fuller, Donald 2627 Greenwalt, Julie 281 Hardie, John 2190 Horowitz, David 2379 Fung, Winky Wing Ki 3576 Grew, David 2467 Harima, Yoko 199 Horton, Janet 295 Funk, Ryan 267 Grew, David 2907 Harkenrider, Matthew 237 Hosni, Ali 2893 Furlan, Carlo 3168 Grimm, Shu-Ya Lisa 2585 Harris, David 2589 Hosono, Makoto 3481 Furlan, Carlo 171 Groarke, John 3288 Harris, Jeremy 2938 Hossain, Murshed 3745 Furutani, Shunsuke 3492 Grossman, Craig 217 Harrison, Amy 2935 Hou, Wei-Hsien 2807 Grover, Surbhi 212 Hartsell, William 2624 Hou, Ying 3140 Guan, Xiyin 2798 Hartsell, William 2139 Howell, Rebecca 3646 G Gudur, Madhu Sudhan Hasan, Shaakir 2914 Hsieh, Cheng-En 2850 Gabos, Zsolt 3754 Reddy 156 Hasan, Yaser 2267 Hsu, Feng-Ming 2318 Galalae, Razvan 2572 Guha, Chandan 1041 Hasegawa, Masatoshi 3473 Hu, Kenneth Shung 2829 Galloway, Thomas 263 Guimas, Valentine 2688 Hashimoto, Yaichiro 2482 Huang, Andrew 2247 Gamez, Mauricio 2766 Gulam, Misbah 3778 Hathout, Lara 2569 Huang, Baotian 3857 Gan, Gregory 3476 Gultekin, Melis 2745 Hattangadi, Jona 3368 Huang, Chun-Ming 2428 Gan, Hua 2371 Gultekin, Melis 2130 Hayashi, Akihiro 2231 Huang, Jiayi 2191 Gao, Ang 1079 Gultekin, Melis 3300 Hayashi, Kazuhiko 2681 Huang, Junjian 2920 Gao, Dexuan 1039 Gunther, Jillian 249 Hayes, Jason 3144 Huang, Kitty 3071 Gao, Lanting 2883 Guo, Gordon 3101 Hayman, Thomas 2366 Huang, Pin-I 3389 Gao, Song 3111 Guo, Yanluan 2316 Hazariwala, Ronica 3314 Huang, Roger 2528 Gao, Wendy 283 Guo, Yanluan 2317 He, Tongming 2954 Huang, Shao Hui 1055 Gao, Zhenhua 3482 Guo, Yanluan 2315 Healy, Erin 2044 Huang, Tzung-Chi 3042 Garg, Rashi 148 Guo, Yu 157 Hearn, Jason 219 Huang, Wei 2384 Gayar, Hesham 3395 Gupta, Apar 2939 Hedayati, Mohammad 190 Huang, Yaoru 2386 Gayar, Omar 2760 Gupta, Deepak 3830 Hegi-Johnson, Fiona 159 Huang, Zhibin 2814 Gayou, Olivier 3586 Gupta, Gaorav 147 Heijmen, Ben J.M. 3679 Huber, Peter 3499 Gensheimer, Michael 9 Gupta, Roohi 3846 Heinzerling, John 3024 Huff , Byron 80 Gerber, Naamit 340 Gurka, Marie 3267 Held, Mareike 3232 Hughes, Michael 2526 Gerngross, Lindsey 1094 Gwynne, Sarah 3330 Helou, Joelle 2511 Hughes, Ryan 2645 Gevaert, Thierry 3737 Gwynne, Sarah 3327 Helou, Joelle 2513 Hui, Zhouguang 1140 Ghadjar, Pirus 2758 Hempel, Dominika 2540 Hung, Tsung Min 2786 Ghaly, Maged 266 Henke, Lauren 201 Hurmuz, Pervin 3471 Giaddui, Tawfi k 324 H Henriques, Benedicte 3757 Hurst, Newton 2824 Giaddui, Tawfi k 2329 Haasbeek, Cornelis 1006 Henry, Ann 2602 Hurwitz, Mark CT-01 Giantsoudi, Drosoula 3810 Haas-Kogan, Daphne Adele 247 Henson, Christina 3227 Hurwitz, Martina 3617 Gibson, Eli 1122 Hadsell, Michael 3399 Hepel, Jaroslaw 298 Husain, Zain 123 Giem, Jared 2273 Hadzitheodorou, Christina 274 Herman, Lauren 2058 Huynh-Le, Minh-Phuong 162 Gilbo, Philip 2874 Hajdok, George 3859 Herman, Michael 3012 Huynh-Le, Minh-Phuong 2479 Gill, Beant 2967 Hajj, Carla 2367 Hermann, Gregory 1136 Hwang, Seha 3648 Gillespie, Erin 2059 Hall, Matthew 89 Herskovic, Alex 307 Hymas, Richard 2133 Giordano, Frank 3443 Hall, Matthew 2477 Herskovic, Alex 2706 Giuliani, Meredith 2879 Hall, William 2397 Herst, Patries 3211 Giuliani, Meredith 3281 Hall, William 173 Heskel, Marina 3054 Gladwish, Adam 1067 Hallman, Mark 30 Heskel, Marina 3052 I Glaser, Scott 2776 Halthore, Aditya 2418 Hess, Clayton 3321 Iftimia, Ileana 3823 Glick, Daniel 315 Hamamoto, Yasushi 3241 Hess, Clayton 2968 Igaki, Hiroshi 2171 Glick, Daniel 2440 Hamilton, Sarah 2536 Heumann, Thatcher 2731 Iganej, Shahrokh 2825 Glide-Hurst, Carri 205 Hamilton, Sarah 3336 Heumann, Thatcher 3193 Iizuka, Yusuke 2388 Goddu, Sreekrishna Murty 3800 Hamilton, Sarah 96 Hickling, Susannah 3609 Illidge, Timothy 3439 Goenka, Anuj 3274 Hammer, Josef 3196 Higgins, Kristin 3055 Imber, Brandon 3318 Gogna, Nirdosh 2633 Han, Bin 3773 Hill-Kayser, Christine 3287 Ingledew, Paris-Ann 3000 Goh, Lili 2927 Han, Chun 2321 Hill-Kayser, Christine 3323 Inokuchi, Haruo 2520 Golden, Daniel 2990 Han, Chunhui 3725 Hiniker, Susan 3185 Ishaq, Omar 3645 Golden, Encouse 1032 Han, Dae Yup 3828 Hirata, Takero 105 Ishibashi, Naoya 3198 Goldsmith, Christy 2135 Han, Dali 2320 Hitchcock, Kathryn 2752 Ishii, Kentaro 2538 Gomez, Caitlin 2522 Han, James 2853 Hitchcock, Whitney 2049 Ishikawa, Hitoshi 2325 Gomez, Maria Antonia 3136 Han, Kathy 2738 Ho, Alice 91 Ishikawa, Kazuki 2323 Gomez-Iturriaga, Alfonso 174 Han, Kathy 191 Ho, Clement 198 Isohashi, Fumiaki 2678 Gondi, Vinai 2254 Hanna, Andrew 1021 Hobbs, Corey 2981 Ito, Yoshinori 2305 Gong, Guanzhong 3598 Hanna, Nevine 2534 Hoff man, Rex 2876 Iuchi, Toshihiko 2161 Gong, Guanzhong 3835 Hanna, Nevine 326 Hogue, Cory 2571 Ivkov, Robert 1037 Gong, Yutao 3342 Hansen, Henrik 2691 Hojgaard, Martin 3590 Iwabuchi, Michio 3176 Goodman, Ben 2403 Hansen, Henrik 2683 Holcombe, Charles 1081 Iwata, Hiromitsu 3446 Goodman, Karyn 62 Hansen, Tara 2088 Hollen, Tyler 264 Iwata, Hiromitsu 3070 Gopal, Anant 3549 Haque, Waqar 3308 Holliday, Emma 2805 Izaguirre, Enrique 2777 Gorovets, Daniel 2259 Harada, Arisa 3186 Holmes, Jordan 2186 Goyal, Uma 3848 Harada, Hideyuki 2233 Hong, Cheng 2543 Grant, Jonathan 3373 Harada, Ken 3233 Hong, Giang 2985 Gray, Phillip 2553 Harada, Satoshi 3495 Hong, Ji-Hong 1062 Gray, Phillip 291 Hardenbergh, Patricia 304 Hong, Theodore 36 Grecula, John 3545 Harder, Eileen 124 Hoover, Andrew 2909 Green, Garrett 2619 Harder, Eileen 3086 Hoppe, Bradford 179 Green, Olga 204 Harder, Eileen 3084 Hoppe, Richard 336
ASTRO 2014 / 56TH ANNUAL MEETING 187 Kamran, Sophia 2650 Kim, Jae-Sung 2436 Kuczmarska, Aleksandra 2855 J Kamran, Sophia 2772 Kim, Jin Ho 2847 Kudithipudi, Vijay 2393 Jackson, Matthew 145 Kamrava, Mitchell 2680 Kim, Jin Ho 2848 Kumar, Aryavarta 3384 Jackson, William 2552 Kanakamedala, Madhava 2867 Kim, Kyung Hwan 1026 Kumar, Parvesh 2622 Jacobson, Alex 3403 Kanakamedala, Madhava 2899 Kim, Kyung Su 3069 Kumar, Rejnish 2901 Jager, Elise Anne 2822 Kanayama, Naoyuki 2815 Kim, Leonard 3660 Kumar, Sanath 3116 Jagsi, Reshma 293 Kandula, Shravan 149 Kim, Michelle 2162 Kumarasiri, Akila 229 Jain, Anshu 3162 Kang, Hyun-Cheol 2504 Kim, Michelle 77 Kupelian, Patrick 85 Jain, Prachi 2213 Kang, John 3639 Kim, Miranda 2806 Kusano, Aaron 2995 Jain, Supriya 3130 Kang, Julie Jung 2192 Kim, Sungjune 166 Kusano, Aaron 2977 Jairam, Vikram 2189 Kang, Julie Jung 285 Kim, Tae Hyung 1112 Kusumawidjaja, Grace 2181 James, Joshua 3610 Kang, Young-nam 3688 Kim, Tae Hyung 2444 Kwok, Young 2584 James, Nicholas 18 Kannarunimit, Danita 3662 Kim, Youn 334 James, Sarah 2330 Kapoor, Rishabh 2931 Kim, Youngjun 3573 Jani, Ashish 2262 Kapoor, Vaishali 3486 Kim, Yusung 2665 L Jani, Shirish 3682 Karagoz, Gulay 3690 Kimura, Tomoki 3058 Lai, I-Chun 3299 Janowski, Einsley-Marie 3264 Karakaya, Ebru 2695 King, Martin 3483 Lai, Shihfan 2103 Jarvis, Lesley 2081 Karam, Irene 2790 King, Martin 144 Lai, Stephen 2834 Jastaniyah, Noha 194 Karan, Tania 1078 Kirby, Neil 3697 Lai, Yo-Liang 2383 Jaswal, Jasbir 2997 Karasawa, Katsuyuki 3398 Kirkland, Robert 3313 Lalani, Nafi sha 294 Jawad, Maha 311 Karasawa, Katsuyuki 3134 Kirsch, David 115 Lam, Tai Chung 3239 Jayachandran, Priya 2260 Karasawa, Kumiko 2029 Kishan, Amar 2498 Lam, Wai Wang 3329 Jeff eris, Jennifer 2209 Karlin, Jeremy 69 Kishan, Amar 2385 Lang, Jinyi 3532 Jegadeesh, Naresh 143 Kashani, Rojano 1100 Kishan, Amar 3381 Lanni, Thomas 2958 Jensen, Alexandra 2851 Kashani, Rojano 3611 Kishi, Takahiro 2349 Lanning, Ryan 2275 Jensen, Lindsay 2512 Kasuya, Goro 2664 Kisling, Kelly 3334 LaPlant, Quincey 2160 Jeong, Jeho 3628 Kasuya, Takeo 2354 Kittel, Jeff rey 2203 Lapuz, Carminia 2740 Jeong, Seong-Yun 3512 Kathpal, Madeera 2024 Klein, Eric 1074 Larrea, Luis 3292 Jeong, Seong-Yun 3511 Kathpal, Madeera 3584 Klein, Jonathan 2392 Laruelo, Andrea 3484 Jeong, Yuri 3664 Kato, Masako 2111 Knoll, Miriam 3284 Lashkari, Marzieh 2425 Jeongshim, Lee 2454 Katoh, Norio 2647 Knoll, Miriam 2020 Laskar, Siddhartha 246 Jeppesen, Stefan 3093 Katsuta, Yoshiyuki 3338 Ko, Huaising 2898 Latifi , Kujtim 2375 Jeraj, Robert 1090 Kattevilder, Robert 2559 Kobayashi, Hidetoshi 3230 Lauro, Christine 2970 Jhavar, Sameer 3190 Katz, Leah 3017 Koc, Mehmet 1109 Lautenschlaeger, Tim 2635 Jiang, Wei 3066 Kavanaugh, James 2583 Kocak, Esengul 2376 Lawrence, Yaacov 2447 Jie, Shen 3206 Kawakami, Masakuni 3668 Kocak, Esengul 2761 Lazow, Stefanie 2227 Jimenez, Rachel 3306 Kawamura, Mariko 2300 Kodaira, Takeshi 2782 Le Grange, Franel 3394 Jimenez-Jimenez, Esther 2435 Kawamura, Mariko 2017 Kohutek, Zachary 22 Leatherwood, Amy 3280 Jin, Jian-Yue 164 Kawanaka, Takashi 2334 Kole, Thomas 110 Lecavalier-Barsoum, Magali 2565 Jing, Hao 151 Kawashiro, Shohei 3221 Kollar, Laura 3393 Lecavalier-Barsoum, Magali 2193 JingBo, Wu 1004 Kazberuk, Dorota 2595 Kollar, Laura 3129 Lederman, Ariel 2644 Jo, Kwanghyun 3811 Keall, Paul 3602 Kollmeier, Marisa 2637 Lee, Andrew 3277 Joh, Daniel 3255 Keane, Florence 2765 Komaki, Ritsuko 3046 Lee, Andrew 63 Johnson, Jedediah 3796 Keene, Kimberly 2387 Kondaveeti, Satish 2888 Lee, Anna 2121 Johnson, Julian 3396 Keiler, Louis 2099 Kong, Feng-Ming 3163 Lee, Eun-Jung 3430 Johnson, Julian 2120 Kelada, Olivia 49 Kong, Jie 1118 Lee, Grace 2096 Johnson, Matthew 2284 Kelley, Kevin 3105 Koo, Tae Ryool 2451 Lee, Jae 3265 Johnson, Matthew 180 Kelly, Douglas 3199 Koottappillil, Brian 2999 Lee, Jason 3242 Johnson, Skyler 2630 Kemmerer, Eric 3154 Korhonen, Juha 3822 Lee, Joohwan 3179 Jones, Bernard 3595 Kenjo, Masahiro 3401 Korideck, Houari 3855 Lee, Keum Sil 3488 Jones, Guy 2022 Kennedy, William 2205 Kornerup, Josefi ne 3324 Lee, Kuei 3489 Jones, Guy 2929 Kennoki, Norifumi 2350 Kortylewicz, Janina 187 Lee, Larissa 242 Jones, Ryan 3358 Keole, Sameer 135 Koshy, Matthew 1001 Lee, Larissa 2739 Joshi, Nikhil 2200 Kerns, Sarah 113 Kotecha, Rupesh 2533 Lee, Percy 54 Ju, Melody 1093 Kertzscher, Gustavo 3349 Kotecha, Rupesh 2251 Lee, Seok Ho 2669 Judith, Aaron 3657 Kesava Ramgopal, Koukourakis, Michael 3423 Lee, Suk 3687 Jung, Julip 3160 Adavikolanu 2127 Kountouri, Melpomeni 2563 Lee, Suk 3683 Jwa, Eunjin 2113 Khan, Luluel 176 Kovalchuk, Nataliya 3356 Lee, Victor 261 Khan, Luluel 2253 Koyfman, Shlomo 2771 Lee, Yongsook 2674 Khattab, Mohamed 3498 Koyfman, Shlomo 2964 Lee, Yun Hee 3161 K Khwaja, Shariq 3276 Kozak, Malgorzata 2462 Lefresne, Shilo 2426 Kabarriti, Rafi 1 Kiang, Alan 3256 Kozono, David 220 Lefresne, Shilo 175 Kabarriti, Rafi 3462 Kidd, Elizabeth 1070 Kraft, Johannes 3553 Lei, Xin 2449 Kachnic, Lisa 3289 Kidd, Elizabeth 2667 Krauss, Daniel 2501 Leif, Jessica Lowenstein 3850 Kadoya, Noriyuki 319 Kierkels, Roel 230 Krauss, Daniel 1132 Leiker, Andrew 1095 Kahalley, Lisa 248 Kiess, Ana 3517 Krauze, Andra 3260 Lens, Eelco 3650 Kainz, Kristofer 3651 Kilburn, Jeremy 3092 Kreofsky, Cole 2837 Leonard, Charles 2016 Kalapurakal, John 250 Kim, Byounghyuck 3023 Kriz, Jan 338 Leonard, Kara 3340 Kalbasi, Anusha 2532 Kim, Dong Wook Nathan 3506 Kropp, Lauren 2832 Leong, Nelson 299 Kamomae, Takeshi 3681 Kim, Ellen 3076 Kubicek, Gregory 259 Leong, Trevor 3447 Kamp, Florian 3626 Kim, Hayeon 2956 Kubo, Akiko 2684 Lester, Scott 3090 Kim, Hyun 3755 Kucharczyk, Michael 2177 Lester-Coll, Nataniel 300
188 ASTRO 2014 / 56TH ANNUAL MEETING Lester-Coll, Nataniel 2953 Liu, Jianfei 28 Maidment III, Bertram 3145 Meister, Moshe 2588 Letourneau, Etienne 3589 Liu, Jing 3107 Mailhot Vega, Raymond 2952 Mellon, Eric 2362 Leung, Chung Man 3419 Liu, Lipin 3110 Maisonet, Olivier 3217 Melotek, James 2593 Levin-Epstein, Rebecca 2250 Liu, Ning 3075 Maity, Amit 3432 Mendenhall, William 1056 Li, Allen 3583 Liu, Peter 3519 Mak, Kimberley 2004 Meng, Jin 1088 Li, BaoQing 2634 Liu, Qingfeng 333 Mak, Kimberley 3010 Meng, Mao-Bin 2313 Li, Baosheng 3123 Liu, Weixin 2796 Mak, Kimberley 255 Merrell, Kenneth 3408 Li, Dengwang 3603 Liu, Wenyang 3675 Malone, Shawn 346 Merrell, Kenneth 101 Li, Fengxiang 3673 Liu, Wenyang 41 Manabe, Yoshihiko 3040 Merrick, Scott 3633 Li, Fengxiang 3674 Liu, Wu 3616 Mancini, Brandon 1012 Meyer, Jeff rey 104 Li, Guang 3760 Liu, Yilin 206 Mancosu, Pietro 3841 Meyer, Kurt 2198 Li, Guangjun 3701 Lloyd, Shane 3169 Mangla, Ankit 3164 Mezera, Megan 2741 Li, Guichao 2343 Lloyd, Shane 3219 Mann, Justin 3077 Mian, Omar 3236 Li, Heng 314 Lloyd, Shane 2548 Mannina, Edward 2415 Mian, Omar 2369 Li, Heng 3813 Lo, Andrea 76 Manon, Rafael 2792 Michalski, Dariusz 3748 Li, Jason 3710 Lo, Simon 3727 Manoor Maiya, Vikram 2892 Michalski, Jeff 2579 Li, Jiancheng 3836 Loblaw, Andrew 2535 Manyam, Bindu 3405 Michaud, Anthony 2699 Li, Jinluan 2352 Lock, Michael 2974 Manzerova, Julia 2122 Mickevicius, Nikolai 2272 Li, Linna 2093 Logie, Natalie 3244 Manzerova, Julia 2727 Mikell, John 2476 Li, Mei 2690 Logie, Natalie 2779 Maraldo, Maja 337 Mikhaeel, George 3167 LI, Minghuan 15 Loiselle, Christopher 1024 Marciscano, Ariel 213 Mikkelsen, Ross 225 Li, Ning 2431 Lok, Benjamin 2125 Marciscano, Ariel 2199 Milecki, Piotr 2566 Li, Ping 3502 Lok, Benjamin 3245 Marconi, Daniel Grossi 2917 Miller, Brett 282 Li, Puyao 2216 Longo, John 2465 Marconi, Daniel Grossi 2949 Miller, Luke 3128 Li, Qian 1069 Lopater, Zachary 3202 Marcus, David 2592 Miller, Robert 184 Li, Ruijiang 3831 Lopez, Jose 2973 Marina, Ovidiu 308 Miller, Seth 2539 Li, Ruijiang 4 Lopresti, Mary 2089 Marina, Ovidiu 2483 Ming, Xin 3155 Li, Shidong 3620 Louie, Alexander 3739 Markovina, Stephanie 200 Mirabeau-Beale, Kristina 2085 Li, Shuai 2098 Louie, Alexander 2959 Maroongroge, Sean 2941 Mishra, Mark 2975 Li, Shuai 2077 Louie, Alexander 303 Marples, Brian 3485 Mislmani, Mazen 1071 Li, Tao 1119 Lovelock, D. Michael 2582 Marsh, James 2157 Miszczyk, Leszek 3269 Li, Taoran 29 Lu, NingNing 2344 Martin, Andre-Guy 3834 Mitchell, Darrion 3507 Li, Tianfang 3837 Lu, Sharon 2717 Martin, Jeff rey 1083 Mitin, Timur 289 Li, Weiwei 2074 Lu, Weiguo 3555 Martin, Neil 2986 Mitra, Devarati 3285 Li, Winnie 3742 Lucas, John 1051 Marwaha, Gaurav 2215 Mitra, Devarati 3271 Li, Xia 207 Lucas, John 2248 Masino, Alexander 2289 Mittauer, Kathryn 3585 Li, Xin 2180 Lucas, John 3759 Mason, Josh 2505 Miyakawa, Akifumi 2230 Lian, Jun 3678 Ludmir, Ethan 2331 Mason, Mathew 1128 Miyawaki, Daisuke 2843 Liang, Jieming 309 Lukens, John 2603 Mason, Matthew 3262 Miyazawa, Kazunari 3187 Liang, Jun 3309 Lukovic, Jelena 1134 Masood, Umar 3788 Mo, Xiaohu 3346 Liang, Xing 3860 Lutz, Ryan 2368 Masoud Rahbari, Reza 3535 Moalikyar, Omeed 3400 Liang, Yun 2370 Ly, Bevan 3740 Massabeau, Carole 2132 Moding, Everett 68 Liao, Jay 2845 Ly, Bevan 3240 Masunaga, Shin-ichiro 3493 Modlin, Leslie 3534 Liao, Zhongxing 84 Lymberiou, Timothy 2094 Mathew, Prince 2225 Modlin, Leslie 2278 Lim, Hyeon Woo 2443 Mathews, Joshua 3335 Moeller, Benjamin 2463 Lim, Jihoon 2696 Matsumoto, Kenji 3669 Moghanaki, Drew 3218 Lim, Trevor 1033 M Matsuo, Masayuki 3480 Mohamad, Issa 2841 Lin, Angela 2703 Ma, Charlie 3251 Matsuo, Masayuki 186 Mohamed, Abdallah 2916 Lin, Chi 1111 Ma, Charlie 3851 Matsuo, Yukinori 3039 Mohamed, Abdallah 2911 Lin, Chun Chieh 19 Ma, Faqiang 2793 Mattes, Malcolm 1135 Mohindra, Pranshu 1086 Lin, Jeff 243 Ma, Jennifer 2730 Mattes, Malcolm 2126 Mohr, Angela 3126 Lin, Jolinta 3150 Ma, Jinli 153 Matulewicz, Lukasz 3343 Molinier, Jessica 3735 Lin, Lilie 2689 Ma, John 2659 Matuszak, Martha 279 Moningi, Shalini 3359 Lin, Mu-Han 312 Ma, John 2757 Matysiak, Witold 3793 Moningi, Shalini 2380 Lin, Teh 3715 Ma, Lijun 3728 Maymani, Rebekah 2735 Moningi, Shalini 3351 Lin, Yu-Wei 2542 Ma, Lin 296 Mazloom, Ali 3174 Moningi, Shalini 2374 Lin, Zhixiong 1050 Ma, Lin 2789 McClinton, Chris 2708 Monjazeb, Arta 3624 Linam, Justin 3566 Machiels, Melanie 2322 McCloskey, Susan CT-06 Monjazeb, Arta 3435 Lindberg, Karin 2276 MacKillop, William 2643 McGovern, Susan 3305 Monjazeb, Arta 3523 Ling, Diane 1084 MacKillop, William 305 McGuffi n, Merrylee 2039 Monroe, Alan 2860 Ling, Ted 2359 Maclean, Jillian 2204 McGuffi n, Merrylee 2955 Moon, Dominic 218 Ling, Ted 2308 Maghsoudi, Kaveh 2732 McGuire, Sarah 8 Mooney, Karen 3580 Lischalk, Jonathan 3614 Magnan, Sindy 2626 McHaffi e, Derek 2576 Moore, Kevin 3558 Liss, Adam 93 Magnuson, William 2773 McKeever, Matthew 2668 Moraes, Fabio Ynoe 2605 Liszewski, Brian 3347 Mahajan, Anita 3294 McLaughlin, Patrick 111 Moraes, Paulo 2255 Liu, Anwen 3539 Mahajan, Anita 251 McNiven, Andrea 3348 Morillo Macías, Virginia 2424 Liu, Chang 3721 Mahal, Brandon 2591 Medhora, Meetha 3527 Morimoto, Masahiro 3104 Liu, Chihray 3361 Mahal, Brandon 2596 Mehmood, Qurrat 3068 Morris, Zachary 2458 Liu, Feng 1076 Mahantshetty, Umesh 1064 Mehta, Minesh 74 Mortensen, Steen 3118 Liu, Hui 2328 Mahe, Marc 2661 Mei, Feng 2697 Mosaly, Prithima 3370 Liu, Jerry 2767 Mahmood, Usama 2944 Mei, Feng 3635 Mosaly, Prithima 3372 Liu, Jerry 2755 Mai, Sabine 60 Meier, Timothy 3333 Moteabbed, Maryam 3854
ASTRO 2014 / 56TH ANNUAL MEETING 189 Motegi, Atsushi 3006 Nichol, Alan 273 Palma, Bianey 3833 Phillips, John 343 Mou, Benjamin 3047 Nicholas, Zachary 2749 Palmer, Joshua 2377 Phillips, Mark 3556 Mourad, Waleed 3201 Nichols, Elizabeth 2118 Palmer, Joshua 2378 Pilones, Karsten 121 Mourad, Waleed 2530 Nicolay, Nils 3500 Palmgren, Jan-Erik 3732 Pilote, Laurie 2969 Mourad, Waleed 2527 Nishibuchi, Ikuno 2326 Palorini, Federica 86 Pineiro Retif, Rafael 3762 Mourad, Waleed 2849 Nishimura, Yasumasa 2303 Palta, Manisha 2475 Pinnaro, Paola 2036 Moustafa, Mahmoud 1042 Nishioka, Takeshi 3444 Pan, Hubert 271 Pinnix, Chelsea 145.5 Mouw, Kent 189 Niska, Joshua 2398 Pan, Hubert 3065 Pinnix, Chelsea 3184 Mowery, Yvonne 2886 No, Hyunsoo 2112 Pang, Qingsong 3033 Pitroda, Sean 329 Mui, Wing Lun 2801 Noh, Jae Myoung 2104 Papineni, Rao 188 Plastaras, John 3197 Muirhead, Rebecca 2470 Noid, George 3596 Parashar, Bhupesh 1073 Plichta, Kristin 2828 Mula-Hussain, Layth 3234 Nomiya, Takuma 2492 Paravati, Anthony 133 Plishker, William 3581 Mullen, Thomas 3353 Nonaka, Hotaka 3097 Parikh, Rahul CT-08 Podder, Tarun 3099 Muller, Karin 2407 Nonaka, Tetsuo 2337 Parisi, Elisabetta 322+1143 Pokhrel, Damodar 3056 Mumber, Matthew Peter 3364 Nout, Remi 239 Park, Catherine 3426 Polf, Jerimy 3808 Munbodh, Reshma 2281 Novak, Avrey 284 Park, Henry 2491 Polgar, Csaba 292 Murai, Taro 2266 Nowak, Kamila 1046 Park, Henry 53 Polishchuk, Alexei 2219 Murai, Taro 2890 Nuyttens, Joost 3273 Park, John 3579 Pollack, Alan 2616 Murakami, Ryuji 2748 Nyfl ot, Matthew 3089 Park, Jong In 3826 Pollock, Bruce 2228 Murakami, Yuji 2301 Park, Kawngwoo 2663 Pollom, Erqi 102 Muraro, Elena 3417 Park, Sang-June 2734 Poon, Ian 3220 Muren, Ludvig 290 O Park, Sean 119 Poon, Miranda Sze Wing 231 Murofushi, Keiko 2682 Obeid, Layal 25 Parra, Andres 3557 Poorvu, Philip 2726 Murphy, Colin 1029 Odawara, Soichi 3455 Parvathaneni, Upendra 3391 Popovtzer, Aron 2811 Murphy, Colin 2503 Oechsner, Markus 3761 Paryani, Nitesh 2925 Porzio-Kwiecinski, Therese 3216 Murray, Louise 3643 Off or, Onyinye 1044 Paryani, Nitesh 3027 Pos, F.J. 2517 Musunuru, Hima 2594 Ogino, Hiroyuki 2484 Patel, Abhilasha 2473 Poulsen, Per 3613 Mutic, Sasa 202 Ogita, Mami 2080 Patel, Abhilasha 2164 Pratx, Guillem 3663 Mutter, Robert 2065 Ognibene, Grant 2141 Patel, Abhilasha 2653 Press, Robert 2287 Myojin, Miyako 2311 Ogunleye, Tomi 3777 Patel, Ashish 3293 Pretz, Jennifer 3374 Oguri, Mitsuhiko 3112 Patel, Chirayu 139 Price, Samantha 2221 Oh, RyoongJin 2401 Patel, Kirtesh 1091 Prieto, Isabel 2889 N Oh, Steven 2581 Patel, Kruti 2114 Prior, Phillip 3637 Na, Yong Hum 3694 Ohga, Saiji 3181 Patel, Nisha 2148 Prior, Phillip 3832 Nabavizadeh, Nima 2304 Ohri, Nisha 3204 Patel, Ravi 158 Pugh, Thomas 112 Nabhani, Thomas 2546 Ohri, Nitin 106 Patel, Ravi 2345 Pyakuryal, Anil 3474 Nabid, Abdenour 24 Ohri, Nitin 318 Patel, Sagar 241 Naczynski, Dominik 3491 Ohri, Nitin 136 Patel, Samir 2839 Nagai, Aiko 3011 Okano, Naoko 3467 Patel, Shyamal 2229 Q Nagai, Aiko 2223 Okawa, Kohei 3731 Patel, Shyamal 2846 Qi, Xiangrong 3704 Nagar, Himanshu 2716 Okonogi, Noriyuki 3494 Patel, Suchit 3098 Qi, Xiangrong 88 Nagar, Himanshu 2710 Okoye, Christian 1059 Patel, Suchit 3096 Qi, Xin 2567 Naghavi, Arash 2946 Oksuz, Didem 2549 Pater, Piotr 3631 Qi, Xin 2568 Naik, Mihir 344 Olivera, Gustavo 277 Patton, Caroline 2966 Qiu, Haoming 2411 Nakajima, Naomi 2175 Olivera, Jesús 3659 Paudel, Nava 1099 Qu, Melody Xuanlu 2302 Nakajima, Naomi 2176 Olsen, Jeff rey 59 Paudel, Nava 3861 Quan, Kimmen 99 Nakajima, Naomi 2174 Olson, Adam 3014 Paulino, Arnold 252 Quigley, Matthew 1019 Nakamura, Mitsuhiro 3569 Olson, Robert 3290 Paulson, Eric 50 Quinlan-Davidson, Sean 2751 Nakamura, Naoki 3224 Olson, Robert 3222 Paulson, Eric 3647 Quinlan-Davidson, Sean 2671 Nakayama, Masao 3513 Onishi, Hiroshi 52 Paulson, Eric 3703 Quinn, Thomas 3520 Naoi, Yutaka 3734 Oohira, Shingo 3574 Pavan, Guilherme 3352 Quivrin, Magali 2628 Napieralska, Aleksandra 2896 Orman, Amber 2632 Peguret, Nicolas 2357 Quon, Harry 2885 Narang, Amol 2614 Orman, Amber 2506 Peng, Jean 3588 Qureshi, Muhammad 2976 Narang, Amol 2194 Osborne, Eleanor 3312 Penniment, Michael CT-03 Narang, Amol 21 Osmundson, Evan 2421 Pennington, Andreea 3785 Narayanasamy, Ganesh 2769 Osmundson, Evan 3546 Pennington, Joseph 3409 R Naydich, Boris 2481 Osmundson, Evan 2196 Perez, Bradford 2222 Raber, Jacob 2249 Neboori, Hanmanth 2662 O’Sullivan, Brian 215 Perez, Jessica 3487 Rabin, Tatiana 3131 Negahdar, Mohammadreza 3050 Ota, Seiichi 3357 Persson, Gitte 3035 Rackley, Thomas 14 Negahdar, Mohammadreza 3049 Owen, Dawn 45 Petereit, Daniel 2143 Rafat, Marjan 3425 Nelson, Aaron 3707 Ozkaya Akagunduz, Ozlem 3311 Petersen, Ivy 2116 Rafat, Marjan 3475 Nelson, Aaron 2523 Ozkaya Akagunduz, Ozlem 2835 Petric, Primoz 2670 Rahimi, Asal 2091 Ng, Sweet 150 Ozkaya Akagunduz, Ozlem 2804 Peulen, Heike 3133 Rahman, Rifaquat 2183 Ngan, Samuel 38 Ozsahin, Esat Mahmut 2817 Pham, Anthony 122 Raince, Jagdeep 3644 Nguyen, Dan 235 Pham, Anthony 2280 Rajagopalan, Malolan 2005 Nguyen, Nhu Tram 2912 Pham, Anthony 2774 Rajan, Rajesh 3765 Nguyen, Nhu Tram 3547 Pham, Huong 288 Rajpara, Raj 141 Nguyen, Nhu Tram 3147 P Pham, Ngoc 127 Raju, Uma 3501 Nguyen, Paul 2580 Padilla, Laura 3572 Pham, Trang 2095 Rakhra, Sunpreet 2031 Nguyen, Quynh 3038 Page, Brandi 2070 Pham, Yvonne 2489 Raldow, Ann 2399 Ngwa, Wilfred 2998 Paik, Eun Kyung 2402 Philippens, Marielle 2913 Raleigh, David 2641 Ngwa, Wilfred 3642 Pallotta, Stefania 3689 Phillips, John 2480 Ram, Ashwin 2613
190 ASTRO 2014 / 56TH ANNUAL MEETING Ram, Ashwin 2618 Rowe, Lindsay 3094 Senan, Suresh 55 Sio, Terence 3263 Rana, Zaker 2043 Ruan, Dan 228 Seo, YoungsSeok 3286 Sio, Terence 3794 Rana, Zaker 3275 Ruan, Dan 3550 Seo, Yuji 3504 Sio, Terence 2940 Rana, Zaker 3279 Ruan, Dan 3551 Serra, Diane 3213 Sio, Terence 3208 Rancati, Tiziana 3641 Ruggieri, Ruggero 3744 Serrano, Nicholas 3676 Sio, Terence 1096 Rand, Alexander 2928 Ruiz-Alonso, Ana 3536 Servagi Vernat, Stephanie 2299 Sioshansi, Shirin 2391 Rand, Alexander 2933 Russo, Gregory 2202 Setakornnukul, Jiraporn 3064 Siva, Shankar 3079 Randolph, David 2195 Rusthoven, Chad 20 Sethi, Rajni 2700 Siva, Shankar 3036 Rangarajan, Ramya 2747 Rutenberg, Michael 3858 Sethi, Roshan 3295 Slade, Alexander 1020 Rao, Min 1082 Rutter, Charles 131 Setton, Jermey 146 Slotman, Ben CT-05 Rao, Nalini 2124 Rwigema, Jean-Claude 2877 Seymour, Zachary 2493 Small, William 236 Rao, Shyam 3434 Ryoo, Joan 2932 Seymour, Zachary 2242 Smith, Adam 3113 Rao, Yuan 2737 Sezen, Duygu 2474 Smith, Clayton 222 Rash, Dominique 2698 Shaff er, Jenny 2417 Smith, Linda 2147 Rasmussen, Jacob 2768 S Shaff er, Jenny 2404 Smith, Tamara 2521 Rath, Goura Kishor 1065 Sabater, Sebastia 2715 Shah, Anand 2960 Snider III, James 3412 Rathod, Shrinivas 3258 Sabit, Khusraw 2206 Shah, Bhartesh 2971 Snider III, James 2153 Ray, Geoff rey 3304 Sabolch, Aaron 2646 Shah, Mira 2279 Snider III, James 27 Reddy, Jay Paul 3149 Sachdev, Sean 2858 Shah, Nikesh 3320 Solanki, Abhishek 2601 Reddy, Vishruth 3440 Sachdev, Sean 2882 Shaikh, Fauzia 57 Son, Christina 2550 Redmond, Kristin 3298 Sachsman, Suzanne 3173 Shaikh, Fauzia 3317 Son, Jaeman 3803 Redmond, Kristin 1023 Saeed, Hina 3404 Shaikh, Talha 2333 Song, Andrew 2263 Refaat, Tamer 2013 Saeed, Nadia 2469 Shaikh, Talha 2358 Song, Sanghyuk 3383 Rehman, Sana 1010 Safdieh, Joseph 2537 Shaitelman, Simona 1035 Song, Yipeng 3538 Ren, Gang 2355 Sahgal, Arjun 178 Shankar, Vangipuram 3724 Sonier, Marcus 3749 Ren, Hua 1114 Sahgal, Arjun 2338 Sharabi, Andrew PL-01 Soon, Yu Yang 2924 Ren, Lei 46 Sai, Sei 3469 Sharma, Sonam 2881 Speers, Corey 70 Resende Salgado, Lucas 2446 Saito, Tetsuo 3231 Sharp, Hadley 2056 Speirs, Christina 3156 Reynolds, Robert 3720 Saito, Tetsuo 3225 Shasha, Daniel 2544 Spektor, Alexander 3451 Rhee, Woo Joong 3228 Saitoh, Jun-ichi 2676 Shaw, Edward 1013 Spencer, Christopher 2472 Rhome, Ryan 2208 Saksornchai, kitwadee 2018 Shekel, Efrat 2119 Spencer, Christopher 1058 Ricchetti, Francesco 2763 Sakthivel, Vasanthan 2908 Shen, Colette 2285 Spickermann, Maximilian 3170 Rice, Stephanie 2891 Sakumi, Akira 3691 Shen, Lijun 2439 Spieler, Benjamin 2487 Rice, Stephanie 108 Saleh, Ziad 82 Shen, Lijun 2437 Spiotto, Michael 2895 Richard, Patrick 2962 Salem, Ahmed 67 Shen, Sui 2087 Spiotto, Michael 2894 Richard, Patrick 3809 Salinas, Vanessa 3315 Shen, Xinglei 341 Spratt, Daniel 1124 Rico, Florentino 3563 Salter, Bill 3852 Shen, Yali 2452 Spratt, Daniel 3478 Rimner, Andreas 1142 Samiee, Sara 3283 Shen, Zhilei 3142 Spratt, Daniel 1126 Rimner, Andreas 44 Samuelian, Jason 3059 Sheng, Ke 3636 Sreeraman, Radhika 3307 Rimner, Andreas 3124 Samuels, Stuart 16 Shenouda, Mina 2028 Srivastava, Shiv 3671 Rineer, Justin 2145 Santanam, Lakshmi 233 Sher, David 320 Stalpers, Lukas 2257 Ríos Pozo, María 2138 Santhanam, Anand 154 Sherr, David 2363 Stalpers, Lukas 2220 Risberg, Miranda 3623 Santos, Daniel 3838 Shi, Xiutao 1077 Stanescu, Teo 203 Rizzo, Anthony 2166 Sapienza, Lucas 1025 Shi, Zeliang 2047 Stanton, Paul 167 Roach, Michael 1002 Sapienza, Lucas 2826 Shibamoto, Yuta 2557 Stauder, Michael 2045 Robar, James 3713 Sapienza, Lucas 2714 Shikama, Naoto 2001 Stecklein, Shane 3618 Robertson, Scott 2923 Saracino, Biancamaria 109 Shimizu, Arisa 3291 Steenbeke, Femke 3738 Robertson, Scott 2629 Saraiya, Siddharth 3103 Shimizu, Shinichi 3799 Stegmaier, Petra 2852 Robinson, Cliff ord 2211 Sarojini, Sreeja 3472 Shin, Jacob 2083 Stephans, Kevin 51 Robinson, Timothy 3565 Sato, Hiroo 2442 Shin, Jacob 2820 Sterzing, Florian 58 Rochefort, Pauline 3769 Sato, Mariko 3424 Shin, Samuel 2232 Sterzing, Florian 2599 Rockne, Russell 3564 Savir, Guy 2258 Shin, Samuel 3821 Stessin, Alexander 327 Rodrigues, George 2508 Schaidle, Colleen 3212 Shintani, Takashi 3005 Stewart, Alexandra 2541 Rodrigues, George 3125 Schaner, Philip 2778 Shioyama, Yoshiyuki 3108 Stish, Bradley 258 Rodriguez Villalba, Silvia 3390 Scher, Eli 2750 Shirai, Katsuyuki 3007 Stone, Brandon 3415 Roeder, Falk 254 Schmidberger, Heinz 3459 Shiraishi, Kenshiro 2564 Straka, Christopher 2531 Roenjom, Marianne Feen 2775 Schmuecking, Michael 3146 Shiraishi, Yutaka 2515 Strasser, Jon 2134 Roeper, Barbara 3310 Schoenfeld, Jonathan 3436 Shridhar, Ravi 1040 Strom, Eric 1106 Roeske, John 1102 Scholey, Jessica 3607 Shukla, Monica 2573 Strom, Tobin 2347 Rolfo, Maureen 2904 Schreiber, David 2948 Shulman, Jesse 2873 Strom, Tobin 2486 Romeo, Antonino 1143 Schreibmann, Eduard 2270 Shultz, David 2238 Sturdza, Alina 195 Romeo, Antonino 2356 Schuemann, Jan 48 Shumway, Dean 2631 Stuschke, Martin 323 Romesser, Paul 345 Schuster, Jessica 3252 Shumway, Dean 2052 Su, Zhong 3776 Romesser, Paul 3789 Schutzer, Matthew 2957 Shusharina, Nadya 2840 Su, Zhong 1107 Rong, Yi 3784 Sckolnik, Steven 3200 Sifuentes, Joshua 2529 Sudhyadhom, Atchar 2615 Rose, Brent 2142 Scorsetti, Marta 2406 Silva, Maria Leticia 2245 Sugie, Chikao 2012 Rose, Jim 2499 Scott, Michael 1123 Simon, Antoine 2562 Suh, Yae-eun 2830 Rose, Jim 2736 Scott, Michael 2836 Simone, Charles 3139 Suh, Yang-Gun 2842 Rosenberg, Stephen 2770 Scroggins, Bradley 330 Simontacchi, Gabriele 2107 Summers, Paige 3805 Rossetti, Andrew 3266 Seibert, Tyler 208 Simpson, Daniel 3627 Sun, Baozhou 2704 Rottmann, Joerg 3733 Sekar, Yuvaraj 3344 Sineshaw, Helmneh 287 Sun, Jian 3095 Rovirosa, Angeles 2712 Sekii, Shuhei 2291 Singh, Hardev 2611 Sun, Lova 2158
ASTRO 2014 / 56TH ANNUAL MEETING 191 Sun, Yunguang 3516 Thau, Matthew 2335 Van Dijk, Laura 1085 Wang, Xin 2423 Sun, Yunguang 3515 Thibault, Isabelle 269 Van Leeuwen, Caspar 3630 Wang, Xin 1120 Suneja, Gita 306 Thibault, Isabelle 3268 Van Sornsen de Koste, John 3608 Wang, Xin 2701 Suntharalingam, Mohan CT-04 Thomas, Evan 3001 Vance, Sean 2719 Wang, Yu-Ming 3238 Sura, Karna 321 Thomas, Evan 3856 Vanderstraeten, Barbara 232 Wang, Zhi 1115 Suttie, Clare 2101 Thompson, Catherine 2639 Vanoni, Valentina 2110 Ward, Matthew 2906 Suttie, Clare 3604 Thompson, Jonathan 3541 Varadhan, Raj 3655 Ward, Matthew 2821 Suwinski, Rafal 2432 Thompson, Kenton 3686 Varadhan, Raj 3350 Warkentin, Heather 3002 Suzuki, Yoshiyuki 3437 Thomson, David 3693 Vargo, John 265 Warrell, Gregory 2507 Sveistrup, Joen 2485 Thomson, David 214 Vatner, Ralph 3522 Warren, Laura 2144 Swanick, Cameron 2685 Thor, Maria 3638 Vatner, Ralph 3723 Watkins, William 3619 Syh, Joseph 2733 Tian, Sibo 3431 Vaughan, Andrew 3414 Waxweiler, Timothy 2884 Symon, Zvi 2597 Tian, Xi 3510 Veldwijk, Marlon 3438 Wazer, David 2066 Szeja, Sean 2218 Tijssen, Rob 3692 Velec, Michael 155 Wee, Chan Woo 2794 Szeja, Sean 3413 Timmerman, Robert 56 Velker, Vikram 2725 Wei, Randy 2128 Tinkle, Christopher 3406 Vendrely, Veronique 34 Wei, Xiong 3048 Tinkle, Christopher 2648 Venkat, Puja 2709 Weiner, Ashley 2441 Tinkle, Christopher 3402 Venkat, Puja 2707 Weiner, Joseph 2587 T Todor, Dorin 1103 Verbakel, Wilko 3845 Weir, Joshua 2780 Tachiki, Lisa 3670 Tonlaar, Nathan 2149 Verhoeven, Karolien 2108 Weir, Robert 2445 Taggar, Amandeep 2265 Torok, Jordan 3171 Verma, Jonathan 2115 Weiss, Elisabeth 3568 Tai, An 81 Torres-Roca, Javier 1031 Videtic, Gregory 3031 Weller, Michael 1129 Tait, Lauren 2657 Torres-Roca, Javier 3561 Vieira, Andre 3705 Welsh, James 3818 Takagi, Masaru 2864 Torres-Roca, Javier 3559 Vigneault, Eric 2554 Wen, Ning 1075 Takahashi, Ippei 3460 Toya, Ryo 2788 Villa, Salvador 1015 Whalley, Deborah 2638 Takahashi, Noriyoshi 3032 Toyomasu, Yutaka 2887 Vinogradskiy, Yevgeniy 129 Wheatley, Matthew 3135 Takahashi, Shigeo 3016 Tran, Phuoc 1047 Virk, Michael 2212 White, Benjamin 3599 Takahashi, Wataru 1141 Treharne, Gregory 2693 Visser, Jorrit 3791 White, Evan 3699 Takamatsu, Shigeyuki 2390 Trifi letti, Daniel 2123 Viswanathan, Akila 1061 White, Evan 3772 Takamatsu, Shigeyuki 2389 Trifi letti, Daniel 2951 Vitzthum, Lucas 3337 Widlak, Piotr 3453 Takanaka, Tsuyoshi 3003 Troeller, Almut 83 Volotskova, Olga 3479 Wiedenmann, Nicole 5 Takaoka, Taiki 2408 Trovo, Marco 3004 Voong, Khinh Ranh 2455 Wilcox, Shea 2900 Takeda, Ken 2759 Trovo, Marco 3083 Vujovic, Olga 2019 Wilke, Christopher 3175 Takeda, Ken 2813 Trovo, Marco 2008 Vyas, Shilpa 256 Wilke, Christopher 3407 Takehana, Keiichi 2812 Truong, Pauline 95 Willers, Henning 223 Takeuchi, Yuki 3051 Tryggestad, Erik 3795 Willett, Addison 257 Takiar, Vinita 2679 Tsai, Mu-Hung 2856 W Williams, Norman 2006 Taku, Nicolette 2746 Tsegmed, Uranchimeg 2395 Waddle, Mark 2934 Williams, Terence 2382 Talamonti, Cinzia 3758 Tseng, Chia-Lin 270 Wahl, Daniel 2412 Wiltink, Lisette 183 Tamari, Keisuke 2224 Tseng, Yolanda 2068 Wahl, Michael 75 Witztum, Alon 3600 Tan, Daniel 3248 Tsiamas, Panagiotis 3844 Walker, Amanda 117 Wo, Jennifer 2466 Tan, Jun 2312 Tuano, Diana 2109 Wallace, Harold 2551 Wobb, Jessica 2140 Tan, Jun 2310 Tuli, Richard 3544 Wallach, Jonathan 2025 Wobb, Jessica 1087 Tan, Lai 2795 Tuohy, Rachel 3709 Wallner, Paul 2980 Wobb, Jessica 3542 Tan, Vivian 1028 Turaka, Aruna 3008 Walston, Steve 3540 Wojcieszynski, Andrzej 2003 Tanaka, Hiroshi 3246 Turaka, Aruna 3018 Wang, Ange 3296 Wolfe, Adam 1043 Tanaka, Nobumichi 1131 Wang, Bin 3468 Wong, Andrew 2057 Tandberg, Daniel 3021 Wang, Chengtao 2803 Wong, Anthony 2965 Tanderup, Kari 196 U Wang, Chunhao 87 Wong, Jeff rey 3194 Tang, Chad 3029 Udayakumar, Wang, Dongxu 3792 Wong, Ru xin 2197 Tang, Chad 3030 Thirupandiyur 2600 Wang, Edina 3505 Wong, Tony 3798 Tang, Linglong 1009 Ueda, Yoshihiro 3594 Wang, Haotong 3385 Woo, Jennifer 3261 Tang, Yu 2450 Ueki, Nami 3081 Wang, Huan-Huan 3753 Woo, Jennifer 3257 Tanguturi, Shyam 2461 Ugurluer, Gamze 2673 Wang, Jianyang 3377 Woo, Joong Yeol 3722 Tanguturi, Shyam 1022 Uh, Jinsoo 3301 Wang, Jiazhou 1105 Woody, Neil 94 Tanzler, Emily 2802 Umezawa, Rei 1116 Wang, Jin 2297 Woolf, David 2032 Tao, Jessie 3421 Umezawa, Rei 2309 Wang, Jin 2298 Wooten, Charles 268 Tao, May Lin 2042 Ung, Kim Ann 2430 Wang, Jing 1101 Wooten, Hasani 209 Tao, Randa 142 Urbanic, James 185 Wang, Jingbo 169 Wray, Justin 325 Tatekawa, Kotoha 3180 Urbanski, Bartosz 2002 Wang, Lan 2319 Wright, Christopher 72 Taunk, Neil 1121 Urdaneta, Alfredo 2607 Wang, Lora 2360 Wright, Jean 2062 Taylor, Kinley 3371 Wang, Qi 3013 Wright, Jean 2136 Taylor, Robert 1068 Wang, Suzhen 2071 Wu, Abraham 128 Teboh Forbang, Roland 2373 V Wang, Suzhen 2072 Wu, Jianzhou 3751 Telivala, Tejas 3781 Vainshtein, Jeff rey 216 Wang, Tao 3518 Wu, Junxin 2327 Tennyson, Nathan 3209 Vainshtein, Jeff rey 2754 Wang, Ti-Hao 3606 Wu, Q. Jackie 3063 Teng, Feifei 3022 Valderrama, Adriana 3259 Wang, Tonghe 3766 Wu, Szu-Yuan 3503 Tetreault, Audrey 2984 Valentini, Chiara 3143 Wang, Tony 2252 Wu, tao 2105 Thaker, Nikhil 3316 Vallieres, Martin 3 Wang, Wei 2046 Wu, Vincent 2783 Thaker, Nikhil 2992 Van de Pol, Sandrine 2502 Wang, Weili 3151 Wurstbauer, Karl 3053 Thammineni, Pratap Reddy 2073 Van der Heide, Hugo 2868 Wang, Xiao Shen 1049 Wzietek, Iwona 37 Thariat, Juliette 2859 Van Diessen, Judi 3120 Wang, Xin 2201
192 ASTRO 2014 / 56TH ANNUAL MEETING Ying, Hongmei 2787 Zhang, Yan 2438 X Ying, James 2478 Zhang, Yibao 161 Xia, Fen 3450 Yip, Connie 3020 Zhang, Ying 2655 Xiang, Liangzhong 3849 Yip, Darwin 2854 Zhang, You 3591 Xiao, Canhua 2915 Yip, Darwin 3392 Zhang, Zhenhuan 3497 Xiao, Qin 2448 Yip, Stephen 47 Zhao, Bo 3601 Xiao, WeiWei 2808 Yoo, Hyun 3429 Zhao, Bo 3783 Xie, Liyi 3127 Yoo, Stella 3207 Zhao, Diana Yi 3457 Xing, Ligang 3508 Yoo, Sua 2055 Zhao, Fen 2178 Xingwen, Fan 3456 Yoon, Hong In 2677 Zhao, Hanxi 98 Xu, Beibei 2897 Yoon, Kyoung Jun 3654 Zhao, Jing 125 Xu, Karen 2660 Yorozu, Atsunori 1130 Zhao, Li 3807 Xu, Qiong 3712 Yoshitake, Tadamasa 3109 Zhao, Nan 3842 Xu, Ting 226 Younan, Lawrence 2844 Zhao, Nan 3843 Xu, Ting 3537 Young, Kristina 3416 Zhao, Shuang 181 Young, Kristina 120 Zhao, Shuang 3562 Young, Rebekah 2705 Zhao, Weizhao 33 Y Young, Rebekah 2092 Zheng, Dandan 3102 Yadav, Budhi 2060 Yu, Edward 2009 Zheng, Shuai 3552 Yamada, Yoshiya 272 Yu, Esther 2429 Zheng, Yuanshui 3816 Yamamoto, Takaya 3026 Yu, James 302 Zheng, Zhiyuan 2586 Yamashita, Hideomi 3119 Yu, Jialu 3331 Zhou, Jessica 2743 Yan, Di 3653 Yu, Naichang 2947 Zhou, Jessica 3278 Yang, Bin 3365 Yu, Suhong 3666 Zhou, Jun 2 Yang, Ching-Chieh 2434 Yu, Victoria 3640 Zhou, Lin 3009 Yang, Ching-Chieh 2246 Yu, Wen 13 Zhou, Meixiang 3025 Yang, Daniel 2937 Yuan, Lulin 227 Zhou, Qichao 2797 Yang, Fei 2656 Yue, Yong 2365 Zhou, Xin 1057 Yang, George 2604 Yuen, Florence 3214 Zhuang, Hong-Qing 2269 Yang, Jia 3477 Zhung, Joanne 3756 Yang, Jia 3525 Zhung, Joanne 3062 Yang, Jinsong 2324 Z Ziehr, David 23 Yang, Jinsong 2340 Zahra, Amir 3253 Ziehr, David 2608 Yang, Ruijie 3341 Zaini, Mehran 3819 Zielinska-Chomej, Yang, Jonathan 2079 Zaki, Mark 2339 Katarzyna 3448 Yang, Jonathan 2545 Zamdborg, Leonid 2082 Zilli, Thomas 3752 Yang, Jonathan 1016 Zang, Jian 3188 Zlateva, Yana 1097 Yang, Wensha 3698 Zaorsky, Nicholas 2993 Zumsteg, Zachary 73 Yang, Xiaofeng 2063 Zapatero, Almudena PL-02 Yang, Xiaofeng 2575 Zarepisheh, Masoud 234 Yang, Yong 3621 Zavitsanos, Peter 2857 Yang, ZhaoZhi 2014 Zaza, Khaled 2636 Yao, Min 1052 Zeitlin, Ross 2610 Yao, Weiguang 3717 Zellars, Richard Cedric 2152 Yap, Mei Ling 3080 Zellars, Richard Cedric 2146 Yaparpalvi, Ravindra 3746 Zeng, Chuan 3804 Yard, Brian 66 Zhang, Chi 3496 Yashar, Catheryn 2129 Zhang, Hao 3597 Yassa, Michael 2053 Zhang, Li 2035 Yathiraj, Prahlad 211 Zhang, Li 2038 Yazici, Gozde 3774 Zhang, Li Yuan 3452 Ybarra, Norma 3632 Zhang, Minsi 3427 Ye, Fan 2606 Zhang, Ning 2785 Ye, Hong 3254 Zhang, Peng 3470 Ye, Jason 2961 Zhang, Peng 2314 Ye, Jason 2078 Zhang, Peng 192 Ye, Jin-Song 3750 Zhang, Pengpeng 3575 Yeboa, Debra 2988 Zhang, Qian 2090 Yeung, Daniel 2762 Zhang, Qinghui 3770 Yeung, Rosanna 2051 Yeung, Rosanna 2054 Yi, Byong Yong 3362
ASTRO 2014 / 56TH ANNUAL MEETING 193 Index by Track (Abstracts only)
BREAST CANCER Abo-Madyan, Yasser 2026 Acharya, Sahaja 2086 Warren, Laura 2144 Anne, Pramila 90 Falchook, Aaron 2027 Shen, Sui 2087 Rineer, Justin 2145 Ho, Alice 91 Shenouda, Mina 2028 Hansen, Tara 2088 Zellars, Richard Cedric 2146 Fowble, Barbara 92 Karasawa, Kumiko 2029 Lopresti, Mary 2089 Smith, Linda 2147 Liss, Adam 93 Chandra, Ravi 2030 Zhang, Qian 2090 Patel, Nisha 2148 Woody, Neil 94 Rakhra, Sunpreet 2031 Rahimi, Asal 2091 Tonlaar, Nathan 2149 Truong, Pauline 95 Woolf, David 2032 Young, Rebekah 2092 Chin, Joanna 2150 Hamilton, Sarah 96 Duelge, Jason 2033 Li, Linna 2093 Chang, Jennifer 2151 Bergom, Carmen 97 Ambroa Rey, Eva 2034 Lymberiou, Timothy 2094 Zellars, Richard Cedric 2152 Setton, Jermey 146 Zhang, Li 2035 Pham, Trang 2095 Snider III, James 2153 Gupta, Gaorav 147 Pinnaro, Paola 2036 Lee, Grace 2096 Fasola, Carolina 2154 Garg, Rashi 148 Bosnic, Sandi 2037 Chung, Yoonsun 2097 Eblan, Michael 2155 Kandula, Shravan 149 Zhang, Li 2038 Li, Shuai 2098 Dowlatshahi, Morteza 2156 Ng, Sweet 150 McGuffi n, Merrylee 2039 Keiler, Louis 2099 Jing, Hao 151 Cordova, Elisa 2040 Demas, Kristina 2100 CENTRAL NERVOUS SYSTEM Boelke, Edwinq 152 Del Cerro Penalver, Elia 2041 Suttie, Clare 2101 Mehta, Minesh 74 Ma, Jinli 153 Tao, May Lin 2042 Dai Kubicky, Charlotte 2102 Wahl, Michael 75 Polgar, Csaba 292 Rana, Zaker 2043 Lai, Shihfan 2103 Lo, Andrea 76 Lalani, Nafi sha 294 Healy, Erin 2044 Noh, Jae Myoung 2104 Kim, Michelle 77 Horton, Janet 295 Stauder, Michael 2045 Wu, Tao 2105 Choe, Kevin 78 Ma, Lin 296 Wang, Wei 2046 Bourgier, Celine 2106 Belcaid, Zineb 79 Chen, Peter 297 Shi, Zeliang 2047 Simontacchi, Gabriele 2107 Huff , Byron 80 Hepel, Jaroslaw 298 Alco, Gul 2048 Verhoeven, Karolien 2108 Thibault, Isabelle 269 Leong, Nelson 299 Hitchcock, Whitney 2049 Tuano, Diana 2109 Tseng, Chia-Lin 270 Sapienza, Lucas 1025 Bazan, Jose 2050 Vanoni, Valentina 2110 Pan, Hubert 271 Kim, Kyung Hwan 1026 Yeung, Rosanna 2051 Kato, Masako 2111 Yamada, Yoshiya 272 Eldredge-Hindy, Harriet 1027 Shumway, Dean 2052 No, Hyunsoo 2112 Nichol, Alan 273 Tan, Vivian 1028 Yassa, Michael 2053 Jwa, Eunjin 2113 Hadzitheodorou, Christina 274 Murphy, Colin 1029 Yeung, Rosanna 2054 Patel, Kruti 2114 Ayala-Peacock, Diandra 275 Braunstein, Lior 1030 Yoo, Sua 2055 Verma, Jonathan 2115 Bohoudi, Omar 276 Torres-Roca, Javier 1031 Sharp, Hadley 2056 Petersen, Ivy 2116 Shaw, Edward 1013 Golden, Encouse 1032 Wong, Andrew 2057 Cascales Garcia, Maria Cao, Kim 1014 Lim, Trevor 1033 Herman, Lauren 2058 Almudena 2117 Villa, Salvador 1015 De Rose, Fiorenza 1034 Gillespie, Erin 2059 Nichols, Elizabeth 2118 Yang, T. Jonathan 1016 Shaitelman, Simona 1035 Yadav, Budhi 2060 Shekel, Efrat 2119 Farnia, Benjamin 1017 Cooper, Benjamin 1036 Belkacemi, Yazid 2061 Johnson, Julian 2120 Akram, Kothwal 1018 Shikama, Naoto 2001 Wright, Jean 2062 Lee, Anna 2121 Quigley, Matthew 1019 Urbanski, Bartosz 2002 Yang, Xiaofeng 2063 Manzerova, Julia 2122 Slade, Alexander 1020 Wojcieszynski, Andrzej 2003 Bekelman, Justin 2064 Trifi letti, Daniel 2123 Hanna, Andrew 1021 Mak, Kimberley 2004 Mutter, Robert 2065 Rao, Nalini 2124 Tanguturi, Shyam 1022 Rajagopalan, Malolan 2005 Wazer, David 2066 Lok, Benjamin 2125 Redmond, Kristin 1023 Williams, Norman 2006 Braunstein, Lior 2067 Mattes, Malcolm 2126 Loiselle, Christopher 1024 Cuaron, John 2007 Tseng, Yolanda 2068 Kesava Ramgopal, Marsh, James 2157 Trovo, Marco 2008 Cao, Lu 2069 Adavikolanu 2127 Sun, Lova 2158 Yu, Edward 2009 Page, Brandi 2070 Wei, Randy 2128 Caudell, Jimmy 2159 Erickson, Delnora 2010 Wang, Suzhen 2071 Yashar, Catheryn 2129 LaPlant, Quincey 2160 Duma, Marciana-Nona 2011 Wang, Suzhen 2072 Gultekin, Melis 2130 Luchi, Toshihiko 2161 Sugie, Chikao 2012 Thammineni, Nikhila 2073 Ahlawat, Stuti 2131 Kim, Michelle 2162 Refaat, Tamer 2013 Li, Weiwei 2074 Massabeau, Carole 2132 Elson, Andrew 2163 Yang, ZhaoZhi 2014 Chen, Jiayi 2075 Hymas, Richard 2133 Patel, Abhilasha 2164 Leonard, Charles 2016 Yang, T. Jonathan 2076 Strasser, Jon 2134 Chirindel, Alin 2165 Kawamura, Mariko 2017 Li, Shuai 2077 Goldsmith, Christy 2135 Rizzo, Anthony 2166 Saksornchai, Kitwadee 2018 Ye, Jason 2078 Wright, Jean 2136 Azoulay, Melissa 2167 Vujovic, Olga 2019 Yang, T. Jonathan 2079 Chen, Peter 2137 Carlson, Julie 2168 Knoll, Miriam 2020 Ogita, Mami 2080 Ríos Pozo, María 2138 Carlson, Julie 2169 Ding, Yun 2021 Jarvis, Lesley 2081 Hartsell, William 2139 Diaz Pardo, Dayssy 2170 Jones, Guy 2022 Zamdborg, Leonid 2082 Wobb, Jessica 2140 Igaki, Hiroshi 2171 De Paula, Ugo 2023 Shin, Jacob 2083 Ognibene, Grant 2141 Desai, Brijal 2172 Kathpal, Madeera 2024 Belkacemi, Yazid 2084 Rose, Brent 2142 Anker, Christopher 2173 Wallach, Jonathan 2025 Mirabeau-Beale, Kristina 2085 Petereit, Daniel 2143 Nakajima, Naomi 2174
194 ASTRO 2014 / 56TH ANNUAL MEETING Nakajima, Naomi 2175 Shultz, David 2238 Dominello, Michael 17 Wang, Lan 2319 Nakajima, Naomi 2176 Bagshaw, Hilary 2239 Vendrely, Veronique 34 Han, Dali 2320 Kucharczyk, Michael 2177 Chang, Jennifer 2240 Ahmed, Kamran 35 Han, Chun 2321 Zhao, Fen 2178 Ahmed, Kamran 2241 Hong, Theodore 36 Machiels, Melanie 2322 Bovi, Joseph 2179 Seymour, Zachary 2242 Wzietek, Iwona 37 Ishikawa, Kazuki 2323 Li, Xin 2180 Fogarty, Gerald 2243 Ngan, Samuel 38 Yang, Jinsong 2324 Kusumawidjaja, Grace 2181 Choi, Seohee 2244 Czito, Brian 39 Ishikawa, Hitoshi 2325 Fujitani, Nobumasa 2182 Silva, Maria Leticia 2245 Engels, Benedikt 40 Nishibuchi, Ikuno 2326 Rahman, Rifaquat 2183 Yang, Ching-Chieh 2246 Liu, Wenyang 41 Wu, Junxin 2327 Debus, Charlotte 2184 Huang, Andrew 2247 Olsen, Jeff rey 59 Liu, Hui 2328 Anwar, Mekhail 2185 Lucas, John 2248 Mai, Sabine 60 Giaddui, Tawfi k 2329 Holmes, Jordan 2186 Raber, Jacob 2249 Doll, Corinne 61 James, Sarah 2330 Diletto, Barbara 2187 Levin-Epstein, Rebecca 2250 Goodman, Karyn 62 Ludmir, Ethan 2331 Chiesa, Silvia 2188 Kotecha, Rupesh 2251 Lee, Andrew 63 Chen, Yun 2332 Jairam, Vikram 2189 Wang, Tony 2252 Bitterman, Danielle 64 Shaikh, Talha 2333 Hardie, John 2190 Khan, Luluel 2253 Cardenas, Michael 65 Kawanaka, Takashi 2334 Huang, Jiayi 2191 Gondi, Vinai 2254 Quan, Kimmen 99 Thau, Matthew 2335 Kang, Julie Jung 2192 Moraes, Paulo 2255 Colbert, Lauren 100 Chofl et, Amanda 2336 Lecavalier-Barsoum, Masson-Cote, Laurence 2256 Merrell, Kenneth 101 Nonaka, Tetsuo 2337 Magali 2193 Stalpers, Lukas 2257 Pollom, Erqi 102 Sahgal, Arjun 2338 Narang, Amol 2194 Savir, Guy 2258 Choi, Chihwan 103 Zaki, Mark 2339 Randolph, David 2195 Gorovets, Daniel 2259 Meyer, Jeff rey 104 Yang, Jinsong 2340 Osmundson, Evan 2196 Jayachandran, Priya 2260 Hirata, Takero 105 Boda-Heggemann, Judit 2341 Wong, Ru Xin 2197 Burkeen, Jeff rey 2261 Ohri, Nitin 106 Cheng, Jessica 2342 Meyer, Kurt 2198 Jani, Ashish 2262 Koc, Mehmet 1109 Li, Guichao 2343 Marciscano, Ariel 2199 Song, Andrew 2263 Bernard, Mark 1110 Lu, NingNing 2344 Joshi, Nikhil 2200 Althaqfi , Saif 2264 Lin, Chi 1111 Patel, Ravi 2345 Wang, Xin 2201 Taggar, Amandeep 2265 Kim, Tae Hyung 1112 Cuneo, Kyle 2346 Russo, Gregory 2202 Murai, Taro 2266 Dover, Laura 1113 Strom, Tobin 2347 Kittel, Jeff rey 2203 Hasan, Yaser 2267 Ren, Hua 1114 Colbert, Lauren 2348 Maclean, Jillian 2204 Chan, Jason 2268 Wang, Zhi 1115 Kishi, Takahiro 2349 Kennedy, William 2205 Zhuang, Hong-Qing 2269 Umezawa, Rei 1116 Kennoki, Norifumi 2350 Sabit, Khusraw 2206 Schreibmann, Eduard 2270 Berman, Abigail 1117 Freilich, Jessica 2351 Dyer, Michael 2207 Eaton, Bree 2271 Kong, Jie 1118 Li, Jinluan 2352 Rhome, Ryan 2208 Mickevicius, Nikolai 2272 Li, Tao 1119 Dalah, Entesar 2353 Jeff eris, Jennifer 2209 Giem, Jared 2273 Wang, Xin 1120 Kasuya, Takeo 2354 Ahmed, Zain 2210 Broomfi eld, Joel 2274 Sekii, Shuhei 2291 Ren, Gang 2355 Robinson, Cliff ord 2211 Lanning, Ryan 2275 Di, Liu 2292 Romeo, Antonino 2356 Virk, Michael 2212 Lindberg, Karin 2276 Dean, Mary 2293 Peguret, Nicolas 2357 Jain, Prachi 2213 Arneson, Kyle 2277 Doi, Yoshiko 2294 Shaikh, Talha 2358 Chang, Eric 2214 Modlin, Leslie 2278 Fernandes, Annemarie 2295 Ling, Ted 2359 Marwaha, Gaurav 2215 Shah, Mira 2279 Boggs, Hunter 2296 Wang, Lora 2360 Li, Puyao 2216 Pham, Anthony 2280 Wang, Jin 2297 Abrams, Matthew 2361 Barker, Christopher 2217 Munbodh, Reshma 2281 Wang, Jin 2298 Mellon, Eric 2362 Szeja, Sean 2218 Abraham, Christopher 2282 Servagi Vernat, Stephanie 2299 Sherr, David 2363 Polishchuk, Alexei 2219 Estabrook, Neil 2283 Kawamura, Mariko 2300 Baschnagel, Andrew 2364 Stalpers, Lukas 2220 Johnson, Matthew 2284 Murakami, Yuji 2301 Yue, Yong 2365 Price, Samantha 2221 Shen, Colette 2285 Qu, Melody Xuanlu 2302 Hayman, Thomas 2366 Perez, Bradford 2222 Badiyan, Shahed 2286 Nishimura, Yasumasa 2303 Hajj, Carla 2367 Nagai, Aiko 2223 Press, Robert 2287 Nabavizadeh, Nima 2304 Lutz, Ryan 2368 Tamari, Keisuke 2224 Abel, Ryan 2288 Ito, Yoshinori 2305 Mian, Omar 2369 Mathew, Prince 2225 Masino, Alexander 2289 Atsumi, Kazushige 2306 Liang, Yun 2370 Bates, James 2226 Chang, Jennifer 2290 Ariga, Takuro 2307 Gan, Hua 2371 Lazow, Stefanie 2227 Ling, Ted 2308 Bernstein, Michael 2372 Pollock, Bruce 2228 GASTROINTESTINAL CANCER Umezawa, Rei 2309 Teboh Forbang, Roland 2373 Patel, Shyamal 2229 Penniment, Michael CT-03 Tan, Jun 2310 Moningi, Shalini 2374 Miyakawa, Akifumi 2230 Suntharalingam, Mohan CT-04 Myojin, Miyako 2311 Latifi , Kujtim 2375 Hayashi, Akihiro 2231 Chiang, Yun 10 Tan, Jun 2312 Kocak, Esengul 2376 Shin, Samuel 2232 Fu, Shen 11 Meng, Mao-Bin 2313 Palmer, Joshua 2377 Harada, Hideyuki 2233 Chhabra, Arpit 12 Zhang, Peng 2314 Palmer, Joshua 2378 Colaco, Rovel 2234 Yu, Wen 13 Guo, Yanluan 2315 Horowitz, David 2379 Colaco, Rovel 2235 Rackley, Thomas 14 Guo, Yanluan 2316 Moningi, Shalini 2380 Clavier, Jean-Baptiste 2236 Li, Minghuan 15 Guo, Yanluan 2317 Berriochoa, Camille 2381 Ahmed, Kamran 2237 Samuels, Stuart 16 Hsu, Feng-Ming 2318 Williams, Terence 2382
ASTRO 2014 / 56TH ANNUAL MEETING 195 Lai, Yo-Liang 2383 Xiao, Qin 2448 Scott, Michael 1123 Kalbasi, Anusha 2532 Huang, Wei 2384 Lei, Xin 2449 Crehange, Gilles 1125 Kotecha, Rupesh 2533 Kishan, Amar 2385 Tang, Yu 2450 Spratt, Daniel 1126 Hanna, Nevine 2534 Huang, Yaoru 2386 Koo, Tae Ryool 2451 Ashamalla, Hani 1127 Loblaw, D. Andrew 2535 Keene, Kimberly 2387 Shen, Yali 2452 Mason, Mathew 1128 Hamilton, Sarah 2536 Iizuka, Yusuke 2388 Chen, Helen 2453 Weller, Michael 1129 Safdieh, Joseph 2537 Takamatsu, Shigeyuki 2389 Jeongshim, Lee 2454 Yorozu, Atsunori 1130 Ishii, Kentaro 2538 Takamatsu, Shigeyuki 2390 Voong, Khinh Ranh 2455 Tanaka, Nobumichi 1131 Miller, Seth 2539 Sioshansi, Shirin 2391 Bhirud, Abhijeet 2456 Krauss, Daniel 1132 Hempel, Dominika 2540 Klein, Jonathan 2392 Bennion, Nathan 2457 Mikell, John 2476 Stewart, Alexandra 2541 Kudithipudi, Vijay 2393 Morris, Zachary 2458 Hall, Matthew 2477 Lin, Yu-Wei 2542 Apisarnthanarax, Smith 2394 Anderson, Eric 2459 Ying, James 2478 Hong, Cheng 2543 Tsegmed, Uranchimeg 2395 Anand, Aman 2460 Huynh-Le, Minh-Phuong 2479 Shasha, Daniel 2544 Comito, Tiziana 2396 Tanguturi, Shyam 2461 Phillips, John 2480 Yang, T. Jonathan 2545 Hall, William 2397 Kozak, Malgorzata 2462 Naydich, Boris 2481 Nabhani, Thomas 2546 Niska, Joshua 2398 Moeller, Benjamin 2463 Hashimoto, Yaichiro 2482 Dolezel, Martin 2547 Raldow, Ann 2399 De Bari, Berardino 2464 Marina, Ovidiu 2483 Lloyd, Shane 2548 Ernst, Iris 2400 Longo, John 2465 Ogino, Hiroyuki 2484 Oksuz, Didem 2549 Oh, Ryoong Jin 2401 Wo, Jennifer 2466 Sveistrup, Joen 2485 Son, Christina 2550 Paik, Eun Kyung 2402 Grew, David 2467 Strom, Tobin 2486 Wallace, Harold 2551 Goodman, Ben 2403 Amin, Raima 2468 Spieler, Benjamin 2487 Jackson, William 2552 Shaff er, Jenny 2404 Saeed, Nadia 2469 Cho, Eunpi 2488 Gray, Phillip 2553 Chang, Daniel 2405 Muirhead, Rebecca 2470 Pham, Yvonne 2489 Vigneault, Eric 2554 Scorsetti, Marta 2406 Baden, Craig 2471 Finkelstein, Steven 2490 Chiang, Andrew 2555 Muller, Karin 2407 Spencer, Christopher 2472 Park, Henry 2491 Crawford, E. David 2556 Takaoka, Taiki 2408 Patel, Abhilasha 2473 Nomiya, Takuma 2492 Yanagi, Takeshi 2557 Engineer, Reena 2409 Sezen, Duygu 2474 Seymour, Zachary 2493 Counago, Felipe 2558 Feng, Mary 2410 Palta, Manisha 2475 Evans, Joseph 2494 Kattevilder, Robert 2559 Qiu, Haoming 2411 Seymour, Zachary 2495 Ferrer, Ferran 2560 Wahl, Daniel 2412 GENITOURINARY CANCER Counago, Felipe 2496 Asakura, Hirofumi 2561 Bhooshan, Neha 2413 Hurwitz, Mark CT-01 Counago, Felipe 2497 Simon, Antoine 2562 Chuong, Michael 2414 Zapatero, Almudena PL-02 Kishan, Amar 2498 Kountouri, Melpomeni 2563 Mannina, Edward 2415 James, Nicholas 18 Rose, Jim 2499 Shiraishi, Kenshiro 2564 Blacksburg, Seth 2416 Lin, Chun Chieh 19 Chhabra, Arpit 2500 Lecavalier-Barsoum, Shaff er, Jenny 2417 Rusthoven, Chad 20 Krauss, Daniel 2501 Magali 2565 Halthore, Aditya 2418 Narang, Amol 21 Van de Pol, Sandrine 2502 Milecki, Piotr 2566 Chuong, Michael 2419 Kohutek, Zachary 22 Murphy, Colin 2503 Qi, Xin 2567 Bota, Krista 2420 Ziehr, David 23 Kang, Hyun-Cheol 2504 Qi, Xin 2568 Osmundson, Evan 2421 Nabid, Abdenour 24 Mason, Josh 2505 Hathout, Lara 2569 Dyer, Brandon 2422 Brower, Jeff rey 107 Orman, Amber 2506 Commandeur, Frédéric 2570 Wang, Xin 2423 Rice, Stephanie 108 Warrell, Gregory 2507 Hogue, Cory 2571 Morillo Macías, Virginia 2424 Saracino, Biamcamaria 109 Rodrigues, George 2508 Galalae, Razvan 2572 Lashkari, Marzieh 2425 McLaughlin, Patrick 111 Edwards, Albert 2509 Shukla, Monica 2573 Lefresne, Shilo 2426 Pugh, Thomas 112 Fuller, Donald 2510 Blay, Christophe 2574 Huang, Chun-Ming 2428 Kerns, Sarah 113 Helou, Joelle 2511 Yang, Xiaofeng 2575 Yu, Esther 2429 Fachal, Laura 114 Jensen, Lindsay 2512 McHaffi e, Derek 2576 Ung, Kim Ann 2430 Kang, Julie Jung 285 Helou, Joelle 2513 Chalubinska-Fendler, Li, Ning 2431 Abramowitz, Matthew 286 Bagley, Jack 2514 Justyna 2577 Suwinski, Rafal 2432 Sineshaw, Helmneh 287 Shiraishi, Yutaka 2515 Agoston, Peter 2578 Benezery, Karine 2433 Pham, Huong 288 Thompson, Catherine 2516 Michalski, Jeff 2579 Yang, Ching-Chieh 2434 Mitin, Timur 289 Pos, F.J. 2517 Nguyen, Paul 2580 Jimenez-Jimenez, Esther 2435 Muren, Ludvig 290 Engels, Benedikt 2519 Oh, Steven 2581 Kim, Jae-Sung 2436 Baumann, Brian 290.5 Inokuchi, Haruo 2520 Lovelock, D. Michael 2582 Shen, Lijun 2437 Gray, Phillip 291 Smith, Tamara 2521 Kavanaugh, James 2583 Zhang, Yan 2438 Shen, Xinglei 341 Gomez, Caitlin 2522 Kwok, Young 2584 Shen, Lijun 2439 Caster, Joseph 342 Nelson, Aaron 2523 Grimm, Shu-Ya Lisa 2585 Glick, Daniel 2440 Phillips, John 343 Cheng, Jonathan 2524 Zheng, Zhiyuan 2586 Weiner, Ashley 2441 Naik, Mihir 344 Bryant, Curtis 2525 Weiner, Joseph 2587 Sato, Hiroo 2442 Romesser, Paul 345 Hughes, Michael 2526 Meister, Moshe 2588 Lim, Hyeon Woo 2443 Malone, Shawn 346 Mourad, Waleed 2527 Harris, David 2589 Kim, Tae Hyung 2444 Den, Robert 347 Huang, Roger 2528 Crehange, Gilles 2590 Weir, Robert 2445 Erho, Nicholas 348 Sifuentes, Joshua 2529 Mahal, Brandon 2591 Resende Salgado, Lucas 2446 Taunk, Neil 1121 Mourad, Waleed 2530 Marcus, David 2592 Lawrence, Yaacov 2447 Gibson, Eli 1122 Straka, Christopher 2531 Melotek, James 2593
196 ASTRO 2014 / 56TH ANNUAL MEETING Musunuru, Hima 2594 GYNECOLOGIC CANCER Hansen, Henrik 2691 HEAD AND NECK CANCER Kazberuk, Dorota 2595 Jastaniyah, Noha 194 Eng, Tony 2692 Berk, Lawrence CT-07 Mahal, Brandon 2596 Sturdza, Alina 195 Treharne, Gregory 2693 Yathiraj, Prahlad 211 Symon, Zvi 2597 Tanderup, Kari 196 Best, Ryan 2694 Grover, Surbhi 212 Chang, Albert 2598 Bishop, Andrew 197 Karakaya, Ebru 2695 Marciscano, Ariel 213 Sterzing, Florian 2599 Ho, Clement 198 Lim, Jihoon 2696 Thomson, David 214 Udayakumar, Markovina, Stephanie 200 Mei, Feng 2697 O'Sullivan, Brian 215 Thirupandiyur 2600 Henke, Lauren 201 Rash, Dominique 2698 Vainshtein, Jeff rey 216 Solanki, Abhishek 2601 Small, William 236 Michaud, Anthony 2699 Grossman, Craig 217 Henry, Ann 2602 Harkenrider, Matthew 237 Sethi, Rajni 2700 Moon, Dominic 218 Lukens, John 2603 Croke, Jennifer 238 Wang, Xin 2701 Lee, Victor 261 Yang, George 2604 Nout, Remi 239 Croke, Jennifer 2702 Chua, Melvin Lee Kiang 262 Moraes, Fabio Ynoe 2605 Damast, Shari 240 Lin, Angela 2703 Galloway, Thomas 263 Ye, Fan 2606 Patel, Sagar 241 Sun, Baozhou 2704 Hollen, Tyler 264 Urdaneta, Alfredo 2607 Lee, Larissa 242 Young, Rebekah 2705 Vargo, John 265 Ziehr, David 2608 Lin, Jeff 243 Herskovic, Alex 2706 Ghaly, Maged 266 Engelman, Alexander 2609 Viswanathan, Akila 1061 Venkat, Puja 2707 Funk, Ryan 267 Zeitlin, Ross 2610 Hong, Ji-Hong 1062 McClinton, Chris 2708 Wooten, Charles 268 Singh, Hardev 2611 Chino, Junzo 1063 Venkat, Puja 2709 Herskovic, Alex 307 Blas, Kevin 2612 Mahantshetty, Umesh 1064 Nagar, Himanshu 2710 Wang, XiaoShen 1049 Ram, Ashwin 2613 Rath, Goura Kishor 1065 Chang-Halpenny, Christine 2711 Lin, Zhixiong 1050 Narang, Amol 2614 Castelnau-Marchand, Rovirosa, Angeles 2712 Lucas, John 1051 Sudhyadhom, Atchar 2615 Pauline 1066 Ferraris, Gustavo 2713 Yao, Min 1052 Pollack, Alan 2616 Taylor, Robert 1068 Sapienza, Lucas 2714 Cruz, Misael 1053 Syed, A. Nisar 2617 Li, Qian 1069 Sabater, Sebastia 2715 Baral, Shweta 1054 Ram, Ashwin 2618 Kidd, Elizabeth 1070 Nagar, Himanshu 2716 Huang, Shao Hui 1055 Green, Garrett 2619 Mislmani, Mazen 1071 Lu, Sharon 2717 Mendenhall, William 1056 Asher, David 2620 Chaudary, Naz 1072 Elshaikh, Mohamed 2718 Zhou, Xin 1057 Faria, Sergio 2621 Zhang, Ying 2655 Vance, Sean 2719 Spencer, Christopher 1058 Kumar, Parvesh 2622 Yang, Fei 2656 Bauer, Nicolas 2720 Okoye, Christian 1059 Arunsingh, Moses 2623 Tait, Lauren 2657 Abacioglu, Mehmet Ufuk 2721 Caudell, Jimmy 1060 Hartsell, William 2624 Clark, Grant 2658 Chapman, Christina 2722 Rangarajan, Ramya 2747 Cooper, Samuel 2625 Ma, John 2659 Chen, Josephine 2723 Murakami, Ryuji 2748 Magnan, Sindy 2626 Xu, Karen 2660 Desai, Neil 2724 Nicholas, Zachary 2749 Fuller, Donald 2627 Mahe, Marc 2661 Velker, Vikram 2725 Scher, Eli 2750 Quivrin, Magali 2628 Neboori, Hanmanth 2662 Poorvu, Philip 2726 Quinlan-Davidson, Sean 2751 Robertson, Scott 2629 Park, Kawngwoo 2663 Manzerova, Julia 2727 Hitchcock, Kathryn 2752 Johnson, Skyler 2630 Kasuya, Goro 2664 Amini, Arya 2728 Cassidy, Richard 2753 Shumway, Dean 2631 Kim, Yusung 2665 Dise, Joseph 2729 Vainshtein, Jeff rey 2754 Orman, Amber 2632 Felder, Shira 2666 Ma, Jennifer 2730 Liu, Jerry 2755 Gogna, Nirdosh 2633 Kidd, Elizabeth 2667 Heumann, Thatcher 2731 Alizadeh-Kashani, Moein 2756 Li, BaoQing 2634 McKeever, Matthew 2668 Maghsoudi, Kaveh 2732 Ma, John 2757 Lautenschlaeger, Tim 2635 Lee, Seok Ho 2669 Syh, Joseph 2733 Ghadjar, Pirus 2758 Zaza, Khaled 2636 Petric, Primoz 2670 Park, Sang-June 2734 Takeda, Ken 2759 Kollmeier, Marisa 2637 Quinlan-Davidson, Sean 2671 Maymani, Rebekah 2735 Gayar, Omar 2760 Whalley, Deborah 2638 Dempsey, Claire 2672 Rose, Jim 2736 Kocak, Esengul 2761 Thompson, Catherine 2639 Ugurluer, Gamze 2673 Rao, Yuan 2737 Yeung, Daniel 2762 Agaoglu, Fulya 2640 Lee, Yongsook 2674 Han, Kathy 2738 Ricchetti, Francesco 2763 Raleigh, David 2641 Cellini, Francesco 2675 Lee, Larissa 2739 Romesser, Paul 2764 Doyle, Paula 2642 Saitoh, Jun-ichi 2676 Lapuz, Carminia 2740 Keane, Florence 2765 MacKillop, William 2643 Yoon, Hong In 2677 Mezera, Megan 2741 Gamez, Mauricio 2766 Lederman, Ariel 2644 Isohashi, Fumiaki 2678 Baliga, Sujith 2742 Liu, Jerry 2767 Hughes, Ryan 2645 Takiar, Vinita 2679 Zhou, Jessica 2743 Rasmussen, Jacob 2768 Sabolch, Aaron 2646 Kamrava, Mitchell 2680 Bair, Ryan 2744 Narayanasamy, Ganesh 2769 Katoh, Norio 2647 Hayashi, Kazuhiko 2681 Gultekin, Melis 2745 Rosenberg, Stephen 2770 Tinkle, Christopher 2648 Murofushi, Keiko 2682 Taku, Nicolette 2746 Koyfman, Shlomo 2771 Cury, Fabio 2649 Hansen, Henrik 2683 Kamran, Sophia 2772 Kamran, Sophia 2650 Kubo, Akiko 2684 Magnuson, William 2773 Beard, Clair 2651 Swanick, Cameron 2685 Pham, Anthony 2774 Carlone, Marco 2652 Boyle, John 2686 Roenjom, Marianne Feen 2775 Patel, Abhilasha 2653 Dunn, Emily 2687 Glaser, Scott 2776 Cox, Brett 2654 Guimas, Valentine 2688 Izaguirre, Enrique 2777 Lin, Lilie 2689 Schaner, Philip 2778 Li, Mei 2690 Logie, Natalie 2779
ASTRO 2014 / 56TH ANNUAL MEETING 197 Weir, Joshua 2780 Younan, Lawrence 2844 Sakthivel, Vasanthan 2908 He, Tongming 2954 Chen, Susie 2781 Liao, Jay 2845 Hoover, Andrew 2909 McGuffi n, Merrylee 2955 Kodaira, Takeshi 2782 Patel, Shyamal 2846 Elicin, Olgun 2910 Kim, Hayeon 2956 Wu, Vincent 2783 Kim, Jin Ho 2847 Mohamed, Abdallah 2911 Schutzer, Matthew 2957 Chen, Yong 2784 Kim, Jin Ho 2848 Nguyen, Nhu Tram 2912 Lanni, Thomas 2958 Zhang, Ning 2785 Mourad, Waleed 2849 Philippens, Marielle 2913 Louie, Alexander 2959 Hung, Tsung Min 2786 Hsieh, Cheng-En 2850 Hasan, Shaakir 2914 Shah, Anand 2960 Ying, Hongmei 2787 Jensen, Alexandra 2851 Xiao, Canhua 2915 Ye, Jason 2961 Toya, Ryo 2788 Stegmaier, Petra 2852 Mohamed, Abdallah 2916 Richard, Patrick 2962 Ma, Lin 2789 Han, James 2853 Marconi, Daniel Grossi 2917 Dimitroyannis, Dimitri 2963 Karam, Irene 2790 Yip, Darwin 2854 Chaudhary, Ahmed 2918 Koyfman, Shlomo 2964 Altun, Musa 2791 Kuczmarska, Aleksandra 2855 Ahn, Peter 2919 Wong, Anthony 2965 Manon, Rafael 2792 Tsai, Mu-Hung 2856 Huang, Junjian 2920 Patton, Caroline 2966 Ma, Faqiang 2793 Zavitsanos, Peter 2857 Doke, Kaleigh 2921 Gill, Beant 2967 Wee, Chan Woo 2794 Sachdev, Sean 2858 Al-Basheer, Ahmad 2922 Hess, Clayton 2968 Tan, Lai 2795 Thariat, Juliette 2859 Robertson, Scott 2923 Pilote, Laurie 2969 Liu, Weixin 2796 Monroe, Alan 2860 Lauro, Christine 2970 Zhou, Qichao 2797 Chilukuri, Srinivas 2861 HEALTH SERVICES RESEARCH Shah, Bhartesh 2971 Guan, Xiyin 2798 Beadle, Beth 2862 Curry, Heather 130 Conrad, Tatiana 2972 Bilimagga, Ramesh 2799 Cuaron, John 2863 Rutter, Charles 131 Lopez, Jose 2973 Bhandare, Niranjan 2800 Takagi, Masaru 2864 Bekelman, Justin 132 Lock, Michael 2974 Mui, Wing Lun 2801 Chin, Re-I 2865 Paravati, Anthony 133 Mishra, Mark 2975 Tanzler, Emily 2802 Cacicedo, Jon 2866 Ashworth, Allison 134 Qureshi, Muhammad 2976 Wang, Chengtao 2803 Kanakamedala, Madhava 2867 Keole, Sameer 135 Kusano, Aaron 2977 Ozkaya Akagunduz, Ozlem 2804 Van der Heide, Hugo 2868 Ohri, Nitin 136 Campbell, Shauna 2978 Holliday, Emma 2805 Diaz Pardo, Dayssy 2869 Durkee, Ben 137 Chang, Tangel 2979 Kim, Miranda 2806 Bhandare, Niranjan 2870 Jagsi, Reshma 293 Wallner, Paul 2980 Hou, Wei-Hsien 2807 Freilich, Jessica 2871 Lester-Coll, Nataniel 300 Hobbs, Corey 2981 Xiao, WeiWei 2808 Antognoni, Paolo 2872 Chen, Aileen 301 Agbahiwe, Harold 2982 Chan, Annie 2809 Shulman, Jesse 2873 Yu, James 302 Braunstein, Steve 2983 Aizer, Ayal 2810 Gilbo, Philip 2874 Louie, Alexander 303 Tetreault, Audrey 2984 Popovtzer, Aron 2811 Cheung, Michael 2875 Hardenbergh, Patricia 304 Hong, Giang 2985 Takehana, Keiichi 2812 Hoff man, Rex 2876 MacKillop, William 305 Martin, Neil 2986 Takeda, Ken 2813 Rwigema, Jean-Claude 2877 Suneja, Gita 306 Dahele, Max 2987 Huang, Zhibin 2814 Cvek, Jakub 2878 Soon, Yu Yang 2924 Kanayama, Naoyuki 2815 Giuliani, Meredith 2879 Paryani, Nitesh 2925 HISTORY Chen, Jonathan 2816 Dunlap, Neal 2880 Corso, Christopher 2926 Yeboa, Debra 2988 Ozsahin, Esat Mahmut 2817 Sharma, Sonam 2881 Goh, Lili 2927 Agarwal, Ankit 2989 Chang, Joseph Tung-Chieh 2818 Sachdev, Sean 2882 Rand, Alexander 2928 Golden, Daniel 2990 Edson, Mark 2819 Gao, Lanting 2883 Jones, Guy 2929 Dhami, Gurleen 2991 Shin, Jacob 2820 Waxweiler, Timothy 2884 Ballas, Leslie 2930 Thaker, Nikhil 2992 Ward, Matthew 2821 Quon, Harry 2885 Kapoor, Rishabh 2931 Zaorsky, Nicholas 2993 Jager, Elise Anne 2822 Mowery, Yvonne 2886 Ryoo, Joan 2932 Curkendoll, Crys 2994 Caldas Magalhaes, Joana 2823 Toyomasu, Yutaka 2887 Rand, Alexander 2933 Kusano, Aaron 2995 Hurst, Newton 2824 Kondaveeti, Satish 2888 Waddle, Mark 2934 Byler, Shannon 2996 Iganej, Shahrokh 2825 Prieto, Isabel 2889 Harrison, Amy 2935 Jaswal, Jasbir 2997 Sapienza, Lucas 2826 Murai, Taro 2890 Bahl, Gaurav 2936 Ngwa, Wilfred 2998 Dhanireddy, Bhaswanth 2827 Rice, Stephanie 2891 Yang, Daniel 2937 Koottappillil, Brian 2999 Plichta, Kristin 2828 Manoor Maiya, Vikram 2892 Harris, Jeremy 2938 Ingledew, Paris-Ann 3000 Hu, Kenneth Shung 2829 Hosni, Ali 2893 Gupta, Apar 2939 Thomas, Evan 3001 Suh, Yae-eun 2830 Spiotto, Michael 2894 Sio, Terence 2940 Warkentin, Heather 3002 Friborg, Jeppe 2831 Spiotto, Michael 2895 Maroongroge, Sean 2941 Kropp, Lauren 2832 Napieralska, Aleksandra 2896 Cihoric, Nikola 2942 INFORMATICS Dhanireddy, Bhaswanth 2833 Xu, Beibei 2897 Dinan, Michaela 2943 Nguyen, Nhu Tram 3547 Lai, Stephen 2834 Ko, Huaising 2898 Mahmood, Usama 2944 Fechter, Tobias 3548 Ozkaya Akagunduz, Ozlem 2835 Kanakamedala, Madhava 2899 Foley, Kimberley 2945 Gopal, Anant 3549 Scott, Michael 2836 Clarke, Sarah 2900 Naghavi, Arash 2946 Ruan, Dan 3550 Kreofsky, Cole 2837 Kumar, Rejnish 2901 Yu, Naichang 2947 Ruan, Dan 3551 Bhateja, Priyanka 2838 Cho, Yeona 2902 Schreiber, David 2948 Zheng, Shuai 3552 Patel, Samir 2839 Anderson, Nigel 2903 Marconi, Daniel Grossi 2949 Kraft, Johannes 3553 Shusharina, Nadya 2840 Rolfo, Maureen 2904 Lin, Steven 2950 Albuquerque, Kevin 3554 Mohamad, Issa 2841 Bertke, Matthew 2905 Trifi letti, Daniel 2951 Lu, Weiguo 3555 Suh, Yang-Gun 2842 Ward, Matthew 2906 Mailhot Vega, Raymond 2952 Phillips, Mark 3556 Miyawaki, Daisuke 2843 Grew, David 2907 Lester-Coll, Nataniel 2953 Parra, Andres 3557
198 ASTRO 2014 / 56TH ANNUAL MEETING Moore, Kevin 3558 Takanaka, Tsuyoshi 3003 Pan, Hubert 3065 Kollar, Laura 3129 Torres-Roca, Javier 3559 Trovo, Marco 3004 Jiang, Wei 3066 Jain, Supriya 3130 Betzing, Christopher 3560 Shintani, Takashi 3005 Ascolese, Anna Maria 3067 Rabin, Tatiana 3131 Torres-Roca, Javier 3561 Motegi, Atsushi 3006 Mehmood, Qurrat 3068 Berriochoa, Camille 3132 Zhao, Shuang 3562 Shirai, Katsuyuki 3007 Kim, Kyung Su 3069 Peulen, Heike 3133 Rico, Florentino 3563 Turaka, Aruna 3008 Iwata, Hiromitsu 3070 Karasawa, Katsuyuki 3134 Rockne, Russell 3564 Zhou, Lin 3009 Huang, Kitty 3071 Wheatley, Matthew 3135 Robinson, Timothy 3565 Mak, Kimberley 3010 Bhatt, Neal 3072 Gomez, Maria Antonia 3136 Feng, Felix CT-02 Nagai, Aiko 3011 Ahmed, Inaya 3073 Brigotti, Samantha 3137 Herman, Michael 3012 Ahmed, Inaya 3074 Bowen, Stephen 3138 LUNG CANCER Wang, Qi 3013 Liu, Ning 3075 Simone, Charles 3139 Stephans, Kevin 51 Olson, Adam 3014 Kim, Ellen 3076 Hou, Ying 3140 Onishi, Hiroshi 52 Aghdam, Nima 3015 Mann, Justin 3077 Dhami, Gurleen 3141 Park, Henry 53 Takahashi, Shigeo 3016 Feng, Wen 3078 Shen, Zhilei 3142 Lee, Percy 54 Katz, Leah 3017 Siva, Shankar 3079 Valentini, Chiara 3143 Senan, Suresh 55 Turaka, Aruna 3018 Yap, Mei Ling 3080 Hayes, Jason 3144 Timmerman, Robert 56 Fischer-Valuck, Ben 3019 Ueki, Nami 3081 Maidment III, Bertram 3145 Shaikh, Fauzia 57 Yip, Connie 3020 Baba, Fumiya 3082 Schmuecking, Michael 3146 Pham, Anthony 122 Tandberg, Daniel 3021 Trovo, Marco 3083 Nguyen, Nhu Tram 3147 Husain, Zain 123 Teng, Feifei 3022 Harder, Eileen 3084 Fernandez, Eduardo 3148 Harder, Eileen 124 Kim, Byounghyuck 3023 Allen, Aaron 3085 Reddy, Jay Paul 3149 Zhao, Jing 125 Heinzerling, John 3024 Harder, Eileen 3086 Lin, Jolinta 3150 Cheung, Patrick 126 Zhou, Meixiang 3025 Duma, Marciana-Nona 3087 Wang, Weili 3151 Wu, Abraham 128 Yamamoto, Takaya 3026 Bremjit, Prashoban 3088 Chen, Yu 3152 Vinogradskiy, Yevgeniy 129 Paryani, Nitesh 3027 Nyfl ot, Matthew 3089 Fan, Yankhua 3153 Creelan, Ben 163 Chang, Joe 3028 Lester, Scott 3090 Kemmerer, Eric 3154 Jin, Jian-Yue 164 Tang, Chad 3029 Dincbas, H. Fazilet 3091 Ming, Xin 3155 Bar Ad, Voichita 165 Tang, Chad 3030 Kilburn, Jeremy 3092 Speirs, Christina 3156 Kim, Sungjune 166 Videtic, Gregory 3031 Jeppesen, Stefan 3093 Biswas, Tithi 3157 Stanton, Paul 167 Takahashi, Noriyoshi 3032 Rowe, Lindsay 3094 Chance, William 3158 Ashworth, Allison 168 Pang, Qingsong 3033 Sun, Jian 3095 Al-Halabi, Hani 3159 Wang, Jingbo 169 Duan, Yili 3034 Patel, Suchit 3096 Jung, Julip 3160 Boyle, John 170 Persson, Gitte 3035 Nonaka, Hotaka 3097 Lee, Yun Hee 3161 Bradley, Jeff rey 317 Siva, Shankar 3036 Patel, Suchit 3098 Jain, Anshu 3162 Ohri, Nitin 318 Ahn, Sung-Ja 3037 Podder, Tarun 3099 Kong, Feng-Ming 3163 Kadoya, Noriyuki 319 Nguyen, Quynh 3038 Dekker, Andre 3100 Mangla, Ankit 3164 Sher, David 320 Matsuo, Yukinori 3039 Guo, Gordon 3101 Slotman, Ben CT-05 Sura, Karna 321 Manabe, Yoshihiko 3040 Zheng, Dandan 3102 Romeo, Antonino 322 Adli, Mustafa 3041 Saraiya, Siddharth 3103 LYMPHOMA Stuschke, Martin 323 Huang, Tzung-Chi 3042 Morimoto, Masahiro 3104 Parikh, Rahul CT-08 Giaddui, Tawfi k 324 Cannon, Nathan 3043 Kelley, Kevin 3105 Aleman, Berthe 138 Koshy, Matthew 1001 Disher, Brandon 3044 Blake, Monika 3106 Patel, Chirayu 139 Roach, Michael 1002 Barsky, Andrew 3045 Liu, Jing 3107 Dabaja, Bouthaina 140 Corso, Christopher 1003 Komaki, Ritsuko 3046 Shioyama, Yoshiyuki 3108 Rajpara, Raj 141 JingBo, Wu 1004 Mou, Benjamin 3047 Yoshitake, Tadamasa 3109 Tao, Randa 142 Chiang, Andrew 1005 Wei, Xiong 3048 Liu, Lipin 3110 Jegadeesh, Naresh 143 Haasbeek, Cornelis 1006 Negahdar, Gao, Song 3111 King, Martin 144 Chaudhuri, Aadel 1007 Mohammadreza 3049 Oguri, Mitsuhiko 3112 Jackson, Matthew 145 Aguilera, Todd 1008 Negahdar, Smith, Adam 3113 Pinnix, Chelsea 145.5 Tang, Linglong 1009 Mohammadreza 3050 Blom, Gerrit 3114 Liu, Qingfeng 333 Rehman, Sana 1010 Takeuchi, Yuki 3051 Edwards, Jason 3115 Kim, Youn 334 Alite, Fiori 1011 Heskel, Marina 3052 Kumar, Sanath 3116 Dabaja, Bouthaina 335 Mancini, Brandon 1012 Wurstbauer, Karl 3053 McGarry, Ronald 3117 Hoppe, Richard 336 Choi, Noah 1133 Heskel, Marina 3054 Mortensen, Steen 3118 Maraldo, Maja 337 Lukovic, Jelena 1134 Higgins, Kristin 3055 Yamashita, Hideomi 3119 Kriz, Jan 338 Mattes, Malcolm 1135 Pokhrel, Damodar 3056 Van Diessen, Judi 3120 Cuaron, John 339 Hermann, Gregory 1136 Akthar, Adil 3057 Cattaneo, Richard 3121 Gerber, Naamit 340 Farnia, Benjamin 1138 Kimura, Tomoki 3058 Bi, Nan 3122 Farr, Jonathan 3165 Cheng, Simon 1139 Samuelian, Jason 3059 Li, Baosheng 3123 Dabaja, Bouthaina 3166 Hui, Zhouguang 1140 Bergsma, Derek 3060 Rimner, Andreas 3124 Mikhaeel, George 3167 Takahashi, Wataru 1141 Bowen, Stephen 3061 Rodrigues, George 3125 Furlan, Carlo 3168 Rimner, Andreas 1142 Zhung, Joanne 3062 Mohr, Angela 3126 Lloyd, Shane 3169 Parisi, Elisabetta 1143 Wu, Q. Jackie 3063 Xie, Liyi 3127 Spickermann, Maximilian 3170 Decker, Roy 1144 Setakornnukul, Jiraporn 3064 Miller, Luke 3128 Torok, Jordan 3171
ASTRO 2014 / 56TH ANNUAL MEETING 199 Aznar, Marianne 3172 Barnes, Mark 3223 Lee, Andrew 3277 Blacksburg, Seth 3363 Sachsman, Suzanne 3173 Nakamura, Naoki 3224 Zhou, Jessica 3278 Mumber, Matthew Peter 3364 Mazloom, Ali 3174 Saito, Tetsuo 3225 Rana, Zaker 3279 Yang, Bin 3365 Wilke, Christopher 3175 Cheney, Matthew 3226 Leatherwood, Amy 3280 Delaney, Kyle 3366 Iwabuchi, Michio 3176 Henson, Christina 3227 Giuliani, Meredith 3281 Hattangadi, Jona 3368 Dabaja, Bouthaina 3177 Rhee, Woo Joong 3228 Barsky, Andrew 3282 Elnahal, Shereef 3369 Dabaja, Bouthaina 3178 Franco, Pierfrancesco 3229 Samiee, Sara 3283 Mosaly, Prithima 3370 Lee, Joohwan 3179 Kobayashi, Hidetoshi 3230 Knoll, Miriam 3284 Taylor, Kinley 3371 Tatekawa, Kotoha 3180 Saito, Tetsuo 3231 Mitra, Devarati 3285 Mosaly, Prithima 3372 Ohga, Saiji 3181 Held, Mareike 3232 Seo, YoungsSeok 3286 Grant, Jonathan 3373 Braunstein, Lior 3182 Harada, Ken 3233 Hill-Kayser, Christine 3287 Pinnix, Chelsea 3184 Mula-Hussain, Layth 3234 Groarke, John 3288 PEDIATRIC CANCER Hiniker, Susan 3185 Aljabab, Saif 3235 Kachnic, Lisa 3289 Boehling, Nick 244 Harada, Arisa 3186 Mian, Omar 3236 Olson, Robert 3290 Eaton, Bree 245 Miyazawa, Kazunari 3187 Alcorn, Sara 3237 Shimizu, Arisa 3291 Laskar, Siddhartha 246 Zang, Jian 3188 Wang, Yu-Ming 3238 Larrea, Luis 3292 Haas-Kogan, Daphne Adele 247 Chen, Bo 3189 Lam, Tai Chung 3239 Patel, Ashish 3293 Kahalley, Lisa 248 Jhavar, Sameer 3190 Ly, Bevan 3240 McCloskey, Susan CT-06 Gunther, Jillian 249 Cassuto, Ophelie 3191 Hamamoto, Yasushi 3241 Kalapurakal, John 250 Balagamwala, Ehsan 3192 Lee, Jason 3242 PATIENT SAFETY Mahajan, Anita 251 Heumann, Thatcher 3193 Arneson, Kyle 3243 Olivera, Gustavo 277 Paulino, Arnold 252 Wong, Jeff rey 3194 Logie, Natalie 3244 Damato, Antonio 278 Mahajan, Anita 3294 Kelsey, Christopher 3195 Lok, Benjamin 3245 Matuszak, Martha 279 Sethi, Roshan 3295 Hammer, Josef 3196 Tanaka, Hiroshi 3246 Chera, Bhisham 280 Gibbs, Iris 3296 Plastaras, John 3197 Avkshtol, Vladimir 3247 Greenwalt, Julie 281 Chin, Joanna 3297 Ishibashi, Naoya 3198 Tan, Daniel 3248 Miller, Brett 282 Redmond, Kristin 3298 Kelly, Douglas 3199 Curry, Heather 3249 Gao, Wendy 283 Lai, I-Chun 3299 Cellini, Francesco 3250 Novak, Avrey 284 Gultekin, Melis 3300 NONMALIGNANT DISEASE Ma, C.M. Charlie 3251 Gwynne, Sarah 3327 Uh, Jinsoo 3301 Sckolnik, Steven 3200 Schuster, Jessica 3252 Fontanilla, Hiral 3328 Alcorn, Sara 3302 Mourad, Waleed 3201 Zahra, Amir 3253 Lam, Wai Wang 3329 Cahlon, Oren 3303 Lopater, Zachary 3202 Gwynne, Sarah 3330 Ray, Geoff rey 3304 Blakaj, Adriana 3203 PATIENT-REPORTED Yu, Jialu 3331 McGovern, Susan 3305 Ohri, Nisha 3204 OUTCOMES Dvorak, Tomas 3332 Jimenez, Rachel 3306 Arora, Divya 3205 Hoppe, Bradford 179 Meier, Timothy 3333 Sreeraman, Radhika 3307 Jie, Shen 3206 Johnson, Matthew 180 Kisling, Kelly 3334 Haque, Waqar 3308 Yoo, Stella 3207 Zhao, Shuang 181 Mathews, Joshua 3335 Liang, Jun 3309 Sio, Terence 3208 Anderson, Bradley 182 Hamilton, Sarah 3336 Roeper, Barbara 3310 Schuster, Jessica 3209 Wiltink, Lisette 183 Vitzthum, Lucas 3337 Ozkaya Akagunduz, Ozlem 3311 Carvajal, Claudia 3210 Miller, Robert 184 Katsuta, Yoshiyuki 3338 Osborne, Eleanor 3312 Urbanic, James 185 Able, Charles 3339 Kirkland, Robert 3313 NURSES Ye, Hong 3254 Leonard, Kara 3340 Hazariwala, Ronica 3314 Herst, Patries 3211 Joh, Daniel 3255 Yang, Ruijie 3341 Salinas, Vanessa 3315 Schaidle, Colleen 3212 Kiang, Alan 3256 Gong, Yutao 3342 Thaker, Nikhil 3316 Serra, Diane 3213 Woo, Jennifer 3257 Matulewicz, Lukasz 3343 Shaikh, Fauzia 3317 Yuen, Florence 3214 Rathod, Shrinivas 3258 Sekar, Yuvaraj 3344 Imber, Brandon 3318 Fujioka, Chiaki 3215 Valderrama, Adriana 3259 Chen, Yu 3345 DeSelm, Carl 3319 Porzio-Kwiecinski, Therese 3216 Krauze, Andra 3260 Mo, Xiaohu 3346 Shah, Nikesh 3320 Maisonet, Olivier 3217 Woo, Jennifer 3261 Liszewski, Brian 3347 Hess, Clayton 3321 Mason, Matthew 3262 McNiven, Andrea 3348 Casey, Dana 3322 PALLIATIVE CARE Sio, Terence 3263 Kertzscher, Gustavo 3349 Hill-Kayser, Christine 3323 Furlan, Carlo 171 Janowski, Einsley-Marie 3264 Varadhan, Raj 3350 Kornerup, Josefi ne S. 3324 Conway, Jessica 172 Lee, Jae 3265 Moningi, Shalini 3351 Farnia, Benjamin 3325 Hall, William 173 Rossetti, Andrew 3266 Pavan, Guilherme 3352 Barron, David 3326 Gomez-Iturriaga, Alfonso 174 Gurka, Marie 3267 Mullen, Thomas 3353 Lefresne, Shilo 175 Thibault, Isabelle 3268 Chao, Samuel 3354 Khan, Luluel 176 Miszczyk, Leszek 3269 Deraniyagala, Rohan 3355 Alcorn, Sara 177 Elliott, David 3270 Kovalchuk, Nataliya 3356 Sahgal, Arjun 178 Mitra, Devarati 3271 Ota, Seiichi 3357 Moghanaki, Drew 3218 Lai, Yu-Hsuan 3272 Jones, Ryan 3358 Lloyd, Shane 3219 Nuyttens, Joost 3273 Moningi, Shalini 3359 Poon, Ian 3220 Goenka, Anuj 3274 Fritscher, Karl 3360 Kawashiro, Shohei 3221 Rana, Zaker 3275 Liu, Chihray 3361 Olson, Robert 3222 Khwaja, Shariq 3276 Yi, Byong Yong 3362
200 ASTRO 2014 / 56TH ANNUAL MEETING RADIATION AND CANCER Chun, Stephen 1092 Hurmuz, Pervin 3471 Masoud Rahbari, Reza 3535 BIOLOGY Ju, Melody 1093 Sarojini, Sreeja 3472 Ruiz-Alonso, Ana 3536 Sharabi, Andrew PL-01 Gerngross, Lindsey 1094 Hasegawa, Masatoshi 3473 Xu, Ting 3537 Yard, Brian 66 Leiker, Andrew 1095 Pyakuryal, Anil 3474 Song, Yipeng 3538 Salem, Ahmed 67 Sio, Terence 1096 Rafat, Marjan 3475 Liu, Anwen 3539 Moding, Everett 68 Spratt, Daniel 1124 Gan, Gregory 3476 Walston, Steve 3540 Karlin, Jeremy 69 Vaughan, Andrew 3414 Yang, Jia 3477 Thompson, Jonathan 3541 Speers, Corey 70 Stone, Brandon 3415 Spratt, Daniel 3478 Wobb, Jessica 3542 Baig, Nimrah 71 Young, Kristina 3416 Volotskova, Olga 3479 Lin, Steven 3543 Wright, Christopher 72 Muraro, Elena 3417 Matsuo, Masayuki 3480 Tuli, Richard 3544 Zumsteg, Zachary 73 Fahim Golestaneh, Azadeh 3418 Hosono, Makoto 3481 Grecula, John 3545 Zhao, Hanxi 98 Leung, Chung Man 3419 Gao, Zhenhua 3482 Osmundson, Evan 3546 Kirsch, David 115 Bornstein, Sophia 3420 King, Martin 3483 Du, Shisuo 116 Tao, Jessie 3421 Laruelo, Andrea 3484 RADIATION AND CANCER Walker, Amanda 117 Chaudhuri, Aadel 3422 Marples, Brian 3485 PHYSICS Blanchard, Miran 118 Koukourakis, Michael 3423 Kapoor, Vaishali 3486 Kabarriti, Rafi 1 Park, Sean 119 Sato, Mariko 3424 Perez, Jessica 3487 Zhou, Jun 2 Young, Kristina 120 Rafat, Marjan 3425 Lee, Keum Sil 3488 Vallieres, Martin 3 Pilones, Karsten 121 Park, Catherine 3426 Lee, Kuei 3489 Li, Ruijiang 4 Pham, Ngoc 127 Zhang, Minsi 3427 Ahmad, Moiz 3490 Wiedenmann, Nicole 5 Matsuo, Masayuki 186 Allen, Bryan 3428 Naczynski, Dominik 3491 Bradshaw, Tyler 6 Kortylewicz, Janina 187 Yoo, Hyun 3429 Furutani, Shunsuke 3492 Ahmed, Merina 7 Papineni, Rao 188 Lee, Eun-Jung 3430 Masunaga, Shin-ichiro 3493 McGuire, Sarah 8 Mouw, Kent 189 Tian, Sibo 3431 Okonogi, Noriyuki 3494 Gensheimer, Michael 9 Hedayati, Mohammad 190 Maity, Amit 3432 Harada, Satoshi 3495 Obeid, Layal 25 Han, Kathy 191 Dadey, David 3433 Zhang, Chi 3496 Adam, Jean-François 26 Zhang, Peng 192 Rao, Shyam 3434 Zhang, Zhenhuan 3497 Snider III, James 27 Evans, Joseph 193 Monjazeb, Arta 3435 Khattab, Mohamed 3498 Liu, Jianfei 28 Harima, Yoko 199 Schoenfeld, Jonathan 3436 Huber, Peter 3499 Li, Taoran 29 Hearn, Jason 219 Suzuki, Yoshiyuki 3437 Nicolay, Nils 3500 Hallman, Mark 30 Kozono, David 220 Veldwijk, Marlon 3438 Raju, Uma 3501 Asuni, Ganiyu 31 Chang, Kenneth 221 Illidge, Timothy 3439 Li, Ping 3502 Braunstein, Steve 32 Smith, Clayton 222 Reddy, Vishruth 3440 Wu, Szu-Yuan 3503 Zhao, Weizhao 33 Willers, Henning 223 Epperly, Michael 3441 Seo, Yuji 3504 Booth, Jeremy 42 Abazeed, Mohamed 224 Epperly, Michael 3442 Wang, Edina 3505 Coates, James 43 Mikkelsen, Ross 225 Giordano, Frank 3443 Kim, Dong Wook Nathan 3506 Rimner, Andreas 44 Xu, Ting 226 Nishioka, Takeshi 3444 Mitchell, Darrion 3507 Owen, Dawn 45 Wray, Justin 325 Borst, Gerben 3445 Xing, Ligang 3508 Ren, Lei 46 Hanna, Nevine 326 Iwata, Hiromitsu 3446 Dong, Qian 3509 Yip, Stephen 47 Stessin, Alexander 327 Leong, Trevor 3447 Tian, Xi 3510 Schuemann, Jan 48 Andreassen, Christian 328 Zielinska-Chomej, Jeong, Seong-Yun 3511 Kelada, Olivia 49 Pitroda, Sean 329 Katarzyna 3448 Jeong, Seong-Yun 3512 Paulson, Eric 50 Scroggins, Bradley 330 Bakhoum, Samuel 3449 Nakayama, Masao 3513 Sterzing, Florian 58 Epperly, Michael 331 Sizemore, Steven 3450 Felix, Manuela 3514 Tai, An 81 Citrin, Deborah 332 Spektor, Alexander 3451 Sun, Yunguang 3515 Saleh, Ziad 82 Ivkov, Robert 1037 Zhang, Li Yuan 3452 Sun, Yunguang 3516 Troeller, Almut 83 Advani, Sunil 1038 Widlak, Piotr 3453 Kiess, Ana 3517 Liao, Zhongxing 84 Gao, Dexuan 1039 Epperly, Michael 3454 Wang, Tao 3518 Kupelian, Patrick 85 Shridhar, Ravi 1040 Odawara, Soichi 3455 Liu, Peter 3519 Palorini, Federica 86 Guha, Chandan 1041 Xingwen, Fan 3456 Quinn, Thomas 3520 Wang, Chunhao 87 Moustafa, Mahmoud 1042 Zhao, Diana Yi 3457 Biswas, Tithi 3521 Qi, Xiangrong 88 Wolfe, Adam 1043 Dong, Xiaorong 3458 Vatner, Ralph 3522 Hall, Matthew 89 Off or, Onyinye 1044 Schmidberger, Heinz 3459 Monjazeb, Arta 3523 Kole, Thomas 110 Brenneman, Randall 1045 Takahashi, Ippei 3460 Dan, Tu 3524 Santhanam, Anand 154 Nowak, Kamila 1046 Abernathy, Lisa 3461 Yang, Jia 3525 Velec, Michael 155 Tran, Phuoc 1047 Kabarriti, Rafi 3462 Epperly, Michael 3526 Gudur, Madhu Sudhan Dholakia, Avani 1048 Cho, Jae Ho 3463 Medhora, Meetha 3527 Reddy 156 Van Dijk, Laura 1085 Dominello, Michael 3464 Epperly, Michael 3528 Guo, Yu 157 Mohindra, Pranshu 1086 Buchsbaum, Jeff rey 3465 Enke, Thomas 3529 Patel, Ravi 158 Wobb, Jessica 1087 Amornwichet, Napapat 3466 Epperly, Michael 3530 Hegi-Johnson, Fiona 159 Meng, Jin 1088 Okano, Naoko 3467 Barrett, Kate 3531 Ding, Yao 160 Higginson, Daniel 1089 Wang, Bin 3468 Lang, Jinyi 3532 Zhang, Yibao 161 Jeraj, Robert 1090 Sai, Sei 3469 Bortolin, Maria Teresa 3533 Huynh-Le, Minh-Phuong 162 Patel, Kirtesh 1091 Zhang, Peng 3470 Modlin, Leslie 3534 Mutic, Sasa 202
ASTRO 2014 / 56TH ANNUAL MEETING 201 Stanescu, Teo 203 Park, John 3579 Ngwa, Wilfred 3642 Vieira, Andre 3705 Green, Olga 204 Mooney, Karen 3580 Murray, Louise 3643 Adamczyk, Marta 3706 Glide-Hurst, Carri 205 Plishker, William 3581 Raince, Jagdeep 3644 Nelson, Aaron 3707 Liu, Yilin 206 Ali, Mirza 3582 Ishaq, Omar 3645 Chai, Xiangfei 3708 Li, Xia 207 Li, Allen 3583 Howell, Rebecca 3646 Tuohy, Rachel 3709 Seibert, Tyler 208 Kathpal, Madeera 3584 Paulson, Eric 3647 Li, Jason 3710 Wooten, Hasani 209 Mittauer, Kathryn 3585 Hwang, Seha 3648 Chiesa, Silvia 3711 Chen, Xinfeng 210 Gayou, Olivier 3586 Fujita, Yujiro 3649 Xu, Qiong 3712 Yuan, Lulin 227 Bhandare, Niranjan 3587 Lens, Eelco 3650 Robar, James 3713 Ruan, Dan 228 Peng, Jean 3588 Kainz, Kristofer 3651 Fawaz, Ziad 3714 Kumarasiri, Akila 229 Letourneau, Etienne 3589 Altman, Michael 3652 Lin, Teh 3715 Kierkels, Roel 230 Hojgaard, Martin 3590 Yan, Di 3653 Defoor, Dewayne 3716 Poon, Miranda Sze Wing 231 Zhang, You 3591 Yoon, Kyoung Jun 3654 Yao, Weiguang 3717 Vanderstraeten, Barbara 232 Abing, Casey 3592 Varadhan, Raj 3655 Chen, Xiaojian 3718 Santanam, Lakshmi 233 Cheng, Hui 3593 Fog, Lotte 3656 Erickson, Kelly 3719 Zarepisheh, Masoud 234 Ueda, Yoshihiro 3594 Sasidharan, Balu Krishna 3657 Reynolds, Robert 3720 Nguyen, Dan 235 Jones, Bernard 3595 Chu, Kwun-Ye 3658 Liu, Chang 3721 Marina, Ovidiu 308 Noid, George 3596 Olivera, Jesús 3659 Woo, Joong Yeol 3722 Liang, Jieming 309 Zhang, Hao 3597 Kim, Leonard 3660 Vatner, Ralph 3723 Colvill, Emma 310 Gong, Guanzhong 3598 Draghici, Roxana 3661 Shankar, Vangipuram 3724 Jawad, Maha 311 White, Benjamin 3599 Nirunsiriphol, Sawanee 3662 Han, Chunhui 3725 Lin, Mu-Han 312 Witztum, Alon 3600 Pratx, Guillem 3663 Ellis, Rodney 3726 Block, Alec 313 Zhao, Bo 3601 Jeong, Yuri 3664 Lo, Simon 3727 Li, Heng 314 Keall, Paul 3602 Bedos, Ludovic 3665 Ma, Lijun 3728 Glick, Daniel 315 Li, Dengwang 3603 Yu, Suhong 3666 Simeonova, Anna 3729 Cui, Taoran 316 Suttie, Clare 3604 Balter, Peter 3667 Ding, Chuxiong 3730 Gladwish, Adam 1067 Chiu, George 3605 Kawakami, Masakuni 3668 Okawa, Kohei 3731 Parashar, Bhupesh 1073 Wang, Ti-Hao 3606 Matsumoto, Kenji 3669 Palmgren, Jan-Erik 3732 Klein, Eric 1074 Scholey, Jessica 3607 Tachiki, Lisa 3670 Rottmann, Joerg 3733 Wen, Ning 1075 Van Sornsen de Koste, Srivastava, Shiv 3671 Naoi, Yutaka 3734 Liu, Feng 1076 John 3608 Amoush, Ahmad 3672 Molinier, Jessica 3735 Shi, Xiutao 1077 Hickling, Susannah 3609 Li, Fengxiang 3673 Simeonova, Anna 3736 Karan, Tania 1078 James, Joshua 3610 Li, Fengxiang 3674 Gevaert, Thierry 3737 Gao, Ang 1079 Kashani, Rojano 3611 Liu, Wenyang 3675 Steenbeke, Femke 3738 Cifuentes Gaitan, Jidney 1080 Antoine, Mikael 3612 Serrano, Nicholas 3676 Louie, Alexander 3739 Holcombe, Charles 1081 Poulsen, Per 3613 Alpuche Aviles, Jorge 3677 Ly, Bevan 3740 Rao, Min 1082 Lischalk, Jonathan 3614 Lian, Jun 3678 Fotouhi Ghiam, Alireza 3741 Martin, Jeff rey 1083 Fanchon, Louise 3615 Heijmen, Ben 3679 Li, Winnie 3742 Ling, Diane 1084 Liu, Wu 3616 Castelli, Joel 3680 Cohen, Randi 3743 Zlateva, Yana 1097 Hurwitz, Martina 3617 Kamomae, Takeshi 3681 Ruggieri, Ruggero 3744 Berbeco, Ross 1098 Stecklein, Shane 3618 Jani, Shirish 3682 Hossain, Murshed 3745 Paudel, Nava 1099 Watkins, William 3619 Lee, Suk 3683 Yaparpalvi, Ravindra 3746 Kashani, Rojano 1100 Li, Shidong 3620 Cho, Kwang Hwan 3684 Dagoglu, Rabia Nergiz 3747 Wang, Jing 1101 Yang, Yong 3621 Fenoglietto, Pascal 3685 Michalski, Dariusz 3748 Roeske, John 1102 Chung, Caroline 3622 Thompson, Kenton 3686 Sonier, Marcus 3749 Todor, Dorin 1103 Risberg, Miranda 3623 Lee, Suk 3687 Ye, Jin-Song 3750 Balter, James 1104 Monjazeb, Arta 3624 Kang, Young-nam 3688 Wu, Jianzhou 3751 Wang, Jiazhou 1105 Bergamo, Angelo 3625 Pallotta, Stefania 3689 Zilli, Thomas 3752 Strom, Eric 1106 Kamp, Florian 3626 Karagoz, Gulay 3690 Wang, Huan-Huan 3753 Su, Zhong 1107 Simpson, Daniel 3627 Sakumi, Akira 3691 Gabos, Zsolt 3754 Lee, HyunSeok 1108 Jeong, Jeho 3628 Tijssen, Rob 3692 Kim, Hyun 3755 Linam, Justin 3566 Carmona, Ruben 3629 Thomson, David 3693 Zhung, Joanne 3756 Agazaryan, Nzhde 3567 Van Leeuwen, Caspar 3630 Na, Yong Hum 3694 Henriques, Benedicte 3757 Weiss, Elisabeth 3568 Pater, Piotr 3631 Fiandra, Christian 3695 Talamonti, Cinzia 3758 Nakamura, Mitsuhiro 3569 Ybarra, Norma 3632 Edwards-Bennett, Sophia 3696 Lucas, John 3759 Boda-Heggemann, Judit 3570 Merrick, Scott 3633 Kirby, Neil 3697 Li, Guang 3760 Akimoto, Mami 3571 Cho, Daniel 3634 Yang, Wensha 3698 Oechsner, Markus 3761 Padilla, Laura 3572 Mei, Feng 3635 White, Evan 3699 Pineiro Retif, Rafael 3762 Kim, Youngjun 3573 Sheng, Ke 3636 Damato, Antonio 3700 Estes, Christopher 3763 Oohira, Shingo 3574 Prior, Phillip 3637 Li, Guangjun 3701 Dang, Phuong-Di 3764 Zhang, Pengpeng 3575 Thor, Maria 3638 Clemente Gutierrez, Rajan, Rajesh 3765 Fung, Winky Wing Ki 3576 Kang, John 3639 Francisco 3702 Wang, Tonghe 3766 Blessing, Manuel 3577 Yu, Victoria 3640 Paulson, Eric 3703 Babic, Steven 3767 Arns, Anna 3578 Rancati, Tiziana 3641 Qi, Xiangrong 3704 Cuijpers, Johan 3768
202 ASTRO 2014 / 56TH ANNUAL MEETING Rochefort, Pauline 3769 Palma, Bianey 3833 Barker, Christopher 3397 Zhang, Qinghui 3770 Martin, Andre-Guy 3834 Karasawa, Katsuyuki 3398 Broomfi eld, Joel 3771 Gong, Guanzhong 3835 Hadsell, Michael 3399 Wang, Ricardo 3772 Li, Jiancheng 3836 Moalikyar, Omeed 3400 Han, Bin 3773 Li, Tianfang 3837 Kenjo, Masahiro 3401 Yazici, Gozde 3774 Santos, Daniel 3838 Tinkle, Christopher 3402 Chen, Allan 3775 Bazalova, Magdalena 3839 Jacobson, Alex 3403 Su, Zhong 3776 Cho, Yu Ra 3840 Saeed, Hina 3404 Ogunleye, Tomi 3777 Mancosu, Pietro 3841 Manyam, Bindu 3405 Gulam, Misbah 3778 Zhao, Nan 3842 Tinkle, Christopher 3406 Choi, Enid 3779 Zhao, Nan 3843 Wilke, Christopher 3407 Bahig, Houda 3780 Tsiamas, Panagiotis 3844 Merrell, Kenneth 3408 Telivala, Tejas 3781 Verbakel, Wilko 3845 Pennington, Joseph 3409 Alite, Fiori 3782 Gupta, Roohi 3846 Cahlon, Oren 3410 Zhao, Bo 3783 Barten, Danique 3847 Bhatt, Aashish 3411 Rong, Yi 3784 Goyal, Uma 3848 Snider III, James 3412 Pennington, Andreea 3785 Xiang, Liangzhong 3849 Szeja, Sean 3413 Cuaron, John 3786 Leif, Jessica Lowenstein 3850 Cuaron, John 3787 Ma, C.M. Charlie 3851 Masood, Umar 3788 Salter, Bill 3852 Romesser, Paul 3789 Balasz, Katarzyna 3853 Akino, Yuichi 3790 Moteabbed, Maryam 3854 Visser, Jorrit 3791 Korideck, Houari 3855 Wang, Dongxu 3792 Thomas, Evan 3856 Matysiak, Witold 3793 Huang, Baotian 3857 Sio, Terence 3794 Rutenberg, Michael 3858 Tryggestad, Erik 3795 Hajdok, George 3859 Johnson, Jedediah 3796 Liang, Xing 3860 Faddegon, Bruce 3797 Paudel, Nava 3861 Wong, Tony 3798 Amini, Arya 3862 Shimizu, Shinichi 3799 Goddu, Sreekrishna Murty 3800 SARCOMA AND CUTANEOUS Ding, Aiping 3801 TUMORS Batista, Vania 3802 Baldini, Elizabeth 253 Son, Jaeman 3803 Roeder, Falk 254 Zeng, Chuan 3804 Mak, Kimberley 255 Summers, Paige 3805 Vyas, Shilpa 256 Casares Magaz, Oscar 3806 Willett, Addison 257 Zhao, Li 3807 Stish, Bradley 258 Polf, Jerimy 3808 Kubicek, Gregory 259 Richard, Patrick 3809 Baumann, Brian 260 Giantsoudi, Drosoula 3810 Pretz, Jennifer 3374 Jo, Kwanghyun 3811 Casey, Dana 3375 Ager, Bryan 3812 Casey, Stephanie 3376 Li, Heng 3813 Wang, Jianyang 3377 Cai, Bin 3814 Casey, Dana 3378 Anand, Aman 3815 Cheney, Matthew 3379 Zheng, Yuanshui 3816 Arenas, Meritxell 3380 Daartz, Juliane 3817 Kishan, Amar 3381 Welsh, James 3818 Cheung, Michael 3382 Zaini, Mehran 3819 Song, Sanghyuk 3383 Dinkla, Anna 3820 Kumar, Aryavarta 3384 Shin, Samuel 3821 Wang, Haotong 3385 Korhonen, Juha 3822 Bhatnagar, Ajay 3386 Iftimia, Ileana 3823 Chapman, Tobias 3387 Craft, David 3824 Crimaldi, Anthony 3388 Ahunbay, Ergun 3825 Huang, Pin-I 3389 Park, Jong In 3826 Rodriguez Villalba, Silvia 3390 Feng, Huiting (Christine) 3827 Parvathaneni, Upendra 3391 Han, Dae Yup 3828 Yip, Darwin 3392 Depauw, Nicolas 3829 Kollar, Laura 3393 Gupta, Deepak 3830 Le Grange, Franel 3394 Li, Ruijiang 3831 Gayar, Hesham 3395 Prior, Phillip 3832 Johnson, Julian 3396
ASTRO 2014 / 56TH ANNUAL MEETING 203 2014 Best of SCIENCE OF TODAY ASTRO HOPE FOR TOMORROW
OCTOBER 17-18, 2014 | EDEN ROC MIAMI BEACH | MIAMI BEACH
Join us in Miami Beach!
ATTEND THIS TWO-DAY MEETING FOR A SUMMARY OF THE TOP SCIENCE FROM THE 2014 ASTRO ANNUAL MEETING.
Register now: www.astro.org/bestofASTRO This live activity has been approved for AMA PRA Category 1 Credit™.
® TARGETING CANCER CARE
DisciplinesD of Leadership ComeC to Miami Beach early and take advantage of the Disciplines of Leadership course taking placep October 15-16, at the Eden Roc Miami Beach. www.astro.org/leadershipcourse.w Exhibitor
10:00 a.m. – 5:00 p.m. 10:00 a.m. – 5:00 p.m. 10:00 a.m. – 5:00 p.m. SUNDAY, SEPTEMBER 14 SUNDAY, TUESDAY, SEPTEMBER 16 SEPTEMBER TUESDAY, MONDAY, SEPTEMBER 15 MONDAY, EXHIBIT HALL HOURS
Exhibit Hall Floor Plan Floor Exhibit Hall Exhibitor List by Product/ServiceExhibitor Category Exhibitor List Exhibitor Industry-Expert Theater Schedule INSIDE: Exhibitor
Deadline for submission: Deadline abstract technol gy ASTRO 20 ASTRO Save theDates! Call for opens: Abstracts December 17,2014 February 26,2015 patient care SAN ANTONIO HENRY B. GONZALEZ CONVENTION CENTER EXHIBIT DATES: OCTOBER 18-20 , MEETING DATES: OCTOBER 18-21 57TH ANNUALMEETING 15 TARGETING CANCER CARE meets 2015 2015 INDUSTRY-EXPERT THEATER* Exhibit Hall, Room 100 This activity allows companies to present their noteworthy products and services through a live presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a fi rst-come, fi rst-served basis. The Industry-Expert Theater content and views expressed therein are those of the exhibitor and not of ASTRO. *Industry-Expert Theaters are not accredited for continuing medical education credits. SUNDAY, SEPTEMBER 14
Time: 12:15 p.m. – 1:15 p.m. Precision in Practice: Optimizing Outcomes and Expanding Applications with Accuray Company: Accuray Contact: Rebecca Byrne Phone: 408-334-7950 Box lunch provided.
MONDAY, SEPTEMBER 15
Time: 6:45 a.m. – 7:45 a.m. Time: 12:30 p.m. – 1:30 p.m. Perirectal Spacers: Emerging The Therapeutic Application of Xofi go® Technology and Impact on Future (radium Ra 223 dichloride) Injection Prostate RT Utilization Company: Bayer HealthCare Company: Augmenix Contact: Michelle Noyes Contact: Eileen Gardner Phone: 862-404-5478 Phone: 508-944-8015 Box lunch provided. Box breakfast provided.
Time: 10:15 a.m. – 10:45 a.m. Exclusive: Pre-release screening footage from the upcoming series “Cancer: The Emperor of All Maladies” by Award-Winning Executive Producer Ken Burns Company: Siemens Contact: Jeff rey Bell, Sr. Manager, Media Relations - Imaging and Therapy Systems Phone: 484-868-8346 Refreshments provided.
TUESDAY, SEPTEMBER 16 6:45 a.m. – 7:45 a.m. 11:45 a.m. – 12:45 p.m. Clinical Advancements in Patient QA and Safety in Electronic Brachytherapy for Modern Radiation Therapy Breast, Skin and Gynecological Company: ScandiDos Cancers Contact: Marni Brown Company: Xoft Inc. Phone: 608-630-9415 Box breakfast provided. Box lunch provided. Exhibitor List (as of July 7, 2014) EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
.decimal 1040 Advanced Shielding Technologies, Inc. 1701 American Society of Clinical Oncology 1401 121 Central Park Place 23355 L & N Turnpike, Bldg. F 2318 Mill Road, Suite 800 Sanford, FL 32771 West Point, KY 40177 Alexandria, VA 22314 Phone: 800-255-1613 Phone: 502-922-3009 Phone: 888-282-2552 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.dotdecimal.com Website: www.advancedshieldingtech.com Website: www.asco.org
21st Century Oncology 838 AEP Linac 2436 Anatom-e XRT Information Systems, Ltd. 544 2270 Colonial Boulevard 3870-B Longview Drive 2047 University Blvd Fort Myers, FL 33907 Douglasville, GA 30135 Houston, TX 77030 Phone: 239-931-7333 Phone: 678-838-3737 Phone: 713-382-3638 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.21stCenturyOncology.com Website: www.alphatronlinac.com Website: www.anatom-e.com R Aktina Medical Corporation 228 Ancer Medical 107 A2J Healthcare 1145 360 North Route 9W 131 Daniel Webster Highway, Box 854 Parc d’Activité des Vallières, 5 allée des Rousselets Congers, NY 10920 Nashua, NH 03060 Thorigny sur Marne, 77 77400 Phone: 845-268-0101 Phone: 97-886-606-93 France R Phone: 0033160942299 Anzai Medical Co. Ltd. 2336 Email: [email protected] ALATRO (Asociacion Iberoamericana De 241 3-6-25 Nishi-ShinagawaShinagawa-ku Website: www.a2jlaser.com Terapia Radiante Oncologica) Tokyo, 141-0033 Av. El Rosario 450 Duite No. 7 Japan ABL Medical 2537 San Isidro, Lima, TX Lima 27 Phone: 81-337-791-611 705 E. 50 S. Peru Email: [email protected] American Fork, UT 84403 Phone: 51-142-295-94 Website: www.anzai-med.co.jp Phone: 801-763-8000 Email: [email protected] Email: [email protected] Website: www.alatro.org/ APSHO 441 Website: www.ablmedical.com 37 Main Street Alliance Oncology 504 Cold Spring Harbor, NY 11724 Acceletronics 428 1801 West End Avenue Phone: 631-935-7684 602 Gordon Drive Suite 700 Website: www.apsho.org Exton, PA 19341 Nashville, TN 37203 Email: [email protected] Phone: 800-543-5144 Phone: 615-263-7888 Email: [email protected] Email: [email protected] AQUILAB SAS 2334 Website: www.acceletronics.com R Parc Eurasante, 250 rue Salvador Allende Loos Les Lille, France 59120 Accuray Inc. 1908 AMAC - American Medical Accounting 1601 France 1310 Chesapeake Terrace and Consulting Phone: 00-333-696-1515-1 Sunnyvale, CA 94089 2864 Johnson Ferry Blvd., Suite 150 Email: [email protected] Phone: 408-716-4600 Marietta, GA 30062 Website: www.aquilab.com Email: [email protected] Phone: 770-693-6031 R Website: www.accuray.com Email: [email protected] A R Website: www.amac-usa.com architection 940 R 425 W. Market St. AccuBoost 218 Louisville, KY 40202 1 Industrial Way AMAG Pharmaceuticals, Inc. 202 Phone: 502-561-1024 Tyngsboro, MA 01879 1100 Winter Street Email: [email protected] Phone: 978-649-0007 Waltham, MA 02451 Website: www.architection.com Email: ryan.fl [email protected] Phone: 617-498-3306 R Website: www.accuboost.com Email: [email protected] LEGEND Website: www.amagpharma.com Augmenix 1943 204 2nd Avenue, Lower Level A Ambassador AME Publishing Company 206 Waltham, MA 02451 P Platinum Sponsor 3/F, 1st Building, Le Su Science Park, 1526, Chunbo Phone: 781-895-3235 Rd., Binjiang District Email: [email protected] G Gold Sponsor Hangzhou, Zhejiang Province 310052 Website: www.augmenix.com/ S Silver Sponsor China Bard Medical Division 1702 B Bronze Sponsor Phone: +86 571 28182610 Email: [email protected] 8195 Industrial Blvd. C Copper Sponsor Website: www.thepbpc.org Covington, GA 30014 R Enhanced RO MarketPlace Phone: 770-784-6223 Listing American Association of Medical 2732 Email: [email protected] Website: www.crbard.com Corporate members in bold. Dosimetrits 2201 Cooperative Way, Suite 600 Herndon, VA 20171 Phone: 703-677-8071 Email: [email protected] Website: www.medicaldosimetry.org EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Bayer HealthCare 1818, 2804 BSD Medical 1743 Churchill Consulting, Inc. 1901 100 Bayer Blvd 2188 W 2200 S 384 Route 148 Whippany, NJ 07981 Salt Lake City, UT 84119 Killingworth, CT 06419 Phone: 862-404-3000 Phone: 801-972-5555 Phone: 860-663-5630 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.xofi go-us.com Website: www.bsdmedical.com Website: www.ChurchillConsulting.com A R R
Beekley Medical 2634 Buck Engineering & Consulting GMBH 2709 Cianna Medical 1838 1 Prestige Lane Gartenstrasse 11 6 Journey, Suite 125 Bristol, CT 06010 Reutlingen, 72764 Aliso Viejo, CA 92656 Phone: 800-233-5539 Germany Phone: 949-360-0059 Email: [email protected] Phone: 49-7121-930721-0 Email: [email protected] Email: [email protected] Website: www.ciannamedical.com Best Medical International, Inc. 336, 410, 2901 Website: www.b-e-c.net 7643 Fullerton Road CIRS 1644 Springfi eld, VA 22153 C4 Imaging 2734 2428 Almeda Ave., Suite 316 Phone: 703-451-2378 2160 Bellfl ower Lane Norfolk, VA 23513 Website: www.teambest.com New Hope, PA 18938 Phone: 757-855-2765 R Phone: 609-933-5895 Email: [email protected] Email: [email protected] Website: www.cirsinc.com Bionix Radiation Therapy 1627 Website: www.c4imaging.com R 5154 Enterprise Boulevard Toledo, OH 43612 Cancer CarePoint, Inc. 704 CivaTech Oncology 109 Phone: 419-727-8421-262 17 Executive Park Drive, Suite 520 PO Box 14310 Email: [email protected] Atlanta, GA 30329 Research Triangle Park, NC 27709 Website: www.bionixrt.com Phone: 800-998-5859 Phone: 919-815-0238 Email: [email protected] Email: [email protected] BK Medical 2601 Website: www.cancercarepoint.com Website: www.civatechoncology.com 8 Centennial Drive R R Peabody, MA 01960 Phone: 978-326-1300 Cancer Treatment Centers of America 2301 CIVCO Medical Solutions 1808 Email: [email protected] 2610 Sheridan Road 1401 8th St. SE Website: www.analogicultrasound.com Zion, IL 60099 Orange City, IA 51041 Phone: 847-746-4384 Phone: 712-737-8688 Bogardus Medical Systems, Inc. 1801 Email: [email protected] Email: [email protected] 3555 N. W. 58th St., Suite 500 Website: www.cancercenter.com Website: www.CIVCO.com Oklahoma City, OK 73112 B R Phone: 405-917-0500 Carbon Medical Technologies 1044 Email: [email protected] 1290 Hammond Rd. Cleveland Clinic Taussig Cancer Institute 1844 Website: www.oncochart.com St. Paul, MN 55110 9500 Euclid Avenue, R32 R Phone: 651-653-8512 Cleveland, OH 44195 Email: [email protected] Phone: 216-444-6931 Boiron 2908 Website: www.carbonmed.com Email: mineff [email protected] 6 Campus Boulevard Website: www.clevelandclinic.org/cancer Newtown Square, PA 19073-3267 Carl Zeiss Meditec, Inc. 1738 Phone: 610-325-7464 5160 Hacienda Drive Cold Shot Chillers 2933 Website: www.boironusa.com Dublin, CA 94568 14020 Interdrive West Phone: 925-557-4100 Houston, TX 77032 Brainlab 1328 Email: [email protected] Phone: 281-227-8400 3 Westbrook Corporate Center, Suite 400 Website: www.zeiss.com Email: [email protected] Westchester, IL 60154 R website: www.waterchillers.com Phone: 708-409-1343 Email: [email protected] CDR Systems, Inc. 1902 Coumans Care 2739 Website: www.brainlab.com #33, 235105 Wrangler Drive, SE PO Box 84 A R Calgary, AB T1X 0K3 Hartland, WI 53029 Canada Phone: 262-367-7726 LEGEND Phone: 403-850-7035 Website: www.coumanscare.com A Ambassador Email: [email protected] Website: www.cdrsys.ca C-RAD Inc. 1346 P Platinum Sponsor R 70 SE 4th Ave. G Gold Sponsor Delray Beach, FL 33483 S Silver Sponsor Cemar Electro Inc. 2202 Phone: 561-742-9260 1370 55th Avenue Email: [email protected] B Bronze Sponsor Lachine, QC H8T 3J8 Website: www.c-rad.com C Copper Sponsor Canada R R Enhanced RO MarketPlace Phone: 514-631-5807 Listing Email: [email protected] Website: www.cemarelectro.com CorporateCorporate membersmembers inin bold.bold. R
ASTRO 2014 / 56TH ANNUAL MEETING 209 EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
CRC Press 2934 Eckert & Ziegler BEBIG, Inc. 1002 Gammex 1220 3473 Sitio Borde 115 Hurley Road, Building 3A 7600 Discovery Drive Carlsbad, CA 92009 Oxford, CT 06478 Middleton, WI 53562 Phone: 760-944-9906 Phone: 203-262-0571 Phone: 608-828-7000 Website: www.crcpress.com Email: [email protected] Email: [email protected] Website: www.bebig.com Website: www.gammex.com Cura Medical Technologies 245 23 Rancho Circle Elekta 1308 GE Healthcare 2228 Lake Forest, CA 92630 400 Perimeter Center Terrace, Suite 50 P. O. Box 414 Phone: 85-883-170-56 Atlanta, GA 30346 Milwaukee, WI 53201 Phone: 770-670-2592 Phone: 262-544-3011 CYRPA 538 Email: [email protected] Website: www.gehealthcare.com Avenue Louise, 489 Website: www.elekta.com Brussels, 1050 A R GenomeDx Biosciences 343 Belgium 311 Water Street, Suite 400 Website: www.cyrpa.com Elsevier 1502 Vancouver, BC V6B 1B8 1600 JFK Boulevard Canada D3 Oncology Solutions 2242 Philadelphia, PA 19103 Phone: 604-558-4777 5750 Centre Avenue, Suite 500 Phone: 404-460-1831 Website: www.genomedx.com/ Pittsburgh, PA 15206 Email: [email protected] Phone: 412-365-0719 Website: www.us.elsevierhealth.com Genomic Health, Inc. 301 Email: [email protected] 301 Penobscot Drive Website: www.d3onc.com Equicare Health Inc. 1144 Redwood City, CA 94063 R 201-2020 Yukon St. Phone: 866-662-6897 Vancouver, BC V5Y 3N8 Email: [email protected] Dara BioSciences 344 Canada Website: www.OncotypeDX.com 8601 Six Forks Road, Suite 160 Phone: 604-398-2956 Raleigh, NC 27615 Email: [email protected] Gold Anchor 2907 Phone: 919-861-0286 Website: www.equicarehealth.com Vassvagen 21 Email: [email protected] R Huddinge, 14139 Website: www.darabio.com Sweden Everson Tesla Inc. 238 Phone: 46-706-105-411 Demos Medical Publishing 740 615 Daniels Road Email: [email protected] 11 West 42nd Street, 15th Floor Nazareth, PA 18064 Website: www.FineNeedleMarker.com New York, NY 10036 Phone: 610-216-6279 R Phone: 212-804-6316 Email: [email protected] Email: [email protected] Website: www.eversontesla.com GuangZhou Raydose Software 2546 Website: www.demosmedpub.com Technology, LLC Focal Therapeutics 2910 Room 502, Glorious Tower ,850 East Dongfeng Road DIACOR 2428 30 Enterprise GuangZhou, Guang Dong Province 510600 2550 Decker Lake Blvd. Suite 220 China West Valley, UT 84119 Aliso Viejo, CA 92656 Phone: +86-20-87764746 Phone: 800-342-2679 Phone: 949-600-5050 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.raydose.com Website: www.diacorinc.com Website: www.focalrx.com H&H Design-Build 2904 DOSIsoft 2533 Foss Therapy Services Inc. 702 130 East Main St. 45-47 Avenue Carnot 8794 Avalon St. New Albany, IN 47150 Cachan, 94230 Alta Loma, CA 91701 Phone: 812-206-6178 France Phone: 909-980-6229 Email: [email protected] Phone: 33-141-242-626 Email: [email protected] Website: www.hhdesignbuild.com Email: [email protected] Website: www.fosstherapyservices.net R Website: www.dosisoft.com Full Circle PR 2603 Hermes Medical Solutions, Inc. 2935 e+CancerCare 944 3001 North Rocky Point Drive East, Suite 200 710 Cromwell Drive, Suite A 104 Woodmont Blvd, Suite 500 Tampa, FL 33607 Greenville, NC 27858 Nashville, TN 37205 Phone: 727-230-9265 Phone: 866-437-6372 Phone: 615-467-7407 Website: www.fullcircle-pr.com Email: [email protected] Email: [email protected] Website: www.hermesmedical.com Website: www.epluscancercare.com GammaWest Cancer Services 2642 24 South 1100 East Hitachi 602 e2v 2438 Suite 306 50 Prospect Avenue 520 White Plains Road Salt Lake City, UT 84102 Tarrytown, NY 10591 Tarrytown, NY 10591 Phone: 801-608-5554 Phone: 914-524-6654 Phone: 914-592-6050 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.gammawest.com Website: www.hitachi-america.us Website: www.e2v.com
210 ASTRO 2014 / 56TH ANNUAL MEETING EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Hologic, Inc. 1402 Iron Medical Systems, Inc. 2905 Leoni CIA Cable Systems S.A.S. 2700 35 Crosby Drive 3104 E. Camelback Rd., #562 5, avenue Victor Hugo, ZAC du Jardin d’Entreprises Bedford, MA 01730 Phoenix, AZ 85016 Gellainville, 28000 Phone: 781-999-7300 Phone: 602-343-6440 France Email: [email protected] Email: [email protected] Phone: 0033-237333204 Website: www.hologic.com Website: www.ironmedicalsystems.com Email: [email protected] B R Website: www.leoni-healthcare.com IsoAid 1201 HyperDrive Medical 2903 7824 Clark Moody Blvd Liberty Medical Inc. 2544 1110 Sunset Drive Port Richey, FL 34668 22135 Davis Dr. #112 Salt Spring Island, BC V8K 1E6 Phone: 727-207-5973 Sterling, VA 20164 Canada Email: [email protected] Phone: 888-257-2408 Phone: 257-227-0757 Website: www.isoaid.com Email: [email protected] Email: [email protected] R Website: www.libertymedicalinc.com Website: www.hyperdrivemed.com R IsoRay Medical, Inc. 738 IBA 1727 350 Hills Street, Suite 106 LifeLine Software, Inc. 436 Chemin du Cyclotron, 3 Richland, WA 99354 2407 Pemberton Place Louvain-la-Neuve, 1348 Phone: 509-375-1202 Austin, TX 78703 Belgium Email: [email protected] Phone: 866-592-1343 Phone: 32-470-048-622 Website: www.isoray.com Email: [email protected] Email: [email protected] R Website: www.lifelinesoftware.com Website: www.iba-worldwide.com R A James L. Davis 1102 13521 Walsingham Rd. LinaTech, LLC 2402 Imaging Technology News 1842 Largo, FL 33774 1294 Kifer Road, Suite 705 3030 West Salt Creek Lane, Suite 201 Phone: 727-596-0408 Sunnyvale, CA 94086 Arlington Heights, IL 60005 Email: [email protected] Phone: 408-733-2051 Phone: 847-391-1000 Website: www.jld-radcon.com Email: [email protected] Email: [email protected] R Website: www.linatech.com Website: www.ITNonline.com Klarity 2416 Linbeck Group LLC 2736 ImpediMed, Inc. 1042 80 Westgate Drive 3900 Essex 5900 Pasteur Court, Suite 125 Newark, OH 43055 Suite 120 Carlsbad, CA 92008 Phone: 740-788-8107 Houston, TX 77027 Phone: 877-247-0111 Email: [email protected] Phone: 713-621-2350 Email: [email protected] Website: www.klaritymedical.com Website: www.impedimed.com R Logos Systems Int’l 341 R 175 El Pueblo Road Kobold, LLC 104 Scotts Valley, CA 95066 INSYS Therapeutics, Inc. 1944 PO Box 1994 Phone: 831-600-6101 1333 South Spectrum Blvd., Suite 100 Veradale, WA 99037 Email: [email protected] Chandler, AZ 85286 Phone: 509-703-5090 Website: www.logosvisionsystem.com Phone: 602-910-2617 Email: [email protected] Email: [email protected] Website: www.koboldmedical.com/ MACROMEDICS BV 2636 Website: www.insysrx.com R Kouwe Hoek 18 Waddinxveen, 2741 PX IntraOp Medical Corporation 1703 Kunshan GuoLi Vacuum Electric Co., Ltd 542 Netherlands 570 Del Rey Avenue Shuixiu Road 1418 Phone: 31-018-238-9777 Sunnyvale, CA 94085 Kunshan City, 215316 Website: www.macromedics.com Phone: 408-636-1020-128 China Email: [email protected] Phone: 86-512-577-3562-1 Math Resolutions 244 Website: www.intraopmedical.com Website: www.glvac.com 5975 Gales Lane Columbia, MD 21045 IOP Publishing 208 Landauer, Inc. 608 Phone: 410-997-9578 150 South Independence Mall West, Suite 929 2 Science Road Website: www.MathResolutions.com Philadelphia, PA 19106 Glenwood, IL 60425 Phone: 215-627-0880 Phone: 877-476-8433 Max Medical Co., Ltd. 101 Email: [email protected] Email: [email protected] 4-5-1, Nishinakajima, Yodogawa-ku Website: www.ioppublishing.org Website: www.landauermp.com/ Osaka, 532-0011 R LEGEND Japan Phone: +81-6-6886-7351 A Ambassador LAP of America LLC 2002 Email: [email protected] P Platinum Sponsor 161 Commerce Rd., Suite 3 Website: www.maxmedical.co.jp Boynton Beach, FL 33426 G Gold Sponsor Phone: 561-416-9250 Maxim Government Services 2909 S Silver Sponsor Email: [email protected] 7227 Lee DeForest Dr. B Bronze Sponsor Website: www.lap-laser.com/medical-systems/ Columbia, MD 21046 R Phone: 866-260-9142 CorporateC Copper members Sponsor in bold. Website: www.maximgov.com R Enhanced RO MarketPlace Listing Corporate members in bold. EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Mayo Clinic 2640 Mitsubishi Electric Corporation 2602 Nualine Laser 342 13400 East Shea Boulevard 503 Keystone Drive 4333 Belcarra Court Scottsdale, AZ 85259 Warrendale, PA 15086-7537 Dublin, CA 94568 Phone: 507-284-4873 Phone: 742-724-3422 Phone: 925-388-6026 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.mayoclinic.org Website: www.nualinelaser.com MM Leadership Management Solutions 2204 Medspira, LLC 2036 4705 Skyway Oncology Services International 212 2718 Summer St. NE Paradise, CA 95969 400 Rella Boulevard, Suite 123 Minneapolis, MN 55413 Montebello, NY 10901 Phone: 612-789-0013 Mobius Medical Systems 2528 Phone: 845-357-6560 Email: [email protected] 5012 Tamarisk Street Email: [email protected] Website: www.medspira.com Bellaire, Texas 77401 Website: www.thinkosi.com/ Phone: 888-263-8541 R Mevion Medical Systems 728 Email: [email protected] 300 Foster Street Website: www.mobiusmed.com Oncology Systems Limited 1244 Littleton, MA 01460 94 Fernbank Avenue Phone: 978-540-1500 Modus Medical Devices Inc. 1937 Delmar, NY 12054 Email: [email protected] 1570 North Routledge Park Phone: 518-475-1085 Website: www.mevion.com London, ON N6H 5L6 Email: [email protected] G R Canada Website: www.osl-usa.com/rte.asp Phone: 519-438-2409 Miaderm 837 Email: [email protected] Orfi t Industries America 1438 2412 Calle San Miguel Website: www.modusmed.com 350 Jericho Turnpike, Suite 302 Encinitas, CA 92024 Jericho, NY 11753 Phone: 617-461-5959 MPM Medical Inc. 2303 Phone: 516-935-8500 Email: [email protected] 2301 Crown Ct Email: martinj.ratner@orfi t.com Website: www.miaderm.com Irving, TX 75038 Website: www.orfi t.com Phone: 972-893-4090 R Mick Radio-Nuclear Instruments, Inc., 902 Email: [email protected] an Eckert & Ziegler BEBIG Company Website: www.mpmmed.com Oxford Instruments Service, LLC 2502 521 Homestead Avenue R 64 Union Way Mount Vernon, NY 01550 Vacaville, CA 95687 Phone: 203-262-0571 MuCheck-Oncology Data Systems 1139 Phone: 888-673-5151 Email: [email protected] 1601 SW 89th Street E-100 Email: [email protected] Website: www.micknuclear.com Oklahoma City, OK 73159 Website: www.oxford-instruments.com/ct-mr R Phone: 405-680-5222 Email: [email protected] Panacea Medical Technologies Pvt. Ltd. 443 Micropos Medical 2643 Website: www.mucheck.com 119 Envision Technology Center Stena Center 1 R EPIP Area Phase1, Whitefi eld Gothenburg, 41292 Bangalore, Karnataka 560 066 Sweden Myriad Genetic Laboratories 242 India Phone: +46 31 772 80 99 320 Wakara Way Phone: +91-9686541355 Email: [email protected] Salt Lake City, UT 84108 Email: [email protected] Website: www.micropos.se Phone: 801-584-3535 Website: www.panceamedical.com R Email: [email protected] Website: www.myriad.com Paramed Medical Systems Inc. 2341 MIM Software 2127 6204 Oakton Street 25800 Science Park Drive, Suite 180 NELCO 627 Morton Grove, IL 60053-2721 Cleveland, OH 44122 2 Burlington Woods Dr, Suite 300 Phone: 847-470-0580 Phone: 216-455-0600 Burlington, MA 01803 Website: www.paramedmedicalsystems.com Email: [email protected] Phone: 781-933-1940 Website: www.mimsoftware.com Website: www.nelcoworldwide.com Patient Relationship Management (PRM) 2645 R 17581 Haralson Drive Mirada Medical 308 Eden Prairie, MN 55347 999 18th Street, Ste 2025N Novocure 2144 Phone: 952-239-0411 Denver, CO 80202 195 Commerce Way Website: prmplatform.com Phone: 330-379-9228 Portsmouth, NH 03801 Email: [email protected] Phone: 603-436-2809 P-Cure Ltd. 444 Website: www.mirada-medical.com Email: [email protected] 500 Lake Cook Rd. Website: www.novottftherapy.com Deerfi eld, IL 60015 Mission Search 502 Phone: 847-874-7771 2203 N. Lois Ave, Suite 1225 Novocure 2243 Email: [email protected] Tampa, FL 33607 1500 Broadway, 29th Floor Website: www.p-cure.com Phone: 813-870-9500 New York, NY 10036 Email: [email protected] Phone: 212-767-7546 Perioperative Services, LLC 236 Website: www.MissionSearch.com Email: [email protected] 111 Continental Drive, Suite 412 Website: www.novottftherapy.com Newark, DE 19713 Phone: 302-709-4502 Email: [email protected] Website: www.periopradonc.com
212 ASTRO 2014 / 56TH ANNUAL MEETING EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Perkins + Will 2931 Prowess, Inc. 2628 Radiology Oncology Systems, Inc. 1638 10100 North Central Expressway 1844 Clayton Road 6725 Mesa Ridge Road, Suite 100 Dallas, TX 75231 Concord, CA 94520 San Diego, CA 92121 Phone: 214-283-8700 Phone: 925-356-0360 Phone: 858-454-8100 Website: www.perkinswill.com Email: [email protected] Email: [email protected] Website: www.prowess.com Website: www.oncologysystems.com Phantom Laboratory 1802 PO Box 511 PTW 2307 RaySearch Laboratories AB 2315 Salem, NY 12865 140 58th Street Suite 5H3 401 Franklin Ave., Suite 100 A Phone: 518-692-1190 Brooklyn, NY 11220 Garden City, NY 11530 Email: [email protected] Phone: 516-827-3181 Phone: 877-778-3849 Website: www.phantomlab.com Email: [email protected] Email: [email protected] Website: www.ptwny.com Website: www.raysearchlabs.com Philips Healthcare 1128 3000 Minuteman Road Qfi x 1208 Revenue Cycle, Inc. 801 Andover, MA 01810 440 Church Road 1817 West Braker Lane, Bldg. F Ste. 200 Phone: 800-229-6417 Avondale, PA 19311 Austin, TX 78758 Email: [email protected] Phone: 800-526-5247-713 Phone: 512-583-2000 Website: www.philips.com/healthcare Email: sales@qfi x.com Email: [email protected] A Website: www.qfi x.com Website: www.revenuecycleinc.com/ R R Pitts Little Corp. 1301 2711 Alton Road QLRAD Inc. 305 RK Builders Inc. 2434 Birmingham, AL 35210 80 South West 8th Street, Suite 2000 1124 Nipomo St., Suite C Phone: 205-833-5911 Miami, FL 33130 San Luis Obispo, CA 93401 Email: [email protected] Phone: 770-335-5601 Phone: 805-541-2060 Website: www.pittslittle.com/ Email: [email protected] Email: [email protected] Website: www.QLRAD.com Website: www.rkbuildersinc.com Precision X-Ray 2143 15 Commerce Drive, UNIT 1 RAD Technology Medical Systems 328 RS&A, Inc. 1043 North Branford, CT 06471 20801 Biscayne Blvd., Suite 403 465 Forum Parkway Phone: 203-484-2011 Aventura, FL 33180 Rural Hall, NC 27045 Email: [email protected] Phone: 305-898-2544 Phone: 336-969-0583 Website: www.pxinc.com Email: [email protected] Email: [email protected] R Website: www.radtechnology.com Website: www.rsa-inc.com/
Precisis Euromechanics GmbH 2932 RadiaDyne 302 RT Temps 540 Hauptstr. 73 3801 Kirby DrSuite 710 9 West Front Street Heidelberg, 69117 Houston, TX 77098 Media, PA 19063 Germany Phone: 713-807-9100 Phone: 800-677-8233 Phone: 49-622-165-5930-0 Website: www.radiadyne.com Website: rttemps.com Email: s.ueltzhoeff [email protected] Website: www.pe-collimators.com Radiation Business Solutions 1602 S+S Par Scientifi c 1104 1044 Jackson Felts Road 10625 Telge Road ProTom International, Inc. 2508 Joelton, TN 37080 Houston, TX 77095 1100 Parker Square, Ste., 230 Phone: 615-746-4711 Phone: 281-815-1300 Flower Mound, TX 75028 Email: [email protected] Email: tj@parscientifi c.com Phone: 972-410-3551 Website: www.radiationbusiness.com Website: www.ParScientifi c.com Email: [email protected] Website: www.protominternational.com Radiation Products Design, Inc. 1202 Sarah Cannon 2742 R 5218 Barthel Industrial Drive 3322 West End Avenue Albertville, MN 55301 Suite 900 ProNova Solutions 637 Phone: 763-497-2071 Nashville, TN 37203 1450 Dowell Springs Blvd. Email: [email protected] Phone: 615-329-7216 Suite 230 Website: www.rpdinc.com Website: www.sarahcannonresearch.com Knoxville, TN 37909 R ScandiDos 2536 Radiation Therapy Oncology Group 2738 2693 Research Park Drive, Suite 202 LEGEND 1818 Market St., Suite 1600 Madison, WI 53711 Philadelphia, PA 19103 Phone: 608-630-9415 A Ambassador Phone: 215-717-0843 Email: [email protected] P Platinum Sponsor Email: [email protected] Website: www.scandidos.com Website: www.rtog.org/ G Gold Sponsor Sensus Healthcare 402 S Silver Sponsor Radiological Imaging Technology - RIT 320 851 Broken Sound, Pkwy #215 B Bronze Sponsor 5065 List Dr Boca Raton, FL 33487 Colorado Springs, CO 80919-3321 Phone: 800-324-9890 C Copper Sponsor Phone: 719-590-1077 Email: [email protected] R Enhanced RO MarketPlace Email: [email protected] Website: www.sensushealthcare.com CorporateListing members in bold. Website: www.radimage.com R Corporate members in bold. R
ASTRO 2014 / 56TH ANNUAL MEETING 213 Shandong Xinhua Medical. 2516 Standard Imaging 1138 Vantage Oncology 2236 Instruments Co., Ltd 3120 Deming Way 1500 Rosecrans Avenue, Suite 400 No.7 Taimei Road, Zibo New & Hi - Tech Zone Middleton, WI 53562 Manhattan Beach, CA 90266 Shandong, 255086 Phone: 800-261-4446 Phone: 310-335-4000 China Email: [email protected] Email: [email protected] Phone: 86-533-358-7719 Website: www.standardimaging.com/ Website: www.vantageoncology.com Email: [email protected] R Website: www.shinva.com Varian Medical Systems 618, 807 Sumitomo Heavy Industries, Ltd. 1744 3100 Hansen Way Shielding Construction Solutions, Inc. 802 Think Park Tower 1-1, Osaki 2-chome, Shinagawa Palo Alto, CA 94304 4620 S. Coach Drive Tokyo, JAPAN 141-6025 Phone: 650-424-5927 Tucson, AZ 85714 Japan Email: [email protected] Phone: 520-917-0661 Phone: 81-3-6737-2566 Website: www.varian.com Email: [email protected] Email: [email protected] A R Website: www.shieldingconstruction.com Website: www.shi.co.jp/english/index.html R Veritas Medical Solutions 2340 Sun Nuclear Corporation 1928 5 Great Valley Parkway, Suite 210 Siemens Medical Solutions USA, Inc. 928 3275 Suntree Blvd. Malvern, PA 19355 51 Valley Stream Parkway Melbourne, FL 32940 Phone: 888-242-6760 Malvern, PA 19355 Phone: 321-259-6862-275 Email: [email protected] Phone: 914-524-5168 Email: [email protected] Website: www.veritas-medicalsolutions.com Email: [email protected] Website: www.sunnuclear.com/ R Website: www.medical.siemens.com C R A Vertual, Ltd. 2102 Suremark Company 2044 Logistics Institute Siris Medical 105 4645 Industrial Street, 2C Hull, UK HU6 7RX 128 Bonny St. Simi Valley, CA 93063 United Kingdom Mountain View, CA 94043 Phone: 800-406-3399 Phone: 44-148-234-7572 Phone: 860-214-9284 Email: [email protected] Email: [email protected] Website: www.suremark.com Website: www.vertual.co.uk Sirtex Medical 111 C 16 Upton Drive Synergen Health 204 Suites 2-4 3131 McKinney Avenue ViewRay, Inc. 416 Wilmington, MA 01887 Dallas, TX 75204 2 Thermo Fisher Way Phone: 888-474-7839 Phone: 21-495-266-02 Oakwood Village, OH 44146 Email: [email protected] Website: www.SynergenHealth.com Phone: 408-368-2244 Website: www.sirtex.com Email: [email protected] Technical Prospects, LLC 1745 Website: www.viewray.com SIT USA 442 1000 S. County Road CB S R 14530 Falling Waters Drive Appleton, WI 54914 Jacksonville, FL 32258 Phone: 920-757-6583 Vision RT, Ltd. 2408 Phone: 925-768-4034 Email: [email protected] 8840 Stanford Boulevard, Suite 3200 Email: [email protected] Website: www.technicalprospects.com Columbia, MD 21045 Website: www.soiort.com Phone: 866-778-2379 Theragenics Corporation 2302 Email: [email protected] Sky Factory 839 5203 Bristol Industrial Way Website: www.visionrt.com 801 N. 18th Street, PO 1177 Buford, GA 30518 R Fairfi eld, IA 52556 Phone: 770-831-5137 Phone: 641-472-1747 Email: [email protected] Wolters Kluwer Health 601 Email: [email protected] Website: www.theragenics.com/ Two Commerce Square, 2001 Market Street Website: www.SkyFactory.com R Philadelphia, PA 19103 Phone: 215-521-8781 SpecMed 2038 Top Grade Medical Equipment Co., LTD. 644 Website: www.lww.com 113 Teal St. No. 11 Yongchang North Road, BDA St. Rose, LA 70087 Beijing, P.R.C. 10076, Xecan 1039 Phone: 504-464-9471 China 275 Grove Street, Bldg. 2, Suite 400 Email: [email protected] Phone: 86-106-788-5599 ext. 398 Newton, MA 02466 Website: www.spec-med.com Email: [email protected] Phone: 617-686-9953 Website: www.topgradehc.com Spectrum Pharmaceuticals, Inc. 1302 Xoft 1938 11500 S. Eastern Avenue, #240 Toshiba Medical Systems 2138 101 Nicholson Lane Henderson, NV 89052 2441 Michelle Drive San Jose, CA 95134 Phone: 702-835-6300 Tustin, CA 92780-7043 Phone: 408-493-1500 Email: [email protected] Phone: 714-669-4190 Email: [email protected] Website: www.sppirx.com Email: [email protected] Website: www.xoftinc.com R Website: www.medical.toshiba.com S R
Springer 1501 TRG Oncology Equipment 1303 Xstrahl Limited 1338 233 Spring Street 5318 E. 2nd Street, #682 480 Brogdon Road, Suite 100 New York, NY 10013 Long Beach, CA 90803 Suwanee, GA 30024 Phone: 212-460-1500 Phone: 949-622-0022 Phone: 678-482-6800 Email: [email protected] Website: www.oncologyequipment.com/ Email: [email protected] Website: www.springer.com R Website: www.xstrahl.com Exhibitor Listing by Product/Service
ACCELERATOR IBA 1727 MIM Software 2127 Acceletronics 428 Logos Systems Int’l 341 Oncology Systems Limited 1244 Hitachi 602 Micropos Medical 2643 Oxford Instruments Service LLC 2502 IBA 1727 Phantom Laboratory 1802 P-Cure Ltd. 444 LAP of America LLC 2002 PTW 2307 Phantom Laboratory 1802 Max Medical Co. Ltd. 101 QLRAD Inc. 305 Philips Healthcare 1128 Mevion Medical Systems 728 Radiological Imaging Technology - RIT 320 PTW 2307 Mitsubishi Electric Corporation 2602 ScandiDos 2536 Radiation Products Design Inc. 1202 Oncology Services International 212 Shandong Xinhua Medical Instruments Co. Ltd. 2516 Radiology Oncology Systems Inc. 1638 Pancea Medical Technologies Pvt. Ltd. 443 Standard Imaging 1138 Siemens Medical Solutions USA Inc. 928 ProTom International Inc. 2508 Sun Nuclear Corporation 1928 Technical Prospects LLC 1745 Radiology Oncology Systems Inc. 1638 Varian Medical Systems 618, 807 Top Grade Medical Equipment Co. Ltd. 644 RS&A Inc. 1043 Toshiba Medical Systems 2138 Shandong Xinhua Medical Vision RT Ltd. 2408 Instruments Co. Ltd. 2516 EMR/DATA MANAGEMENT/IT Xoft 1938 Shielding Construction Solutions Inc. 802 Anatom-e XRT Information Systems, Ltd. 544 Xstrahl Ltd. 1338 SIT USA 442 Bogardus Medical Systems Inc. 1801 Sumitomo Heavy Industries Ltd. 1744 Churchill Consulting Inc. 1901 Top Grade Medical Equipment Co. Ltd. 644 Elekta 1308 INFORMATION/TECHNOLOGY TRG Oncology Equipment 1303 Equicare Health Inc. 1144 Anatom-e XRT Information Systems, Ltd. 544 Varian Medical Systems 618, 807 GuangZhou Raydose Software Technology LLC 2546 Bogardus Medical Systems Inc. 1801 Patient Relationship Management (PRM) 2645 Equicare Health Inc 1144 Revenue Cycle Inc. 801 Hermes Medical Solutions Inc. 2935 BRACHYTHERAPY Varian Medical Systems 618, 807 MIM Software 2127 21st Century Oncology 838 Vision Tree Software Inc. 2741 MuCheck-Oncology Data Systems 1139 AccuBoost 218 Patient Relationship Management (PRM) 2645 Best Medical International Inc. 336, 410, 2901 Siemens Medical Solutions USA Inc. 928 BK Medical 2601 FACILITY CONSTRUCTION/DESIGN Varian Medical Systems 618, 807 BSD Medical 1743 Advanced Shielding Technologies Inc. 1701 VisionTree Software Inc. 2741 C4 Imaging 2734 Architection 940 Cianna Medical 1838 H&H Design-Build 2904 CivaTech Oncology 109 IBA 1727 MEDICAL DEVICE CIVCO Medical Solutions 1808 James L. Davis 1102 .decimal 1040 Cleveland Clinic Taussig Cancer Institute 1844 NELCO 627 A2J Healthcare 1145 DIACOR 2428 Pancea Medical Technologies Pvt. Ltd. 443 ABL Medical 2537 Eckert & Ziegler BEBIG Inc. 1002 Perkins + Will 2931 AccuBoost 218 Hologic Inc. 1402 Pitts Little Corp. 1301 Anatome-e XRT Information Systems, Ltd. 544 IsoAid 1201 RAD Technology Medical Systems 328 Augmenix 1943 IsoRay Medical Inc. 738 RK Builders Inc. 2434 Best Medical International Inc. 336, 410, 2901 Kobold LLC 104 Shielding Construction Solutions Inc. 802 BK Medical 2601 Liberty Medical Inc. 2544 Sky Factory 839 BSD Medical 1743 LifeLine Software, Inc. 436 Veritas Medical Solutions 2340 Buck Engineering & Consulting GMBH 2709 Mick Radio-Nuclear Instruments Inc., an Eckert & C4 Imaging 2734 Ziegler BEBIG Company 902 Carbon Medical Technologies 1044 MIM Software 2127 FINANCIAL/INSURANCE Carl Zeiss Meditec Inc. 1738 MuCheck-Oncology Data Systems 1139 Alliance Oncology 504 CDR Systems Inc. 1902 Pancea Medical Technologies Pvt. Ltd. 443 AMAC - American Medical Accounting and CivaTech Oncology 109 Prowess Inc. 2628 Consulting 1601 e2v 2438 Radiation Products Design Inc. 1202 Churchill Consulting Inc. 1901 Eckert & Ziegler BEBIG Inc. 1002 RK Builders Inc. 2434 Perioperative Services LLC 236 Elekta 1308 Shandong Xinhua Medical Instruments Co. Ltd. 2516 Radiation Business Solutions 1602 Focal Therapeutics 2910 Spec-Med 2038 Revenue Cycle Inc. 801 Foss Therapy Services Inc. 702 Theragenics Corporation 2302 Gammex 1220 Varian Medical Systems 618, 807 GE Healthcare 2228 Xoft 1938 IMAGING/DIAGNOSTICS Gold Anchor 2907 Acceletronics 428 Hitachi 602 Anatom-e XRT Information Systems, Ltd. 544 Hologic Inc. 1402 DEVICE/EQUIPMENT Acceletronics 428 ImpediMed Inc. 1042 Accuray Inc. 1908 AQUILAB SAS 2334 IntraOp Medical Corporation 1703 Oncology Services International 212 Best Medical International Inc. 336, 410, 2901 IsoRay Medical Inc. 738 Precision Euromechanics GmbH 2932 BK Medical 2601 Klarity 2416 Radiation Products Design Inc. 1202 C-RAD Inc. 1346 Kobold LLC 104 Siemens Medical Solutions USA Inc. 928 DIACOR 2428 Liberty Medical Inc. 2544 Toshiba Medical Systems 2138 DOSIsoft 2533 LinaTech LLC 2402 Gammex 1220 Medspira, LLC 2036 GE Healthcare 2228 Mevion Medical Systems 728 DOSIMETRY/DETECTORS Genomic Health, Inc. 301 Micropos Medical 2643 Anatom-e XRT Information Systems, Ltd. 544 Hermes Medical Solutions Inc. 2935 MIM Software 2127 Best Medical International Inc. 336, 410, 2901 Logos System Int’l 341 Oxford Instruments Service LLC 2502 DOSIsoft 2533 ASTRO 2014 / 56TH ANNUAL MEETING 215 P-Cure Ltd. 444 PHARMACEUTICAL Augmenix 1943 Philips Healthcare 1128 Bayer HealthCare 1818, 2804 IntraOp Medical Corporation 1703 Precision Euromechanics GmbH 2932 Dara BioSciences 344 James L. Davis 1102 ProTom International Inc. 2508 INSYS Therapeutics Inc. 1944 Max Medical Co. Ltd. 101 Qfi x 1208 Miaderm 837 NELCO 627 RS&A Inc. 1043 Spectrum Pharmaceuticals Inc. 1302 Shielding Construction Solutions Inc. 802 S+S Par Scientifi c 1104 Veritas Medical Solutions 2340 Sensus Healthcare 402 Shandong Xinhua Medical Instruments Co. Ltd. 2516 PRACTICE MANAGEMENT SIT USA 442 21st Century Oncology 838 RADIATION THERAPY Spec Med 2038 Alliance Oncology 504 .decimal 1040 Sumitomo Heavy Industries Ltd. 1744 Anatom-e XRT Information Systems, Ltd. 544 21st Century Oncology 838 Technical Prospects LLC 1745 AMAC - American Medical Accounting and A2J Healthcare 1145 Theragenics Corporation 2302 Consulting 1601 Acceletronics 428 Toshiba Medical Systems 2138 e+CancerCare 944 AccuBoost 218 Varian Medical Systems 618, 742, 807 Patient Relationship Management (PRM) 2645 Accuray Inc. 1908 ViewRay Inc. 416 Perioperative Services LLC 236 Aktina Medical Corporation 228 Vision RT Ltd. 2408 Radiation Business Solutions 1602 Alliance Oncology 504 Xstrahl Ltd. 1338 Revenue Cycle Inc. 801 Anatom-e XRT Information Systems, Ltd. 544 Vantage Oncology 2236 Anzai Medical Co. Ltd. 2336 VisionTree Software, Inc. 2741 Augmenix 1943 OTHER Best Medical International Inc. 336, 410, 2901 Advanced Shielding Technologies Inc. 1701 Bionix Radiation Therapy 1627 AEP Linac 2436 PROFESSIONAL SOCIETY Brainlab 1328 Anatome-e XRT Information System, Ltd. 544 ALATRO (Asociacion Iberoamericana De Terapia Buck Engineering & Consulting GMBH 2709 Boiron 2908 Radiante Oncologica) 241 Carbon Medical Technologies 1044 CIVCO Medical Solutions 1808 American Association of Medical Dosimetrists 2732 Cianna Medical 1838 Cold Shot Chillers 2933 American Society of Clinical Oncology 1401 CIRS 1644 D3 Oncology Solutions 2242 APHSO 441 CivaTech Oncology 109 Equicare Health Inc. 1144 CIVCO Medical Solutions 1808 Foss Therapy Services Inc. 702 Cleveland Clinic Taussig Cancer Institute 1844 Genomic Health, Inc. 301 PUBLISHER C-RAD Inc. 1346 ImpediMed, Inc. 1042 AME Publishing Company 206 DOSIsoft 2533 Iron Medical Systems Inc. 2905 Anatom-e XRT Information Systems, Ltd. 544 e2v 2438 Landauer Inc. 608 Demos Medical Publishing 740 Eckert & Ziegler BEBIG Inc. 1002 MIM Software 2127 Elsevier 1502 Elekta 1308 Myriad Genetic Laboratories 242 Imaging Technology News 1842 Focal Therapeutics 2910 Perioperative Services LLC 236 Springer 1501 Foss Therapy Services Inc. 702 Radiation Business Solutions 1602 Gold Anchor 2907 Radiation Therapy Oncology Group 2738 GuangZhou Raydose Software Technology LLC 2546 RS&A Inc. 1043 QUALITY ASSURANCE Hologic Inc. 1402 Sky Factory 839 AMAC - American Medical Accounting IBA 1727 Vertual Ltd. 2102 and Consulting 1601 IntraOp Medical Corporation 1703 AQUILAB SAS 2334 IsoAid 1201 C4 Imaging 2734 IsoRay Medical, Inc. 738 PATIENT HANDLING/POSITIONING Churchill Consulting Inc. 1901 Klarity 2416 A2J Healthcare 1145 CIRS 1644 Landauer Inc. 608 Aktina Medical Corporation 288 CIVCO Medical Solutions 1808 LAP of America LLC 2002 Best Medical International Inc. 336, 410, 2901 DOSIsoft 2533 LifeLine Software Inc. 436 Bionix Radiation Therapy 1627 Eckert & Ziegler BEBIG Inc. 1002 Max Medical Co. Ltd. 101 Brainlab 1328 Foss Therapy Services Inc. 702 Medspira LLC 2036 Buck Engineering & Consulting GMBH 2709 Gammex 1220 Mevion Medical Systems 728 CDR Systems Inc. 1902 GuangZhou Raydose Software Technology LLC 2546 Miaderm 837 Cemar Electro Inc. 2202 Hermes Medical Solutions Inc. 2935 Micropos Medical 2643 CIVCO Medical Solutions 1808 IBA 1727 MIM Software 2127 C-RAD Inc. 1346 LifeLine Software Inc. 436 Mirada Medical 308 DIACOR 2428 Logos Systems Int’l 341 Mitsubishi Electric Corporation 2602 Elekta 1308 Micropos Medical 2643 Mobius Medical Systems 2528 Focal Therapeutics 2910 Mobius Medical Systems 2528 Modus Medical Devices Inc. 1937 Gold Anchor 2907 Modus Medical Devices Inc. 1937 MPM Medical Inc. 2303 Klarity 2416 Oncology Systems Limited 1244 MuCheck-Oncology Data Systems 1139 Kobold LLC 104 Phantom Laboratory 1802 Nualine Laser 342 LAP of America LLC 2002 Radiation Therapy Oncology Group 2738 Oncology Services International 212 Leoni CIA Cable Systems S.A.S. 2700 Radiological Imaging Technology - RIT 320 Oncology Systems Ltd. 1244 Micropos Medical 2643 ScandiDos 2536 Orfi t Industries America 1438 Nualine Laser 342 Standard Imaging 1138 Oxford Instruments Service LLC 2502 Qfi x 1208 Sun Nuclear Corporation 1928 Panacea Medical Technolgies Pvt. Ltd. 443 QLRAD Inc. 305 P-Cure Ltd. 444 S+S Par Scientifi c 1104 Phantom Laboratory 1802 Vision RT Ltd. 2408 RADIATION PROTECTION/SHIELDING Precision X-Ray 2143 Advanced Shielding Technologies Inc. 1701 PTW 2307 architection 940 Qfi x 1208 QLRAD Inc. 305 SEARCH FIRM/STAFFING/RECRUITMENT AQUILAB SAS 2334 RadiaDyne 302 Cancer CarePoint Inc. 704 Beekley Medical 2634 Radiation Therapy Oncology Group 2738 Cancer Treatment Centers of America 2301 Best Medical International Inc. 336, 410, 2901 Radiological Imaging Technology - RIT 320 Landauer Inc. 608 Brainlab 1328 Radiology Oncology Systems Inc. 1638 Mission Search 502 Carbon Medical Technologies 1044 RaySearch Laboratories AB 2315 CIRS 1644 RS&A Inc. 1043 CIVCO Medical Solutions 1808 S+S Par Scientifi c 1104 TREATMENT ACCESSORIES Cleveland Clinic Taussig Cancer Institute 1844 ScandiDos 2536 AEP Linac 2436 D3 Oncology Solutions 2242 Shandong Xinhua Medical Instruments Co. Ltd. 2516 Aktina Medical Corporation 288 DOSIsoft 2533 SIT USA 442 Beekley Medical 2634 Eckert & Ziegler BEBIG Inc. 1002 Standard Imaging 1138 Best Medical International Inc. 336, 410, 2901 Elekta 1308 Sumitomo Heavy Industries Ltd. 1744 BSD Medical 1743 GE Healthcare 2228 Sun Nuclear Corporation 1928 CDR Systems Inc. 1902 Genomic Health Inc. 301 Technical Prospects LLC 1745 C-RAD Inc. 1346 HyperDrive Medical 2903 Top Grade Medical Equipment Co. Ltd. 644 Eckert & Ziegler BEBIG Inc. 1002 LinaTech LLC 2402 TRG Oncology Equipment 1303 Hitachi 602 Medspira LLC 2036 Vantage Oncology 2236 Liberty Medical Inc. 2544 MIM Software 2127 Varian Medical Systems 618, 807 Medspira LLC 2036 Mirada Medical 308 Vertual Ltd. 2102 Miaderm 837 Mitsubishi Electric Corporation 2602 ViewRay Inc. 416 MIM Software 2127 Mobius Medical Systems 2528 Vision RT Ltd. 2408 Mirada Medical 308 Myriad Genetic Laboratories 242 Xoft 1938 RS&A Inc. 1043 Oncology Systems Ltd. 1244 Xstrahl Ltd. 1338 S+S Par Scientifi c 1104 Oxford Instruments Service LLC 2502 Shandong Xinhua Medical Instruments Co. Ltd. 2516 Phantom Laboratory 1802 RADIOISOTOPE SOURCE MANUFACTURER Sky Factory 839 Philips Healthcare 1128 Eckert & Ziegler BEBIG Inc. 1002 Suremark Company 2044 Precision X-Ray 2143 IBA 1727 Vision RT Ltd. 240 Prowess Inc. 2628 IsoAid 1201 RaySearch Laboratories AB 2315 Theragenics Corporation 2302 ScandiDos 2536 TREATMENT PLANNING Shandong Xinhua Medical Instruments Co. Ltd. 2516 RECRUITMENT AND STAFFING ABL Medical Corporation 2537 Vantage Oncology 2236 Mission Search 502 Accuray Inc. 1908 Varian Medical Systems 618, 807 RT Temps 540 Anatom-e XRT Information System Ltd. 544 ViewRay Inc. 416 2014 ANNUAL MEETING Unrestricted Educational Grant Supporters Bayer HealthCare Lilly Merck Pfi zer
ASTRO 2014 / 56TH ANNUAL MEETING 217 Meeting Dates: September 14 -17, 2014 • Moscone Center • San Francisco
2 9 0 1 2 9 0 3 2 9 0 4 2 9 0 5 2 9 0 7 2 9 0 8
2 4 5 2 4 4 3 4 3 3 4 4 4 4 3 4 4 4 5 4 0 5 4 4 1 0 4 4 1 14 4 5 2 4 3 2 4 2 2 4 1 3 4 1 3 4 2 4 4 1 4 4 2 5 3 8 5 4 2 6 44 7 42 9 4 4 1 0 4 3 1 0 4 2 1 1 44 1 2 44 1 3 46
7 4 0 8 3 9 9 4 0 1 0 3 9 1 0 4 0 1 13 3 9
2 3 8 6 37 7 3 8 8 3 7 8 38 1 1 38 1 3 38
2 3 6 3 36 4 36
FOOD 2 28 3 28 4 28 6 27 7 28 9 28 1 1 28 1 3 28 CAFE H A L L A H A L L B
2 18 3 20 1 2 20
4 16 6 18
2 12
4 10
2 0 8 3 08 6 08 8 07 1 2 08 1 3 08
1 1 1 2 0 6 3 0 5
1 0 9 2 0 4 5 0 4 7 0 4 1 1 0 4 1 3 0 3
1 0 7 2 0 2 3 0 1 3 02 4 02 5 0 2 6 0 1 6 02 7 0 2 8 0 1 8 02 9 02 1 0 02 1 1 0 2 1 2 0 1 1 2 0 2 1 3 0 1 1 3 0 2 1 4 0 1 1 4 0 2
1 0 5 1 04 EN T R AN C E EN T R 1 0 1
Industry Expert Theater
ASTRO 2014 / 56TH ANNUAL MEETING 218 2 9 0 9 2 9 1 0 2 9 3 1 2 9 3 2 2 9 3 3 2 9 3 4 2 9 3 5
2 7 4 4
1 7 4 5 2 0 4 4 2 1 4 3 2 1 4 4 2 2 4 3 2 5 4 6 2 6 4 5 2 6 4 4 2 7 4 3 2 7 4 2 1 6 4 4 1 7 4 3 1 7 44 1 8 4 4 1 9 4 3 1 9 44 2 2 4 2 2 3 4 1 2 5 4 4 2 6 4 3 2 6 4 2 2 7 4 1
1 8 4 2 2 3 40 2 6 4 0 2 7 3 9 2 7 4 0
2 0 3 8 2 7 3 8
1 4 38 1 6 38 1 7 38 1 8 3 8 1 9 3 7 1 9 38 2 0 3 6 2 1 38 2 3 3 6 2 4 3 6 2 4 3 8 2 5 3 7 2 6 3 6 2 7 3 5 2 7 3 6
2 2 36 2 3 3 4 2 4 3 4 2 5 3 3 2 5 36 2 6 3 4 2 7 3 4
2 7 3 2
1 6 27 1 7 27 1 9 28 2 1 27 2 2 28 2 4 28 2 5 28 2 6 28 FOOD H A L L C CAFE Exhibitor Service 1 8 18 2 4 16
2 3 15 2 5 16 Center
1 8 08 1 9 08 2 3 07 2 4 08 2 5 08 2 7 09
2 8 1 0
1 7 0 3 2 2 0 4 2 3 0 3 2 6 0 3 2 8 0 8
1 5 0 1 1 5 0 2 1 6 0 1 1 6 0 2 1 7 0 1 1 7 0 2 1 8 0 1 1 8 0 2 1 9 0 1 1 9 02 2 0 02 2 1 02 2 2 0 2 2 3 0 1 2 3 02 2 4 02 2 5 0 2 2 6 0 1 2 6 02
2 8 0 4
2 7 00 R AN C E EN T R AN C E 2 8 0 0
Exhibit Exhibitor Sales Lounge Office Office
219 ASTRO 2014 / 56TH ANNUAL MEETING NOTES Visit the ASTRO Resource Center to learn about ASTRO’s newest products and services.
WE ARE LOCATED IN THE NORTH LOWER LOBBY, OUTSIDE HALL D.
2014 Survivor Circle Stop by the Survivor Circle in the Resource Center. Meet this year’s Survivor Circle Award winner and the Survivor Circle Grant recipients. Plus, don’t forget to complete your Passport for a chance to win great prizes.*
EXTENDED HOURS FOR 2014: Saturday, September 13–Tuesday, September 16: 8:00 a.m. – 5:00 p.m. Wednesday, September 17: 8:00 a.m. – 12:00 p.m.
• Learn more about APEx, ASTRO’s new practice accreditation program.
• Ask about RO-ILS: Radiation Oncology Incident Learning System – the only medical specialty society-sponsored radiation oncology incident learning system.
• Have your photo taken for your ROhub profi le in the ASTRO member directory.
• Pick up ASTRO’s new Choosing Wisely list of “Five Things Physicians and Patients Should Question.”
• Pick up new patient brochures and view new patient videos for lung, breast and prostate.
• Apply for ASTRO membership – new members will receive a special gift for joining on-site.
• Search for job openings and job seekers on the ASTRO Career Center site.
*Conference and Exhibit Hall Registrants only.
®
TARGETING CANCER CARE RecognizingThank ASTRO’s 2014 Y Corporateo Membersu .decimal Genomic Health, Inc. PTW-New York 21st Century Oncology Gold Anchor (Naslund Medical) Qfi x Acceletronics/Rad Parts Healthcare Administrative RAD Technology Medical Accuray Incorporated Partners Systems Advanced Particle Therapy Hitachi, Ltd. Radiation Business Solutions a-fabco, Inc. Hologic, Inc. Radiation Products Design, Inc. Aktina Medical Corporation IBA Radiological Imaging Alliance Oncology IntraOp Medical Corporation Technology (RIT) AMAC Iron Medical Systems, Inc. RADMAX, Ltd. Amgen, Inc. IsoAid, LLC RaySearch Laboratories, AB architection, PLLC IsoRay Medical, Inc. RC Billing Augmenix James L. Davis, Inc. Revenue Cycle, Inc. Bayer HealthCare Klarity Medical Products, LLC RK Builders, Inc. Pharmaceuticals Kobold, LLC RS&A Bionix Radiation Therapy LAP of America, LLC ScandiDos AB Boehringer Ingelheim Leoni CIA Cable Systems, S.A.S. Sensus Healthcare Pharmaceuticals MedTech Billing Services, Inc. Shandong Xinhua Medical Bogardus Medical Systems, Inc. Mevion Medical Systems Instruments, Co., Ltd. Brainlab AG Mick Radio-Nuclear Shielding Construction Bristol-Myers Squibb Instruments, Inc. Solutions, Inc. BSD Medical MIM Software, Inc. Siemens Healthcare C. R. Bard, Inc. Mirada Medical Sirtex Medical Cancer CarePoint, Inc. Mission Search Spectrum Pharmaceuticals Cianna Medical Mitsubishi Standard Imaging CivaTech Oncology, Inc. Mobius Medical Systems, LP Sun Nuclear Corporation CIVCO Medical Solutions Modus Medical Devices, Inc. SYNERGEN Health LLC CompHealth Locum Tenens NELCO The Bergendahl Institute, LLC D3 Oncology Solutions New Bedford Corporation Theragenics Corporation Diacor, Inc. Oncology Services International Vantage Oncology e+CancerCare Oncology Systems Limited Varian Medical Systems Eckert & Ziegler BEBIG, Inc. Oncure Medical Corporation Vertual, Ltd. ELEKTA ORFIT Industries America ViewRay, Inc. eMedical Strategies Philips Healthcare Vision RT Equicare Health, Inc. ProNova Solutions Weatherby Healthcare Everson Tesla Inc. ProTom International, Inc. Xoft, Inc. Gammex, Inc. Prowess, Inc. Xstrahl, Ltd.
CORPORATE MEMBER 3URWRQ7KHUDS\LQ \RXUFRPPXQLW\"
6R(DV\
With *, you bring proton therapy to your local community and enhance your cancer patients’ lives.
is the compact and affordable IMPT solution from IBA. The most advanced Proton Therapy solution, available for your clinic.
www.IBA-ProteusONE.com
* ProteusONE is the brand name of a configuration of the Proteus 235 including some new developments subject to review by competent authorities before marketing.